-j9九游会网址

��ࡱ�>�� ��@u/��������� !"#$%&'()* ,-./0123456789:;<=>?@abcdefghijklmnopqrstuvwxyz[\]^_`abcdeff/g/h/i/j/k/l/m/n/o/p/q/r/s/�����@��������������������  !"#$%&'()* ,-./0123456789:;<=>?@abcdefghijklmnopqrstuvwxyz[\]^_`abcdefghijklmnopqrstuvwxyz{|}~�root entry�������� �f�ֿ����@� workbook������������"*�etextdata����bsummaryinformation(����������������������������������������������������������������������������������������������������������������������������������������      !"#$%&'()* ,-./0123456789:;<=>?@abcdefghijklmnopqrstuvwxyz[\]^_`abcdefghijklmnopqrstuvwxyz{|}~��������������������������������������������������������������������������������������������������������������������������������      !"#$%&'()* ,-./0123456789:;<=>?@abcdefghijklmnopqrstuvwxyz[\]^_`abcdefghijklmnopqrstuvwxyz{|}~�������������������������������������������������������������������������������������������������������������������������������������������������� � �������\poareadernistrator b�a�=��=�;w!8x@�"��1����[so1����[so1����[so1����[so1�����[so1�����_o�ŗў1����_o�ŗў1�����_o�ŗў1�����_o�ŗў1�����_o�ŗў1����_o�ŗў1�����[so1�����_o�ŗў1�����_o�ŗў1����[so1����_o�ŗў1����[so1� ���[so1�>���[so1����[so1� ���[so1����[so1�8���[so1�����[so1���arial1����[so1� ���[so1����[so1h8���[so1,8���[so1�<���[so18���[so1�?���[so1�4���[so1� ���[so1�4���[so1����[so1����[so1�����_o�ŗў "��"#,##0;"��"\-#,##05"��"#,##0;[red]"��"\-#,##07"��"#,##0.00;"��"\-#,##0.00a"��"#,##0.00;[red]"��"\-#,##0.00i*2_ "��"* #,##0_ ;_ "��"* \-#,##0_ ;_ "��"* "-"_ ;_ @_ w))_ * #,##0_ ;_ * \-#,##0_ ;_ * "-"_ ;_ @_ y,:_ "��"* #,##0.00_ ;_ "��"* \-#,##0.00_ ;_ "��"* "-"??_ ;_ @_ g 1_ * #,##0.00_ ;_ * \-#,##0.00_ ;_ * "-"??_ ;_ @_ /\$#,##0_);\(\$#,##0\)9\$#,##0_);[red]\(\$#,##0\);\$#,##0.00_);\(\$#,##0.00\)e \$#,##0.00_);[red]\(\$#,##0.00\)�0.000� 0_);\(0\) �0_ �0.0000i�""��"#,##0.00_);[red]\("��"#,##0.00\);�"��"#,##0.000;"��"\-#,##0.000���� ����� ����� ����� ����� ����� ����� ����� ����� ����� ����� ����� ����� ����� ����� �� �*���� ����* ����� � / �,���� �)���� ���� ����- � ���� ���� ����� � ���� ����� ����   ���� ����� ����� ����� ����� ����p� � ���p � ���� ���� � ����$ �!����� �"���� �  �#���ff��7 ����/ ���� �$���`� ����a>� �%���* ���� ���� ����> ���� ����, ����- ���� ����9 ����$ ����. ���� ����. ����1 ����, ����1 ����5 ����3 ����4 ��� � ��� � ���� �&�� � �8� �8� �8� �8� �x� �x �x� �  � �  � �  � �  � � 8� � � �� � x@ @ � �|@ @ 5 �x@ @ 5 �|@ @ 5 �x@ @ 5 �x@ @ 5 �x@ @ 5 �|@ @ � �8@ @ � ��<@ @ � ��<@ @ � �8@ @ � �1|@ @ � �|@ @ 5 ��|@ @ 5 �|@ @ 5 �x@ @ 5 ��|@ @ 5 �<@ @ � � <@ @ � �|@ @ � �x@ @ � ��<@ @ � �1|@ @ � � 8� �8� �� �� �x@ @ � �x@ @ � �1|@ @ � �|@ @ � �|@ @  �x@ @  �x@ @  �|@ @  �x@ @  �x@ @  ��|@ @  ��|@ @  �|@ @ 5 ��|@ @ � ��|@ @ � �ax@ @ 5 �|@ @ � � |@ @ � �ax@ @ 5 �ax@ @  �!x@ @ � �8� ��� ��� �� �� � x� �x� �x1 �� �� �� �� �� �� � � �� �x@ @ � �|@ @ � �x@ @ � ��@ @ 5 ��@ @ 5 ��@ @ 5 ��@ @ 5 �|@ @ 5 �x@ @ 5 �8@ @ � ��@ @ � �x@ @ � �|@ @ � ���@ @ 5 ��@ @ 5 ��@ @ 5 ��@ @ 5 �|@ @ 5 �8@ @ � �8@ @ � �<@ @ � �|@ @ � ��@ @ 5 ��@ @ 5 �<@ @ � ��<@ @ � �x!@ @ � �8� ���@ @ 5 �� ���@ @ 5 ��� �� � � �|@ @ � ��|@ @ � �x@ @ � �x@ @ � �x@ @ � �|@ @ � ��|@ @ � �x� � |@ @ � ��|@ @ � ��|@ @ � �8@ @ � � |@ @ � ��|@ @ � �x1 � 8@ @ � � 8@ @ � �� |@ @  ||��b�2}(}j}(}s}(}t}(}u}(}v}(}w}(}x}(}z}(}�������8^ĉ����!20% - :_��ew[��r� 3�2�&�20% - :_��ew[��r� 3� ��eq�����eq�������!40% - :_��ew[��r� 3�2�'�40% - :_��ew[��r� 3��]����]����!60% - :_��ew[��r� 3�2�(�60% - :_��ew[��r� 3�������� �� �lʑ�� ��lʑ�!60% - :_��ew[��r� 2�2�$�60% - :_��ew[��r� 2� h�� 4���h�� 4� f�jt�e,g�� �f�jt�e,g� h�����h���!�ʑ'`�e,g� �5��ʑ'`�e,g� "h�� 1���h�� 1� #h�� 2���h�� 2�!$60% - :_��ew[��r� 1�2� �60% - :_��ew[��r� 1� %h�� 3���h�� 3�!&60% - :_��ew[��r� 4�2�,�60% - :_��ew[��r� 4� '���q������q� (���{������{�)�h�guscq:_��ew[��r� 6�&�1�:_��ew[��r� 6�!?40% - :_��ew[��r� 6�2�3�40% - :_��ew[��r� 6�!@60% - :_��ew[��r� 6�2�4�60% - :_��ew[��r� 6� a8^ĉ 2� b8^ĉ 3� c8^ĉ 4�d 8^ĉ_sheet1�� �pk �n�@theme/pk �n�@ theme/theme/pk�n�@ky�}�theme/theme/thememanager.xml �m � @�}�w��7c�(eb�ˮ��c�aǡҟ����7��՛k y,� �e�.���|,���h�,l����xɴ��i�sq}#ր���� ֵ �!�,�^�$j=�gw���)�e� & 8�pk�n�@�����theme/theme/theme1.xml�yoo5�#�����mv�l�m���6ц��ۢ���7����&�j�hh��� q j�ĥ|�@�_�g{fv�uhb#@�=$3����{~�\��0a�iy��wj"i��4����ai=@r�t�oi;�\�|��kxc�$!֧r��x�lcyy�0�����&\$x�����݄-��jk� �i�r��;� i�y��1��*�b&�(q�h\]z��kf�����r&�l�c����!y�it0�j�,o^[��"�ny[y�7�|]�`|�bx�ht2�����%}`j�����zi�p��v�*�f��)hv@�q�v�֬5\|���̭n��l�x�d ���zck����7���v���� ����������7����`�����kȅ�/|��>ga4�q�ylx�����d$(^�bf�!р?�h�°�)r��lp!�/м���;ʅ!��p�l���3 �1���ŷ�_���o�@h��d/?���/����o�x�[���!m�d���� �f �jnf�b �1��[i$q�5�����f؃�ׂ�����#� se=oɖ��u��z��u1�p�f~�bz��c|���ũ���4�jj}$�1q��c8u8")qh��b<�ݧա�. �|��}�:�zm2�#'��vh~��;�ٽ�:����&�.�3��c�3��s��!nx�෰�}bf"��zr��#�8ꍉ��5w�[q�m(3~��y�"��>��0�u�6?��8�|�m�*�=y!��w>�.w3d��pz���q���jp�f�h��3s��� ���sj��;�:���n[����|3ۂ�ϗ<;'*�i��u��ř����6��{2cq�z[��v��?_�o��˯��r �zw���6�x����x�8�� ԍ�[ҵ���q5s(%�!-��q�4�rp��f \}@u<�q�|�t���ige\�y� {ik�pp�$��g[c$v�|l�w�pq)��"s�-�j�e�z5' ��fu-թ�սh�<:�j�����l^���5��a�����h�y�32�v�>*ܢ�z<_��d��$���{�gu�"v�z�`���3�v���d߀�y�te�8�]�7�r��g��o�#k���rt�z͕f�b��� ���1���r���ep*a���d6y>�f�p�m�:܌x�/(�ԁlh��elc�l�!�r��ʿ��^��jt>)v�!�1)���k�dbbuuved�ξ楔o�x|�fl*�1�_�*�3�.ale�/pu��m���']�����8fy��r�s��d 7�z�`�*�n^ٍrwť�%�r ���*z?� �ձ�@��#�)� s�bylþ�������i*��6�9��m�y&��\��i���hł�=(k&�� v��.k��lduĕ�{d ������ꦚ�e��nɵ��g�(�mn5ߜjv�6����&3(��a���/e4�r;��,/�ު"zb�f5��8��w��v��="\p��ka�f!xqqc,� �����!��e�:��p[|��� l ��l�t���#h�� &m��w��j�f})m��%�.в���4vٜ��\�lc�vlm�n55x�d��ф8�ǘ/i�o^|�� �/s�� &��%0�������y��pk �n�@_rels/pk�n�@�֧�6 _rels/.rels���j�0 ���}q��%v/��c/�}�(h"���o� ������=������ ����c?�h�v=��ʌ��%[xp��{۵_�pѣ<�1�h�0���o�r�bd���je�4b$��q_����6l��r�7`�������0̞o��,�en7�li�b��/�s���e��е����pk �n�@theme/theme/_rels/pk�n�@ ѐ��'theme/theme/_rels/thememanager.xml.rels��m �0���wooӻ�&݈э���5 6?$q�� �,.�a��i����c2�1h�:�q��m��@rn��;d�`��o7�g�k(m&$r(.1�r'j��њt���8��v�"��aȼ�h�u}��|�$�b{��p����8�g/]�qasم(����#��l�[����pk�n�@ �$��[content_types].xml���n�0e�h���-j��@%�ǎǣ|�ș$�ز�u��l�tb� l,���x\���v��t�u^h�d}㨫���)��*1p�'���^ח��0)�t�9��l�#��$��>����� `?�cs]7�zb$�x��u��-lv�{9>�d�v�nj����,���5�(�bȥs��zҕhhs�0u~,}�2��to�f�0,�į�*�=댬o[g��v;� �9���'�3��3�y ; ��o�opk�n�@ �$��  [content_types].xmlpk �n�@�_rels/pk�n�@�֧�6  _rels/.relspk �n�@theme/pk �n�@ $theme/theme/pk �n�@�theme/theme/_rels/pk�n�@ ѐ��'  theme/theme/_rels/thememanager.xml.relspk�n�@����� theme/theme/theme1.xmlpk�n�@ky�}� ntheme/theme/thememanager.xmlpk ?; ��`�y�o�hqh���^-nbo�hqh����vv���4"�!  ;��!  ;k �� ol�v$)y%m^�wg�l��]�w,g;s�u�oi�0�]$o�oi��tu���oi�o��t�vu__ t�^2016t^hridr{| �s-n�e t�y�e t�yfu�t tbr �wĉ y :s�yr�u/e�n��^�uo��t,gmox1 �b�_uiro�ir 1.1 �bu }{|o�ir 1.1.1 ��qp���{|o�ir1.1.1.1 r� � }{|o�ir1.1.1.1.1 �z1�)y6qr� � }{|o�ir2u{|2ur� � }benzylpenicillin�l\breilm�l\(ur� � }��%benzylpenicillin sodium for injection 0.48g(80nusmo)�s�t�t�to�ɩ�v6ro�;`�s �vo��qw[h23021439 30786903712001412 2.4g(400nusmo) �vo��qw[h2302093086903712000439�wo�ɩ�v-n��o�n��w�[�^ � gp�lq�s �vo��qw[h13021634^�>y:s86902777000569 0.96g(160nusmo) �vo��qw[h2302144186903712001337 0.96g�160nusmo � nss6ro����n gp�lq�s �vo��qw[h1302065586902690000714 �vo��qw[h1302163286902777001108 4.8g(800nusmo) �vo��qw[h2002373786903712004024 �vo��qw[h2001303686902692000224�ẽ�|�� q\n���b;so����n gp�lq�s �vo��qw[h2003394686904129001460 �vo��qw[h1302065786902690000332 �vo��qw[h3702007986904129000708 �vo��qw[h3702008086904129000821 �vo��qw[h1302065686902690000691 �vo��qw[h1999362286902777001375r� � }vphenoxymethylpenicillin �s g8^ʑbr�w ���|brr� � }v��gr phenoxymethylpenicillin potassium tabletsgrbr 0.236g�40nusmo � �vo��qw[h2005649286903712002105)phenoxymethylpenicillin potassium tablets 0.236g(40nusmo) �vo��qw[h1302271586902690000769 0.472g(80nusmo) �vo��qw[h2002375986902690000950penicillin v potassium tablets0.25g sandoz gmbh h20091039869788070001370.236g(40nusmo)( cc16h18n2o5s��)0 ym_l�n*yo�n���n gp�lq�s �vo��qw[h20073700869047440008860.236g(40nusmo)( cc16h18n2o5s��)30�vo�ɩ�vul4yё�w6ro� gp�lq�s �vo��qw[h20053249no�no�ǒɩ86900480000913yn{|ynăfr� � }benzathine benzylpenicillin�l\(uăfr� � })benzathine benzylpenicillin for injection120nusmo �vo��qw[h2004472786902692000118�wo�ɩ�v-n��o�n(�w�[�^) gp�lq�s �vo��qw[h2003329186902777001580nf��as�vr� � }procaine benzylpenicillin�u��g oxacillin�l\(u�u��g��oxacillin sodium for injection0.5g( cc19h19n3o5s��) �vo��qw[h1302126886902777000828^t3�6ro� gp�lq�s �vo��qw[h3702194786904152001024/lu��g cloxacillin�l\(u/lu��g�� cloxacillin sodium for injection1.5g( cc19h18cln3o5s���{) wmws�(u n mo�n gp�lq�s �vo��qw[h20043383869058210001951.0g( cc19h18cln3o5s���{) �vo��qw[h20054872869041290011490.5g( cc19h18cln3o5s) �vo��qw[h1302127386902777001023 �vo��qw[h20033640869027770011600.5g( cc19h18cln3o5s���{) �vo��qw[h20043146869058210010622.0g( cc19h18cln3o5s���{) �vo��qw[h20043767869058210009350.5g( cc19h18c1n3o5s��) �v�]6ro�6rbr gp�lq�s �vo��qw[h2002340986902297000742&(5)�s g8^ʑbr�w�u��g�����voxacillin sodium capsules���vbr �vo��qw[h5102239586902297000056� y��g nafcillin&(6.1)1.1.1.1.3 ^1�(lăr� � }{|o�ir?�����g amoxicillin?�����g���vamoxicillin capsules0.125g( cc16h19n3o5s��) �vo��qw[h37021925869041520000650.25g( cc16h19n3o5s��) �vo��qw[h1302072686902699000043�v(��g0.5g( cc16h19n3o5s��) �vo��qw[h2004460586903712000088 �vo��qw[h2302093286903712000064?�yr�~�e([oq\)6ro� gp�lq�s �vo��qw[h4402120386900567000058^�]}v�nq\6ro����n gp�lq�s^�]}v�nq\6ro�;`�s �vo��qw[h2006745086900381000029�swmt���6ro����n gp�lq�s-nq\rlq�s �vo��qw[h200032638690060000006920 )y%m*ys^ m6ro� gp�lq�s �vo��qw[h1202080786900931000011 �vo��qw[h1302396486902777000019 �vo��qw[h4402135186900600000083 �vo��qw[h1999303486904129000074 ff�kq���6ro� gp�lq�s �vo��qw[h5302188086905580000030?�����grcegramoxicillin dispersible tablets �vo��qw[h10980075869027770000710.25g( cc16h19n3o5s���{) �vo��qw[h1999102886902699000036 �vo��qw[h2004651086902777000125 �vo��qw[h2004641686902699000111?�����ggramoxicillin tablets �vo��qw[h1302072886902699000098 wm�s^6ro��s gp�lq�s �vo��qw[h2008342086905758001333amoxicillin tablets �vo��qw[h2302094186903712000026(lă��g ampicillin�l\(u(lă��g��ampicillin sodium for injection0.5g( cc16h19n3o4s��) �vo��qw[h13021627869027770011461.0g( cc16h19n3o4s��) �vo��qw[h1302162886902777000446ampicllin sodium for injection �vo��qw[h2302092686903712000781 �vo��qw[h19993033869041290010712g( cc16h19n3o4s��) �vo��qw[h2002372086903712000941 �vo��qw[h13020653869026900005851g( cc16h19n3o4s��) �vo��qw[h1302065286902690000707 �vo��qw[h1999303286904129000630&(7) �s g�msobr ���|br p�?q�z�st�t�v���?�����g���|amoxicillin granules���|br �vo��qw[h2302265786903712000033?�����gr^�m�`bramoxicillin for suspensionr^�m�`br �vo��qw[h5302182086905580000016?����n0.125g/s t���6ro��s gp�lq�s hc2009003086979053000117 �vo��qw[h37023129869041290000981.5g� cc16h19n3o5s�� � ��k�tň30g0)y%m^?q�zo��s �vo��qw[h12021253869009000000280.125g� cc16h19n3o5s�� � �vo��qw[h12021195869009310000350.125g( cc16h19n3o5s���{) �vo��qw[h4402497086900600000052�n(l��g lenampicillin�vx��n(l��ggr#lenampicillin hydrochloride tablets�s#k0.25g( cc16h19n3o4s��) �vo��qw[h< 20040328869041290002101.1.1.1.4 ^1��bgp�~ܔusހ̃r� � }{|o�ir�t�b��g piperacillin�l\(u�t�b��g��!piperacillin sodium for injection0.5g( cc23h27n5o7s��)p���6ro� gp�lq�s �vo��qw[h37020555869040210002331.0g( cc23h27n5o7s��) �vo��qw[h37020553869040210009674.0g( cc23h27n5o7s��) �vo��qw[h2000323586904152000676 �vo��qw[h1999303086904129000852 �vo��qw[h1999303186904129000654?�m��g azlocillin�l\(u?�m��g��azlocillin sodium for injection1.0g( cc20h23n5o6s��) �vo��qw[h20044479�x�n5%869058210002182.0g( cc20h23n5o6s��) �vo��qw[h2004448086905821000225 �vo��qw[h20056373869026900001340.5g� cc20h23n5o6s���{ � �vo��qw[h20057716869041520012911.0g� cc20h23n5o6s���{ � �vo��qw[h20057717869041520014202.0g� cc20h23n5o6s���{ � �vo��qw[h2005771886904152002687azlocillin sodium for lnjection �vo��qw[h20056300869041290004252.0g( cc20h24n5o6s���{) �vo��qw[h20058949869022970000701.0g� cc20h23n506s���{ � )y%mns%m6ro� gp�lq�s �vo��qw[h20063321869008670006282.0g� cc20h23n506s���{ � �vo��qw[h2006332286900867000635?�pn#kym_lёns�^i`�uir6ro� gp�lq�s �vo��qw[h1096015086904656001056 �vo��qw[h1096015186904656001070 �vo��qw[h1096015286904656001087�xă��g sulbenicillin�m��g mezlocillin�l\(u�m��g�� mezlocillin sodium for injection2.0g( cc21h25n5o8s2���{) wm�sgy�r6ro����n gp�lq�s �vo��qw[h20046344869057550007971.0g( cc21h25n5o8s2���{) �vo��qw[h2004358786905821000706 �vo��qw[h2004358886905821000201 �vo��qw[h20054414869026900003942.0g� cc21h25n5o8s2�� � _lςwm�[6ro� gp�lq�s �vo��qw[h20067999869014400001032.5g� cc21h25n5o8s2�� � �vo��qw[h20068000869014400001101.0g(�nc21h24n5o8s2 ��) �vo��qw[h2005345286904021001704�l\(u�ẽ�| g0.5g( cc21h25n5o8s2 ��) �vo��qw[h2005577286904129000401�rlb�qr^�|��0.5g( cc21h25n5o8s2��) �vo��qw[h10960073869041520007511.0g( cc21h25n5o8s2��) �vo��qw[h10960074869041520011231.5g( cc21h25n5o8s2��) �vo��qw[h20043913869041520033632.0g( cc21h25n5o8s2��) �vo��qw[h2004391186904152001857q\��n�n;so�ɩ�v���n gp�lq�s �vo��qw[h1402378286902954001587 �vo��qw[h20043655869029540025770.5g( cc21h25n5o8s2���{) �vo��qw[h2004470886902777002143 �vo��qw[h2005314086900867000581�|��br3.0g( cc21h25n5o8s2��) �vo��qw[h20043912869041520018644.0g( cc21h25n5o8s2��)1 �vo��qw[h20043910869041520018401.1.1.1.5 ��qp���v��b6ro�ir�s y�er� � }6rbr?�����gkq�b�~x�amoxicillin and clavulanate ?�����gkq�b�~x���gr-amoxicillin and clavulanate potassium tablets(0.375g(c16h19n3o5s 0.25gnc8h9no5 0.125g) �vo��qw[h1999405686900600000038&0.375g(c16h19n3o5s0.25gnc8h9no50.125g) ��ws�yr6ro� gp�lq�s �vo��qw[h2005342486904010000022�[mp̃ �vo��qw[h1092003486902690000042?�����gkq�b�~x���gr(4:1)����c�gr0.3125g(?�����g0.25g�tkq�b�~x�0.0625g) q\� t��o�n gp�lq�s �vo��qw[h2006368486902927000067�[gy0.3125g�?�����g0.25g �kq�b�~x�62.5mg � ws�nhq�xncq6ro� gp�lq�s �vo��qw[h1095026686901594000066%0.457g(c16h19n3o5s0.4gnc8h9no50.057g) �vo��qw[h2001077286900600000076 ?�����gkq�b�~x���rcegr9amoxicillin and clavulanate potassium dispersible tabletsrcegr*156.25mg�c16h19n3o5s 125mgnc8h9no531.25mg � �vo��qw[h2005390586904744000053 �vo��qw[h2004111486900381000012�r~v@l 0.5g:0.125gsmithkline beecham plc h2011052886978275000233?�����gkq�b�~x���rcegr(7:1)=amoxicillin and clavulanate potassium(7:1)dispersible tablets��5� ws�nたr6ro����n gp�lq�s �vo��qw[h2001073886901556000028?�����gkq�b�~x���rcegr�2:1 �>amoxicillin and clavulanate potassium dispersible tablets�26"1 �$\�g�r)187.5mg�c16h19n305s 125mgnc8h9no5 62.5mg � #w'y� _�[�s �o�n gp�lq�s �vo��qw[h2004120186902825000060 ?�����gkq�b�~x�rcegr 156.25mg�c16h19n305s 125mgnc8h9no5 31.25mg � �vo��qw[h2004122386902825000077?�����gkq�b�~x���(4:1)rcegr=amoxicillin and clavulanate potassium(4:1)dispersible tabletszs�#k*156.25mg(c16h19n3o5s125mg�tc8h9no5 31.25mg)no�ɩ�v�l3��e�_o�n gp�lq�s �vo��qw[h2000072086901317000014?�����gkq�b�~x���(7:1)rcegr?amoxicillin and clavulanate potassium �7:1 � dispersible tablets܀~�'228.5mg(c16h19n3o5s200mgnc8h9no528.5mg � �vo��qw[h2004162186903712000071?�����gkq�b�~x������v(4:1)3amoxicillin and clavulanate potassium capsules(4:1)�]�l 156.25mg(c16h19n3o5s 125mgnc8h9no5 31.25mg) ym_l�]�lo�n gp�lq�s �vo��qw[h2003019086904667000017&(13)p�͑�^a�g �l\(u?�����g��kq�b�~x���:amoxicillin sodium and clavulanate potassium for injection!1.2g(c16h19n3o5s 1gnc8h9no5 0.2g) �vo��qw[h2001318786904152001222#0.6g(c16h19n3o5s 0.5gnc8h9no5 0.1g) �vo��qw[h2005639586903712002037#1.2g(c16h19n3o5s 1.0gnc8h9no5 0.2g) �vo��qw[h20023834869037120034471.2g(c16h19n3o5s1gnc8h9no50.2g) �vo��qw[h2005415986904010000312 �vo��qw[h2002301886904129000579 �vo��qw[h2002321286902777002310 �vo��qw[h2005883386900600000373< �vo��qw[h20058966869006000003800.3g� t?�����g0.25g,kq�b�~x�0.05g �^�]}v�nq\)y�_6ro����n gp�lq�s �vo��qw[h2003412886900377000286%0.3g(c16h19n3o5s 0.25gnc8h9no5 0.05g) �vo��qw[h2005631086903712003645"0.6g(c16h19n3o5s0.5gnc8h9no5 0.1g) vnws�y&o6ro� gp�lq�s �vo��qw[h2002347286905006001115 �vo��qw[h2001342786905006001252 �vo��qw[h19993044869041290007531.2g� t?�����g��1gnkq�b�~x���0.2g � �vo��qw[h2004335786900867000710͑�^�y�[o�nɩ�v�^yox6ro� gp�lq�s �vo��qw[h2006732786901041000335 ?�����gkq�b�~x������|.amoxicillin and clavulanate potassium granules 156.25mg�?�����g0.125g �kq�b�~x�31.25mg � �vo��qw[h1095024486901594000059 ?�����gkq�b�~x���r^�m�`br4amoxicillin and clavulanate potassium for suspension)228.5mg(c16h19n3o5s 200mgnc8h9no5 28.5mg) �vo��qw[h2004110986900381000036?�����gkq�b�~x���r^�m�`br(7:1)�s g�m�`br �vo��qw[h2001069486901556000011?�����gkq�b�~x����14:1 �r^�m�`br�n)r��)0.6429g(c16h19n3o5s 0.6gnc8h9no5 0.0429g) nwmwmy��[n(ɩ�v)�]vn�n��o�n gp�lq�s �vo��qw[h20051654869044340000355ml( t?�����g400mg,kq�b�~x�57mg)smithkline beecham limited h2010076186978469000223 �vo��qw[h2001077386900600000106?�����g��]fwamoxicillin and sulbactam �l\(u?�����g����]fw��5amoxicillin sodium and sulbactam sodium for injection�ꏗg1.5g�?�����g1.0gn��]fw0.5g �ns6ro�ɩ�v�l3�,{n6ro� gp�lq�s �vo��qw[h2003118286901161002882�(��g%0.75g(c16h19n3o5s0.5g �c8h11no5s0.25g) �vo��qw[h20030611869037120020061.5g(?�����g1.0g,��]fw0.5g) �vo��qw[h2002001686903712003256 p��g �vo��qw[h2003028086902692000026yr�yslaboratorios bago s.a. h20130529869793170000680.375g�?�����g0.25gn��]fw0.125g � �vo��qw[h2005114386903712003317 �vo��qw[h2004029486902692000392&(14)?�����gl/l��gamoxicillin and flucloxacillinp�?q�z͑�^a�g �l\(u?�����g��l/l��g��:amoxicillin sodium and flucloxacillin sodium for injectionf�g0.5g�?�����g0.25gnl/l��g0.25g � q\�/cn�l�v6ro� gp�lq�s �vo��qw[h20050164869029460021891.0g(?�����g0.5gnl/l��g0.5g) �vo��qw[h20060097869029460004442g(?�����g1gnl/l��g1g) �vo��qw[h2006009686902946000307_z0.5g� tl/l��g0.25gn?�����g0.25g � �vo��qw[h20052084869008670006591.0g� tl/l��g0.5gn?�����g0.5g � �vo��qw[h2005208586900867000642(lă��g��]fwampicillin and sulbactam �l\(u(lă��g����]fw��4ampicillin sodium and sulbactam sodium for lnjection3g� t(lă��g2.0g, ��]fw1.0g � �vo��qw[h20043038869003770002240ampicillin sodium/sulbactam sodium for injection�qpq#k%0.75g(0.5gc16h19n3o4sn0.25gc8h11no5s) �vo��qw[h1096010986903712001030 2.25g(2:1) �vo��qw[h2005750986903712003386$1.50g(1.0gc16h19n3o4sn0.5gc8h11no5s) �vo��qw[h10960110869037120039663.0g�(lă��g2.0gn��]fw1.0g � �vo��qw[h20033396869037120019934ampicillin sodium and sulbactam sodium for injection'0.75g(c16h19n3o4s 0.5gnc8h11no5s 0.25g) �vo��qw[h1999364886904152000669 �vo��qw[h2001302286904129000593&1.50g(c16h19n3o4s 1.0gnc8h11no5s 0.5g) �vo��qw[h20054910869041290003024ampicillin sodium and sulbactam sodium for injectoin �vo��qw[h2002387786902777000644o�z�ehaupt pharma latina s.r.l. h2010070786978720000566%1.5g(c16h19n3o4s 1.0gnc8h11no5s 0.5g) �vo��qw[h2005872786900600000359�m��g��]fwmezlocillin and sulbactam �l\(u�m��g����]fw��5mezlocillin sodium and sulbactam sodium for injection_�g0.625g(�m��g��0.5gn��]fw��0.125g) �vo��qw[h2005202086904152003103(1.25g(c21h25n5o8s2 1.0gnc8h11no5s 0.25g) �vo��qw[h20030072869041520025575mezlocillin sodium and sulbactam sodium for injection�q��s&1.25g(c21h25n5o8s21.0gnc8h11no5s0.25g) �vo��qw[h2001082086905821000133'2.5g(c21h25n5o8s2 2.0gnc8h11no5s 0.50g) �vo��qw[h2003007386904152002564�l\(u�m��g����]fw��(4:1)5mezlocillin sodium and sulbactam sodium for injectionsomfw �vo��qw[h2003121486902954000641&3.75g(c21h25n5o8s23.0gnc8h11no5s0.75g) �vo��qw[h2004099186904152001833 �vo��qw[h2003034486905821000324�t�b��g��]fwpiperacillin and sulbactam �l\(u�t�b��g����]fw��6piperacillin sodium and sulbactam sodium for injectionnt2.5g( t�t�b��g2.0g,��]fw0.5g) ns�m�sd�o�n���n gp�lq�s �vo��qw[h2004029286900144004523�l\(u�t�b��g����]fw��(4:1)<piperacillin sodium and sulbactam sodium for injection(4:1)�vfw1.25g(�t�b��g1gn��]fw��0.25g) �vo��qw[h2005170586903712002167;piperacillin sodium and sulbactam sodium for injection�4:1 �2.5g(�t�b��g2.0g,��]fw0.5g) �vo��qw[h2005117886903712003331;piperacillin sodium and sulbactam sodium for injection�4�1 �~v�[1.25g� t�t�b��g1.0gn��]fw0.25g � �vo��qw[h2005033886904152000607>m�~1.25g��t�b��g1.0gn��]fw0.25g  nwm�e�no�n gp�lq�s �vo��qw[h20052026869007920017692.5g� t�t�b��g2.0gn��]fw0.5g �vo��qw[h2005202786900792001776�l\(u�t�b��g����]fw��(2:1);piperacillin sodium and sulbactam sod< ium for injection(2:1)1.5g( t�t�b��g1.0gn��]fw0.5g) xnsz\�f6ro����n gp�lq�s �vo��qw[h20051606869050250002813.0g( t�t�b��g2.0gn��]fw1.0g) �vo��qw[h2005160786905025000762�t�b��g�nu�]fw ��t�b��g nu�]fw �piperacillin and tazobactam �l\(u�t�b��g���nu�]fw��8piperacillin sodium and tazobactarn sodium for injection ��lup'2.25g(c23h27n5o7s2.0gnc10h12n4o5s0.25g) �vo��qw[h1999017986900792000526%4.5g(c23h27n5o7s4.0gnc10h12n4o5s0.5g) �vo��qw[h20030234869007920011417piperacillin sodium and tazobactam sodium for injection�^�_�r ym_lwm�ru6ro� gp�lq�s �vo��qw[h1999019086904636000161 0.5625g(c23h27n5o7s0.5gnc10h12n4o5s0.0625g) �vo��qw[h2007358386905821000560yr�lf4.5g��t�b��g4.0gn�nu�]fw0.5g �!wyeth lederle spa�rsňon��`l6ro� gp�lq�s � �vo��qw[j20110021�x�n10%86979476000039����1.125g( t�t�b��g1.0gn�nu�]fw0.125g) p���)y�t�`n6ro� gp�lq�s �vo��qw[h1999018286904021000851.0.5625g( tc23h27n5o7s 0.5g�tc10h12n4o5s 0.0625g) �vo��qw[h2007360086904152003585 1.125g(c23h27n5o7s 1.0gnc10h12n4o5s 0.125g) �vo��qw[h2007360186904152000546)2.25g(c23h27n5o7s 2.0gnc10h12n4o5s 0.25g) �vo��qw[h2007360286904152000522,1.125g( tc23h27n5o7s 1.0gnc10h12n4o5s 0.125g) �vo��qw[h2008322886904129001514*2.25g( tc23h27n5o7s 2.0gnc10h12n4o5s 0.25g) �vo��qw[h20083229869041290015211.125g( t�t�b��g1g,�nu�]fw0.125g) �vo��qw[h20045800869027770017952.25g( t�t�b��g2g,�nu�]fw0.25g) �vo��qw[h2004579986902777002105 �vo��qw[h2005430786900600000328'4.5g(c23h27n5o7s 4.0gnc10h12n4o5s 0.5g) �vo��qw[h2005430686900600000311��]fw sutbactam�l\(u��]fw��sulbactam sodium for injection0.5g( cc8h11no5s��) �vo��qw[h2005571886904152003059�fas��gkq�b�~x�ticarcillin and clavulanate �l\(u�fas��g��kq�b�~x���<ticarcillin disodium and potassium clavulanate for injection$3.2g(c15h16n2o6s2 3.0g,c8h9no5 0.2g) �vo��qw[h2006368686900377002228<ticarcillin disodium and clavulanate potassium for injection"1.6g�c15h16n2o5s21.5gnc2h9no50.1g � wmwswmupsf[6ro� gp�lq�s �vo��qw[h2005772786905776000998"3.2g(c15h16n2o6s23.0gnc8h9no50.2g) �vo��qw[h2005772886905776001001$1.6g(c15h16n2o6s2 1.5gnc8h9no5 0.1g) �vo��qw[h2006430486904129001170%3.2g (c15h16n2o6s2 3.0gnc8h9no5 0.2g) �vo��qw[h2006430586904129000166 �vo��qw[h2006685386900600000557$3.2g(c15h16n2o6s2 3.0gnc8h9no5 0.2g) �vo��qw[h2006685486900600000540=ticarcillin disodium and clavulanate potassium for injection1.6g�(�fas��g1.5g�tkq�b�~x�0.1g) �vo��qw[h20059337869041520017103.2g��fas��g3.0g�tkq�b�~x�0.2g � �vo��qw[h20059338869041520017271.1.1.2 4yb[̃ }{|o�ir1.1.1.2.1 ,{n�n4yb[̃ }{|o�ir1.1.1.2.1.1 �s g(u4yb[(lă cefalexin4yb[(lăgrcefalexin tablets0.125g( cc16h17n3o4s��)qx�e�ts�n-n�e6ro��s �vo��qw[h11020352869002220002180.25g� cc16h17n304s���{ � �vo��qw[h1999303886904129000692 �vo��qw[h1202043686900867001120 �vo��qw[h23020942869037120006680.25g� cc16h17n3o4s�� � �vo��qw[h1202081486900931000882 )y%m^-n.yo�n gp�lq�s �vo��qw[h12020056869009280007034yb[(lă���vcefalexin capsules �vo��qw[h19993037869041290005170.25g( cc16h17n3o4s���{) q\nw#ko�n���n gp�lq�s �vo��qw[h2005874086904141001622 �vo��qw[h44023209869003810013090.125g( cc16h17n3o4s ��) �vo��qw[h1202081386900931000752 lbp[_lo�nɩ�v gp�lq�s �vo��qw[h3202098686901749000934 �vo��qw[h2302093686903712000736 �vo��qw[h19993036869041290009060.25g( cc16h17n3o4s��) �vo��qw[h23020935869037120007294yb[(lă���|cefalexin granules �vo��qw[h12020795869009310007140.125g( cc16h17n3o4s���{) �vo��qw[h3702058586904129001057 ꏙlo�nɩ�v gp�lq�s �vo��qw[h37021248869039440002074yb[�b�[ cefradine �s g8^ʑbr�w0���|br���|brp�?q�z4yb[�b�[���vcefradine capsules �vo��qw[h23020938869037120007500.25g� cc16h19n3o4s �� � �vo��qw[h1202081586900931000691��b �vo��qw[h3202098486901749001139cephradine, velosef�lwc y ^�pvc�� �s�{�s^x -n� nwm�e5��[6ro� gp�lq�s �vo��qw[h310200018690084200018624 �vo��qw[h4402234886900377001689 �vo��qw[h4302221586905006000262 �vo��qw[h200588448690414100022912 q\n�ens6ro����n gp�lq�s �vo��qw[h3702070686904187002362lx���v ς�]-nso��t�]n gp�lq�s �vo��qw[h3202119186901679000424 �vo��qw[h20003027869041290006614yb[�b�[���|cefradine granules0.125g �vo��qw[h44021526p�?q�z86900381001880cefradine granules �vo��qw[h12020796869009310008374yb[�(lă cefadroxil4yb[�(lă���vcefadroxil capsules0.125g( cc16h17n3o5s���{) �vo��qw[h20063974869041410003280.25g� cc16h17n305s���{ � �vo��qw[h12020452869008670014720.5g( cc16h17n3o5s���{) �vo��qw[h20063976869041410017140.25g( cc16h17n3o5s��) �vo��qw[h2302198686903712001481'ka �wo�ɩ�v'kao�n gp�lq�s �vo��qw[h13020793869027700008014yb[�(lăgrcefadroxil tablets �vo��qw[h2001334886902770001631 �vo��qw[h20023450869027700< 016624yb[�(lărcegrcefadroxil dispersible tablets[� y�un�v�y�b���n gp�lq�s6ro�n�s �vo��qw[h20010123869023420000554yb[�(lă���|cefadroxil granules�k��ň6g� cc16h17n3o5s��0.125g � �vo��qw[h10960160869027700009790.125g( cc16h17n3o5s��) �vo��qw[h20053103869041410009391.1.1.2.1.2 �l\(u4yb[u�g cefazolin�l\(u4yb[u�g��cefazolin sodium for injection0.5g( cc14h14n8o4s3��) �vo��qw[h13021636869027770005451g( cc14h14n8o4s3��) �vo��qw[h2002369186904129000562 �vo��qw[h2302094686903712000682 �vo��qw[h2302094586903712000408 �vo��qw[h13020765869027770007292.0g( cc14h14n8o4s3���{) �vo��qw[h2002347486903712000866 �vo��qw[h2004519486904744000831 �vo��qw[h1999305086904129000616nss6ro��lsnslo�n gp�#��nlq�s �vo��qw[h20054715869026900004932.0g( cc14h14n8o4s3��) ul4yё�w�|��br gp�lq�s �vo��qw[h2000377886900478000109&(22)�l\(u4yb[�b�[cefradine for injection _\k�/n6ro� gp�lq�s �vo��qw[h2004305086903009000135 �vo��qw[h2302144486903712001436 �vo��qw[h23023428869037120012522.0g( cc16h19n3o4s��) �vo��qw[h2002373686903712004062cefradine for injettion �vo��qw[h1302066286902690000622 �vo��qw[h1302066186902690000653 �vo��qw[h3702055886904021001001 �vo��qw[h2001302986904021000424 �vo��qw[h2000301586904129000487 �vo��qw[h2000301686904129000838 �vo��qw[h1302128186902777000927 �vo��qw[h44021353869006000008854yb[kx�cephathiamidinep��n�~(uo��l\(u4yb[kx�cefathiamidine for injection0.5g( cc19h28n4o6s2��) �vo��qw[h20058159p�?q�z�n�~(uo�86904141000212 �vo��qw[h20065433869029460013971.0g( cc19h28n4o6s2��)0 �vo��qw[h2004411986900381000296 �vo��qw[h20058160869041410019502.0g( cc19h28n4o6s2��)0 �vo��qw[h20065435869029460022024yb[�fu ceftezole�l\(u4yb[�fu��ceftezole sodium for injection�v�f#k 0.5g(�n4yb[�fu��) �vo��qw[h2002059186903712000958 1.0g(�n4yb[�fu��) �vo��qw[h2002059286903712000989 2.0g(�n4yb[�fu��) �vo��qw[h2004024086903712001979yrp[>y y )y%m�e0n6ro� gp�lq�s �vo��qw[h2002070286900949000041 �vo��qw[h2002070386900949000034 �vo��qw[h2004009986900949000133 �vo��qw[h2007401986904141002087�e0n6ro�*h_o>y�)y%m�e0n6ro� gp�lq�srsň � �vo��qw[j2015009586900949000270 �vo��qw[j2010010986979156000472 �vo��qw[h2007401686904141002094 �vo��qw[h2008442786902777002976 �vo��qw[h2008442886902777002983 0.75g(�n4yb[�fu��) �vo��qw[h2004009786900949000119 1.5g(�n4yb[�fu��) �vo��qw[h20040098869009490001264yb[�n� p��]$o�oi��say$o�[�l\(u4yb[�n���cefazedone sodium for injection��>y y0.5g( c4yb[�n�c18h15cl2n5o5s3���{) �vo��qw[j20110010869791560005401.0g( c4yb[�n�c18h15cl2n5o5s3���{) �vo��qw[j20110009869791560005571.1.1.2.2 ,{�n�n4yb[̃ }{|o�ir1.1.1.2.2.1 �s g(u4yb[kt�� cefuroxime4yb[kt��o�grcefuroxime axetil tablets^tkt#k0.125g( cc16h16n4o8s��) �vo��qw[h2004187986902699000555�sio�[0.25( cc16h16n4o8s���{) �vo��qw[h2002019286900377001108opn�e0.5g( cc16h16n4o8s��) �vo��qw[h2004044186901679000837�]#k b�� pyro�n gp�lq�s �vo��qw[h2001002586902013000506 ^��oul4yё�w6ro�;`�s �vo��qw[h19990234869004800005244yb[kt��o�rcegr%cefuroxime axetil dispersible tablets�^#k q\n�mzs�e��6ro� gp�lq�s �vo��qw[h2003089086904203000143 �vo��qw[h2001009686900600000687cefuroxime axetil tablets��r#kglaxo wellcome uk limited h2013034386978462000589 �vo��qw[h1999034186901679000202���r�e �m3w�t6ro� gp�lq�s �vo��qw[h2001011686900555000466cefuroxime axetil tablets �vo��qw[h20094023869027700038020.25g( cc16h16n4o8s��) �vo��qw[h2000040086900555000633 �vo��qw[h19990342869016790002644yb[kt��o����vcefuroxime axetil capsules �vo��qw[h2000040186900555000725�zep�e0.125g( cc16h16n4o8s���{) �m3w�zepo�n gp�lq�s �vo��qw[h2004112386900513000019 �vo��qw[h1999025186900480000326os���o ^�]ws�e6ro� gp�lq�s �vo��qw[h20030854869004070000644yb[n�p cefprozil4yb[n�prcegrcefprozil dispersible tablets���r� 0.25g(�n4yb[n�p��) �vo��qw[h20052514869003810009204yb[n�p���vcefprozil capsules^�]}v�nq\iqns6ro����n gp�lq�s �vo��qw[h20060492869003720002430.25g� cc18h19n3o5s�� � �vo��qw[h20080310869040210028314yb[n�pgrcefprozil tablets �vo��qw[h2006124686901749000156 ^�� ws�n�nnso�n gp�lq�s �vo��qw[h2004196086901604000093�e ywc �vo��qw[h1999029386900842000148  nwm�o6ro� gp�lq�s �vo��qw[h20083387869007270005914yb[kqmcefaclor�s g8^ʑbr�w ʑ�cʑbr�w ���|br0�s g�msobr�s g�msobrp�?q�z4yb[kqm���vcefaclor capsules0.25g( cc15h14cln3o4s��) �vo��qw[h20034090869004070003090.5g �vo��qw[h2004605686901679000820 ff�kq���6ro� gp�lq�s0 �vo��qw[h5302194286905580000276 �vo��qw[h2003359986901679000455cefaclor capsules �vo��qw[h2007370486902699002719 ^;r�r mz#k2.5g ym_l8l�[o�n���n gp�lq�s �vo��qw[h20041452869047510009473.0g �vo��qw[h20055024869003770003923.0g( cc16h16n4o8s��) �vo��qw[h2003023886900555000282�o�z#k �m3w�o�z�lo�n���n gp�lq�s �vo��qw[h20030540869005530000311.5g( cc16h16n4o8s��) �vo��qw[h1999000586900555000701 �vo��qw[h20063773869027770024264yb[�u cefmetazole�l\(u4yb[�u�� cefmetazole sodium for injection 0.5g( c4yb[�u���{) �y�^w�y�bo�n���n gp�lq�s �vo��qw[h2005240386904791000600 ^nns�mz��\o�n gp�lq�s �vo��qw[h2006059386900340000572ȏ�rnf0.5g( cc15h17n7o5s3��)'y�q6ro�*h_o>y h20110338869789950002541.0g� cc15h17n7o5s3���{ � �vo��qw[j2010006586979156000410hq ���n��1g,{n nqqnfpn�s*h_o>ys^zx�]�s h2009032886979008000186 0.25g( c4yb[�u��) �v�]t�oo�n gp�#��nlq�s �vo��qw[h2007002486902156000036�`eu 1.0g( c4yb[�u��) �vo��qw[h2005206986902156000166 2.0g( c4yb[�u��) �vo��qw[h2007002586902156000029 0.5g��n4yb[�u�� � �vo��qw[h20070240869037120032634yb[�f�[cefotiam �l\(u�vx�4yb[�f�[$cefotiam hydrochloride for injection(�pq#k0.5g( cc18h23n9o4s3��) �vo��qw[h2004146886903712003577iow#k1.0g( cc18h23n9o4s3��) �vo��qw[h2004146986903712002686wm�f�daewon pharm.co.,ltd. h2010067186978352000033 y�n�[0.5g� cc18h23n9o4s3���{ �hanmi pharm. co.,ltd. h20130714869790310011431.0g� cc18h23n9o4s3���{ � h2013071386979031001136 ��f�e 0.25g� c4yb[�f�[�� � �vo��qw[h2006098786900792001301#cefotiam hydrochoride for injection0.5g( c4yb[�f�[c18h23n9o4s3��) �vo��qw[h20056344869007920014311.0g( c4yb[�f�[c18h23n9o4s3��) �vo��qw[h20020399869007920020014yb[�n cefoxitin�l\(u4yb[�n��cefoxitin sodium for injection0.5g( cc16h17n3o7s2��) �[�_whq �6ro� gp�lq�s �vo��qw[h20073668869043390001852.0g( cc16h17n3o7s2���{) �vo��qw[h2006328186900377002242�vn#k1.0g( cc16h17n3o7s2���{) �vo��qw[h2005932686903712002068 �vo��qw[h2006790886905758001111 1.0g(�n4yb[�n��) �vo��qw[h20056973869026900001101.0g� cc16h17n3o7s2�� � �vo��qw[h20063481869041520017892.0g� cc16h17n3o7s2�� � �vo��qw[h2006348286904152003332 �vo��qw[h2006508086904129001385 1.0g( c4yb[�n��) �vo��qw[h2005750386900553000246 2.0g( c4yb[�n��) �vo��qw[h20057504869005530002390.5g( cc16h17n3o7s2���{) �vo��qw[h20083490869005550009162.0g( cc16h17n307s2���{) �vo��qw[h20063747869005550000771.0( cc16h17n307s2���{) �vo��qw[h2005557086900555000039 �vo��qw[h20057973869017490001321.1.1.2.3 ,{ n�n4yb[̃ }{|o�ir1.1.1.2.3.1 �s g(u4yb[0w<\cefdinir4yb[0w<\rcegrcefdinir dispersible tablets0.1g )y%m^%mpqo�n gp�lq�s �vo��qw[h2008067886900912000504 ^�y<\ �vo��qw[h200611948690092800105250mg �vo��qw[h20060980869009280010694yb[0w<\���vcefdinir capsules �vo��qw[h2008010786901444000666hq�l y0.1g c�c14h13n5o5s2 ����{<astellas toyama co.,ltd.takaoka plant�rsňon�^�]}v�nq\iqns6ro����n gp�lq�s � �vo��qw[j2011006386979363000401nvb<\)y%m;s< o�ɩ�v%m�^6ro� gp�lq�s �vo��qw[h20054035869009110000314yb[kq��cefixime4yb[kq��rcegrcefixime dispersible tabletshq:_%nup ^nhq:_o�n���n gp�lq�s �vo��qw[h2005166386900353000392 �\ 0.1g� c4yb[kq���� � 9nn;sro�n gp�#��nlq�s �vo��qw[h2005094586901157002582  nwm�e�no�n��l� gp�lq�s �vo��qw[h2006123786900795000226cefixime disperion tabletsyrnf�[100mg� cc16h15n5o7s2���{ � �vo��qw[h20040588869021380001774yb[kq��grcefixime tablets �vo��qw[h2006087986904129001101cefixime tablets�^�t0.1g ( cc16h15n5o7s2��) �vo��qw[h2004065686904129001354�s�rwc100mg(�nc16h15n5o7s2��) ς�]n^t6ro� gp�lq�s �vo��qw[h2005207686901650000146��� �t\�n��a�o�n���n gp�lq�s �vo��qw[h20040553869036870002504yb[kq�����vcefixime capsules0.2g ^n�|��o�n gp�lq�s �vo��qw[h2005080086900366000112n�y }100mg �vo��qw[h1093012886900381001859 �vo��qw[h1093012786900381001569*t�[ �vo��qw[h2004042286904021002688 �vo��qw[h2004042186904021002589���r�� �vo��qw[h2002051386900555000336 �vo��qw[h2004072586900555000244 �vo��qw[h2004082386900555000213r��suy100mg� cc16h15n507s2�� � �vo��qw[h2004070486900867000550 �vo��qw[h2006044086900867000888�x^tkq �vo��qw[h20060932869009110001164yb[kq�����|cefixime granules50mg( cc16h15n5o7s2��) �vo��qw[h1094012886900381001934�q�c50mg( cc16h15n5o7s2���{)ёu�o�n���n gp�lq�sws�nёu�6ro��s �vo��qw[h2004164586901529001069 �vo��qw[h2004072686900555000220 �vo��qw[h20020512869005550003434yb[�n�cefetame�s g�msobr �vx�4yb[�n�o�r^�m�`br.cefetamet pivoxil hydrochloride for suspension�^ȏ#k!1g:0.125g� c�vx��n�o��� ��vs_�n4yb[�n�90.65mg � ym_lnfm�^ո6ro� gp�lq�s �vo��qw[h2004067886904685000129.cefetamet pivoxil hydrochloride for suspension�[ }�90.65mg( cc14h15n5o5s2���{) ym_l�cq6ro� gp�lq�s �vo��qw[h2005454486904756000454181.3mg( cc14h15n5o5s2���{) �vo��qw[h20010452869047560002634yb[�l�� cefpodoxime ���|br0�s g�msobr 4yb[�l��o�r^�m�`br#cefpodoxime proxetil for suspension�unfpq 0.1g� c4yb[�l���� �o��� �vo��qw[h20051933869003770022114yb[�l��o����|cefpodoxime proxetil granule�x^t�l40mg� cc15h17n5o6s2�� � �vo��qw[h20060706869009110001091.1.1.2.3.2 �l\(u4yb[{v�� cefotaxime�l\(u4yb[{v����cefotaxime sodium for injection0.5g( cc16h17n5o7s2��) �vo��qw[h23020947869037120003541.0g( cc16h17n5o7s2��) �vo��qw[h2302094886903712000361 �vo��qw[h1302066686902690000660 �vo��qw[h13020665869026900006392g �vo��qw[h2002368186902690000806�q�y�� �vo��qw[h1098027786902701000092 �vo��qw[h10960279869027010000852.0g �vo��qw[h2005482286902701000108 �vo��qw[h37020571869040210008202.0g( cc16h17n5o7s2��) �vo��qw[h2002362686900796000713 �vo��qw[h4402283986900555000503 �vo��qw[h1302076686902777000705 �vo��qw[h20033533869027770006824yb[�f~g ceftriaxone�l\(u4yb[�f~g�� ceftriaxone sodium for injection0.5g( cc18h18n8o7s3��) �vo��qw[h2302172086903712001511 �vo��qw[h3702057286904021001018#ceftriaxone sodium for injection �vo��qw[h2004457086902690000196 �vo��qw[h2003349486902777001627�q^x#k1.0g( cc18h18n8o7s3��) �vo��qw[h2302172186903712001405 �vo��qw[h1998313586900600000861 �vo��qw[h2005678086903712003713 �vo��qw[h20023427869007920007312.0g( cc18h18n8o7s3��) �vo��qw[h2002301386900600000731 �vo��qw[h20043215869041410012191g/�t �vo��qw[h2003323586902690000462 �vo��qw[h2000301986904129000494 �vo��qw[h1302288186902777000590wl��  nwmwl6ro� gp�lq�s �vo��qw[h1098303786900723000076�l\(u4yb[�f~g�~ �vo��qw[h1098303686900723000069 �vo��qw[h2002361486904129000500�b'l4yb[ latamoxef�l\(u�b'l4yb[��latamoxef sodium for injection{vtup0.25g( cc20h20n6o9s���{) �vo��qw[h10930215869057750001660.5g( cc20h20n6o9s���{) �vo��qw[h10930103869057750000291.0g( cc20h20n6o9s���{) �vo��qw[h10930104869057750001730.25g� cc20h20n6o9s�� � ym_l�`��ho�n gp�lq�s �vo��qw[h20083975869046510000230.5g� cc20h20n6o9s�� � �vo��qw[h20083976869046510000301.0g� cc20h20n6o9s�� � �vo��qw[h20083977869046510000474yb[s|��cefminox�l\(u4yb[s|����cefminox sodium for injection �vo��qw[h20065439869003770021501.0g� cc16h21n7o7s3�� � �vo��qw[h20065123869041520018950.25g(�nc16h21n7o7s3��) wmwsup�^6ro� gp�lq�s �vo��qw[h20067131869057930005370.25g( cc16h21n7o7s3��) pnnfo�n���n gp�lq�s �vo��qw[h20055401869030940001641.0g( cc16h21n7o7s3��) �vo��qw[h20045283869026900001720.5g( cc16h21n7o7s3���{) ws f�zepo�n gp�lq�s �vo��qw[h20063939869054050001221.0g( cc16h21n7o7s3���{) �vo��qw[h20043142869054050001910.5g(�nc16h21n7o7s3��) �vo��qw[h2005880486904021001209 �vo��qw[h2006580786904129000388 �vo��qw[h2006580886904129000449 2.0g(�n4yb[s|����) �vo��qw[h20057061869041410006631.5g( cc16h21n7o7s3��) �vo��qw[h20073069869004780004442.0g( cc16h21n7o7s3��) �vo��qw[h2007307086900478000499��xup �e,gf�l6r�go�n*h_o>y �ul4y�~nmyr:sf�l;so� gp�lq�srsň � �vo��qw[j2< 0100086869790650002351.0g(�nc16h21n7o7s3��) �vo��qw[h2004612686900792001820 �vo��qw[h20058792869007920013250.5g� cc16h21n7o7s3�� � �vo��qw[h2006512286904152002847 �vo��qw[h2006310286902777002501 �vo��qw[h2006559586901650000559 s'y;so����n gp�lq�s �vo��qw[h20070034869009760000521.5g(�nc16h21n7o7s3��) �vo��qw[h2005629586900976000106 �vo��qw[h20059651869017490007054yb[�tn���]fwcefoperazone and sulbactam �l\(u4yb[�tn�����]fw��5cefoprazone sodium and sulbactam sodium for injectionôpq#k$1.0g(c25h27n9o8s20.5gnc8h11no5s0.5g) �vo��qw[h19980085869037120041166cefoperazone sodium and sulbactam sodium for injection%1.0g(c25h27n9o8s2 0.5gnc8h11no5s0.5g) �vo��qw[h20043200869040210016291.0g(4yb[�tn�0.5gn��]fw0.5g) �vo��qw[h2003381986902777001252�l\(u4yb[�tn�����]fw��(2:1);cefoperazone sodium and sulbactam sodium for injection(2:1)1.5g��n4yb[�tn���1gn�n��]fw��0.5g � �vo��qw[h2003108686902777002273�nf�m��^t6ro� gp�lq�s �vo��qw[h2002059786901187000213$2.0g(c25h27n9o8s21.0gnc8h11no5s1.0g) �vo��qw[h20003400869037120009342.0g�4yb[�tn�1.0gn��]fw1.0g � �vo��qw[h20033068869027770003164.0g(4yb[�tn�2.0gn��]fw2.0g) �vo��qw[h2003382086902777001177$4g(c25h27n9o8s2 2.0gnc8h11no5s 2.0g) �vo��qw[h20033580869041410018820.5g(4yb[�tn�0.25gn��]fw0.25g) �vo��qw[h2003381886902777001245&1.5g(c25h27n9o8s2 1.0gnc8h11no5s 0.5g) �vo��qw[h2006376986903712003805&1.5g�c25h27n908s2 1.0gnc8h11n05s 0.5g � �vo��qw[h2001320386900453001275(2.0g( t c25h27n9o8s2 1.0g,c8h11no5s 1.0g) �vo��qw[h2004320186904021001643$4.0g(c25h27n9o8s22.0gnc8h11no5s2.0g) �vo��qw[h2005468386905821000805&0.5g(c25h27n9o8s20.25gnc8h11no5s0.25g) �vo��qw[h20003426869037120009031g(4yb[�tn�0.5gn��]fw0.5g) _lςr`^t;so����n gp�lq�s �vo��qw[h20033653869014450013101g�4yb[�tn�0.5gn��]fw0.5g � �vo��qw[h2004355086901749000460 �vo��qw[h10960113869011870001832g(4yb[�tn�1.0gn��]fw1.0g) �vo��qw[h20033654869014450013032g�4yb[�tn�1gn��]fw1g � �vo��qw[h20043551869017490004534yb[�nvu ceftazidime�l\(u4yb[�nvuceftazidime for injection�e)y#k0.5g( cc22h22n6o7s2��) �vo��qw[h2001025486900377001955 �vo��qw[h2003301786900377000385 �vo��qw[h20033016869003770003781.0g( cc22h22n6o7s2��) �vo��qw[h19990365869003770015282.0g( cc22h22n6o7s2��) �vo��qw[h2001025586900377001313 �vo��qw[h2302172286903712001528 �vo��qw[h2302172386903712001504 �vo��qw[h2003302086903712003621 �vo��qw[h20013268869037120009651.0g� cc22h22n607s2�� � �vo��qw[h2001319786900453000582 �vo��qw[h2001307586904021000615 �vo��qw[h20043906869005550002373g �vo��qw[h2004390786900555000251 �vo��qw[h2002350186902777001559 �vo��qw[h2002350086902777002167 �vo��qw[h2004313886902777001214 �vo��qw[h20033816869027770012210.5g� cc22h22n6o7s2�� � �vo��qw[h20043855869017490005451.0g� cc22h22n6o7s2�� � �vo��qw[h2004385686901749000255 y��#k=glaxosmithkline manufacturing s.p.a.�rsňon t�y�[�pq }�skq6ro��ς�] � gp�lq�s � �vo��qw[j20130106869784760003154yb[u�� ceftizoxime�l\(u4yb[u���� ceftizoxime sodium for injection0.5g( cc13h13n5o5s2��) �vo��qw[h20040320869037120036380.75g( cc13h13n5o5s2��) �vo��qw[h20041917869037120034161.0g( cc13h13n5o5s2��) �vo��qw[h2004032186903712003461 �vo��qw[h2004191986903712003430 �vo��qw[h5302207186905821000423 �vo��qw[h53022072869058210004782.0g( cc13h13n5o5s2��) �vo��qw[h20059272869005550000600.5g( cc13h13n5o5s2��)(50nusmo) �vo��qw[h20003066869009490000650.75g( cc13h13n5o5s2��)(75nusmo) �vo��qw[h20043026869009490001021.0g( cc13h13n5o5s2��)(100nusmo) �vo��qw[h20003065869009490000721.5g( cc13h13n5o5s2��)(150nusmo) �vo��qw[h20043025869009490000962.0g( cc13h13n5o5s2��)(200nusmo) �vo��qw[h2004302486900949000089�v�onup �wso�n���n gp�lq�s �vo��qw[h1089000486900978002856 �vo��qw[h1089006286900978003655 �vo��qw[h2008424086900600001134 �vo��qw[h20084241869006000011414yb[�tn� cefoperazone)p��nv�̃b`�u�nv�̃_w��v͑�^a�g ��_{� g�~̃f[/ecbor;n�n;s^�n n$r�[�e�so(u0�l\(u4yb[�tn���!cefoperazone sodium for injection0.5g( cc25h27n9o8s2��) �vo��qw[h44022450,p�?q�zp��nv�̃b`�u�nv�̃_w��v͑�^a�g ��_{� g�~̃f[/ecbor;n�n;s^�n n$r�[�e�so(u0869003770019791.0g( cc25h27n9o8s2��) �vo��qw[h23021446869037120013821g( cc25h27n9o8s2��) �vo��qw[h1302066486902690000738 �vo��qw[h2102189486901187000145�o�#k �vo��qw[h32026274869014450003822.0g( cc25h27n9o8s2��) �vo��qw[h32026432869014450010514.0g �vo��qw[h2003341086901445002249!cefoperazone sodium for injection �vo��qw[h3702056886904021000493 �vo��qw[h20013030869040210020151.0g( cc25h27n9o8s2���{) �vo��qw[h37020591869041290007150.5g(�nc25h27n9o8s2��) �vo��qw[h20003249869016500009791.5g(�nc25h27n9o8s2��) �vo��qw[h2004302786901650000< 3992.0g(�nc25h27n9o8s2��) �vo��qw[h2001319486901650000986 �vo��qw[h4402141786900600000908 �vo��qw[h20013205869006000007864yb[0w�u cefodizime�l\(u4yb[0w�u��cefodizime sodium for injection�^=n��2.0g( cc20h20n6o7s4���{) �vo��qw[h2005171386900453000384�r�r1.0g/�t ^n��l6ro��s gp�lq�s �vo��qw[h20041550869002670014922.0g/�t �vo��qw[h2004155186900267001515�l\(u4yb[0w�y��0.5g( cc20h20n6o7s4���{) �vo��qw[h20041613869004530013291.0g( cc20h20n6o7s4���{) �vo��qw[h2004161486900453001343ؚ�_ q\n���n6ro� gp�lq�s �vo��qw[h2002044686904130000070 �vo��qw[h2005000786904130000155 �vo��qw[h2001004486904130000117 �vo��qw[h20020447869041300000870.25g( cc20h20n6o7s4��) �vo��qw[h2006039586900478000505ёul�y0.5g( cc20h20n6o7s4��) �vo��qw[h2004181986900478000253 0.5g( c4yb[0w�u���{) h2011054386978995000315 1.0g( c4yb[0w�u���{) h20110544869789950003084yb[�f~g�nu�]fwceftriaxone and tazobactam1.1.1.2.4 ,{�v�n4yb[̃ }{|o�ir4yb[!t��cefepime �l\(u�vx�4yb[!t��$cefepime hydrochloride for injectionasm#k �vo��qw[h2005060286900377000552 �vo��qw[h2005060386900377000569r`ς 1.0g� c4yb[!t���� � �vo��qw[h2005196586901445001143�pq1.0g( cc19h24n6o5s2���{) �vo��qw[h20060512869040210026570.5g( cc19h24n6o5s2��) �vo��qw[h20060990869041410014552.0g( cc19h24n6o5s2��) �vo��qw[h2006099186904141000373�o�rz �vo��qw[h2004163186900553000468 �vo��qw[h2004163286900553000475���r�� �vo��qw[h2005797486900555000176 �vo��qw[h20080414869006000011034yb[9sw cefpirome �l\(ukxx�4yb[9swcefpirome sulfate for injection0.25g( cc22h22n6o5s2��) �vo��qw[h2006459586901749000712 �vo��qw[h2005934686904751000862 �vo��qw[h2005980486900600000601 �vo��qw[h2005934786904751000886 1.0g� c4yb[9sw�� � �vo��qw[h20057981869014450011501.0g( cc22h22n6o5s2��) �vo��qw[h20064594869017490007361.0g( cc22h22n6o5s2���{) �vo��qw[h20059803869022970001481.0g� cc22h22n6o5s2���{ � �vo��qw[h20059791869041290011872.0g(�nc22h22n6o5s2��) ς�]�tn�^o�n gp�lq�s �vo��qw[h20073162869016710004774yb[{v)r cefoselis �l\(ukxx�4yb[{v)rcefoselis sulfate for injection0n� 0.5g� c4yb[{v)r���{ � �vo��qw[h2006006686901445001181 1.1.2 �xr� ��p{|o�ir�k?��wwsbiapenemp�vq�n�bu }�l�u�ehe�v͑�^a�g�l\(u�k?��wwsbiapenem for injection)y�q0.3gck'y)ytfo�nɩ�v���n gp�lq�s �vo��qw[h2008074386901523001591�[�o �vo��qw[h2008022586901594000431�lw�wws faropenem�lw�wws��grfaropenem sodium tabletsӄ�� �vo��qw[h2008017186905776001087t�0.2g( cc12h15no5s��) �vo��qw[h2006097786904010000183�w�wws meropenem�l\(u�w�wwsmeropenem for injection�s^0.5g/�tesumitomo dainippon pharma co., ltd. oita plant�rsňon� oo�s6ro��ς�] � gp�lq�s � �vo��qw[j2014016986978991000913 p��0.25g( cc17h25n3o5s��) �m3w^wm�n6ro� gp�lq�s �vo��qw[h2001024986900523000399 �vo��qw[h2001025086900523000412 �vo��qw[h2006528486902777002372wmck�yr wmck��^t6ro� gp�lq�s �vo��qw[h2003033186904641001627^<\�wws p�ns|��panipenem and betamipron �l\(u^<\�wws p�ns|��kq p�[ 0.5g:0.5g3daiichi sankyo propharma co., ltd., hiratsuka plant h2010011286979008000261�n���wws��s�nnimipenem and cilastatin �l\(u�n���wws-��s�nn��,imipenem and cilastatin sodium for injection1���1.0g��n���wws�e4lir 0.5gn��s�nn 0.5g �jw pharmaceutical corporation h2012040386978341000051 �l\(u�n���wws��s�nn��(imipenem-cilastatin sodium for injection1.0g��n���wws0.5gn��s�nn��0.5g �8lۏo�n gp�lq�s h2012006286979182000057,imipenem and cilastatin sodium for injectionp�io��!0.5g:�n���wws250mgn��s�nn��250mg(�n��s�nn��)ranbaxy laboratories limited h2010069986978770001131!1.0g:�n���wws500mgn��s�nn��500mg(�n��s�nn��) h2010069886978770001148,imipenem and cilastatin sodium for injection�l�� merck sharp & dohme corp. �rsň�mg�]؞�ln6ro� gp�lq�s � �vo��qw[j2013012386979524000127)0.5g�c12h17n3o4s 0.25gnc16h26n2o5s 0.25g � �swmt���6ro����n gp�lq�s �vo��qw[h2008401886900599000347'1.0g�c12h17n3o4s 0.5gnc16h26n2o5s 0.5g � �vo��qw[h2008401986900599000354�s�n�wws ertapenem�l\(u�s�n�wwsertapenem for injection!`nkn 1g(�n�s�n�wws��)8laboratoires merck sharp & dohme chibret�mg�]؞�ln6ro� gp�lq�srsň � �vo��qw[j2012005286978633001117 1.1.3 (l�w�|��{|o�ir?�s|asfamikacin kxx�?�s|asf�l\�mamikacin sulfate injection2ml:0.2g(20nusmo) �vo��qw[h3702056286904021001988�to�ɩ�v n�|6ro����n gp�lq�s �vo��qw[h2302168386903705000927 ��#ko�n���n gp�lq�s �vo��qw[h3702202686904127001127  nwm�y0n6ro� gp�lq�s �vo��qw[h3102117086900673001086 )y%mё�o�n gp�lq�s �vo��qw[h1202061086900874000581 �l\(ukxx�?�s|asfamikacin sulfate for injection 0.2g�20nusmo � �lws���n`�^x6ro� gp�lq�s �vo��qw[h4102170286903021000342�^'y � } gentamicin kxx��^'y � }�l\�mgentamycin sulfate injection1ml:4nusmo �vo��qw[h41025299869030210004342ml:8nusmo �vo��qw[h3702197386904127002698gentamicin sulfate injec< tion �vo��qw[h44022096869003770009722ml:4nusmo �lws�m_6ro����n gp�lq�s �vo��qw[h4102415586903257001243)y�eo�n gp�lq�s �vo��qw[h41020366869030980009792ml:80mg�8nusmo � �[ f�n�yo�n gp�#��nlq�s �vo��qw[h4202205886902000001653 �vo��qw[h1202053786900874000512 �vo��qw[h1302078386902770003246'y‰ � } spectinomycin �l\(u�vx�'y‰ � })spectinomycin hydrochloride for injectionssr�2g(200nusmo)( cc14h24n2o7��) �vo��qw[h1093000686904129000777hy�fs|f netilmicinp��n�~(uo� kxx�hy�fs|fa���|�l\�m(netilmicin sulfate and glucose injection�m"}100ml:kxx�hy�fs|f10nusmona���|5.0g �vo��qw[h2001074086904127002711 kxx�hy�fs|f�l\�mnetilmicin sulfate injection�l\�m 4ml:20nusmo _lς�v�suir6ro� gp�lq�s �vo��qw[h2006795586901490000863 2ml:10nusmo �vo��qw[h2002328986904127002735 �l\(ukxx�hy�fs|f netilmicin sulfate for injectionnfhy�e 0.1g(10nusmo) fkilnfu6ro� gp�lq�s �vo��qw[h2002016686901956000314&(49) gentamycin�%kxx��^'y � }grgentamycin sulfate tablets 40mg(4nusmo)100 �y�^gl)yuiro�n gp�lq�s �vo��qw[h3502037986904774000344�y^ � } tobramycin kxx��y^ � }�l\�mtobramycin sulfate injection2ml:80mg(8nusmo) _lςo�^�o�n gp�lq�s �vo��qw[h3202487086901470000715�o�fs|fetimicin kxx��o�fs|f/ls���l\�m/etimicin sulfate and sodium chloride injection�`��'100ml:kxx��o�fs|f0.1g(10nusmo)� c�o�fs|f�� �n/ls��0.9g�e!�nml�s�oq\�yo�n���n gp�lq�s �vo��qw[h2004147986901697001632.etimicin sulfate and sodium chloride injection1r�v100ml:�o�fs|f0.1g(10nusmo)n/ls��0.9g wmws1r�y6ro� gp�lq�s �vo��qw[h2003072986905759000106 kxx��o�fs|f�l\�metimicin sulfate injectionrb1ml:50mg 8^�]�ew6ro� gp�lq�s �vo��qw[h2002012986901370000112 2ml:100mg �vo��qw[h20020128869013700001361ml:50mg( cc21h43n5o7���{) �vo��qw[h19991423869016970003692ml:100mg( cc21h43n5o7���{) �vo��qw[h1999142286901697000345 �l\(ukxx��o�fs|fetimicin sulfate for injection100mg( cc21h43n5o7��) �vo��qw[h200420008690137000005150mg( cc21h43n5o7��) �vo��qw[h2004199986901370000068_^s|f isepamicin kxx�_^s|f�l\�misepamicin sulfate injection2ml:0.2g�20nusmo � ym_l_�vo�n gp�lq�s �vo��qw[h2008462586904645000060�okq�l 2ml:200mg;asahi kasei pharma corporation nagoya pharmaceuticals plant h2010059186979166000301 2ml:400mg h20100592869791660002954ml:400mg�40nusmo ���n_^s|f�� � ym_lwmcko�n���n gp�lq�s �vo��qw[h2004600086904641002167 1.1.4 p�����{|o�ir/l � }chloramphenicol/l � }�l\�mchloramphenicol injection2ml:0.25g(250,000usmo) �vo�ɩ�v�[u6ro� gp�lq�s �vo��qw[h41020098869032050016152ux � }u(lx�o�thiamphenicol glycinate 1.1.5 �v�s }{|o�iry��s } doxycycline�vx�y��s }grdoxycycline hyclate tablets0.1g( cc22h24n2o8��) _lςck'y0nwm6ro� gp�lq�s �vo��qw[h3202007386901521000480�v�s } tetracycline�vx��v�s }���v#tetracycline hydrochloride capsulesёvf�^0.25g/�| �[y/tcq�vo� gp�lq�s �vo��qw[h1998320286905914002570w � }oxytetracyclines|���s } minocycline�vx�s|���s }���v"minocycline hydrochloride capsules�kqz100mg( cc23h27n3o7���{) �vo��qw[h2001043986902697000052�s�n�`l6ro� gp�lq�s �vo��qw[h1096001086901421000061 �vo��qw[h1096001186901421000047 1.1.6 'y�s�qo�{|o�ir?�gy � } azithromycin�s g8^ʑbr�w ���|br0�s g�msobr?�gy � }grazithromycin tablets0.125g(12.5nusmo)͑�^�y^t6ro�(ɩ�v) gp�lq�s �vo��qw[h2005815086901016000032'yޏ�w'yo��s �vo��qw[h2005604886901122000018 wmwshqf6ro� gp�lq�s �vo��qw[h2007341286905826000015 �vo��qw[h2006534686904127000069 0.25g(25nusmo) �w�[�^�n�\o�n���n gp�lq�s �vo��qw[h2004547986902767000012�~�[ �vo��qw[h1098021886902770000085 0.5g�50nusmo � �vo��qw[h2003108186902770000108 ^�� �vo��qw[h1096016786901187000015?�gy � }���ngr$azithromycin enteric-coated tablets �vo��qw[h2006113786902770000184#azithromycin enteric-coated tablets �vo��qw[h2009006086902699002757?�gy � }���n���v#azithromcin enteric-coated capsules ym_lo�v6ro����n gp�lq�s �vo��qw[h2009015286904676000107?�gy � }���vazithromycin capsules�l�ryr s�n*y mo�n gp�lq�s �vo��qw[h1095006686900154000089azithromycin capsules �vo��qw[h1097006186904021000059 0.5g(50nusmo) �vo��qw[h2005772286900154000010 0.25g�25nusmo � �vo��qw[h2006316086900381000067 ��[)rt6ro� gp�#��nlq�s �vo��qw[h2005925386902503000092 �vo��qw[h1096019586902770000061 �vo��qw[h2003107686902770000092 ?�gy � }���|(a!)azithromycin granules(a!) �l3�ё��o�n gp�lq�s �vo��qw[h2003098386901297000011?�gy � }���|azithromycin granules nm�]o�nɩ�v���n gp�lq�s �vo��qw[h2001033386901453000046 �vo��qw[h2001033286901453000015 �vo��qw[h1098019886904021000011?�gy � }rcegr azithromycin dispersible tabletstm0.25g(25nusmo) cc38h72n2o12�� �vo��qw[h2002072986904012000013[�pn#k �vo��qw[h1999006586900600000045=n�sgypn �vo��qw[h2000010886900453000087 �vo��qw[h2005425586902503000061!azithromycin dispersible tablets_lςς-no�nɩ�v���n gp�lq�s �vo��qw[h2008384386901493001379�_��to�ɩ�v6ro�mq�s �vo��qw[h2002027086< 903710000028?�gy � }r^�m�`brazithromycin for suspension0.1g( cc38h72n2o12��) �vo��qw[h1096011286901187000039 �vo��qw[h2004128186900785000038 �vo��qw[h1098021786902770000047azithromycin for suspension>mgy0.1g�100mg �10nusmo � �vo��qw[h2008344386902503003765�~ � } erythromycin�~ � }���ngr#erythromycin enteric-coated tablets���ngr �vo��qw[h4202199086902000001776 �vo��qw[h1302101786902770003390�~ � }���n���v$erythromycin enteric-coated capsules�e�~�^���n���v �m3wn�t6ro� gp�lq�s �vo��qw[h1999026786900547000023"eythromycin enteric-coated capsule��~ �vo��qw[h2006518086904676000022 )y#w6ro�ɩ�v���n gp�lq�s �vo��qw[h5002170486901055000222 �vo��qw[h2006518186904676000039 �vo��qw[h5002170586901055000239 nwm�o �na�o�n���n gp�lq�s �vo��qw[h3102260386900804001190 �vo��qw[h1097017086900547000016&(61) �l\(usn�|x��~ � }'erythromycin lactobionate for injection0.25g(25nusmo) c�~ � }�� �vo��qw[h43020028869050060010160.30g(30nusmo) c�~ � }�� �vo��qw[h2102167986901122000445_l�c�wswm#ko�n���n gp�lq�s �vo��qw[h36021156869052830003060.3g(30nusmo) c�~ � }�� �vo��qw[h3602115586905283000290 0.3g(30nusmo) �vo��qw[h2302144286903712001429&(60) �l\(usn�|x�?�gy � }'azithromycin lactobionate for injectionvq�n0.125g(12.5nusmo) c?�gy � }�� �vo��qw[h2000019786901161000895p���0.50g�50n?�gy � }usmo � �vo��qw[h2004027786900144006992?�gy � }�l\�mazithromycin injection��&tf2.5ml:0.25g( cc38h72n2012��)_lς4t-n;so�ɩ�v gp�lq�sς�]6ro��s �vo��qw[h20010606869016450000385ml:0.5g( cc38h72n2012��) �vo��qw[h2002034286901645000052�l\(u?�gy � }azithromycin for injection �vo��qw[h2005009886902770002980 �vo��qw[h2006677886904127001264�n`�� 2ml�0.25g �n�[o�nɩ�v���n gp�lq�s �vo��qw[h2001055486902959000097 �l\(u?�gy � }�xx��n"l��6azithromycin sodium dihydrogen phosphate for injection�n'kr�0.125g(12.5n?�gy � }usmo) �vo��qw[h2002054086904021001674 �l\(ul�egx�?�gy � }"azithromycin maleate for injection%mzs )y%muirsf[6ro� gp�lq�s �vo��qw[h2004192086900918000508&azithromycin latobionate for injectionp��[ �vo��qw[h2003117386903712003614 �vo��qw[h2005092386904021002480 �vo��qw[h2002029386900918000072 �vo��qw[h2001036386903712000972'azithromycin lactobionate for injection̑gy 0.25g( c?�gy � }��) �vo��qw[h2001000786901749000859 �vo��qw[h2005092486904021002473 �vo��qw[h2004192186900918000515*pharmacia & upjohn company�rsňon���^t6ro� gp�lq�s � �vo��qw[j2014007386978718001360 l�egx�?�gy � }�l\�mazithromycin maleate injection5ml:0.5g �vo��qw[h20060810869009180000410w�~ � } dirithromycin0w�~ � }���n���v%dirithromycin enteric-coated capsules�� �vo��qw[h2005161486904127003152 �vo��qw[h2006121986904127003169 �vo��qw[h2003057786904203000181!`�rf0.125g� c0w�~ � }�� � �vo��qw[h20052134869008670002910w�~ � }���ngr$dirithromycin enteric-coated tablets�w'y0.25g( cc42h78n2o14��) vnws]nxq6ro����n gp�lq�s �vo��qw[h2003062986904942000176>m�v �vo��qw[h2005176886902503000801s^�z�� ܏'y;so��-n�v � gp�lq�s �vo��qw[h2005110986901862000095%tyn�~ � }erythromycin ethylsuccinate%tyn�~ � }���v$erythromycin ethylsuccinate capsules)rt�l0.25g(25nusmo) cc37h67no13�� �vo��qw[h2000038486902503001020%tyn�~ � }���|$erythromycin ethylsuccinate granules0.1g(10nusmo) cc37h67no13�� �vo��qw[h6102171386902503001006%tyn�~ � }gr#erythromycin ethylsuccinate tablets �vo��qw[h11020347869002220002320.125g(12.5nusmo) cc37h67no13�� �vo��qw[h6102235986902503001044 �vo��qw[h3302137986904756000171%tyn�~ � }rcegr/erythromycin ethylsuccinate dispersible tablets cc37h67no13�� 0.125g(12.5nusmo) �v�]�y&oo�n���n gp�lq�s �vo��qw[h2002025686902292000518kq�b � }clarithromycin�s g8^ʑbr�w ���|br0�s g�msobr0�cʑbr�wkq�b � }grclarithromycin tablets0.125g�12.5nusmo � ^n8��6ro� gp�lq�s �vo��qw[h2005913986900363000115����0.25g( cc38h69no13��) �vo��qw[h109700328690144500177850mg( cc38h69no13��) �vo��qw[h1097003386901445001785)rȏhq �vo��qw[h1096028086902503001488�[ t\�[0.125g( cc38h69no13��) �nws8l�[6ro� gp�lq�s �vo��qw[h2000009286905719000269�y�f#k �vo��qw[h1097015686901016002227 ym_l�n�eo�n���n gp�lq�s �vo��qw[h2006565286904658000132 ym_l��_o�n gp�lq�s �vo��qw[h2008328186904612000208as�eȏ#k25nusmo mg�]-n�nsn6ro� gp�lq�s �vo��qw[h1097021686904520000321kq�b � }���vclarithromycin capsules �vo��qw[h2006346886904127000489 �vo��qw[h2006346986904127002902  nwm�enwmnfo�n gp�lq�s �vo��qw[h2000044986900808001264 �v�]�~ey6ro� gp�lq�s �vo��qw[h2004398386902264000133~v�~o �vo��qw[h2000004686904187003260kq�b � }rcegr"clarithromycin dispersible tablets��0.125g( cc38h69no13���{) �vo��qw[h2004031186903710001308 �[ f�_lo�n gp�lq�s �vo��qw[h2006604786901997000199 �� �vo��qw[h1999037586901749001528 �vo��qw[h1999037686901749001535kq�b � }ʑgr(clarithromycin sustained release tablets �vo��qw[h200310< 4186901445001846)clarithromycin sustained released tablets�hkq �lws�y�ho�n gp�lq�s �vo��qw[h2006110486903020000138&clarithromycinsustained-releasetablets 0.50g(50nusmo) ��3�^_l�l6ro� gp�#��nlq�s �vo��qw[h2005274686903995000058kq�b � }ʑ���v)clarithromycin sustained-release capsules�^wz ^�]�g[�wo�n gp�lq�s �vo��qw[h2005166186900387000146w�~ � } roxithromycin�s g8^ʑbr�w0�cʑbr�w0�s g�msobrw�~ � }grroxithromycin tabletsw�r�_150mgsanofi winthrop industrie h2010001486978821000854fmy� �vo��qw[h1095018286900785000335 150mg(15nusmo) �vo��qw[h2005372586902767000586 ^n|_�o�n gp�lq�s �vo��qw[h2005687286900269001568 �vo��qw[h1095035386904756000034 �vo��qw[h109501838690078500036675mg �vo��qw[h1097027186900453000964w�~ � }���vroxithromycin capsules�nς �vo��qw[h1097029286901749000866 �vo��qw[h1097029186901749000989 50mg(5nusmo) �vo��qw[h2000044586904658000194 �vo��qw[h2005570786901521000060 _lς�y��o�n gp�lq�s �vo��qw[h2005556186901438000146roxithromycin#�apsules�oy�  nwm�o �o��s gp�lq�s �vo��qw[h1097022386900818000448 �vo��qw[h2006435986900381000944 75mg(7.5nusmo) �vo��qw[h2000044686904658000200 �vo��qw[h2005812986904127002315[�pn�g �vo��qw[h1999036186900600000748�n�r ^ �vo��qw[h1097019086904744000435w�~ � }rcegr!roxithromycin dispersible tablets q\np���o�n gp�lq�s �vo��qw[h20083550869041450015050.15g �vo��qw[h2006448586900381000937��#k �vo��qw[h1999102286901445000474=n�sf �vo��qw[h1999114686900453000889w�~ � }o����vroxithromycin soft capsuleso����v 0.15g�15nusmo � ym_l�~�^o�n���n gp�lq�s �vo��qw[h2007030286904728000284w�~ � }ʑgr'roxithromycin sustained release tabletsr`yr �vo��qw[h2004171086901444000413w�~ � }r^�m�`brroxithromycin for suspension�lw 50mg�5nusmo �6 �vo��qw[h1097022286904756000317roxithromycin for suspension �vo��qw[h1999136986900785000342ynp����e � }acetylspiramycinynp����e � }gracetylspiramycin tablets 0.1g(10nusmo �)y%m-n�eo�nɩ�v���n gp�lq�s�e�e6ro��s �vo��qw[h1202025386900964000439 �vo��qw[h4402153186900381001439 �vo��qw[h3702008586904129001286 0.2g(20nusmo) �vo��qw[h3702032486904187001419 1.1.7 �|��{|o�ir�s2un�s � } norvancomycin p��2u'l��gёa�t̃a�g �l\(u�vx��s2un�s � })norvancomycin hydrochloride for injection0.4g �vo��qw[h1302028686902697000120�f��b�[ teicoplanin�l\(u�f��b�[teicoplanin for injection�nm �vo��qw[h10950019869041870032534ml6"0.6g �vo��qw[h2003030286904187003239 �vo��qw[h2004414986902770003123 �vo��qw[h2005426286902503001303 �vx�kq�g � }�l\�m"clidamycin hydrochloride injection2ml:0.3g(�nkq�g � }��) �vo��qw[h2004602786901645000991#clindamycin hydrochloride injection 2ml:0.15g �vo��qw[h20053585869003770004462ml:0.3g �vo��qw[h20053586869003770004774ml:0.3g� ckq�g � }�� � �vo��qw[h20058608869020000011108ml:0.6g ͑�^���o�n���n gp�lq�s �vo��qw[h20020153869010170001308ml:0.6g� ckq�g � }�� � �vo��qw[h2005860986902000001103 5ml :0.6g �vo��qw[h20053587869003770004534ml:0.3g �vo��qw[h2002015286901017000147 �l\(ukq�g � }�xx�o�#clindamycin phosphate for injection�fgy 0.3g( ckq�g � }��) �vo��qw[h2002072486901749000521#clindamycin phosphate for injection0.3g( cc18h33cln2o5s��) �vo��qw[h2009343186904127003992�p0w 0.15g( ckq�g � }��) ym_l]n�eo�n gp�lq�s �vo��qw[h2002027986904661000433 0.45g( ckq�g � }��) �vo��qw[h2002028086904661000426-gz0.45g �vo�ɩ�v�v^to�n gp�lq�s �vo��qw[h2004145786904383000353 �l\(u�vx�< kq�g � }'clindamycin hydrochloride for injection��f 0.3g��nkq�g � }�� � s�n�v�s�y�[6ro� gp�lq�s �vo��qw[h2004012386900151000440ss�r wmws�sbo�n���n gp�lq�s �vo��qw[h2005117786905814000195�g�s � } lincomycin �vx��g�s � }�l\�m"lincomycin hydrochloride injection1ml:0.2g( cc18h34n2o6s���{) �vo��qw[h32021366869015040011141ml:0.2g( cc18h34n2o6s��) �vo��qw[h13020454869026990010952ml:0.6g( cc18h34n2o6s��) �vo��qw[h1302101286902770002027 �vo��qw[h3702071186904187002324 �vo��qw[h4102012886903098000443 �vo��qw[h3702197486904127001677 �vo��qw[h1202039486900874000871&(71)1.1.9 vq�n�x � } fosfomycin�l\(u�x � }��fosfomycin sodium for injection �vo��qw[h2004304686903712003829 �vo��qw[h2003322486903705000309 �vo��qw[h2004304786903712003836 �vo��qw[h1999911186901162001488(l�fws aztreonam�l\(u(l�fwsaztreonam for injection wmws�v��6ro����n gp�lq�s �vo��qw[h2006465086905781000341 �vo��qw[h2006465186905781000365wmws-nst�t6ro��]n���n gp�lq�s �vo��qw[h2006372286905843000722 �vo��qw[h20063723869058430006782.0g� cc13h17n5o8s2�� � �vo��qw[h20063928869057930009570.5g( cc13h17n5o8s2���{) �vo��qw[h2004546086902954000757 �vo��qw[h20055839869007920015850.5g� cc13h17n5o8s2�� � �vo��qw[h2005993986901017000604aztreonam for injection1.0g( cc13h17n5o8s2���{) �vo��qw[h2005548486901041000236 y�|̃ }b�y�|̃ } � polymyxin b&(74)y�|̃ }kxx��|̃ }���|colistin sulfate granules�s)rȏ�n 1g:100nusmo&atlantic laboratories corporation,ltd. h2013028086978992000394 y�0wx� fusidic acid�l\(u y�0wx���sodium fusidate for injection0.5g �m�y10ml�ẽ�q�n�m b��тno�n gp�lq�s �vo��qw[h2006700986902049000044 b��)y�sq\6ro� gp�lq�s �vo��qw[h2005815186902066001239 �vo��qw[h2005815286902066001246 �vo��qw[h2008420786902946002288�ble }colistin&(72) �s g8^ʑbr�w �s gcebr�x � }�����vfosfomycin calcium capsules �vo��qw[h2000375786902699002405�x � }��grfosfomycin calcium tablets�~<\�^0.5g( cc3h7o4p��) �vo��qw[h2000369486901162000290&(76)�|̃ }�ϟ̃ } � 1.2 tb�b̃o�ir1.2.1 �x��{|�s2u'lăvu{|o�ir y�e�x��2uavucompound sulfamethoxazole y�e�x��2uavugrcompoundsulfamethoxazoletablets�x��2uavu0.4g,2u'lăvu80mg )y%m�ru6ro����n gp�lq�s �vo��qw[h1202093886900886000753!compound sulfamethoxazole tablets �vo��qw[h4402156886900381000579�x��2uavu0.4g02u'lăvu80mg0 �vo��qw[h1202078986900931000172�kgr t�x��2uavu0.4g�t2u'lăvu80mg0400 �vo��qw[h2102233286901161002325�x��'vvu sulfadiazine&(78)&(77)2u'lăvu trimethoprimt��x2u'lăvu/sulfamethoxazole, sulfadiazine and trimethoprimt��x2u'lăvugr6sulfamethoxazole �sulfadiazine and trimethoprim tablets�x��2uavu0.2g,�x��'vvu0.2g,2u'lăvu80mg �vo��qw[h1102227686900144006152 1.2.2 �u��n�{|o�ir!t�tx�pipemidic acid!t�tx�grpipemidic acid tablets �vo��qw[h3102071786900818000318�sn�lf ciprofloxacin�vx��sn�lfgr#ciprofloxacin hydrochloride tablets 0.25g( c�sn�lf��) �vo��qw[h1093002986904747001316 �vo��qw[h2302155786903712000460 �vo��qw[h4102414286903098002782 �vo��qw[h1091003186900928001083 0.5g( c�sn�lf��) �vo��qw[h2003321186900407000507�vx��sn�lf���v$ciprofloxacin hydrochloride capsules 0.25g(�n�sn�lf��) �vo��qw[h3302038786904658000477$ciprofloxacin hydrochloride capsules �vo��qw[h1093016886901749000798&(82) snx��sn�lf/ls���l\�m3ciprofloxacin lactate and sodium chloride injection100ml:0.2g( c�sn�lf��) q\nns��6ro� gp�lq�s �vo��qw[h3702210586904098000761 �w�[�^�vo� gp�lq�s �vo��qw[h1302247986902763000979 ciprofloxacin and sodium chloride injection�nfpn c�sn�lf100ml��sn�lf0.2gn/ls��0.9g(bayer pharma ag�rsňon��b3�;so��oep gp�lq�s^�]rlq�s � �vo��qw[j2013017686978271002620��l�lf norfloxacin��l�lfgrnorfloxacin tablets)y%m)y�x�r(���[)6ro� gp�#��nlq�s �vo��qw[h2102014286901176000057 �vo��qw[h1087000286900928000406��l�lf���vnorfloxacin capsules �vo��qw[h3302002986904494002178 �vo��qw[h1202120586900867000963 �vo��qw[h2302093486903712000613 �vo��qw[h1202079386900931000769'll�lf ofloxacin 'll�lf/ls���l\�m'ofloxacin and sodium chloride injection100ml:'ll�lf0.2gn/ls��0.9g �vo��qw[h2002344586904098001492ey yf �vo��qw[h1094005586900144000839�]'ll�lf levofloxacin�vx��]'ll�lfgr"levofloxacin hydrochloride tablets �vo��qw[h2007313286904141000380snx��]'ll�lfgrlevofloxacin lactate tablets0.1g( cc18h20fn3o4��) �vo��qw[h2005870486904127002346 2u�xx��]'ll�lfgrlevofloxacin mesylate tablets)r yf0.1g( cc18h20fn3o4���{) �vo��qw[h1098006786900144006626png 0.1g(�n�]'ll�lf��) �vo��qw[h1999025686901445000818eg�z�o0.1g(�nc18h20fn3o4��) �vo��qw[h1097004586904747000999 0.5g��n�]'ll�lf�� � �vo��qw[h2006638786901445002263q\n���b;so�ɩ�v[�yr gp�#��nlq�s �vo��qw[h2006772486904131000192 0.5g(�n�]'ll�lf��)�]'ll�lfgrlevofloxacin tablets�spn�_�y,{n nqq6ro�(s�n) gp�lq�s �vo��qw[h200006558690022< 6000054 �vo��qw[h2005779786900381000197 �vo��qw[h2004009186900226000016 �vx��]'ll�lfrcegr.levofloxacin hydrochloride dispersible tablets�l�v q\nep�^o�n gp�lq�s �vo��qw[h2000037586904105000937 snx��]'ll�lfrcegr(levofloxacin lactate dispersible tablets 0.1g��n�]'ll�lf�� � �v�]gs�to�n���n gp�lq�s �vo��qw[h20080278869022100021810.1g��nc18h20fn3o4���{ � �vo��qw[h2008048486905755001701 �vx��]'ll�lf���v#levofloxacin hydrochloride capsules0.25g��nc18h20fn3o4���{ � �vo��qw[h2009400986900363000399$levofloxacin hydrochloride capsules �vo��qw[h20067453869030100001790.1g� cc18h20fn3o4�� � �<br>�_8n���v wmwsnf)r6ro����n gp�lq�s �vo��qw[h2005773186905801000269�]kq �vo��qw[h1999005186901749001023 �vo��qw[h1999032886900600000663 �vo��qw[h2006483786901493000679r`ey b��r`^t6ro� gp�lq�s �vo��qw[h2003018486902031000205 �vo��qw[h2005603186902777000354 �vo��qw[h2007387686901529001557 �v�]'y�q6ro� gp�lq�s �vo��qw[h2005808086902132000418 �vo��qw[h2000005586904747001323&(85) �vx��]'ll�lf/ls���l\�m8levofloxacin hydrochloride and sodium chloride injection^t�y�l100ml:0.2g(�n�]'ll�lf��) �vo��qw[h2004429186902180000750100ml:�]'ll�lf0.3gn/ls��0.9g �vo��qw[h2003005086902180000972����e100ml:�]'ll�lf0.25g,/ls��0.9g �vo��qw[h2005105786904145001338100ml:�]'ll�lf0.2gn/ls��0.9g0 �vo��qw[h2000046286901444000611 �vx��]'ll�lfa���|�l\�m0levofloxacin hydrochloride and glucose injection 100ml:�vx��]'ll�lf0.2g(�n�]'ll�lf��)na���|5g �vo��qw[h2001064986901493000754 snx��]'ll�lf/ls���l\�m2levofloxacin lactate and sodium chloride injection100ml:0.2g��nc18h20fn3o4�� � �vo��qw[h20043407869041270029713levofloxacine lactate and sodium chloride injection"200ml:snx��]'ll�lf0.2g( c�]'ll�lf��)n/ls��1.8g �vo��qw[h2004421586904098000174 �vx��]'ll�lf�l\�m$levofloxacin hydrochloride injection2ml:0.1g �vo��qw[h1999032486901749000828ё��\�f5ml:0.1g( cc18h20fn3o4���{) }vbli`;s�y'yf[6ro��s �vo��qw[h1999037086903287000674 ym_l�^i`�6ro����n gp�lq�s �vo��qw[h2003026186904670000912�_�[5ml:0.5g( cc18h20fn3o4���{) q\�nf�_o�n���n gp�lq�s �vo��qw[h2005209186902918000571 2u�xx��]'ll�lf�l\�mlevofloxacin mesylate injection �vo��qw[h19980192869001440065892levofloxacin lactate and chloride sodium injection100ml:0.2g:0.9g �vo��qw[h2005942686904098001133w100ml:0.2g(�nc18h20fn3o4��)(�����s�t���m�t)0100ml:snx��]'ll�lf0.2g((�nc18h20fn3o4��) n/ls��0.9g(�nb\qq$c���m(u��) �vo��qw[h1999002086904747001217*100ml:snx��]'ll�lf0.3g( cc18h20fn3o4���{)n/ls��0.9g �vo��qw[h2003396586904747000173,100ml:0.2gsnx��]'ll�lf0.2g( cc18h20fn3o4��)n/ls��0.9g q\nzؚo�n gp�lq�s �vo��qw[h2004127986904177000088100ml:0.3g:0.9g �vo��qw[h2006625186904098001539(100ml:snx��]'ll�lf0.3g(�nc18h20fn3o4��)n/ls��0.9gym_l��nf1r`o�n���n gp�lq�s �vo��qw[h2006796786904693000555ёոf u��ёո6ro����n gp�lq�s �vo��qw[h2004151586902388000316100ml:0.3g��nc18h20fn3o4�� � �vo��qw[h2005609386904127002469100ml�]'ll�lf0.5gn/ls��0.9g �vo��qw[h2005031086902388000064�]'ll�lf�l\�mlevofloxacin injecion 10ml:0.5g �lszf tuir6ro� gp�lq�s �vo��qw[h2008032186902557001076���lx^1ml:0.1g(�n�]'ll�lf��) �vo��qw[h2000041986901645001288200ml:�]'ll�lf0.2gn/ls��1.8g �vo��qw[h20000687869021800008354levofloxacin lactate and sodium chloride injection#250ml:snx��]'ll�lf0.5g(�n�]'ll�lf��)n/ls��2.25g �vo��qw[h20065162869046930005862ml:0.1g(�n�]'ll�lf��) �vo��qw[h20066458869041270006182ml:0.2g(�n�]'ll�lf��) �vo��qw[h20066459869041270024832ml:0.2g��n�]'ll�lf�� � �vo��qw[h20094094869008740012983ml:0.3g(�n�]'ll�lf��) �vo��qw[h20066460869041270005403ml:0.3g(�n�]'ll�lf�� � �vo��qw[h20030929869016450003355ml:0.3g��n�]'ll�lf�� � �vo��qw[h2009409586900874001304 �]'ll�lf/ls���l\�m*levofloxacin and sodium chloride injection100ml:�]'ll�lf0.3gn/ls�� 0.950g �vo��qw[h2001078286900226000047?levofloxacin hydrochloride and sodium chloride injection100ml��]'ll�lf0.3gn/ls��0.9g �vo��qw[h2006629186901749000248100ml:�]'ll�lf0.5gn/ls��0.9g �vo��qw[h2002063686900226000023 �l\(u�vx��]'ll�lf(levofloxacin hydrochloride for injection=n�s:_>m �vo��qw[h20010396869004530010220.2g� cc18h20fn304���{ � �vo��qw[h20020673869004530003220.3g� cc18h20fn304���{ � �vo��qw[h2002071386900453000339 �l\(usnx��]'ll�lf"levofloxacin lactale for injectioney�~hq 0.3g(�n�]'ll�lf��) _lςey[��^o�n���n gp�lq�s �vo��qw[h2006020586901425000319 �l\(u2u�xx��]'ll�lf#levofloxacin mesylate for injection�[�l 0.1g� c�]'ll�lf�� � �vo��qw[h2005188186904141001318 0.2g� c�]'ll�lf�� � �vo��qw[h2005188286904141000151����d_ �vo��qw[h2006102586902699002597f0.3g( cc18h20fn3o4���{) �vo��qw[h2004009586900978004560 �vo��qw[h2006020686901425000326lw�lf fleroxacin lw�lfa���|�l\�m#fleroxacin and glucose injection50ml:lw�lf0.2gna���|2.5g �vo��qw[h2007315586904145001000< )fleroxacin and glucose injectioninjection100ml�lw�lf0.4gna���|5.0g �vo��qw[h2004428986900269000547 fleroxacin and glucose injectioncspn�[100ml:lw�lf0.2gna���|5.0g �vo��qw[h2000002386904127000298 �vo��qw[h2003030486904127003411100ml:lw�lf0.4gna���|5.0g �vo��qw[h2004664486904145000980 �vo��qw[h2005367886902180001207�b�^ �vo��qw[h1998006286901749001436lw�lf�l\�mfleroxacin injection5ml:0.4g r��\ё�\6ro� gp�lq�s �vo��qw[h20055497869040460008292ml:0.2g �vo��qw[h1998014086901749001443�l\(ulw�lffleroxacin for injection`{� �l3��el�o�n gp�lq�s �vo��qw[h2001060186901332000143 ts|�lf gemifloxacinm��lf lomefloxacin�vx�m��lf���v#lomefloxacin hydrochloride capsules 0.1g� cm��lf�� � �vo��qw[h1202048086900867001274 0.1g( cm��lf��) �vo��qw[h1999002686902000000304�vx�m��lfgr"lomefloxacin hydrochloride tabletsgymhq 0.2g( cm��lf��) �vo��qw[h2000064586900976000502&(88) 蕬q(lx�m��lf�l\�m lomefloxacin aspartate injection5ml:0.2g��nc17h19f2n3o3�� �q\n�efo�nɩ�v���n gp�lq�s �vo��qw[h2006770186904083000530 �l\(u�vx�m��lf(lomefloxacin hydrochloride for injection �vo��qw[h2001019386902918000335nf�zyr �vo��qw[h2001019486902918000441����lf maxifloxacin�vx�����lfgr"moxifloxacin hydrochloride tablets�b ypn"bayer pharma ag�rsňon��b3�;so��oep gp�lq�s � �vo��qw[j2015001586900002000124&(89) �vx�����lf/ls���l\�m8moxifloxacin hydrochloride and sodium chloride injection250ml:����lf0.4gn/ls��2.0g/bayer schering pharma ag�rsňon��b3�;so��oep gp�lq�s^�]rlq�s � �vo��qw[j2014011086978271002828&(84)'ll�lf���vofloxacin capsules _lςğ�lo�n���n gp�lq�s �vo��qw[h3202628686901450000964 �vo��qw[h1094023486901749000897'll�lfgrofloxacin tablets �vo��qw[h3102281186900808000236 �vo��qw[h1092012186904747001842�l)r�_�y �vo��qw[h2002310686900226000030 �lws)y�eo�n���n gp�lq�s �vo��qw[h4102340586903098002621 )y%mёy�܀)ro�n gp�lq�s �vo��qw[h1202077686900872000088 �vo��qw[h1302080586902699001392 1.2.3 ]x�w�tu{|o�ir2u]xu metronidazole2u]xugrmetronidazole tablets �vo��qw[h3702190386904127002742 �vo��qw[h4102012586903098001976 �vo��qw[h1202029786900931000417 _\6ro��ɩ�v � gp�lq�s �vo��qw[h4102138386903139000531 �vo��qw[h2007332286903010001091&(90) 2u]xu/ls���l\�m metronidazole and sodium chloride injection 250ml:500mg �ls)ybo�n���n gp�lq�s �vo��qw[h1302230486902662000360 100ml:0.5g �vo��qw[h1302248686902763000207 100ml:500mg ym_lnml6ro����n gp�lq�s �vo��qw[h2003360186904653000250100ml�2u]xu0.5gn/ls��0.9g �vo��qw[h2005801486904145001147 250ml:0.5g �vo��qw[h3702175486904127002773 2u]xua���|�l\�m#metronidazole and glucose injection250ml:0.5g2u]xu�12.5ga���| �[�_0n�so�n���n gp�lq�s �vo��qw[h3402132986904289000303250ml:0.5ga���|�12.5g/ls��250ml:2u]xu1.25gn/ls��2.0g�v��_ɩ�v(_l�)n�n6ro� gp�lq�s �vo��qw[h3602028086905251000741,metronidazole and sodium choloride injection100ml:2u]xu0.5gn/ls��0.8g �vo��qw[h2004401186902180001269  nwm~vyr;s�u(u�t gp�lq�s �vo��qw[h2000330186900628000386 �vo��qw[h2001332686904098000235250ml:2u]xu0.5gna���|12.5g �vo��qw[h1302248586902763000184250ml:0.5g: 12.5g)y%mё�ɩ�vvns)yo�o�n���n gp�lq�s �vo��qw[h1202057086900933000552 250ml:1.25g �vo��qw[h1302248786902763000191ey]xu ornidazole ey]xu/ls���l\�m(ornidazole and sodium chloride lnjection�q�_�n100ml6"ey]xu0.25gn/ls��0.825g �vo��qw[h2004101786902388000019(ornidazole and sodium chloride injection100ml6"ey]xu0.5gn/ls��0.825g �vo��qw[h2004082986902388000040ey�z�y100ml:ey]xu0.5gn/ls��0.85g ��[n��6ro����n gp�lq�s �vo��qw[h2004032586902525000049#w���[100ml:ey]xu0.25g,/ls��0.86g ws�n#w�to�n gp�lq�s �vo��qw[h2002065986901583000114ey]xu�l\�mornidazole injectiono&o �vo��qw[h2004033786901583000077ornidazole injectionnf�s�z �vo��qw[h2005174486902918000090 5ml:0.25g �vo��qw[h2004010486902918000069�yς100ml�ey]xu0.5gn/ls��0.9g �vo��qw[h2006063486902180000088250ml:ey]xu0.5gn/ls��2.25g �vo��qw[h2005112786902180000071�l\(uey]xuornidazole for injection �vo��qw[h2003077886901583000213�n��fkil�t�eg�y6ro����n gp�lq�s �vo��qw[h2003106686901929000488&(91)ey]xurcegrornidazole dispersible tablets�l�e �vo��qw[h2004037586903098000184�vyr0.25g( cc7h10cln3o3��) �vo��qw[h2004046086904942000046ey]xu���vornidazole capsuleseyzs�g250mg �v�]~v)ro�n gp�#��nlq�s �vo��qw[h2003023986902120000017 �vo��qw[h2003125686902525000056 �vo��qw[h2003125786902525000025p�kqlbp[_lo�nɩ�vws�nwmu�o�n gp�lq�s �vo��qw[h2003052486901748000010�f]xu tinidazole�f]xugrtinidazole tablets vns^nmo�n���n gp�lq�s �vo��qw[h1095015186901803000399 �vo��qw[h1095032086900453000902 �vo��qw[h20033090869041310000488 �vo��qw[h2102171286901161001007�f]xu���vtinidazole capsules�f<\%m �vo��qw[h1097028286901679000356 �vo��qw[h20000382869014700< 01330wc�r �vo��qw[h1097023386904141000540 �vo��qw[h1097037686901450000889&(92) �f]xu/ls���l\�m(tinidazole and sodium chloride injection 100ml:0.4g �vo��qw[h2002366286904098001447100ml:�f]xu0.4gn/ls��0.9g �vo��qw[h1098012886902763000887 �vo��qw[h2005799486904145000676200ml��f]xu0.8gn/ls��1.8g �vo��qw[h2004346286904145001192ո�[ �vo��qw[h1098013386901749000873 �vo��qw[h2002349786904127000830 200ml:0.8g �vo��qw[h1098013286901749000842200ml:�f]xu0.8gn/ls��1.8g �vo��qw[h2002349686904127001424 �f]xua���|�l\�mtinidazole glucose injection100ml:�f]xu0.4gna���|5.0g �vo��qw[h2005478886904127001400100ml��f]xu0.4gn/ls��0.9g �vo��qw[h2008338586904494002819�]ey]xu levornidazole�p�2u]xumetronidazoate benzeoate�p�2u]xurcegr(benzoylmetronidazole dispersible tablets0.32g �vo��qw[h2006074986905781000068pnfvb0.64g �v�]�e�e�6ro� gp�#��nlq�s �vo��qw[h2006086186902273000018_lςhflro�nɩ�v���n gp�lq�s �vo��qw[h2008030286901427001666�p�2u]xu���vbenzoylmetronidazole capsulessopn�[ )y%m*y�l6ro� gp�lq�s �vo��qw[h2002065286900929000030 1.2.4 ]x�wkt�u{|o�irkt�u�y�vnitrofurantoinkt�u�y�v���ngr%nitrofurantoin enteric-coated tablets �vo��qw[h1202016486900886000906kt�uun� furazolidonekt�uun�grfurazolidone tablets �vo��qw[h1202016086900886000852 �vo��qw[h2007333586903010001237 1.3 �br�gfg̃o�ir 1.3.1 �b�~8h�u{|o�ir!t�up��� pyrazinamide!t�up���grpyrazinamide tablets nwm�o �o��s gp�lq�s��yxbu�n� nwm�o �ğ�l6ro� gp�lq�s � �vo��qw[h3102080086900818000295 ^nnswso�nɩ�v gp�lq�s �vo��qw[h4402076186900290000097!t�up������vpyrazinamide capsules �l3��~�e6ro� gp�lq�s �vo��qw[h2102235286901292000023 �vo��qw[h1302080686902699000241 ς�]_�ho�n gp�lq�s �vo��qw[h3202449086901518000196�[(l�w4lhgx���sodium aminosalicylate �[(l�w4lhgx������ngr-sodium aminosalicylate enteric-coated tablets �vo��qw[h4102243386903139000593&(97) �l\(u�[(l�w4lhgx���$sodium aminosalicylate for injection �vo��qw[h2302171986903712001566 )r�y�un�)r�y�u@l � rifapentine)r�y�un���vrifapentine capsules �vo��qw[h1094019986900804001275fso#k �v�]f#ko�n gp�#��nlq�s �vo��qw[h1084000486902195000059rifapentin capsules �e!��yhy6ro� gp�lq�s �vo��qw[h1094001286901704000160)r�ys^ rifampicin)r�ys^���vrifampicin capsules �vo��qw[h2302093386903712002402 nwm�o �na�o�n���n gp�lq�s��yxbu�n� nwm�^�[o�n gp�lq�s � �vo��qw[h3102003686900804001305 �vo��qw[h1302062186902699001637)r�ys^���v(a!)rifampicin capsules (a!)0.225g( cc43h58n4o12��) �vo��qw[h2102336086901292000528�� � } streptomycin�l\(ukxx��� � }"streptomycin sulfate for injection 1g(100nusmo) �vo��qw[h3702018786904129000869 �vo��qw[h1302065086902690000684yn��n�� ethambutol�vx�yn��n��gr ethambutol hydrochloride tablets �vo��qw[h4202212686902000001028 �vo��qw[h4402075886900290000592 �vo��qw[h3302160286904494001768 �vo��qw[h3102114086900818001889�vx�yn��n�����v!ethambutol hydrochloride capsules �vo��qw[h2102190986901292000122_�p�� isoniazid_�p��grisoniazid tablets �vo��qw[h1202023286900886000388 �vo��qw[h2102235086901292000368 �vo��qw[h3102049586900818000578 �vo��qw[h3102049486900818000561&(102)_�p���l\�misoniazid injection �vo��qw[h1202097086900874001106nkx_�p�� protionamidenkx_�p�����ngr#protionamide enteric-coated tablets �vo��qw[h2102233986901292000078ws�f � } capreomycin)r�y^@l rifabutin)r�y � } rifamycin&(99))r�ys^�l\�mrifampicin injection�pq�e5ml�0.3g��n)r�ys^�� � �l3��s�6ro� gp�lq�s �vo��qw[h2005072586901323000275�l\(u)r�ys^rifampicin for injection�~ y#k ͑�^ns��6ro� gp�lq�s �vo��qw[h2004132086901003000403^�s�p����[(l�w4lhgx�_�p�� � pasiniazid yn��!t�u)r�y_�pa!1ethambutol,pyrazinamide,rifampicin and isoniazida!yn��)r�y_�p#ethambutol rifampicin and isoniazid _�y�_�p��/)r�ys^ �isoniazid and rifampicin_�y���vrifampin and isoniazid capsules%0.25g(c43h58n4o12 0.15gnc6h7n3o 0.1g) �vo��qw[h2102335486901292000474_�ygr isoniazid and rifampicin tablets9��[0.45g��kgr t)r�ys^0.3g,_�p��0.15g � �vo��qw[h2002004186901003000106_�yp����_�p��/)r�ys^/!t�up��� �%isoniazid �rifampicin and pyrazinamide_�yp������v,rifampin isoniazid and pyrazinamide capsules�k�| t)r�ys^75mg0_�p��50mg0!t�up���250mg �vo��qw[h2002046586901292000436_�yp���gr1isoniazid and rifampicin and pyrazinamide tablets9��[=0.45g�c43h58n4o12 0.12g �c6h7n3o 0.08gnc5h5n3o 0.25g �<br>br�w�grbr �vo��qw[h2002004286901003000113 1.3.2 �b��θ�u{|o�ir(l�xdapsone��(l�x acedapsone/l�lp�f clofazimine 1.4 �bw̃o�ir 1.4.1 !t�t{|o�ir 1.4.1.1 �tu{|o�irkq �u clotrimazole�t�^u miconazole&(116) 1.4.1.2 nu{|o�irl�^u fluconazoll�^ugrfluconazole tablets �vo��qw[h1097025786900818002671�^� �vo��qw[h1999015186901749001399 �vo��qw[h1097013386903094000362l�^u���vfluconazole capsules �vo��qw[h2002367886900867000222 �vo��q< w[h2006498286904145000331 �vo��qw[h2002367986900867000215 ck'yr�%f�[o�n gp�lq�s �vo��qw[h2002353586904762000851 q\n�~�vo�n gp�lq�s �vo��qw[h2005648086904140000169 �vo��qw[h2006417386902013000070diflucan'yvb�^�k�|0.15g �vo��qw[h1096016486901187000244 �vo��qw[h2004629986904021001742 �vo��qw[h1096016586901187000237l�^urcegrfluconazole dispersible tablets �vo��qw[h2005110086905781000334 �vo��qw[h2005110186905781000327o�z�^u voriconazolep�͑�uw̃a�g o�z�^u���vvoriconazole capsules �v�]�'y�^ns�^o�n gp�lq�s �vo��qw[h2008078786902087001720o�z�^ugrvoriconazole tablesb��ns^yɩ�v���n gp�lq�s6ro��s �vo��qw[h2005584086902033000203&(118)p�?q�z�st�t�v����v͑�uw̃a �g�l\(uo�z�^uvoriconazole for injection �vo��qw[h2005896286902087000624 �vo��qw[h2006449386900453000445vfendz�q*pharmacia & upjohn company�rsň�pfizer pgm � h2013053186978724000760&(117) l�^u/ls���l\�m)fluconazole and sodium chloride injection100ml�l�^u0.2gn/ls��0.9g �vo��qw[h2005557286902180001191100ml:l�^u0.2gn/ls��0.9 )y%m)y�[o�n���n gp�lq�s �vo��qw[h2005749286900933000255 l�^ua���|�l\�m!fluconazole and glucose injection�en100ml:l�^u0.2gna���|5.0g �vo��qw[h2003008386904012001133100ml:l�^u0.2gn/ls��0.9g �vo��qw[h200231518690412700114150ml:l�^u0.1gn/ls��0.45g  nwm�o �ё1go�n gp�lq�s �vo��qw[h1096028586900801000288 �vo��qw[h2004651386900808001301 100ml:200mg pfizer pgm h2014039186978712000154 50ml:100mg h2014038886978712000123 �vo��qw[h3202620286901453001210l�^u�l\�mfluconazole injection 10ml:0.1g �vo��qw[h20020370869040120012875ml�0.2g �vo��qw[h2003061286901749001412 �vo��qw[h3202425186901749001405�l\(ul�^ufluconazole for injectionw^t �vo��qw[h2006004886904141000236 o�f�^u itraconazole�vx� o�f�^u���v#itraconazole hydrochloride capsules0.1g( cc35h38cl2n8o4��) nwm�s�n�t�h(fun)o�n gp�lq�s �vo��qw[h2007014186903202001113 o�f�^urcegritraconazole disperible tablets wmws�^��o�n���n gp�lq�s �vo��qw[h2008049486905844000349 o�f�^u���vitraconazole capsulesf/t�^ �vo��qw[h2001076786902013000537�vb �vo��qw[h2000012486900886000555�e�v�n��0.1g/�| ��[hg�h6ro� gp�lq�s �vo��qw[h2002036786902529000243&(119) p� o�f�^u�l\br�v�^/��l�u o�f�^u�s g�mitraconazole oral solution 150ml:1.5gjanssen pharmaceutica n.v. h20130425 p� o�f�^u�l\br�v/��^�l�u86978539000894 o�f�^u�l\�mitraconazole injection 25ml:0.25g_glaxosmithkline manufacturing s.p.a.�rsňon�lusomedicamenta sociedade tecnica farmaceutica s.a. � h2014077186978536000262 1.4.2 y�p{|o�ir6r � } nysfungin6r �̃ }grnystatin tablets10nusmo �vo��qw[h37022915869041290012626r � }grnysfungin tablets50nusmo �vo��qw[h3302139386904756000331$n'` � }bamphotericin b�l\(u$n'` � }bamphotericin b for injection25mg �vo��qw[h1302028486902697000113 25mg(2.5nusmo) �vo��qw[h3102082186900792000922 �l\(u$n'` � }b�(�so%amphotericin b liposome for injection �kq~g10mg�1nusmo �� c$n'` � }b�� � �vo��qw[h2003089286900792001936 1.4.3 �h}ṽ }{|o�iras�l���q caspofunginp��]$o�oi� �l\(u��x�as�l���q!caspofungin acetate for injection�y[��e50mg��nas�l���q�� �1�t/�v(laboratoires merck sharp & dohme chibret h2013015386978892000128s|as���q micafungin1.4.4 vq�nlހ'vvu flucytosinelހ'vvugrflucytosine tablets �|ns6ro�ɩ�v���n gp�lq�s �vo��qw[h3202633086901622001027 -n�vo��y'yf[6ro� gp�lq�s �vo��qw[h3202579886901770000408&(124)yr�k��� terbinafine�vx�yr�k���gr!terbinafine hydrochloride tablets0.25g(�n�vx�yr�k�����) �vo��qw[h20083377�%86901556000295!terbinafine hydrochloride tabletspq��b s�n��ns6ro� gp�lq�s �vo��qw[h2000025186900100000019 pso �o�[ek�)yim6ro� gp�lq�s �vo��qw[h1998020686902551000150nkq �vo��qw[h1097021886904021000509 1.5 �b�u�ko�ir1.5.1 ^1�{|o�ir�^��l�u_v��b6r �?�fm� aciclovir?�fm�graciclovir tablets �vo��qw[h2000317786904141000038 �vo��qw[h2005658486904145000027 �vo��qw[h4402359286900453000155aciclovir tablets �vo��qw[h1202029086900931000042 �vo��qw[h2005405086902767000029 �vo��qw[h2005886286902770000191 �vo��qw[h1089004486900818000042=n�ys^ vns�y�vo�n���n gp�lq�s �vo��qw[h1090009486901828000077?�fm����vaciclovir capsulesym_lnfm�^ո)y6qo�ir gp�lq�s �vo��qw[h1094003186904684000021 'yޏ�w-no��s gp�lq�s �vo��qw[h2102384086901123000017?�fm�rcegraciclovir dispersible tablets vns�v�s6ro� gp�lq�s �vo��qw[h2001002486901805000014)r�]旗g ribavirini)r�]旗ggrribavirin tabletsvnwsckn6ro�ɩ�v���n gp�lq�s �vo��qw[h1999337386905000000244 �vo��qw[h2007389286904145001475  nwm�o �)ys^o�n gp�lq�s �vo��qw[h1096015786900680000157ribavivin tablets s�n�sm�o�n���n gp�lq�s �vo��qw[h2005421886900148000279 �vo��qw[h2007388286901016003439)r�]旗g tgrribavirin buccal tablets �vo��qw[h370240238690414000017620mg �vo��qw[h1999932486900931000363)r�]旗g���vribavirin<  capsules�~�bkq ym_lڋao�n gp�lq�s �vo��qw[h1094015786904615000526 �l3��~2m6ro� gp�#��nlq�s �vo��qw[h1096013986901307000789)r�]旗g���|ribavirin granules t#k �vo��qw[h2004027286901770000361�ezs�g �vo��qw[h5102351086902120000185 �vo��qw[h5102350986902120000192 5��]o�nmo�n gp�lq�s �vo��qw[h200833098690549200010418vnwscsёxn_lo�n���n gp�lq�s �vo��qw[h2004477986904960000110 �vo��qw[h1097028086901770000354)r�]旗grcegrribavirin dispersible tablets �vo��qw[h2002031786904383000162&(127))r�]旗g�l\�mribavirin injection1ml:0.1g �vo��qw[h1999351286904127000878 5ml:500mg nmws)rl6ro� gp�#��nlq�s �vo��qw[h2004408386903973000490 2ml�250mg �vo��qw[h2003394586902000001554 vns)y#w�^�6ro� gp�lq�s �vo��qw[h2004630986901842000169 �vo��qw[h2005378986902662000285 �vo��qw[h1999306386904187003109 �vo��qw[h1999918786900673001215 1ml:100mg �vo��qw[h1999948886900801000523 �vo��qw[h1999391986902770003154 �vo��qw[h2000317686904127002636�l\(u)r�]旗gribavirin for injectiongy�rr� wmws�(u�^�r6ro� gp�lq�s �vo��qw[h2003052286905754000699�g(�0.1kq ym_l\�\o�n gp�lq�s �vo��qw[h2002027886904655000074gy�rz�g �vo��qw[h2003052386905755001534 �vo��qw[h2005199086905755000926gw��fw �vo��qw[h2003051586900796001482 �vo��qw[h20020350869057540021120.5kq �vo��qw[h2004142586904655000302 wmwsk���z6ro� gp�lq�s �vo��qw[h2002035186905754002037)rȏ#k �vo��qw[h2003059786904744000114 )r�]旗ga���|�l\�mribavirin and glucose injection100ml:)r�]旗g0.2gna���|5g �vo��qw[h2006445986900933000507250ml:)r�]旗g0.5gna���|12.5g �vo��qw[h2006446086900933000491"ribavirin and glucose injection250ml:0.5g)r�]旗g a���|12.5g �vo��qw[h2003383286902763000269 )r�]旗g/ls���l\�m'ribavirin and sodium chloride injectionhy�_100ml:)r�]旗g0.5g�t/ls��0.8g �y�^ n1ro�n gp�lq�s �vo��qw[h2002031486904785001194��eu100ml:)r�]旗g0.5gn/ls��0.9g �vo��qw[h2001008086904098001287&(126)?�fm��l\�maciclovir injection2ml�0.1g �vo��qw[h2005111186902987000021�l\(u?�fm�aciclovir for injection=n�y#k �vo��qw[h1090009586901828000206 �vo��qw[h3102273586900796000096 �vo��qw[h2004381186904744000145aciclovir for injection �vo��qw[h2004511386901956000352ofm� valaciclovir�vx�ofm�gr"valacyclovir hydrochloride tablets �vo��qw[h2006573586901828000169"valaciclovir hydrochloride tablets=n�sz �vo��qw[h1096008086900453000681 �vo��qw[h1096007986900453000759 �vo��qw[h2005772386900818001926�vx�ofm����v#valacyclovir hydrochloride capsules vnsnsn�\o��o�n gp�lq�s �vo��qw[h2006607086901841000290f�z#k �vo��qw[h1097007186902195000165�lfm� famciclovir�lfm����vfamciclovir capsules�n�g�� �vo��qw[h1999109986901122000247 �vo��qw[h2008348286903944000290|_#k �vo��qw[h2002018486900269000707�lfm�grfancilovir tablets=n�sθ �vo��qw[h1999107586900453001497famciclovir tabletswmck�kq �vo��qw[h1999137986904641001580�qpn s�n v�go�n���n gp�lq�s �vo��qw[h1999138586900056000156&(129)�ffm� ganciclovir�ffm����vganciclovir capsules=n�ypn �vo��qw[h2003081786901828000428&(130) �ffm�/ls���l\�m)ganciclovir and sodium chloride injection���100ml:�ffm�0.05gn/ls��0.9g fkilns��uir6ro� gp�lq�s �vo��qw[h2002029486901940000092250ml:�ffm�0.25gn/ls��2.25g �vo��qw[h2002029586901940000085$100ml:0.1g��ffm� � �vq-n��ffm�0.1g0/ls��0.9g �[ f n�\6ro� gp�lq�s �vo��qw[h2006043286902001000129 �ffm�a���|�l\�m!ganciclovir and glucose injection`�l100ml��ffm�0.1gna���|5g fkil'y�[6ro� gp�lq�s �vo��qw[h2005126386901930000217250ml��ffm�0.25gna���|12.5g �vo��qw[h2005126486901930000200�ffm��l\�mganciclovir injection$\<\�� wmws�(u t�vo�n gp�lq�s �vo��qw[h2005172486905822000262t�� �vo��qw[h2005104186904127003664���gy �vo��qw[h2005145686903973000773�l\(u�ffm�ganciclovir for injection=n�yo �vo��qw[h2003041986901828000664 �vo��qw[h1098018886901828000220 �vo��qw[h1098018986901828000213125mg( cc9h13n5o4��) s�n�q�v�y�b���n gp�lq�s �vo��qw[h2006362686900070000071 �to�ɩ�vuir�] z gp�lq�s �vo��qw[h20057670869037080002450.125g� cc9h13n5o4�� � �vo��qw[h20053772869057550005060.05g �vo��qw[h2004458886904141001547 �vo��qw[h2004317886904141001431&(983)�ufm��l\(u�ufm�penciclovir for injectionr`eynf�^ �vo��qw[h2007018686904655000630?��|z��� vidarabine �l\(uus�xx�?��|z���)vidarabine monophosphophate for injection �vo��qw[h2005883586905006000767&vidarabine monophosphate for injection �vo��qw[h20057903869057550005510.1g( cus�xx�?��|z�����) �vo��qw[h2005881886901940000481 �vo��qw[h2005989686900353000156 �vo��qw[h2005989786900353000149 ws�nwm��o�n���n gp�lq�s �vo��qw[h2005864186901563000233�p%t�[1potassium sodium dehydroandrographolide succinate�l\(u�p%t�[?potassium sodium dehydroandrographolide succinate for injection80mg �vo��qw[h2006490786904152< 001819>potassium sodium dehydroandrograpolide succinate for injection �vo��qw[h2006610686901017000758?potassium sodium pehydroandrographolide succinate for injection ͑�^o��s6ro� gp�#��nlq�s �vo��qw[h500216278690106600153940mg �vo��qw[h5002162886901066001652 �vo��qw[h50021641869010660016388teqbr1.5.2 8h��{|�l�u_v��b6rbr?��_�y�o�adefovir dipivoxilp�;m�r'`���p?��_�y�o����vadefovir dipivoxil capsules#k y��10mg �vo��qw[h2008049786900148001092?��_�y�o�gradefovir dipivoxil tablets:��~�r10mg/gr [�pq }�skq()y%m) gp�lq�s �vo��qw[h2005065186900844000016 tck �vo��qw[h2006066686901523000013�neg�� �vo��qw[h2008003286904021002732�nn)y%mo�irxvzb�o�n gp�#��nlq�s �vo��qw[h2005080386900951000046?���n �vo��qw[h2007012386900600000014i` y旽� enfuvirtidep�~��n�u�u�ka�gi`�f�n�n emtricitabinei`�fas� entecaviri`�fas�grentecavir tabletszs[0.5mg �vo��qw[h2005223786900842000292�bs| y�[ lamivudine�bs| y�[grlamivudine tablets:�nfn[�pq }�skq6ro�(ς�]) gp�lq�s �vo��qw[h2003058186901408000015p�y�bs|�s y�[zidovudine and lamivudine�f�k y�[ telbivudin�f�k y�[grtelbivudine tablets }�ko600mg �vo��qw[h2007002886900100000101 1.5.3 ˆ}vv��b6rbrey�s�n� oseltamivirp�ama͑�u�`��xx�ey�s�n����voseltamivir phosphate capsules��� 75mg(�ney�s�n旡�)*f. hoffmann - la roche ltd�rsň� nwmwl6ro� gp�lq�s � �vo��qw[j2009007686978791001325ey\� 75mg��ney�s�n旡� �2  nwm-n� n�~o�n gp�lq�s �vo��qw[h2006541486900748000716�sz�[ fn3�iq�_lo�n���n gp�lq�s �vo��qw[h2006541586901997000151ёryn�� rimantadine�s g8^ʑbr�w �s g�msobr ���|br�lny��� saquinavir 1.5.4 vq�n�b�u�ko�ir�b~��n�u(uo��%p�y y�[�s������s�n y�[?��]as�p�͑�uamahy��bs^�o^��&o�0w���)rxb���hy^������2ux���foscarnet sodium ��2ux���/ls���l\�m.foscarnet sodium and sodium chloride injection100ml���2ux���2.4gn/ls��0.3g ns�no�n���n gp�lq�s �vo��qw[h2006666386904042000366250ml:��2ux���3.0gn/ls��2.25g �vo��qw[h2006668486901930000149�s� 250ml:3.0g �vo��qw[h2000044186901523000815�l\(u��2ux���foscarnet sodium for injection0.64g(�ncna3o5p��) ^n�[܏ɩ�vo�n gp�lq�s �vo��qw[h2004036286900289000442l��y�vp[transfer factor�bu }���n�c6r�v�u�k'`b �̃'`�~ހ�qa�g 1.6 vq�n�b̃o�ir\�j�x berberine�vx�\�j�xgr"berberrine hydrochloride tablets �vo��qw[h1202042586900867000833berberine hydrochloride tablets �vo��qw[h2102245386901162001297�vx�\�j�x���v berberine hydrochloride capsules ^n�st6ro� gp�lq�s �vo��qw[h4402397086900294000161|�e�i� } houttuyfonate|�e�i� }��grsodium houttuyfonate tablets30mg vnwswxn-n6ro� gp�lq�s �vo��qw[h4302087886904971000437�|c�gr nwm�o �o��s gp�lq�s��yxb nwm�o �]n�yo�n gp�lq�su�n � �vo��qw[h3102290486900818001001'y�� }garlicin'y�� }���n��8n%alltride enteric-coated soft capsules�vo��c��f��6ro�(�s�) gp�lq�s �vo��qw[h3502121786904873002249'y�� }���vgarlicin capsules _lςck'yn_l6ro� gp�lq�s �vo��qw[h3202568386901473000422&(145) )rhyu���)rhyu��a���| � linezolidp�n�s � }�l�u�eheb n�s��s�v͑�ua�g�`��v�^/��l�u&(146)p�n�s � }�l�u�eheb n�s��s�v͑�ua�g)rhyu���l\�m�e�l 300ml:600mgfresenius kabi norge as h2011031286979520000015 2 �b�[uk��uo�ir 2.1 �b8tk��uo�ir!t�un� praziquantelkx/lz� bithionolyn���udiethylcarbamazine2.2 �b�uo�ir 2.2.1 r��� }{|o�ir��2u�� artemetherr��� }{|o�irr��� } artemisininhbr2.2.2 vq�n/o(l�u primaquineny�[quinine/l�u chloroquine�xx�/l�ugrchloroquine phosphate tablets1000 �vo��qw[h3102086986900681000910&(155)yn��'vvu pyrimethamine�x��y�� sulfadoxine&(154)�t�vu malaridine&(158)�t�u piperaquine�/l�uhydroxychloroquinefkxx��/l�ugr"hydroxychloroquine sulfate tablets�~pn  nwm-n�6ro� gp�lq�s �vo��qw[h1999026386900834000101&(156)4�br 2.3 q���k�o�ir2utu mebendazol2utugrmebendazole tablets�[pn�x �vo��qw[h6102295286902529000045?��u albendazole?��ugralbendazol tablets ns-no�n���n gp�lq�s �vo��qw[h4202140586901884000028 �vo��qw[h5002030386901016000063albendazole tablets�skq��k�n -n�)y%m�skq6ro� gp�lq�s �vo��qw[h1202049686900969000014?��u���valbendazol capsules �vo��qw[h2007332886903010000025/l]x�g�� niclosamide�t�u piperazine&(164)-�br�s��x�{v'vvupyrantel pamoate�s��x�{v'vvugrpyrantel pamoate tabletsmg�][����luep�^o�n gp�lq�s �vo��qw[h3302159386904494001560&(165)o���br2.4 �bnk��u�s�bў�p�uo�ira���|x����sodium stibogluconate&(166)�u�n� pentamidine&(167)2.5 �b?�s|�]�uo�ir�s�b�nk��uo�ir�s�x�uiudiiodohydroxyquinoline�os|nemetine3 ��pg��u�s^�>uso�b�po�ir3.1 ��pg��u�s^�>uso�b�po�ir3.1.1 ^� ��b'`cox�b6rbr?��s9s�gaspirindegi^m�� ibuprofeng^m��gribuprofen tablets �vo��qw[h1302130486902777002549 �vo��qw[h3702038686904187002584 8^�]6ro��s gp�lq�s �vo��qw[h3202329686901397000362 �vo��qw[h3702038786904187002577^m�����vibuprofen capsules0.2kq _l����mo�n gp�lq�s �vo��qw[h3602229786905381000185�[ynp�(l�wz� paracetamol�[ynp�(l�wz�grparacetamol tablets r��\ğwm6ro� gp�#��nlq�s �vo��qw[h3702111086904043000723 �vo��qw[h5002030786< 901016002883�_t� �vo��qw[h1202111886900969000069 �vo��qw[h2102152486901161002172�s/l��x� diclofenac �s g8^ʑbr�w ʑ�cʑbr�w�s/l��x������ngr(diclofenac sodium enteric-coated tablets �vo��qw[h4102048786903098003116 �vo��qw[h1302098586902770000610 �vo��qw[h4402498986900290000684vb�n�g25 mg �vo��qw[h1102164086900100000071�s/l��x���grdiclofenac potassium tablets�n �vo��qw[h2002021386904656001117�s/l��x������vdiclofenac potassium capsules vnwsё�lo�n gp�#��nlq�s �vo��qw[h2001054986904937000136f� �vo��qw[h2001026486900976000823�s/l��x���ʑgr dicolfenac sodium sustained release tablets�9h �vo��qw[h1097020986900555000527 �s/l��x���ʑgr(`!) diclofenac sodium sustained release tablets �vo��qw[h2001060486900818000455 �vo��qw[h1098029786900100000040 �s/l��x���ʑgr(d!))y�e)r�_ �vo��qw[h1096022886900964000507 �s/l��x���ʑgr(iv)/diclofenac sodium sustained release tablets (c!)�kqpnkq q\�_�x(-n�v)6ro� gp�lq�s �vo��qw[h1098003786900863000134 �s/l��x���ʑ���v,diclofenac sodium sustained release capsules ws�n��o6ro� gp�lq�s �vo��qw[h2003322086901555000838 �swm�m��6ro����n gp�lq�s �vo��qw[h2006698586900601000143 �s/l��x���ʑ���v(`!)  nwma�q\o�n gp�lq�s �vo��qw[h1999113786900676001137�*yr� �vo��qw[h10960217869017700002552t�t��� indometacin2t�t���hindometacin suppositories50�kkq l��^��o�nɩ�v���n gp�lq�s �vo��qw[h4202037786901954000415indomethacin suppositories vnsn�oo�n gp�lq�s �vo��qw[h4202146286901792000127indometacin0suppositories s�n�s t6ro� gp�lq�s �vo��qw[h1102139186900176001781  y�e(l�w�k�g��[�u�[ �compound amidopyrine  y�e(l�g�]�k�y�l\�m.compound aminophenazone and barbital injection2ml �vo��qw[h41025523869030210003972ml:(l�w�k�g0.1g,�[�f�k�g40mg,�]�k�y18mg �vo��qw[h1302451086902770003505fufang anlin babituo zhusheye ѐ�]ss�\6ro� gp�lq�s �vo��qw[h4102544386903273000329 �vo��qw[h41025237869030980018082ml�(l�w�k�g0.1g ��[�f�k�g40mg ��]�k�y18mg �vo��qw[h1202121786900874000277�[cnя metamizole�[cnяgrmetamizole sodium tablets �vo��qw[h3102133186900818000172 �vo��qw[h3702063286904187000122!twf�^ piroxicam!twf�^grpiroxicam tablets �vo��qw[h3102071686900818000363piroxicam tablets �vo��qw[h3702104986904083000134&(171)�s g�msobr ʑ�cʑbr�w ���|br^m��ʑ���v$ibuprofen sustained-release capsules���_�_&,g�t�k�| t;n��b�n^m��0.3kq0���e:n��|0�m�|0lx�x�0z�yn�p!t�t�pn�0 �vo��qw[h1090008986900969000083$ibuprofen sustained release capsules �vo��qw[h1998313786900600000465^m�����|ibuprofen granules �vo��qw[h20066209p�?q�z�%86902777002563^m���m�`�mibuprofen suspension tim100ml:2g �vo��qw[h1998001786901445001617��g  nwm:_u6ro� gp�lq�s �vo��qw[h1999101186900734000201^m���m�`�nbribuprofen suspension drops�nbr 15ml:0.6g �vo��qw[h1999101286900734000195xbi`�m�`�nbr 20ml:0.8g )y'yo�n(�swm) gp�lq�s �vo��qw[h1098025086900560000062�\�� 25ml:0.5g�2% � fkil�n�yo�n gp�#��nlq�s �vo��qw[h1098002186901958000510�%�p�?q�zsn��br^m��sn��ibuprofen cream20g�1g �vo��qw[h2006621086903708000337 5%�20g:1g � �vo��qw[h1999015586900969000106��/l��x� aceclofenac��/l��x����ngr#aceclofenac enteric-coated tablets1r�� _lς t�\o�n���n gp�lq�s �vo��qw[h2005027286901452000429"aceclofenac enteric-coated tabletsnm�r�� �vo��qw[h2004080386904010000374��/l��x�graceclofenac tablets����� ��[wm#k6ro� gp�lq�s �vo��qw[h2002023186902481000237��n u��r`ڋ6ro� gp�lq�s �vo��qw[h2004148086902341000032��/l��x�rcegraceclofenac dispersible tables���n�� �o3�^�n�no�n gp�lq�s �vo��qw[h2005025386903184000067&(172) ʑ�cʑbr�w �s g�msobrl�km��o�flurbiprofen axetill�km��o��l\�mflurbiprofen axetil injection�q�~5ml:50mg s�n�l�_6ro����n gp�lq�s �vo��qw[h2004150886900156000056&(178)l�km�� flurbiprofen y�e?��s9s�gcompound aspirin preparations�|(lx�?��s9s�garginine acetylsalicylate �l\(u�|(lx�?��s9s�g'arginine acetylsalicylate for injection 0.5g��|(lx�?��s9s�g � �vo��qw[h2006726986904152001963 1.0g��|(lx�?��s9s�g � �vo��qw[h2006727086904152001970(arginine acetylsalicylate for injection 0.5g(�|(lx�?��s9s�g) �vo��qw[h2005578986905793000650 1.0g(�|(lx�?��s9s�g) �vo��qw[h20055790869057930006670.5g(�n�|(lx�?��s9s�g��) vnsw�nfo�n���n gp�lq�s �vo��qw[h2006535786901807000098 y�e�[ynp�(l�wz�compound paracetamol  y�e�[ynp�(l�wz�gr(a!) compound paracetamol tablets(ii)cer� y�e �vo��qw[h2001300386900978001552compound paracetamol tablets(a!)ce)r�u!�[ynp�(l�wz�250mg,_n�[�f�k�g150mg,�e4l�tau�v50mg �b3�;so��oep gp�lq�s �vo��qw[h2005694886900002000032�|(lx�^m��ibuprofen arginine���|br �s gcebrv�(l9s�glysine acetylsalicylate�l\(uv�(l9s�g%lysine acetylsalicylate for injectioneg�k�g ���w0n�s�mq\6ro� gp�lq�s �vo��qw[h3402243686904288000885aspirin-dl-lysine for injection �vo��qw[h2005303686905821000720 �vo��qw[h3402243886904288000939 �vo��qw[h5002131886901066001676/l��f�^ lornoxicam�l\(u/l��f�^lornoxicam<  for injection8mg(�k�t�[ň/l��f�^8.6mg) �t\�n nt�o�n gp�lq�s �vo��qw[h2005716086903662001906�s^xθ8mg(�k�t�[ň8.6mg ��d�2ml�l\(u4l �=wasserburger arzneimittelwerk gmbh�rsňon�takeda austria gmbh � h2013057186979574000047 �vo��qw[h2004368586904756000096&(183)/l��f�^grlornoxicam tablets���4mg �vo��qw[h2004028986904756000188ck�^ s�ng�o6ro� gp�lq�s �vo��qw[h20052196869000850000978mgnycomed austria gmbh h2009087286978685000205/l��f�^rcegrlomoxicam dispersible tablets �%f܏'y�vey6ro� gp�lq�s �vo��qw[h2007020686903310000398lornoxicam tablets )y%mr�eo�n gp�lq�s �vo��qw[h2008326386900854000068m"}m�� loxoprofenm"}m����rcegr%loxoprofen sodium dispersible tablets60mg(�nm"}m�����e4lir��) �vo��qw[h2008000986904141002049m"}m�������vloxoprofen sodium capsules60mg( c�e4lm"}m������) �vo��qw[h2007004186904145000621�^z�kq60mg( cc15h17nao3��) q\nzؚo�n���n gp�lq�s �vo��qw[h2005091586904113000257m"}m����grloxoprofen sodium tabletspn~g60mg,{n nqq6ro�( nwm) gp�lq�s �vo��qw[h2003076986900745000054�ȏ60mg(�nc15h17nao3��) �vo��qw[h200306148690080800186860mg/gr �vo��qw[h2003061786900949000058�mf�^ meloxicam�mf�^grmeloxicam tablets�[�zr�7.5mg �vo��qw[h2003048686905849000351��pn�e �vo��qw[h2003039286901679000462��;r�g15mg fq\��op^t�6ro� gp�lq�s �vo��qw[h2001020486901533000171�[:_ �vo��qw[h2001020786901749001214���k�s nwm�r�g1/e/�v5boehringer ingelheim espana, s.a.�rsň� nwm�r�gsň25g//e ğ�wksupg�eo�n gp�lq�s �vo��qw[h2004030186901898000199&(173)&(174)�s g8^ʑbr�w ʑ�cʑbr�w �cʑ���|br2t�t������ngr  nwm�o �ğ�l6ro� gp�lq�s �vo��qw[h31020148869007870001732t�t���ʑ���v&indometacin sustained release capsules s�n�~�g6ro� gp�lq�s �vo��qw[h51020108869000440000522t�t���ʑgr%indometacin sustained-release tabletsa�en  ���(-n�v)6ro� gp�lq�s �vo��qw[h1998019186900098000015n�m�� ketoprofenn�m���q��ketoprofen gelmi`10g:0.3g �vo��qw[h1095012286900952000014�l�e�1g:0.025g,20g//e1a.menarini industrie farmaceutiche riunite s.r.l. h2009105886979063000060�s�en�m�� dexketoprofen�oxb�^x�etodolac�cʑbr�w�oxb�^x�ʑgr"etodolac sustained release tablets�o�� �vo��qw[h2004050786900148000392(l�tu1aminopyrine,caffeine and calcium glycerophosphate(l�tugr9aminopyrine,caffeine and calcium glycerophosphate tablets(l�w�k�g0.15g,�tau�v40mg,u�l�xx���35mg )y%m�n�[o�n�y�b gp�lq�s �vo��qw[h1202104986900858000033(l�w�k�g0.15g,�tau�v0.04g,u�l�xx���0.035g )y%mёn6ro� gp�lq�s �vo��qw[h12021110869008730000495aminopyrine,caffeineandcalciumglycerophosphatetablets �vo��qw[h12021200869008860000439aminopyrine caffeine and calcium glycerophosphate tablets(l�w�k�g0.15g0�tau�v40mg0u�l�xx���35mg �vo��qw[h1202110786900931000080�"}�]�� methocarbamol�"}�]��rcegr!methocarbamol dispersible tablets )y%mt�[uir6ro� gp�lq�s �vo��qw[h2008027386900879000234�"}�]�����vmethocarbamol capsules �%f��~6ro� gp�lq�s �vo��qw[h2202420286903298000199�"}�]��grmethocarbamol tablets �w�[�^^os�to�n gp�lq�s �vo��qw[h1302413386902760000460 �vo��qw[h1202122686900964000637ey�lnf�y oxaproziney�lnf�y���ngr oxaprozin enteric-coated tablets �vo��qw[h20058705869019970000453.1.2 ��b'`cox-2�b6rbr<\��)r nimesulide �s g8^ʑbr�w0�cʑbr�w<\��)rgrnimesulide tablets �vo��qw[h2000028486900381001873nfz �vo��qw[h1998004486900951000299<\��)r���vnimesulide capsules~�kq )y%m�t�lo�n gp�lq�s �vo��qw[h2001030686900862000036 �vo��qw[h2002046286904641002174<\��)rrcegrnimesulide di< spersible tablets�r�~g �vo��qw[h2001073486901862000026ς�i s�n8lck6ro� gp�#��nlq�s �vo��qw[h2001042686900205000174<\��)rʑ���v%nimesulide sustained-release capsules �vo��qw[h2005083286905754002068^^tf^ parecoxib p�/gtg��u�t�]$o�oi��l\(u^^tf^��parecoxib sodium for injectionyr� 40mg/�t*1�t/�v,pharmacia and upjohn company�rsňon���^t6ro� gp�lq�s � �vo��qw[j2013004486978718001094^xegf^ celecoxibp� g%n͑à��s��n�u�s�q@��s�v �`�^xegf^���vcelecoxib capsules�pnf� 0.2g/�|*6�|/�v*pfizer pharmaceuticals llc(rsňon���^t6ro� gp�lq�s) �vo��qw[j20140072869787240008693.1.3 vq�n�s�ugr�"}s|�u �0compound aminopyrine phenacetin tablets�somedon ��s�ugr'compound aminopyrine phenacetin tablets �vo��qw[h12020155869008860001730tabellae aminophenazoniet phenacetini compositae �vo��qw[h6102221586902503002669$(l�w�k�g0.15g,^����n0.15g,�tau�v50mg,��]�k�y15mg �vo��qw[h3702030486904187002461(l�wa���| glucosamine kxx�(l�wa���|���vglucosamine sulfate capsules�~�v�r0.25g��nkxx�(l�wa���|�� �rottapharm ltd. h2009079786979343000025#�k�| tkxx�(l�wa���|/ls��314mg ��vs_�nkxx�(l�wa���|250mg0 �onu�b���n gp�lq�s hc2012003786979160000123 o"}so0.314g��vs_�nkxx�(l�wa���|0.250g) �vo��qw[h2004131686904641000255 �vx�(l�wa���|���v"glucosamine hydrochloride capsulesey�lup�o�6ro��s hc2014000786979136001604 hc2014000886979136001611�vx�(l�wa���|gr!glucosamine hydrochloride tablets]n�r750mg �vo��qw[h2006064786901473000286240mg�v�]�~�s�[iqo�n���n gp�lq�s �vo��qw[h2006080286902122000282ekȏ�e0.24g �vo��qw[h2005130186902273000025(l�|���glucosamine indomethacin(l�|������ngr.glucosamine indometacin enteric-coated tablets�kgr t2t�t���25mg�t�vx�(l�wa���|75mg4���o��� �vo��qw[h1999359786904636000017�kgr t2t�t���25mgn�vx�(l�wa���|75mg �vo��qw[h200835448690277000375840 �rir��y���l\6rbr"�%�p�͑�^��(��u~g�`�nxʋ:n�� �b�^ߏatt3*ng�qo(u�t�]$o�o i�����/ls���l\�m&ossotide and sodium chloride injectionuё�l100ml:y��0.1gn/ls��0.87g �vo��qw[h2005123686903662001791�����l\�mossotide injection 10ml:50mg �%fnfns6ro����n gp�lq�s �vo��qw[h20056531869033180004995ml:25mg �vo��qw[h20057201869019400000782ml:10mg �%f��^o�nɩ�v gp�lq�s �vo��qw[h2000305286903299000303��ty���l\�m(cervus and cucumis polypeptide injection2ml:4mg �vo��qw[h23020001869036870001374ml:8mg �vo��qw[h2302000286903687000120�l\(u����ossotide for injection25mgy�� �vo��qw[h2005123786903662000572ў��_l�s�[�\o�n���n gp�lq�s �vo��qw[h2000342786903783000154�l\(u��ty���~� ў��_lꏙ�6ro� gp�lq�s �vo��qw[h2006062586903726000814'cervs and cucumis polypetide injection �vo��qw[h2005105186903726000562,cervus and cucumis polypeptide for injection ў��_l_lno�n gp�lq�s �vo��qw[h2005095086903740000159���t�c�sir�l\�mbone melon extract injection _\�^��o�n gp�lq�s �vo��qw[h2006410486903134000116 �vo��qw[h2006410386903134000772 �t\�n~gd�6ro� gp�lq�s �vo��qw[h2005870786903671000099 �vo��qw[h2005870886903671000181 �t\�n#w�luir6ro� gp�lq�s �vo��qw[h2302350786903665000340 �vo��qw[h2302350686903665000333�l\(u���t�c�sir��s�[ 25mg(�ny��{|ir(���) �vo��qw[h2005273086903726000623 y�e�����l\�mcompound ossotide injection2ml:30mg ws�n�e~vo�n gp�lq�s �vo��qw[h3202000386901598000208 �vo��qw[h2005400686901370000082�l\(u y�e����compound ossotide for injection�sa30mgy��ir(� �vo��qw[h2005231486902557000758�spg �vo��qw[h2005096386903740000128&(196)��������grossotide tablets�kgr ty��{|ir(� nno�n40mg �[�_�[no�n gp�lq�s �vo��qw[h2005587686904373000400 �vo��qw[s2005301986903740000296  t�gns�^o�n���n gp�lq�s �vo��qw[h2005892786903373000236 y�e/lu�l�[compound chlorzoxazone  y�e/lu�l�[rcegr*compound chlorzoxazone dispersible tablets��ws�yr�kgr t�[ynp�(l�wz�0.15gn/lu�l�[0.125g �vo��qw[h2005018086904010000046 y�e/lu�l�[grcompound chlorzoxazone tablets�kgr t/lu�l�[0.125g,�[ynp�(l�wz�0.15g �vo��qw[h1094004086904012000464composite chlorzoxazone tablets/lu�l�[0.125g,�[ynp�(l�wz�0.15g q\n�r���y�\6ro� gp�lq�s �vo��qw[h3702231086904120000110�a�q�u�r�v y�eotc6rbr�%��% y�e(lz��p�����v:compound paracetamot and amantadine hydrochloride capsules6�k�| t�[ynp�(l�wz�250mg,�vx�ёr�p��100mg,l�egx�/l�oe2mg,�n�][rğ10mg,�tau�v15mg �vo��qw[h3302102386904656000318 y�e(lz��p��gr9compound paracetamol and amantadine hydrochloride tablets �vo��qw[h23023372�%��%869037120031267�kgr t�[ynp�(l�wz�250�kkq ��vx�ёr�p��100�kkq ��n�][rğl0�kkq ��tau�v15�kkq �l�egx�/l�oe2�kkq0 �vo��qw[h2102372986901161002226  y�e(lz��p��rcegrecompound paracetamol and amantadine hydrochloride dispersible tablets6�kgr t��[ynp�(l�wz�0.25gn�vx�ёr�p��0.1gnl�egx�/l�oe2mgn�tau�v15mgn�n�][rğ10mg �vo��qw[h20050830869042030001671�[ynp�(l�wz�250mg,�vx�ёr�p��100mg,�n�][rğ10mg,�tau�v15mg,l�egx���oe2mg �vo��qw[h3702369386904043000709  y�e�vx�*o��ğ�xʑ���vacompound pseudoephedrine hydrochloride sustained release capsules�e�^�lkq!,g�t:n y�e6rbr ��k�| t�vx�*o��ğ�x90mg �l�egx�/l�oe4mg0 �vo��qw[h20010430< 86900969000045:compound paracetamol and amantadine hydrochloride capsules �vo��qw[h2007421086902770003703(lz��f��grpparacetamol triprolidine hydrochloride and pseudoephedrine hydrochloride tabletst�����pn �vo��qw[h2000002286900600000137(lz�*o�����gr��egr �/(l���oegrii�ygr �.compound dextromethorphan hydrobromide tablets�ey~v g�t]�[ynp�(l�wz�500mg,�vx�*o��ğ�x30mg,"l�nx��s��l��15mg��egr8 �<br>�[ynp�(l�wz�500mg,"l�nx��s��l��15mg,�vx�*o��ğ�x30mg,l�egx�/l�oe2mg�ygr4 ��vo��qw[h10970388/�vo��qw[h1097038786900842000124 (lz�*o����oe�t�vgrxparacetamol, pseudoephedrine hydrochloride and chlorpheniramine maleate chewable tablets$�kgr t�[ynp�(l�wz�160mg �l�egx�/l�oe1mg ��vx�*o��ğ�x15mg s�n�^��<\o�n gp�lq�s �vo��qw[h2003022886900073000054(lz�*o��gr�a! �@paracetamol and pseudoephedride hydrochloride compoud tablets(a!)�kgr t�[ynp�(l�wz�325�kkq�t�vx�*o��ğ�x30�kkq0 s�n]n��6ro� gp�lq�s �vo��qw[h2006601886900067000015(l�tğoe���vlparacetamol,caffein,atificial cow-bezoar and chlorphenamine maleate capsules*�k�| t�[ynp�(l�wz�250�kkq,�tau�v15�kkq,l�egx�/l�oe1�kkq,�n�][rğ10�kkq �vo��qw[h1302343186902777000163mparacetamol,caffein,artificial cow-bezoar and chlorphenamine maleate capsules*�k�| t�[ynp�(l�wz�250mg,�tau�v15mg,l�egx�/l�oe1mg,�n�][rğ10mglbp[_lo�nɩ�v_lς6ro����n gp�lq�s �vo��qw[h3202549286901747000028(l�tğoegrlparacetamol,caffein, atificial cow-bezoar and chlorphenamine maleate tablets�kq ym_lo�vo�n gp�lq�s �vo��qw[h3302216286904759000031*�kgr t�[ynp�(l�wz�250�kkq0�tau�v15�kkq0l�egx�/l�oe1�kkq0�n�][rğ10�kkq �vo��qw[h1202119886900919000026�oe*o��gr,composite benorilate pseudoephedrine tabletsy�u �vo��qw[h1097023086902089000165^m*o��rcegr?ibuprofen and pseudoephedrine hydrochloride dispersible tabletsxb�[�kgr t^m��200mg,�vx�*o��ğ�x30mg �vo��qw[h2002068586900560000116^m*o��o����v ibuprofen and pseudoephedrine soft capsulesnfm�_��^m��100mgn�vx�*o��ğ�x15mg �wo�ɩ�vi`�_nfo�n gp�lq�s �vo��qw[h2006061086902774000081z�(l�toegrfparacetamol aminophenazone caffeine and chlorphenamine maleate tablets �vo��qw[h3102250886900818002947fparacetamol,aminophenazone,caffeine and chlorphenamine maleate tablets �vo��qw[h3502138786904873000788z��tgr paracetamol and caffeine tablets�rt~v g�[ �vo��qw[h1096001386900842000414z����oe�m�`�mmparacetamol,pseudoephedrine hydrochloride,dextromethorphan hydrobromide and chlorphenamine maleate suspension�l��0�kml t�[ynp�(l�wz�32mgn�vx�*o��ğ�x3mgn"l�nx��s��l��1mgnl�egx�/l�oe0.2mg �vo��qw[h2004169486900734000041z����oegrdparacetamol,pseudoepherine hydrochloride,dextromethorphan hydrobromide and chlorphenamine maleate ta-�[ynp�(l�wz�325mg,�vx�*o��ğ�x30mg,"l�nx��s��l��15mg,l�egx�/l�oe2mg �vo��qw[h2001011586900734000140�[ynp�(l�wz�0.25g,�vx�ёr�p��0.1g t�gw��po�n�y�b�su\���n gp�lq�s �vo��qw[h2202475186903454000506:compound paracetamol and amantadine hydrochloride tablets �%f�nlo�nɩ�v gp�lq�s �vo��qw[h2202574786903319000900 �_�]�_o�6ro� gp�lq�s �vo��qw[h3702364986903942000094 kf�wwm�e6ro� gp�lq�s �vo��qw[h1402385186902856000091 y�e �^���|br.compound zinc gluconate and ibuprofen granulesたr�q#ka���|x� �0.1g,^m��0.15g,l�egx�/l�oe2mg �vo��qw[h3202646986901556000080�oe*o���n�mbpseudoephedrine hydrochloride, chlorpheniramine maleate and dextromethorphan hydrobromide solution�`�[�s g�n�mbr/100ml��kml t�vx�*o��ğ�x 3mg,"l�nx��s��l�� 1mg,l�egx�/l�oe 0.2mg � �vo��qw[h2003005186901421000016/100ml��kml t�vx�*o��ğ�x 6mg,"l�nx��s��l�� 2mg,l�egx�/l�oe 0.4mg � �vo��qw[h2003005486901421000023_pseudoephedrine hydrochloride chlorphenamine maleate and dextromethorphan hydrobromide solution(60ml:�vx�*o��ğ�x180mg,"l�nx��s��l��60mg,l�egx�/l�oe12mg �vo��qw[h2004577986900560000024(l���oegr�a! �dparacetamol,pseudoephedrine hydrochloride,dextromethorphan hydrobromide and chlorpheniramine maleate.�[ynp�(l�wz�500mg0"l�nx��s��l��15mg0�vx�*o��ğ�x30mg0l�egx�/l�oe2mg. �vo��qw[h2001306386900969000137(l�tğoe�s g�n�mhparacetamol �caffeine �cow-bezoar and chlorphenanine maleate oral solution�k�tň120ml _l��t�vo�n gp�lq�s �vo��qw[h2005856986905306000269�k�tň60ml�k/eň10ml86905306000252�sqb*o��rcegr:dispersible pseudoephedrine hydrochloride compound tablets&�kgr t�[ynp�(l�wz�80mg,�vx�*o��ğ�x7.5mg,l�egx�/l�oe0.5mg q\��v�w�v�^o�n gp�lq�s �vo��qw[h2002045886902892000109 (lz�*o����oegr(a!)pparacetamol pseudoephedrine hydrochloride and chlorphenamine maleate tablets (a!)wm�s���_� �m3wwm�so�n gp�lq�s �vo��qw[h4402355786900503000425a����|6guaifenesin and dextromethorphan hydrobromide granulesns��ar(gz�u�l��0.1g,"l�nx��s��l��15mg. �vo��qw[h1999004086901556000134a�gr5guaifenesin and dextromethorphan hydrobromide tablets�sfw�kgr t"l�nx��s��l��15�kkq0ar(gz�u�l��100�kkq0 �vo��qw[h2003068186901122000902 a�gr/a�gr(sc�gr)�`�[ tar(gz�u�l��100mg,"l�nx��s��l��15mg �vo��qw[h2003071286901421000030(lz�ğ��oeepediat< ric paracetamol,atificial cow-bezoar and chlorphenamine maleate \?q(lz�ğ��oe���|npediatric paracetamol,atificial cow-bezoar and chlorphenamine maleate granules!�[ynp�(l�wz�0.125g,�n�][rğ5mg,l�egx�/l�oe0.5mg �vo��qw[h4402497786900503000388npediatric paracetamol,atificial cow �bezoar and chlorphenamine maleate granules �vo��qw[h1302373986902770001105opediatric paracetamol, atificial cow-bezoar and chlorphenamine maleate granules �vo��qw[h1202106286900900000110opediatric paracetamol atificial cow-bezoar and chlorphenamine maleate granules#�k�� t�[ynp�(l�wz�125�kkq,l�egx�/l�oe0.5�kkq,�n�][rğ5�kkq )y%m-n)y6ro� gp�lq�s �vo��qw[h1202106686900958000223��i�x capsaicin��i�xsn��capsaicin cream20g:5mg �vo��qw[h2003003186903318000512��i�xo���capsaicin ointment30g�22.5mg� c��i;`�x���{ � �y�^w�r�kqo�n gp�lq�s �vo��qw[h2008008986904797000680egls|yr leflunomideegls|yrgrleflunomide tabletsk�>m �vo��qw[h20080047869011220009641r�ns ς�]��_-#k�q6ro� gp�lq�s �vo��qw[h2000055086901645000670 3.2 �b�uθo�ir�y4l�n�x colchicine�y4l�n�xgrcolchicine tablets �vo��qw[h20003842869000560000571mg ff6ro�ɩ�v���n gp�lq�s �vo��qw[h5302153486905614000470 �vo��qw[h5302138986905614000401 r v�� allopurinol r v��grallopurinol tablets �vo��qw[h5002045586901016000308 �vo��qw[h3102033486900804000094nl��� benzbromaronenl������vbenzbromarone capsulesȏ�s �vo��qw[h2004059286902033000029benzbromarone capsules �vo��qw[h2001079086901533000034nl���grbenzbromarone tablets�z�r)r�nexcellagmbh�rsňon�fq\��op^t�6ro� gp�lq�s � �vo��qw[j2013014186978811000079\ t� �vo��qw[h2004034886901997000052&(202)ʑ�cʑbr�w r v��ʑgr%allopurinol sustained-release tabletsf��� �vo��qw[h2004174386905801000061 r v��ʑ���v%allopurinol sustained-reease capsuleseyȏ�_)rў��_l�o)r��hy�_6ro� gp�lq�s �vo��qw[h2004133886903719000036n�x� probenecidn�x�grprobenecid tablets �vo��qw[h20058786869008180003944 g��uo�ir 4.1 ?�gr{|g��uo�ir��*y<\fentanylc �g|jx���*y<\�l\�mfentanyl citrate injection 10ml�0.5mg �vo��qw[h2000368886902000001813 2ml�0.1mg �vo��qw[h42022076869020000017522ml:0.1mg(�n��*y<\��) �vo��qw[h201135088690143500013210ml:0.5mg(�n��*y<\��) �vo��qw[h2011350986901435000149�vo�ɩ�v�]n gp�lq�s�^jwrlq�s �vo��qw[h2012329886902581000045 �vo��qw[h2012329786902581000052�t�fvu pethidine�vx��t�fvu�l\�m!pethidine hydrochloride injection 2ml�100mg �vo��qw[h21022413869011610017001ml�50mg �vo��qw[h2102305886901161000994 �vo��qw[h4202207486902000000557 r�wm6ro��s gp�lq�s �vo��qw[h6302002286905956000428taumorphinecg�vx�taugrmorphine hydrochloride tablets �vo��qw[h2006322086901161002011&(207)�vx�tau�l\�m morphine hydrochloride injection1ml�10mg �vo��qw[h2102243686901161001922(lz���n� ��[ynp�(l�wz���n� �oxycodone acetaminophen(lz���n�gr#oxycodone and acetaminophen tablets�l�r�[5mg�vx���n� 325mg�[ynp�(l�wz�!mallinckrodt inc.�rsň��vo�ɩ�v�]n gp�lq�s � �vo��qw[j2015011586900228000243^xbau�� butorphanol r��wx�^xbau���l\�m"butorphanol tartrate injection��lb1ml�1mg �vo��qw[h2002045486901445001723&(205) p�zfg��$v n���s g���*y<\��v4�brfentanyl transdermal patchesy^t t25�_kq/\�e �4.2mg/4�*janssen pharmaceutica nv�rsňon���[hg�h6ro� gp�lq�s � �vo��qw[j201100438697853900083250�_kq/\�e �8.4mg/4� �vo��qw[j2011004286978539000849kxx�tauʑgr morphine sulfate sustained-release tabelets��e�^�[ �vo��qw[h1098006286900098000039 �vo��qw[h1098026386900098000046�vx�tauʑgr0morphine hydrochloride sustained-release tablets��^ �vo��qw[h1093007886900978003099 �vo��qw[h1093000186900978003730��ln� methadone �s g8^ʑbr�w �s g�msobr�vx���ln�grmethadone hydrochloride tablets �vo��qw[h1998322186900928000642&(210)��n� oxycodone�vx���n�ʑgr1oxycodone hydrochloride prolonged-release tabletsey�e�^�[/bard pharmaceuticals limited� ����-n�v �6ro� gp�lq�sۏ�srsň � �vo��qw[j2014012586978660000862^t��*y<\ remifentanilp�kb/g�������*y<\ sufentanyl �g|jx����*y<\�l\�msufentanil citrate injection���<\1ml:75�g(�vs_�n���*y<\50�g)idt biologika gmbh h20100123869784100000505ml:375�g(�vs_�n���*y<\250�g)"�_�vimpfstoffwerk dessau-tornau gmbh h20100124869784100000672ml�100�g ��n���*y<\�� � �vo��qw[h20054172869020000017831ml�50�g��n���*y<\�� � �vo��qw[h2005417186902000001790�s"l�s�_�vdihydrocodeinenn��au buprenorphine0wpo��dezocine0wpo���l\�mdezocine injection1ml�5mg �vo��qw[h2008032986901749001962 4.2 ^�?�gr{|g��uo�ir (lz��_�v[i�s,ii�s]!paracetamol and codeine phosphate(lz��_�vgr(`!),paracetamol and codeine phosphate tablets(i)zs���u�kgr t�[ynp�(l�wz�0.5g,�xx��s�_�v8.4mg �vo�ɩ�v�]n gp�lq�s �vo��qw[h1088000786900228000021(lz��_�vgr(i);�kgr t�[ynp�(l�wz�(c8h9no2)0.5g � t�xx��s�_�vc18h21no3. h3po4.3/2h20)8.4mg0< �vo��qw[h2102114586901161000147(lz��_�vgr(a!),paracetamol and codeine phosphate tablets(a!)�[�^���kgr t�[ynp�(l�wz�0.3g,�xx��s�_�v15mg �vo��qw[h1093004486900228000038�[ynp�(l�wz�300mg,�xx��s�_�v15mg ul4y�~nmyr:s���n6ro��s �vo��qw[h1093010786900484000025(lz��fl�yparacetamol and tramadolp�͑�^�u�u(lz��fl�ygr.paracetamol and tramadol hydrochloride tablets�s��[�kgr t��vx��fl�y37.5mgn�[ynp�(l�wz�325mg �vo��qw[h2005067686902529000014*tramadol hydrochloride paracetamol tablets�kgr t�[ynp�(l�wz�325mgn�vx��fl�y37.5mg �vo��qw[h2008058386903094000751(lz��s"l�s�_�v ��[ynp�(l�wz��s"l�s�_�v �paracetamol and dihydrocodeine(lz��s"l�s�_�vgr4paracetamol and dihydrocodeine tartrate tablets500mg�[ynp�(l�wz� �10mgr��wx��s"l�s�_�v u��]n�]6ro� gp�#��nlq�s �vo��qw[h2007362686902391000013/paracetamol and dihydrocodeine tartrate tablets��vkq�kgr t:�[ynp�(l�wz�0.5gnr��wx��s"l�s�_�v10mg zwm�fw6ro� gp�lq�s �vo��qw[h2003092086904219000014^bh�u bucinnazine�vx�^bh�ugr!bucinnazine hydrochloride tablets �vo��qw[h1202015986900886000241&(218)�vx�^bh�u�l\�m#bucinnazine hydrochloride injection �vo��qw[h1202096686900874001144i�ln2u }bulleyaconitine ai�ln2u }grbulleyaconitine a tables0.4mg �nws f��6ro� gp�lq�s �vo��qw[h2005742186905650000953i�ln2u }o����vbulleyaconitine soft capsulessq�~ fo�ɩ�v���n gp�lq�s �vo��qw[h2003106086905614003143 y�en'l(lz�&propoxyphene napsylate and paracetamolw��[ rotundinew��[grrotundine tablets d��\��#ko�n gp�lq�s �vo��qw[h1502051286903864000295&(221) m���_�v(^m���s�_�v)ibuprofen and codeinem���_�vʑgrbcompound codeine phosphate and ibuprofen sustained release tablets`:nnf^m��0.2g,�xx��s�_�v13mg �vo��qw[h2001051686900978002344m���_�vgr'ibuprofen and codeine phosphate tablets�snf���kgr t^m��0.2gn�xx��s�_�v12.5mg �vo��qw[h2002051486900228000083�fl�ytramadol�s g8^ʑbr�w ʑ�cʑbr�w �s g�msobr �vx��fl�yʑ���v1tramadol hydrochloride sustained release capsules 5��]�v�^6ro� gp�lq�s �vo��qw[h1098012286905551000090�vx��fl�yʑgr0tramadol hydrochloride sustained release tablets�l�_m �vo��qw[h20030564869008630000420tramadol hydrochloride sustained-release tabletsgyȏyr �vo��qw[h2001082686902770001648!tramadol hydrochloride sr tablets�oefarmaceutici formenti s.p.a h2010017486978482000477�vx��fl�y���vtramadol hydrochloride capsules h2010013886978482000460�vx��fl�ygrtramadol hydrochloride tablets �vo��qw[h2003332986900387000283 �vo��qw[h1096010686902770000931&(223)�vx��fl�y�l\�m tramadol hydrochloride injsctiongrunenthal gmbh h2009107286978482000446 tramadol hydrochloride injection �vo��qw[h2002378586900808000151 �vo��qw[h1080000186902770000948�v"l^l�ntetrahydropalmatine5 ����(uo�ir 5.1 hq������o�ir 5.1.1 8teq����o�iri`l�p enflurane�msobr�w150ml �lsn�t6ro� gp�lq�s �vo��qw[h1302317686902671000023_l�p isoflurane100ml �vo��qw[h1998014186902632000017~�`��n�mbr baxter healthcare of puerto rico h2013049286978257000350�[�� �vo��qw[h2002026786904012001140!`��[ q\n�y�n6ro� gp�lq�s �vo��qw[h19990157869041160000320wl�p desfluraneo�[240ml h2009020186978257000237nl�p sevoflurane8teq(unl�p�u�o�y�[250ml/�t maruishi pharmaceutical co.,ltd. h2015002086979127000050#sevoflurane solution for inhalation8teq'`�n�mbr �vo��qw[h2008068186904010000459120ml  nwmr`^t;so� gp�lq�s �vo��qw[h2007017286900675000025'ls�n.l nitrous oxidelsobr�w 5.1.2 y� �����o�irn�lz�propofoln�lz��l\�mpropofol injectiony��[ 50ml�0.5g0fresenius kabi austria gmbh(rňon�s�n9��h$\�eas�k;so� gp�lq�s � �vo��qw[j201300248697900200227850ml�1g �vo��qw[j2013002386979002002261ꏽe�[ 10ml:100mg ^n vzs6ro� gp�lq�s �vo��qw[h2005184386900469000026 20ml:0.2g&fresenius kabi ab(rňon�s�n9��h$\�eas�k;so� gp�lq�s � �vo��qw[j2013001386979002002254pn�~y� �v�]�v^to�n gp�#��nlq�s �vo��qw[h2004007986902249000073 �vo��qw[h2003011586902249000097 50ml:0.5g �vo��qw[h2003011486902249000066�r��#k ��[�r��6ro� gp�lq�s �vo��qw[h2001036886902499000564�_nf)r�� 20ml:200mg&corden pharma s.p.a.�rsňon�?��e)r�^6ro� gp�lq�s � �vo��qw[j2013016386978241001202 50ml:500mg��eq_2corden pharma s.p.a.�rsňon�astrazeneca uk limited � h2013050486978241001189 50ml:1000mg4astrazeneca uk limited(rsňon�astrazeneca uk limited � h2013046586978241001165kx�u�y��thiopental sodium/l��n�ketamine�vx�/l��n��l\�m ketamine hydrochloride injection �vo��qw[h3202282086901445000160�t��u�n midazolam�t��u�n�l\�mmidazolam injection �vo��qw[h2011343386904661000563midazolaminjection2ml�10mg��n�t��u�n�� � �vo��qw[h20067041869020000010732ml�2mg��n�t��u�n�� � �vo��qw[h20067040869020000010661ml:5mgjenahexal pharma gmbh h2008045386978495000020midazolam injection�rg�5ml:5mg �vo��qw[h2003107186901436001145 �vo�< �qw[h19990027869014360006122ml:2mg �vo��qw[h2003103786901435000101 �vo��qw[h1098002586901436000995 n�lz�-n/������sn propofol medium and long chain fat emulsionp�n�lz���s�230 � n����s n�lz�-n/������sn�l\�m5propofol medium and long chain fat emulsion injection 20ml�0.2g �vo��qw[j20110058869792500001015propofol medium and long chain fat emulsion injection �vo��qw[j2011005786979250000118�nx���sodium hydroxybutyrate�oxb�to� etomidate�oxb�to��l\�metomidate injection 10ml:20mg �vo��qw[h3202299286901436000582 �vo��qw[h3202237986901445000283 �oxb�to��l\(usnbr etomidate emulsion for injection�[�y)r�l\(usnbrb.braun melsungen ag h2009013186979001000299 �oxb�to�sn�r�l\�m etomidate fat emulsion injection�y\)r10ml:20mg,g�t:n�l\(usnbr0 �vo��qw[h2002051186901436001039 5.2 @\萻���o�ir5.2.1 o�{|@\萻���o�irnas�v tetracaine�l\(u�vx�nas�v&tetracaine hydrochloride for injection �vo��qw[h2008430786902066001789 �vo��qw[h2002014486904661000150nf��as�vprocaine �vx�nf��as�v�l\�m procaine hydrochloride injection2ml:40mg �vo��qw[h3702283286904083000820 20ml:0.1g �vo��qw[h3102081986900808000786 �vo��qw[h2002310186904661000242 s�n�vlo�n gp�lq�s �vo��qw[h1102032786900202000498 �vo��qw[h3102081886900808000816 �vx�nf��as�v/ls���l\�m4procaine hydrochloride and sodium chloride injection 250ml:2.5g �vo��qw[h1202124786900933001092250ml:5g �vo��qw[h1202124886900933000767 ^�]}v�nq\ftq6ro� gp�lq�s �vo��qw[h4402239586900375000769 �vo��qw[h3102081786900808000533&(237) �s g�msobr �n�mbr�vx�nas�v��fmtetracaine hydrochloride jelly1% 5g:0.05g (ss�k/e t�vx�nas�v0.05g)��[)rt�|nso�n gp�#��nlq�s �vo��qw[h61022993869025020000175.2.2 p���{|@\萻���o�ir^�kas�v bupivacaine �vx�^�kas�v�l\�m#bupivacaine hydrochloride injection �vo��qw[h3702210686904098000648 5ml:37.5mg �vo��qw[h3702210786904098000631 �vo��qw[h3102284086900673000096 �vo��qw[h3102283986900673000102)ryas�v lidocaine �xx�)ryas�v�l\�mlidocaine carbonate injection10ml:0.173g(�n)ryas�v��) �vo��qw[h2006385686903205000205 �vo��qw[h10960194869014530006265ml:86.5mg(�n)ryas�v��) �vo��qw[h10960193869014530006645ml:86mg(�nc14h22n2o��) �vo��qw[h2004304986900601000075 �vx�)ryas�v�l\�m!lidocaine hydrochloride injection5ml:0.1g �vo��qw[h3702214786904098000686 20ml:0.4g �vo��qw[h2002354486903205000410 �vo��qw[h1102032286900202000344 �vo��qw[h4402382586900375001384 2ml:4mg(�n�z) �vo��qw[h3702376686904083000899  nwmgvfo�n gp�lq�s �vo��qw[h3102107186900665000271 10ml�0.2g -n�v'y�q6ro� gp�lq�s �vo��qw[h2006538886900967000436 10ml:0.2g �vo��qw[h3702283986904098000662 �vo��qw[h3702210886904098000655�vx�)ryas�v�l\�m(�nbr(u) �vo��qw[h31022163869008080003975ml�0.1g �vo��qw[h2006538786900967000412 �vo��qw[h3202479886901453000473 �vo��qw[h1202100086900874001151 y�e?��fas�v6rbrcompound articaine preparations  y�e�vx�?��fas�v�l\�m*compound articaine hydrochloride injection1.7ml:�vx�?��fas�v68mg,�� nz� }17�g l���q\0n�s6ro� gp�lq�s �vo��qw[h2004588186904286000399&(240) y(u�msobr 8teqbr �q��br�vx�)ryas�v��fm lidocaine hydrochloride mucilage��fmbr10g:0.2g �vo��qw[h1088000886901453000589)ryas�v(`!) lidocaine(`!)w�tas�v ropivacaine 2u�xx�w�tas�v�l\�mropivacaine mesilate injection�lc� 10ml:119.2mg �vo��qw[h2006089786904127002834[�pn�tu��zs�huir6ro����nɩ�v gp�lq�s �vo��qw[h2005219886902463000231ropivacaine mesylate injection�r��pn 10ml�120mg��[�r��6ro�lq�s �vo��qw[h2006047786902499000120 10ml:23.8mg �vo��qw[h2011344686901748000195ropivacaine mesylate injection 10ml:89.4mg ym_l�nt6ro����n gp�lq�s �vo��qw[h2005152086904735000598 �vx�w�tas�v�l\�m#ropivacaine hydrochloride injectionr`m10ml:100mg ( c�vx�w�tas�v��) �vo��qw[h2006013786901445001174ssfw10ml:75mg(�nc17h26n2o.hcl��) �vo��qw[h2005271686904021002138�pn�t 100mg/10ml//eastrazeneca ab h2014076386979096001850 75mg/10ml//e h2014076486979096001881 �l\(u�vx�w�tas�v'ropivacaine hydrochloride for injection75mg(�n�vx�w�tas�v��) �vo��qw[h2005266686902066001178 75mg 5�t/�v �vo��qw[h2005032586900340000107�]^�kas�vlevobupivacainep�^�kas�v��s�239 � n����s�v�`� �vx��]^�kas�v�l\�m'levobupivacaine hydrochloride injection�as �vo��qw[h2002057086901445001426 owcas10ml:�vx��]^�kas�v50mg �vo��qw[h20050403869006010003895ml:�vx��]^�kas�v37.5mg �vo��qw[h2007002386900601000372 5.3 �������ro�ir 5.3.1 ��~go�ir5.3.1.1 ^��s�gs�w����~g_o�ir?��f�^�� atracurium �l\(u��xx�?��f�^�� �vo��qw[h2006129886900675000018�~�^�n��vecuronium bromide�l\(u�~�^�n��vecuronium for injection �vo��qw[h2006745886904127002582 vecuronium bromide for injection �vo��qw[h2006694186901749000644�n�g �vo��qw[h1999117286904735000383w�^�n��rocuronium bromidew�^�n���l\�mrocuronium bromide injection1r�s~g n.v.<  organon h2013048686979034000648�t�^�n��pipecuronium bromide�l\(u�t�^�n��"pipecuronium bromide for injection?��z4mg//e,5/e/�v��sd�2ml�nbr5/e �gedeon richter plc. h2014073186979164000174 b����ꏷ^uir6ro� gp�lq�s �vo��qw[h2008446586902049000204�l�^�n��pancuronium bromidez���x?��f�^��cisatracurium besylatep�?��f�^����s�244 � n����s�v�`� z���x?��f�^���l\�m cisatracurium besylate injection[�:g�[ 5ml:10mg,5/e/�v!glaxosmithkline manufacturing spa h2009044186978476000209 �l\(u��xz�?��f�^��$cisatracurium besilate for injection 5mg��nz�?��f�^���� � n�(_lς)o�n gp�lq�s �vo��qw[h2006092786901404000033$cisatracurium besilate for injection �vo��qw[h20060869869014450010995.3.1.2 -n�g'`����~g_o�ir/ls%t�sƀ�xsuxamethonium chloride /ls%t�sƀ�x�l\�m �vo��qw[h3102059986900808001837�]/l��baclofen�]/l��grbaclofen tablets�g�� �vo��qw[h1998010386904561000052ݐzf ks��sf[6ro����n gp�lq�s hc2014001386979129000126�reyeg }novartis farma s.p.a h2014032686978679001959 5.3.2 vq�n���ro�ir��ğ�x ephedrine�vx���ğ�x�l\�m!ephedrine hydrochloride injection1ml�30mg10 �vo��qw[h2102241286901161001915~��sm\esmolol �vx�~��sm\�l\�mesmolol hydrochloride injection �vo��qw[h20055297869057930005511r�~ �vo��qw[h1999105986904021001100 �vo��qw[h1999105886904021000653 �l\(u�vx�~��sm\#esmolol hydrochloride for injection �vo��qw[h2004042786903662001517&(252)6 �~u }�s�wir(�:on�u(uo�ir 6.1 �~u }{|o�ir 6.1.1 �~u }a{|o�ir�~u }a vitamin aabi�~u }ao����vvitamin a soft capsules �~u }a2.5nusmo �vo��qw[h3502024686904873000641 6.1.2 �~u }b{|o�ir �~u }b1' vitamin b1 '�~u }b1�l\�mvitamin b1 injection �vo��qw[h3702105786904083000752 �vo��qw[h1202061386900874001212 �vo��qw[h4402210386900377001726 �~u }b2' vitamin b2 '�~u }b2grvitamin b2 tablets5mg �vo��qw[h1202059386900858000286vitamin b2 tablets �vo��qw[h1202031886900873000162 �vo��qw[h1202016986900886000364 �~u }b6' vitamin b6 '�~u }b6�l\�mvitamin b6 injection �vo��qw[h1202052286900874001205vitamin b6 injection �vo��qw[h1302102286902770000573vitmin b6 injection �vo��qw[h4102424286903021000069 �vo��qw[h4402210686900377001887 �vo��qw[h3202170486901397000980 �vo��qw[h4102027186903098000573 �vo��qw[h3702072086904187001884 �~u }b12' vitamin b12 ' �~u }b12�l\�mvitamin b12 injection 2ml:0.5mg �vo��qw[h3702105486904083000707&(255)�~u }b1grvitamin b1 tablets �vo��qw[h4402122486900567000850 �vo��qw[h1102035386900222000089 �vo��qw[h4202061186901815000363 �vo��qw[h3702185286904127001516 �vo��qw[h3102030786900787000210vitamin b1 tablets �vo��qw[h1202059286900858000309 �vo��qw[h1202031786900873000155 �vo��qw[h1202016886900886000265&(256)&(257)�~u }b6grvitamin b6 tablets �vo��qw[h3702185386904127001653 �vo��qw[h1202059486900858000316 �vo��qw[h1202031986900873000100 �vo��qw[h1202017086900886000517�px�nicotinic acid�px�ʑgr(nicotinic acid sustained-release tablets,g�` ns�m[��yo�n gp�#��nlq�s �vo��qw[h2003071486900111000473�px�grnicotinic acid tablets nwm�o �o��s gp�lq�s��yxb nwm�o �ğ�l6ro� gp�lq�su�n � �vo��qw[h3102154886900818001506 �vo��qw[h1202022186900886000289&(259)�px��l\�mnicotinic acid injection2ml:20mg �vo��qw[h4402024186900375001841�pp��� nicotinamide 6.1.3 �~u }c{|o�ir�~u }c vitamin c�~u }c�l\�mvitamin c injection �vo��qw[h3702206286904152000874 10ml:2.0g �vo��qw[h42020431869018420003052.5ml�1g �vo��qw[h1102064086900144003939 20ml�2.5g �vo��qw[h2005427586902662000902 20ml:2.5g �vo��qw[h3702071586904187002072 �vo��qw[h37021161869039730003842ml:0.5g �vo��qw[h3202271286901397000751 �vo��qw[h2004608986904127001059 �vo��qw[h3702071886904187002102vitamin c injection �vo��qw[h2002347586900801001070 �vo��qw[h12020393869008740007722ml�0.5g �vo��qw[h4102385886903098000351 �vo��qw[h12020392869008740008335ml:1g �vo��qw[h3202271386901397000881 �vo��qw[h3102148686900673000294 �vo��qw[h3702071686904187002089�l\(u�~u }cvitamin c for injection �vo��qw[h2005378486902918000922 �vo��qw[h2004327386902918001486 �vo��qw[h2009356186905758001296&(261)�~u }cgrvitamin c tablets �vo��qw[h1302278286902770001402 �vo��qw[h3702185486904127002131 �vo��qw[h1202059586900858000354 �vo��qw[h1202017186900886000326 �vo��qw[h4202061486901815000356 �vo��qw[h2102071386901162001518 6.1.4 �~u }d{|o�ir �~u }d2' vitamin d2 '�~u }d2�l\�mvitamin d2 injection1ml:5mg(20nusmo) �vo��qw[h2005443386905283001006vitamin d2 injection1ml:10mg(40nusmo) �ls�qz6ro� gp�#��nlq�s �vo��qw[h1302246886902829000226 �vo��qw[h2005443286905283000993&(262)�~u }d2o����vvitamin d2 soft capsules 0.25mg(1n< usmo) _l�)yknwmo�n���n gp�lq�s �vo��qw[h3602122686905360000144 �~u }d3' vitamin d3 '�~u }d3�l\�mvitamin d3 injection 1ml:7.5mg  nwm�(uo�n���n gp�lq�s �vo��qw[h3102140486900774000490&(263) 6.1.5 y�e�~u }6rbr yt�~u }bcompound vitamin b yt�~u }bgrcompound vitamin b tablets0�~u }b103�kkq0�~u }b201.5�kkq0�~u }b600.2�kkq0�pp���10�kkq0�lx���1�kkq �vo��qw[h12020590869008580002310�~u }b1 3mg0�~u }b2 1.5mg0�~u }b6 0.2mg0�pp���10mg0�lx���1mg �vo��qw[h1202031086900873000575compound vitaminb tablets �vo��qw[h1202023386900886000784r^u��k dried yeastr^u��kgrdried yeast tablets 0.2g(�nr^u��k��) �vo��qw[h34022978869043730000734l�n'`�~u }water-soluble vitaminp�m�t��y%�{q(u �l\(u4l�n'`�~u }#water-soluble vitamin for injection4lpn�~�nns^t6ro� gp�lq�s �vo��qw[h3202300286901415000213 nwm,{nuso�n gp�lq�s��yxb�wmwst^t6ro����n gp�lq�su�n � �vo��qw[h3102298086900651001350 �vo��qw[h5002079586901066002956#water-soluble vitamin for injection �vo��qw[h2005892286904141001394 ��n'`�~u }�i �ii �fat-soluble vitamin�i �ii � ��n'`�~u }�l\�m(a!) fat-soluble vitamin injection(a!)�~�n)r9syr10ml �vo��qw[h3202313886901415000190 �l\(u��n'`�~u }(`!)$fat-soluble vitamin(`!) for injectioni�k�t:�~u }a 310^�415.0�gn�~u }d2 4.50^�6.00�gn�~u }e 2.90^�3.50mgn�~u }k1 90.0^�120.0�g �vo��qw[h2005257186902066001185 �l\(u��n'`�~u }(a!)$fat-soluble vitamin(a!) for injectionj�k�t:�~u }a 445.0^�595.0�gn�~u }d2 2.25^�3.00�gn�~u }e 4.10^�5.00mgn�~u }k1 67.5^�90.0�g �vo��qw[h2005257286902066001161fat-soluble vitamin injection ��[�[epo�n gp�lq�s �vo��qw[h2005962386902456000323$fat-soluble vitamin for injection(a!)h�k/e t�~u }a�h�ix�o�1940ug(3300iu);�~u }d2 5ug(200iu);�~u }e9100ug(10iu);�~u }k1 150ug0 ��[�_)yo�n���n gp�lq�s �vo��qw[h200604898690246900047112�y yt�~u } 12 vitamins �%p�m�t��y%�{q(u�n�~v�(lx�&five vitamins and lysine hydrochloride�~u }advitamin a and d �~u }ad�nbr(���v�w).vitamin a and d drops (soft capsule container)!2000usmo��k�| t�~u }a 1500usmon�~u }d 500usmo � ws�nwm��o�n gp�lq�s �vo��qw[h200572632700usmo��k�| t�~u }a2000usmon�~u }d700usmo � �vo��qw[h20057262�~u }ad�nbrvitamin a and d drops o�s�e-�k�| t�~u }a1500usmon�~u }d500usmo(n!k'`sň)<br>br�w:n��nbr����v�w �q\n���vwm muir6ro����n gp�lq�s �vo��qw[h3702297386904077000072-�k�| t�~u }a2000usmon�~u }d700usmo(n!k'`sň)<br>br�w:n��nbr����v�w � �vo��qw[h3702297486904077000102�kkq t�~u }a9000usmo,�~u }d3000usmo �vo��qw[h3502024786904873001310�kkq t�~u }a5nusmo,�~u }d5000usmo �vo��qw[h3502024886904873001433�k�| t�~u }a2000usmo,�~u }d700usmo �vo��qw[h3502115286904873001969�yr�n�~u }a1800usmo,,�~u }d600usmo �vo��qw[h3302107286904636000178 6.2 �wir(�{|o�ir6.2.1 ��bra���|x���calcium gluconateabcia���|x���grcalcium gluconate tablets _\6ro�(ɩ�v) gp�lq�s �vo��qw[h4102332386903139001668 �vo��qw[h1202022986900886000449&(268)a���|x����l\�mcalcium gluconate injection10ml:1g �vo��qw[h1302175986902662001718 �vo��qw[h1202096386900874001038/ls��calcium chloride/ls���l\�mcalcium chloride injection �vo��qw[h5102314986902087000679 �vo��qw[h310216608690080100022620ml:1g �vo��qw[h3102165986900801000233�xx���calcium carbonate�xx���grcalcium carbonate tablets 0.3g(�nca��) �swm�~nmyr:suirsf[6ro��s �vo��qw[h4402425586900594000045 fkil tnm�s�n;so� gp�lq�s �vo��qw[h4202252186901972000558 �xx���d3(�~u }d3�xx���)' '  calcium carbonate and vitamin d3'�xx���d3gr(calcium carbonate and vitamin d3 tablets �vo��qw[h1095002986901421000160 �xx���d3gr�a! �,calcium carbonate and vitamin d3 tablets �a! �g��kgr t��0.5kqn�~u }d3 5�_kq(200�ve�usmo) s�n�^܏6ro� gp�lq�s �vo��qw[h200936758690007600005172&(271)p�]o{p�u  y�e�xx����l~����|0compound calcium carbonate effervescent granules�v{#k/1.5kq/��, t�xx��� 0.375kq(�ncq }����0.15kq),n�~u }d3 31.25�ve�usmo �vo��qw[h2004089686904077000041�xx���d3���|*calcium carbornate and vitamin d3 granules"3g: y�e(�k�� t��500mg/�~u }d3 5�g �200�ve�usmo) �vo��qw[h2009033486900076000068�lx���calcium pantothenate�lx���grcalcium pantothenate tablets �vo��qw[h1202021886900886000937�~d2�xa���grwei d2 lin pu gai�%p�?q�zwei d2 lin pu gai pian"a���|x���0.197g,�xx�"l��0.139g,�~u }d2 100usmo60gr/�t �vo��qw[h11022441�%p�?q�z�su[�n�y869001440021546.2.2 vq�n y�y�_ϑcq }�i �ii �multi-trace elements�i �ii � y�y�_ϑcq }�l\�m(a!)!multi-trace elements injection(a!)�[��� �vo��qw[h3202390786901415000220!multi-trace elements injection(a!) �v�]�'y�^sopno�n gp�lq�s �vo��qw[h2005625486902189000478kxx� � zinc sulfaterxu��kselenious yeastrxu��k���vselenious yeast capsules�[ ^�^0.143g(�vs_�nse100�g)��vnns�ouiro�n���n gp�lq�s �vo��qw[h2005253286904450000156rxu��kgrselenious yeast tablets��~\50�g(�n�kgr70mgrxu��k-n trxϑ��) ar9n_lup�lo�n���n gp�lq�s �vo��qw[h10940161869038200026777 %�{q�l�uo�ir 7.1 ��y%�{qo�ir7.1.1 (l�wx�{|��y%�{qo�ir7.1.1.1 s^a��w(l�wx�6rbr- y�e(l�wx�18aa[18aa-`!018aa-a!018aa-b!�18aaf �018aa-< d!]<compound amino acid 18aa[18aa-`!018aa-a!018aa-b!�18aaf �018aa-d!] p� g͑�^%�{qθi��`� y�e(l�wx��l\�m(18aa)#compound amino acid injection(18aa)250ml:12.5g(;`(l�wx�) �vo��qw[h2005476486904127003305 y�e(l�wx��l\�m�18aa �$compound amino acid injection (l8aa)500ml:25g�;`(l�wx� � �vo��qw[h1202060586900933000156250ml:12.5g�;`(l�wx� � �vo��qw[h1202060486900933000132 500ml:25g �vo��qw[h2002316386901415000312 �vo��qw[h1999386986901521000725 �vo��qw[h1999380386902763000375 �vo��qw[h2002363986904289000457 y�e(l�wx��l\�m(18aa-`!)%compound amino acid injection�18aa-`! �250ml:17.5g(;`(l�wx�) �vo��qw[h2005361786904127001387 y�e(l�wx��l\�m�18aa-i �&compound amino acid injection (l8aa-i) �vo��qw[h2004319486904289000396&compound amino acid injection (l8aa-`!)�q}t �vo��qw[h1999320186901415000336500ml:35g(;`(l�wx�) �vo��qw[h1999320286901415000350 �vo��qw[h2005361886904127001370\?q y�e(l�wx��l\�m(18aa-`!)1paediatric compound amino acid injection (l8aa-`!)100ml:6.74g(;`(l�wx�) ^n)r�l6ro����n gp�lq�s �vo��qw[h20063888 p�?q�z g͑�^%�{qθi��`�869003090000870paediatric compound amino acid injection�18aa-`! � �vo��qw[h20064777869041270030080paediatric compound amino acid injection�18aa �i �~��tyr20ml:1.348g(;`(l�wx�) �vo��qw[h1090008386900874000680\?q y�e(l�wx��l\�m �18aa-i �1paediatric compound amino acid injection�18 aa-`! �1r�tyr100ml:6.74g�;`(l�wx� � �vo��qw[h1090004486900933000910 y�e(l�wx��l\�m(18aa-a!)&compound amino acid injection (18aa-a!)250ml:21.25g�;`(l�wx� � �vo��qw[h2005783886900309000513%compound amino acid injection(18aa-a!)250ml:21.25g(;`(l�wx�) �vo��qw[h2005711686904127003336&compound amino acid injection (l8aa-a!)pn�q}t �vo��qw[h1098002986901415000367250ml�21.25g�;`(l�wx� � ^n'y�q6ro� gp�lq�s �vo��qw[h2006501686900273000250500ml:42.5(;`(l�wx�) �vo��qw[h2006501786900273000274250ml:28.5g�;`(l�wx� � �vo��qw[h2005784086900309000544500ml:42.5g�;`(l�wx� � �vo��qw[h2005783986900309000520250ml:28.5g(;`(l�wx�) �vo��qw[h1098003186901415000329 y�e(l�wx��l\�m �18aa-iii �&compound amino acid injection (l8aa-b!)250ml:25.9g�;`(l�wx� � �vo��qw[h1092011086900933000217 y�e(l�wx��l\�m �18aa-iv �&compound amino acid injection�18 aa-c! �1r#k�h250ml:8.7g�;`(l�wx� � �vo��qw[h1097014986900933000118500ml:17.4g�;`(l�wx� � �vo��qw[h1097015086900933000194  y�e(l�wx�(19aa-`!)compound amino acid (l9aa-`!)\?q y�e(l�wx��l\�m(19aa-`!)/pediatric compound amino acid injection(19aa-`!)100ml:6.0g(;`(l�wx�) �vo��qw[h20066688869041450009667.1.1.2 �u�u�(u�w(l�wx�6rbr7.1.1.2.1 (u�n���u�v(l�wx�6rbr  y�e(l�wx��9aa �compound amino acid�9aa �  y�e(l�wx��l\�m�9aa �"compound amino acid injection(9aa)250ml:13.98g(;`(l�wx�) �vo��qw[h1999376886904289000501  y�e(l�wx��l\�m(9aa) �vo��qw[h1999380086902763000337"compound amino acid injection�9aa �250ml:13.98g�;`(l�wx� � �vo��qw[h1999343386900933000200 �vo��qw[h19999462869020010003657.1.1.2.2 (u�n���u�v(l�wx�6rbr  y�e(l�wx��3aa �compound amino acid�3aa �  y�e(l�wx��l\�m(3aa)"compound amino acid injection(3aa)250ml:10.65g(;`(l�wx�) �vo��qw[h1999379986902763000344  y�e(l�wx��l\�m�3aa �"compound amino acid injection�3aa �250ml:10.65g(;`(l�wx� � �vo��qw[h1999343286900933000170  y�e(l�wx��6aa �compound amino acid�6aa �  y�e(l�wx��20aa �compound amino acid�20aa � y�e(l�wx��l\�mcompound amino acid injection�[s^ 500ml:50g h20120546869790010005657.1.1.2.3 (u�nr$o�v(l�wx�6rbr(�^�o�w) y�e(l�wx��15aa0015-hbc0[15]�s��[2] �9compound amino acid (15aa015-hbc0(15) and dipeptides (2))p�͑�^r$o�`� y�e(l�wx��l\�m�15aa �$compound amino acid injection (15aa)250ml:20g(;`(l�wx�) �vo��qw[h1999376486904289000570 y�e(l�wx��l\�m(15aa)#compound amino acid injection(15aa) �vo��qw[h1999380186902763000368 �vo��qw[h1999386586901521000732 y�e(l�wx��l\�m(15-hbc)%compound amino acid injection(15-hbc)250ml:6.9%(;`(l�wx�17.25g) r��\���tёwm6ro� gp�lq�s �vo��qw[h3702216786904051000647 y�e(l�wx��l\�m �15-hbc �%compound amino acid injection�15-hbc � (l y}t15-hbc250ml:17.25g�;`(l�wx� � �vo��qw[h1087000386900933000149 y�e(l�wx�(15)�s��(2)�l\�m6compound amino acids (15) and dipeptides (2) injection500ml:67g((l�wx�/�s��) �vo��qw[h20066058869021800012144compound amino acids(15) and dipeptides(2) injection7��[iq500ml�67g �(l�wx�/�s�� � fresenius kabi austria gmbh rsňon�ns^t6ro� gp�lq�s �vo��qw[j2014000986978432000632 y�e(l�wx��18aa-f! �18b �compound amino acid�18aa-f! �18b � y�e(l�wx��l\�m(18aa-f!)&compound amino acids injection(18aa-f!)�~/e�[200ml:20.650g(;`(l�wx�)  n�6ro��^�] � gp�lq�s �vo��qw[h20020157869004750000657.1.1.2.4 ���q%�{q�v(l�wx�6rbrn(lp�7�(lp���alanyl glutaminen(2)-l-n(lp�-l-7�(lp����l\�m#n(2)-l-alanyl-l-glutamine injection 100ml:20g �vo��qw[h20044900869036< 6200002250ml:10g �vo��qw[h2004489986903662000046 n(lp�7�(lp����l\�malanyl glutamine injection50ml:10g,�����s�t���m�tň �1�t/�v �vo��qw[h2004496586901017000048 �l\(un(lp�7�(lp���'n(2)-l-alanyl-l-glutamine for injection"20g��k�td�100mlmp̃�l\(u4l�tn!k'`o(u�ẽ�[�m��m�wyo(u � �vo��qw[h2006050386905781000457 �vo��qw[h2005387786904127000229�r*y �vo��qw[j2010011486978433000501 �vo��qw[h2005340986901415000022 �vo��qw[h2005387686904127000236 n(lp�-7�(lp����l\�malany glutamine injection �vo��qw[h2004370286902180000125 �vo��qw[h2004639186902180000118glutamine for injection#kdweu10g �vo��qw[h2005082986905793000575 �vo��qw[h2005082886905793000582&(283) p�à�n�u �as�nc���n�u l-7�(lp���qt�nx� l-glutamine and sodium gualenate l-7�(lp���qt�nx������|)l-glutamine and sodium gualenate granules���n�g0.67g�l-7�(lp���663.3mg �qt�nx���2.0mg!kotobuki pharmaceutical co., ltd. h2009105286978554000039 y�e7�(lp���compound glutamine 7.1.2 ���sn{|o�ir7.1.2.1 ������snbr���sn�c14-24 ��'yf��l �fat emulsion (c14-24)���sn�l\�m(c14-24)fat emulsion injection(c14-24)250ml:50g�'yf��l ��3g�us�x� � �vo��qw[h3402348086904289000204fat emulsion injection(c14^�24)500ml:50g('yf��l):6g(us�x�) �vo��qw[h3402348186904289000259fat emulsion injection250ml�50g�'yf��l ��3g�us�x� � �vo��qw[h2005436986900273000342���sn�l\�m(c14^�24)�1�)r9syr100ml:20g('yf��l):1.2g(us�x�) �vo��qw[h1999319686901415000091100ml:30g('yf��l):1.2g(us�x�) �vo��qw[h1999319986901415000121250ml:50g('yf��l):3g(us�x�) �vo��qw[h1999319786901415000107250ml:75g('yf��l):3g(us�x�) �vo��qw[h1999320086901415000138 �vo��qw[h1999319586901415000176 �vo��qw[h2002349886904127001462100ml:20g('yf��l)�1.2g(us�x�) �vo��qw[h2004664986902180000651100ml:30g('yf��l)�1.2g(us�x�) �vo��qw[h2006526786902180000316250ml25g('yf��l):3g(us�x�) �vo��qw[h2004664886902180000644250ml:75g('yf��l)�3.0g(us�x�) �vo��qw[h2006714086902180000323 �vo��qw[h2003318286902180000392fat emuision injection �vo��qw[h1999357986902249001360�r���yr250ml:75g('yf��l):3.0g(us�x�) �vo��qw[h2003385586902499000366 ������sn�l\�m(oo)&long chain fat emulsion injection (oo)kq�q��250ml:50g(���)n3g��x� � baxter s.a. h2011018186978346000247100ml:20g(���)n1.2g��x� � h2011018086978346000230�-3|��l���sn�c14-24 ��-3 fish oil fat emulsion �-3|��l���sn�l\�m#�-3 fish oil fat emulsion injection$\�e100ml�10g��|6r|��l ��1.2g�us�x� � �vo��qw[j20150040869014150004667.1.2.2 -n/������snbr-n/������sn�c6-24 �*medium and long chain fat emulsion (c6-24)-n/������sn�l\�m(c6^�24)3medium and long chain fat emulsion injection(c6^�24)�r��250ml:'yf��l25gn-n��u�l nx�o�25gnus�x�3g �vo��qw[h2003060986901415000077500ml:'yf��l25gn-n��u�l nx�o�25gnus�x�3g �vo��qw[h2003060886901415000053�~�g���sn�l\�m(c6^�24))structural fat emulsion injection (c6^�24)�r�e250ml:�~�gu�l no�50g fresenius kabi ab rsňon�ns^t6ro� gp�lq�s �vo��qw[j2011003186978432000519-n/������sn�c8-24 �ve �,medium and long chain fat emulsion�c8-24 �ve �-n/������sn�l\�m(c8-24)3medium and long chain fat emulsion injection(c8-24).100ml:10g('yf��l):10g(-n��u�l nx�o�):1.2g(us�x�):2.5g(u�l)^�]~vyr�oiq;s�u(u�t gp�lq�s �vo��qw[h2001021386900376000331-n/������sn�l\�m(c8-24ve)6medium and long chain fat emulsion injection (c8-24ve)�r�o���[250ml:50g(20%)#b.braun melsungen ag�g;s�u�ς�] � gp�lq�srsň �vo��qw[j2014004486979001000619.250ml:12.5g('yf��l)12.5g(-n��u�l nx�o�)3g(us�x�)6.25g(u�l) �vo��qw[h2001021186900376000836*250ml:25g�'yf��l �25g�-n��u�l nx�o� �3g�us�x� �6.25g�u�l � �vo��qw[h2001021486900376000843*500ml:25g('yf��l)25g(-n��u�l nx�o�)6g(us�x�)12.5g(u�l) �vo��qw[h2001021286900376000195 7.1.3 yt���{|o�ir ���sn(l�wx�a���|$fat emulsion amino acids and glucose p�͑�u�u�n4o���r�����x���sn(l�wx��17 �a���|�11% ��l\�m7fat emulsion,amino acids(17) and glucose(11%) injectionas�e1440ml!fresenius kabi ab rsňon�ns^t6ro� gp�lq�s �vo��qw[j2013018586978432000564 7.2 ���q%�{qo�ir7.2.1 (l�wx��w���q%�{qo�ir (l�wx��w���q%�{qbrenteral nutritional powder(aa)�s gcebr�%�p� g%�{qθi��t n��ۏߘ�v͑�u�`� ���q%�{q�|br�tp �enteral nutritional powder(tp)�[ }�s g�|br 400g/p �24p/�{abbott laboratories b.v. h2013032086979366000088 ���q%�{q�|(aa)enteral nutritional powder (aa)�~�l80.4g/��nestle healthcare nutrition h2009073286979330000021 y�e%�{q�m�`brcompound nutrition suspension125g/��r��\wmgluirsf[6ro� gp�lq�s �vo��qw[h2000356286904038000110 ���q%�{q�m�`�m(sp)"enteral nutritional suspension(sp)~vnf�r500ml(1kcal/ml)�~� ^�n6ro�(�e!�) gp�lq�s �vo��qw[h2001028586901630000081 ���q%�{q�m�`�m(tpf)#enteral nutritional suspension(tpf)��hq�r500ml(1.5kcal/ml) �vo��qw[h2003001186901630000012 ���q%�{q�m�`�m�tpf �500ml(0.75kal/ml)�~� ^�n6ro���e!� � gp�lq�s �vo��qw[h2003001286901630000036$enternal n< utritional suspension(tpf)500ml(1kcal/ml) �vo��qw[h2001028486901630000098���q%�{q�m�`�m�tpf-fos)'enteral nutritional suspension�tpf-fos)so�~so500ml/�t h2010055386979366000040���q%�{q�m�`�m(tp-mct)'enteral nutritional suspension (tp-mct)1kcal/ml �500ml �vo��qw[h2009328386901630000340 ���q%�{qsnbr(tp) enteral nutritional emulsion(tp)^t }snbr500ml/��1fresenius kabi deutschland gmbh �rsňon�ns^t6ro� gp�lq�s � �vo��qw[j2014007586979002002636�s gsnbr �vo��qw[h2002058886901415000275 ���q%�{qsnbr(tpf)!enteral nutritional emulsion(tpf)^thq500ml �vo��qw[h2004018886901415000251 ���q%�{qsnbr(tpf-d)#enteral nutritional emulsion(tpf-d)^t�n �vo��qw[j2014007786979002002643 ���q%�{qsnbr(tpf-t)#enteral nutritional emulsion(tpf-t)^t�� 200ml/�t�4l�gst � �vo��qw[h2004072286901415000282 ���q%�{qsnbr(tp-he)#enteral nutritional emulsion(tp-he)^tؚ/fresenius kabi deutschland gmbh�rsňon�ns^t6ro� gp�lq�s � �vo��qw[j2013017886979002002339&(289)  y�e(l�wx��8-a!)compound amino acid�8-a!)  y�e(l�wx����v(8-11)compound amino acid capsules�t�[0.35g �vo��qw[h20000478869005470000547.2.2 �w���w���q%�{qo�ir�w���w���q%�{qbr �s gcebr �s g�msobr&short peptide enteral nutrition powder~vnf }r^�|br milupa gmbh h2015002886980083000015�s g4l�ˆ}voral protein hy droly satecebr5g �^�t�vnws �6ro� gp�lq�s �vo��qw[h45021316869050830002547.2.3 teˆ}v�w���q%�{qo�ir �u�uyr_�w���q%�{qbr(disease-specific enteral nutrition agent teˆ}v�w���q%�{qbr.high energy enteral nutritional polymeric diet teˆ}v�w���q%�{qbr��|br �)intacted protein enteral nutrition powder��hq }320g/,t h20130888869790670002337.2.4 vq�n y�e�-n�x�compound �-ketoacida y�e� �n�x�grcompound �-ketoacid tablets_ t0.63g/grs�n9��h$\�eas�k;so� gp�lq�s �vo��qw[h20041442869000330000948 �o }�s����qr�l�r��o�ir8.1 nn��wso�o }�svq{|�rsň����t���_�-n�v �6ro� gp�lq�s � �vo��qw[j2013006086978997002652�|ˆ}v �͑�~�n���\ }�mt�l\�m8mixed protamine zinc recombinant human insulin injection o�l�g 70/30 3ml:300usmo�{�� �lillyfrance�rsňon��rsň ����t���_�-n�v �6ro� gp�lq�s � �vo��qw[j2012002686978997002461�|ˆ}vuirtb�n���\ }�l\�m7isophane protamine biosynthetic human insulin injection���tup n$novo nordisk a/s�rsň����t���_�-n�v �6ro� gp�lq�s � �vo��qw[j20120034< 86978997002492�|ˆ}vuirtb�n���\ }�l\�m� ���m 30r �$novo nordisk a/s(rsň:���t���_(-n�v)6ro� gp�lq�s) �vo��qw[j2012002786978997002454 lilly egypt s2013000786978603000096 s201300158697860300008930/70�mt͑�~�n���\ }�l\�m030/70mixture recombinant human insulin injectionu��30r 10ml:400iu �vo��qw[s2002003186903546000018 �vo��qw[j2012003086978997002478gisophane protamine biosynthetic human insulin injection (pre-mixed 30r)3ml:300�ve�usmo�{�� �?novo nordisk pharmaceutical industries,inc.�rsň����t���_�-n�v �6ro� gp�lq�s � �vo��qw[j2010004086978997002034���tupr300iu/3ml//e�{�� �enovo nordisk producao farmaceutica do brasil<br>�rsň ����t���_�-n�v �6ro� gp�lq�s � �vo��qw[j2010011786978997002201enovo nordisk producao farmaceutica do brasil<br>�rsň� ���t���_�-n�v �6ro� gp�lq�s � �vo��qw[j2010011686978997002218�|ˆ}vuirtb�n���\ }�l\�m����m50r �gisophane protamine biosynthetic human insulin injection (pre-mixed 50r)���tup 50r �vo��qw[j2012003286978997002485 �vo��qw[j2008009586978604000170130/70 mixture recombinant human insulin injection �vo��qw[s2003000486903546000032 ���whe�n���\ }{|�rsňon�<br>3ml:300usmo/��kxeq3sanofi-aventis deutschland gmbh (rsň�[�����s�n �6ro� gp�lq�s � �vo��qw[j20140052869788200006710wyr���\ }�l\�minsulin detemir injection���ts^300usmo/3ml//e�{�� � �vo��qw[j2014010686978997002713 8.5.2 �s gm��|o�ir8.5.2.1 �xp�2�{|o�irrsňonschering-pl<br>ough labo n.v. s2014001286978642000910 10�g:1ml//e �vo��qw[s2001000686900115000035 30�g:1ml//e �vo��qw[s2001000786900115000066 50�g:1ml//e �vo��qw[s2001000886900115000059 ͑�~�nr^pb }�2a�l\�m)recombinant human interferon�2a injection�vyr��300niu �l3� nu6ro� gp�#��nlq�s �vo��qw[s2001005086901313000070�[����600niu//e�[�_�[�yuir�] z(ɩ�v)���n gp�lq�s �vo��qw[s2004001086904274000042�q�v�vu100niu(1.0ml)/�t(/e) �vo��qw[s2003003186900070000118300niu(1.0ml)/�t(/e) �vo��qw[s2003003086900070000101500niu(1.0ml)/�t(/e) �vo��qw[s2003003286900070000125͑�~�nr^pb }�-2b�l\�m�gpusހ̃ �4recombinant human interferon �2b injection�p.putida ��[�y�� 1ml:100n�ve�usmo )y%mns�z��uir�] z gp�lq�s �vo��qw[s2000001886900868000030 1ml:300n�ve�usmo �vo��qw[s2000001986900868000023 1ml:500n�ve�usmo �vo��qw[s2000002086900868000016�l\(u͑�~�nr^pb }�2b(gpusހ̃)8recombinant human interferon �2b for injection(p.putida))rr��100niu//e �vo��qw[s1096002286903708000399 �l\(u͑�~�nr^pb }�1b.recombinant human interferon �1b for injection20�g//e �m3w�ytquir�] z gp�lq�s �vo��qw[s200330348690051000005040�g//e �vo��qw[s2003303986900510000074[��ё50�g//e �vo��qw[s1097007086900510000111/recombinant human interferon �1b for injection60�g//e �vo��qw[s2003303586900510000067 �l\(u͑�~�nr^pb }�2a.recombinant human interferon �2a for injection100niu �vo��qw[s1097008786901313000087500niu �vo��qw[s1097008886901313000094z�yn�n��r^pb }�-2a[�-2b]peginterferon �-2a[�-2b]%p�n��0ba'`;m�r'`yn�� �ޏ�~o(u6*ng�ehe�e\po� �ޏ�~o(u n��ǐ12*ng z�yn�n��r^pb }�-2b�l\brpeginterferon alfa-2b injectioniopn��2sp �brinny � company�rsň�schering-plough labo n.v. � s201400268697864200092780�g//e4sp(brinny)company�rsňon t�y schering-plough labo n.v. � s2014002786978642000934z�yn�n��r^pb }�-2a�l\�m,peginterferon alfa-2a solution for injection>mw#k135�g/0.5 ml//e'f.hoffmann-la roche ltd.� nwmwl6ro� gp�lq�srsň � �vo��qw[j2012007486979436000505180�g/0.5 ml//e �vo��qw[j2012007586979436000512 9.2.3 }v�n }{|o�ir͑�~�n}v�n } �2recombinant human interleukin-2 p����~ހlv0ўr� }$v �l\(u͑�~�n}v�n }-2-recombinant human interleukin-2 for injection�_�u s�n�v�suir6ro� gp�lq�s �vo��qw[s10970015 p����~ހlv �ўr� }$v086900152000135 ͑�~�n}v�n }-2�l\�m)recombinant human interleukin-2 injection�e�_�u 50niu/0.4ml//e �vo��qw[s2004000586900152000043͑�~�n}v�~ހ�n }-2(125ala)�l\�m0recombinant human interleukin-2(125ala)injection#k t\20niu �vo��qw[s2004002086900148001177100niu/0.8ml//e �vo��qw[s2004001886900152000067�l\(u͑�~�n}v�n }-2(125ala)5recombinant human interleukin-2(125ala) for injection �vo��qw[s199910108690014800073610niu �vo��qw[s1999100886900148000781 �vo��qw[s199910098690014800084250niu �vo��qw[s199910078690014800061320niu/�t �vo��qw[s1097001786900152000128܏v{#k 1ml:20niu s�n܏v{o�n gp�#��nlq�s �vo��qw[s109800678690021400005910niu/�t �vo��qw[s1097001886900152000104-recombinant human interleukin-2 for injection���v �vo��qw[s1097008386901313000100͑�~�n}v�n } 11�͑�~�n}v�n } 11�u��k � � recombinant human interleukin-11p�>es�u_w��v@�\g�q\�`�(w n�~;sb��l�u�eo(u�l\(u͑�~�n}v�~ހ�n }-11.recombinant human interleukin-11 for injection t�]��1.5mg(1.2�10e7au)//e mg�]]n�n�w�v�] z gp�lq�s �vo��qw[s2006311< 086904488000012 �l\(u͑�~�n}v�n }-11�]�t�|1.2�10e7au(1.5mg)//e �vo��qw[s20030016869040210018033mg(2.4�10e7au)//e �vo��qw[s20030077869044880001042.4�10e7au(3mg)//e �vo��qw[s2003001786904021002527yr\�^3mg(2400nusmo)//e�s�yr�[uir�] z���n gp�lq�s �vo��qw[s2005003886904870000125&(390) ͑�~�n}v�n }-11[`!]#recombinant human interleukin-11(`!)[r�u�uׂ�c�y�[tq�p�u�v���c�sir neurotropin[r�u�uׂ�c�y�[tq�p�u�v���c�sir�l\�m^y�~�ypns^3.6neurotropinusmo/3ml//e �10/e/�v8nippon zoki pharmaceutical co.,ltd. �ono greenery factory s2009009286979092000055[r�u�uׂ�ptq�v�c�sir�l\�mbextracts from rabbit skin inflamed by vaccinia virus for injectioni`�q� 3ml:3.6usmo zno�n(�y�v) gp�lq�s �vo��qw[s2004002286901692000135&(390.1)[r�u�uׂ�c�y�[tq�p�u�v���c�sirgr4.0neurotropinusmo/gr9nippon0zoki0pharmaceutical0co.,ltd., ono greenery factory s20090094869790920000629.2.4 vq�n}v��;`��total glycosides of paeony}v��;`�����v#total glucosides of paeony capsules^ y�g0.3g� t��o��� n\�n104mg � �[�l�zns6ro� gp�lq�s �vo��qw[h2005505886904557000059y� ��l\(u�nmq�utˆ}v(ph4)3human immunoglobulin(ph4) for intravenous injectionp�?q�z͑�^�u�ka�g�t�]$o�oi��l)r�^�� thalidomide�l)r�^��grthalidomide tablets �vo��qw[h3202612986901397000447 �vo��qw[h3202613086901397000904 ��z����1���z��l�e � thymosin �1 p�yn���`��voob��l�u�l\(u��z��l�ethymalfasin for injectionȏnf�e1.6mg b��0wey]n�l6ro��s �vo��qw[h2002054586902018000273�w�l �vo��qw[h2003040786905814000324�t�e �vo��qw[h2005191686905842000297�e���n1.6 mgpatheon italia s.p.a h2012053186978856000058\[r>��c�sircalf spleen etractive \[r>��c�sir�l\�m calf spleen extractive injection2ml:5mgy���380�g8h�| t�gven.mwso�n���n gp�lq�s �vo��qw[h22026121869033560004518h�|8hx�a!ribonucleic acid a! p���$v�`�m�ts�uo(uas�ñy�|8hx�#bcg polysaccharide and nucleic acid as�ñy�|8hx��l\�m-bcg polysaccharide and nucleic acid injection�k�[�t1ml, tas�ñy�|0.35mg,8hx� nno�n30ug ym_lnl�o�n gp�lq�s �vo��qw[s3302000186904726000507as��[1ml/�t, tas�ñy�|0.35mg,8hx� nno�n30�gb��uir6r�txvz@b gp�#��nlq�s �vo��qw[s1998303686902060000092�egy�^1ml//e, tas�ñy�|0.35mg08hx� nno�n30�g vnws�egyuir6ro� gp�lq�s �vo��qw[s2002001986904944000013�����|��bozhi glycopeptide�����|���l\�mbozhi glycopeptide injection2ml:5mg(y�|):1mg(y��) s�n[�gso�n���n gp�lq�s �vo��qw[h1102215686900112000182lb�]6ro� gp�lq�s �vo��qw[h32026653869017430005109sy���_ pidotimod �s g�msobr0���|br9sy���_�s g�n�mpidotimod oral sodution��2�n� 10ml:0.4g �vo��qw[h20030463869016450011039sy���_���|pidotimod granulesёn�r�_2g:0.4g �vo��qw[h20030225869008730006299sy���_���|brpidotimod granules1�pn�v �vo��qw[h2003032586904735000512ܔ�~gpusހ̃pseudomonas aeruginosap�v`'`��$v�`�4o͑�^�~̃a�g �or;n�n;s^�n n$r�[�e�so(u ܔ�~gpusހ̃�l\�m pseudomonas aeruginosa injection1.0ml//e s�nnyr\uir6ro� gp�lq�s �vo��qw[s2004302286900179000019��ǃy�|lentinan��ǃy�|�l\�mlentinan injection�r�c��2ml:1mgёu�o�n���n gp�lq�s�y�]�h�\6ro��s �vo��qw[h2003013186904840000308�l\(u��ǃy�|lentinan for injection)y0w#k ws�n�~�s`�yo�n gp�lq�s �vo��qw[h1095007886901572000019 ws�nf�n6ro� gp�lq�s �vo��qw[h2005574586901605000122&(394.7)��ǃy�|gr�wgr͑0.1g �vo��qw[z200262158690468400028110 �b��$vo�ir 10.1 �~ހ�ko�ir10.1.1 \o(u�ndnasf[�~�go�ir ?� � }�y�g�kf � doxorubicin �l\(u�vx�y�g�kf'doxorubicin hydrochloride for injectionactavis italy s.p.a. h201301868697872000075710mg( cc27h29no11.hcl��) �m3wnpno�n gp�lq�s �vo��qw[h4402435986900549000052 �vo��qw[h3302198086904641000835}v�m�[busulfannas�]�� procarbazine.l�� chlormethine�vx�.l���l\�m �vo��qw[h3102089786900808000625�s�xp���cyclophosphamide�s�xp���grcyclophosphamide tablets120 �s�ey6ro� gp�lq�s �vo��qw[h2202267386903564001325&(399)bcfl�l\(u�s�xp���cyclophosphamide for injection �vo��qw[h3202085786901445000566 �vo��qw[h1402368686902918000311�[s�ubaxter oncology gmbh h2011040786978259000068as” carboplatinas”�l\�mcarboplatin injection�l� �vo��qw[h2002018086904021001452 �vo��qw[h2002018186904021001445/o\�[ 150mg/15ml//ecorden pharma latina s.p.a. h2011023186978313000294�l\(uas”carboplatin for injection �vo��qw[h1092002886904021000295 �vo��qw[h2005900886904127002292�g�~ � } daunorubicin �l\(u�vx��g�~ � }(daunorubicin hydrochloride for injection20mg( cc27h29no10��) �vo��qw[h4402436186900549000069 h2010055286978720000542 �vo��qw[h3302092586904641000583^x�f>mthiotepa^x�f>m�l\�m �vo��qw[h3102060086900808000854z�” cisplatinz�”�l\�mcisplatin injection �nws*n�euiro�n gp�lq�s �vo��qw[h5302174086905646000073��#k 6ml:30mg0 �vo��qw[h2004081386901444000116 20ml6"20mg �vo��qw[h2003067586901607000120 �l\(uz�”(�qr^�w) cisplatin for injection(freeze-drier model) �vo��qw[h2002323686903942000933cisplatin for injection �vo��qw[h200234608690402100< 0912 �vo��qw[h2002346186904021001087nˆ � } mitomycin�l\(unˆ � }mitomycin for injection �vo��qw[h1999902586904641000880 �vo��qw[h3302078686904641000958�s���s@l semustine?��g�kf aclarubicin �l\(u�vx�?��g�kf'aclarubicin hydrochloride for injection20mg( cc42h53no15��) �vo��qw[h1091009286900549000076�[tvu amsacrine�[tvu�l\�mamsacrine injection 1.5ml:75mg �vo��qw[h2005906586905843000012ey�l)r” oxaliplatin ey�l)r”u2����l\�m"oxaliplatin and mannitol injection��ŗ100ml:ey�l)r”50mgnu2���5.1g �vo��qw[h2005253186904127000144ey�l)r”�l\�moxaliplatin injection~�kqzs�^ 20ml:40mg �vo��qw[h2003104886900503000135�l\(uey�l)r”oxaliplatin for injectionpn�l�[)laboratoires thissen�rňon �[�����mg�] �6ro� gp�lq�s � �vo��qw[j2013000486978821001035eyckws �vo��qw[h2006429786901425000401~�r` �vo��qw[h2004081786901445002119 �vo��qw[h2000033786901445000870 �vo��qw[h2000068686901607000335 100ml:0.1g �vo��qw[h2005096286901445000078&(396)}v�m�[�l\�mbusulfan injection}v�^� 10ml:60mg*dsm pharmaceuticals,inc.�rsňon�ym_l'y�q6ro� gp�lq�s � �vo��qw[j2013005586979080000289�nx�.l�� chlorambucil!t�g�kf pirarubicin �l\(u�vx�!t�g�kf'pirarubicin hydrochloride for injection10mg( cc32h37no12��) �vo��qw[h1093010586900549000090 �vo��qw[h2004598386904641001344h��g�kf epirubicin �l\(u�vx�h��g�kf&epirubicin hydrochloride for injection�l�s�e ��^t6ro�(�e!�) gp�lq�s �vo��qw[h2000049686901420000055~���u �vo��qw[h1999028086904641000651.l2uformylmerphalan�y���s@l fotemustine2u_[�meisoindigotinas���s@l carmustineas���s@l�l\�mcarmustine injection2g:125mg �vo��qw[h1202099286900874000482mq2u��� altretaminemq2u������valtretamine capsules�po0.1g q\nmojw6ro��s gp�lq�s �vo��qw[h3702082386904180000594m” lobaplatin p�vq�n”{|o�ir�eheb n����s�l\(um”lobaplatin for injection 10mg��n�e4lir�� � �vo��qw[h2008035986905765000640 �vo��qw[h2005030886905765000251m���s@l lomustinem���s@l���vlomustine capsules �vo��qw[h3202137786901607000342��l�n melphalan&(419)hy��” nedaplatin�l\(uhy��”nedaplatin for injection��� �vo��qw[h2005056386904021001308eyhq�� �vo��qw[h2006429486901425000371 �vo��qw[h2006429586901425000388�l”  t�gr`ёo�n���n gp�lq�s �vo��qw[h2005148186901115000384<\���s@l nimustine �l\(u�vx�<\���s@l%nimustine hydrochloride for injection�[�_g h2010042286979008000322z�”/ls��cisplatin sodium chloride�f��u�� temozolomide�f��u�����vtemozolomide capsules��n _lς)y�x�r^�vo�n gp�lq�s �vo��qw[h2004063786901500000746 �vo��qw[h2004063686901500000739$orion corporation�rsň�s-p labo n.v. � h2013060286978892000104]xas�� nitrocaphane_�s�xp��� ifosfamide�l\(u_�s�xp���ifosfamide for injection9s gs^ �vo��qw[h1095029186901445000924 �vo��qw[h1095029286901445000955 �vo��qw[h2006672686901607000366 �vo��qw[h2008451386902918002506 y�e�s�xp���compound cyclophosphamide y�e�s�xp���gr!compound cyclophosphamide tablets�kgr t�s�xp���50mg��n�s��s;`�v��50ng �vo��qw[h1202100686900873000551�kgr t�s�xp���50mg��n�s��s;`�v��50mg10.1.2 q_�t8hx�tbo�ir?��|ހ�� cytarabine?��|ހ���l\�mcytarabine injection[��_zhospira australia pty ltd h2012018786979309000120 h2012018686979309000137 h2012018586979309000144 �l\(u�vx�?��|ހ��&cytarabine hydrochloride for injection �vo��qw[h2005469586904641001313�l\(u?��|ހ��cytarabine for injection[��_(� h2010059486978720000528 h2010059586978720000535 �t\�n��zs�o�n gp�lq�s �vo��qw[h2302180686903620000163l?\'vvu fluorouracil&(427)l?\'vvu�l\�m 10ml:0.25g �vo��qw[h3102059386900808001325fluorouracil injection 10ml�0.25g �vo��qw[h12020959869008740003212u(lv�dt methotrexatecf2u(lv�dtgrmethotrexate tablets �vo��qw[h310206448690081800227516 �vo��qw[h2202267486903564002841&(428)2u(lv�dt�l\�mmethotrexate injection�[��ebewepharmages.m.b.h.nfg.kg h2008023986979174000218 h2008025186979174000232 1000mg/10mlpfizer (perth) pty limited h2014020786978716000211 500mg/20mlpfizer(perth)ptylimited h2012044086978716000136�l\(u2u(lv�dtmethotrexate for injection ^n�\ws6ro� gp�lq�s �vo��qw[h2005469286900310000342 �vo��qw[h3202644386901445000313 �vo��qw[h3202619786901445000351 �vo��qw[h1402246286902918000489��w2�hydroxycarbamide��w2����vhydroxycarbamide capsulesq\�/cn�[yruir6ro� gp�lq�s �vo��qw[h1402301286902868000102��w2�grhydroxycarbamide tablets �vo��qw[h2001338986900056000040 �vo��qw[h3702128986904146000163�f�rltegafur��as�]�u dacarbazine�l\(u��as�]�udacarbazine for injection �vo�n�_6ro� gp�lq�s �vo��qw[h20063417869034580001440.1g( cc6h10n6o��) �vo��qw[h3202623186901607000229 �vo��qw[h2004362086902918001462l���b�n fludarabinep� n�~�~t0��$vn�y;sb��n�~(u o� �l\(u�xx�l���b�n#fl< udarabine phosphate for injection �vo��qw[h2006422886901736000169�y��ns'baxter oncology gmbh�rsň�[�����s�n �6ro� gp�lq�s � �vo��qw[j2014013186978450000270 �vo��qw[h2005437886904641001306 �vo��qw[h2006730986902918001967l?\'vvu/ls�� fluorouracil and sodium chloridel?\'vvua���|fluorouracil and glucose l?\'vvua���|�l\�m"fluorouracil and glucose injection�y�#k250ml:l?\'vvu0.25gna���|12.5g �vo��qw[h2004172986900933000279500ml:l?\'vvu0.5gna���|25g �vo��qw[h2004172886900933000262 t��n�n gemcitabine �l\(u�vx� t��n�n'gemcitabine hydrochloride for injectionep�b200 mg(�nc9h11f2n3o4�� �eli lilly and company h2011053586978396000167��wc �vo��qw[h2004095886903687000298�l� 0.2g��n t��n�n�� � �vo��qw[h2003010486901444000406 1.0g��n t��n�n�� � �vo��qw[h2003010586901444000086 1.0g(�n t��n�n��) �vo��qw[h2006367586903687000052as��lcarmofuras��lgrcarmofur tablets �vo��qw[h1097005886904146000361as�w�n�n capecitabineas�w�n�ngrcapecitabine table ^w��0.5g*12gr �vo��qw[h2007302486900723000151kx� vdt tioguanines|xb���� mitoxantrone �vx�s|xb�����l\�m$mitoxantrone hydrochloride injections|��[ �vo��qw[h1096019186902210002037 �vo��qw[h1096019286902210002068 �l\(u�vx�s|xb����(mitoxantrone hydrochloride for injection 5mg( cs|xb������) �vo��qw[h2005642786904141001264�] vdtmercaptopurine �s'll?\���1�'ll?\�� � doxifluridine�s'll?\�����vdoxifluridine capsules~�0n �vo��qw[h2000065186901445000610gy���_� �vo��qw[h2001018086904175000059�s'll?\��grdoxifluridine tablets�g�~ �vo��qw[h2003126786904561000748�w1r �vo��qw[h2003107586901749000088�f tey(tegafur �gimeracil and oteracil potassium�f tey���v2tegafur �gimeracil and oteracil potassium capsules�~�^�� �k�| t�f�rl20mg0 t�'vvu5.8mgney�f�b���19.6mg q\n�e�e�no�n gp�lq�s �vo��qw[h2008080286904188000466!�k�| t�f�rl25mg0 t�'vvu7.25mgney�f�b���24.5mg �vo��qw[h2008080386904188000473&(430) �f�rl/ls���l\�m�\f100ml:�f�rl0.5g/ls��0.9g. �vo��qw[h2003036286904098001348�f�rl�l\�mtegafur injection �vo��qw[h2006615086903708000283 �vo��qw[h20043069869040210013605ml:0.2g �vo��qw[h2003329486904021002152 �vo��qw[h2005924886904127000861 20ml:1.0g �l3�o�'yo�n gp�#��nlq�s �vo��qw[h2005701486901333000166 �vo��qw[h1091007886900874000635 �vx�s|xb����a���|mitoxantrone hydrochloridel2��� floxuridine�l\(ul2���floxuridine for injection �vo��qw[h2005800286900310000267floxuridine for injection �vo��qw[h2001317886904641001023[��s�~ indirubin/l'l�uchloroxoquinolinp���$v�`�o(u?\'vvu�f�rlcompound tegafur?\'vvu�f�rlgrcompound tegafur tablets y�e( }gr) �vo��qw[h230235538690362000019410.1.3 \o(u�n8hx�l�u_o�ir>e�~̃ }d dactinomycin�l\(u>e�~̃ }ddactinomycin for injection �vo��qw[h2002350486904641002341s^3� � } bleomycin a5 �l\(u�vx�s^3� � }(bleomycin a5 hydrochloride for injection �vo��qw[h2302180786903620000125 �vo��qw[h1202093386900929000207zseg � }bleomycin hydrochloride �l\(u�vx�zs�� � }%bleomycin hydrochloride for injection �e,gso�*h_o>y ؚ]�]�s h2009088586979082000119zs�[ � } boanmycin p�4y���ޜlv �l\(u�vx�zs�[ � }%boanmycin hydrochloride for injectionn�z�[ �nzs�[ � }��8.73mg �vo��qw[h200408648690092900006110.1.4 \o(u�n�bqb_�gv��b6rbr��uh�xhydroxycamptothecin��uh�x�l\�mhydroxylcamptothecine injection 10ml�10mg �vo��qw[h2004449886903662001340 �vo��qw[h2302262686903662001180 hydroxy lcamptothecine injection2ml:5mg//e*1/e/\�v*6\�v/'y�v܏'y;so�ğ�wޘ�n6ro� gp�lq�s �vo��qw[h42022734869018900001805ml:10mg//e*1/e/\�v*5\�v/'y�v �vo��qw[h4202273586901890000197�l\(u��uh�x!hydroxycamptothecin for injection�b�p2mg( cc20h16n2o5��) �vo��qw[h20010156869005490000215mg( cc20h16n2o5��) �vo��qw[h2001015786900549000038��w�uh�x/ls��)hydroxycamptothecinum and sodium chloride�bqb�f�^ topotecan �l\(u�vx�xb�l�f�^%topotecan hydrochloride for injectioneyw�� �vo��qw[h2006089186901425000043%topotecan hydrochloride for injection�t��e1mg,5�t/�v$glaxosmithkline manufacturing s.p.a. h20130424869784690002611mg,1�t/�v h2013042386978469000254 o�z�f�^ irinotecan �vx� o�z�f�^�l\�m"irinotecan hydrochloride injection_nf�b h2012053086978716000174 h2012052986978716000181 �l\(u�vx� o�z�f�^&irinotecan hydrochloride for injection~��r �vo��qw[h200407118690144500212640mg( cc33h38n4o6�hcl��) �vo��qw[h2002068786901445001433#irinotecan hydrochloride injection 5ml:100mg �vo��qw[h2006127686901445001129 p���6ro��wmws � gp�lq�s �vo��qw[h20084572869058470000702ml�40mg �vo��qw[h200845718690584700006310.1.5 mg �r^pb�_�{ˆ}vtbo�ir�%f�e�x vincristine �l\(ukxx��%f�e�x!vincristine sulfate for injection �vo��qw[h20065857869003100002291mg( cc46h56n4o10�h2so4��) �vo��qw[h4402177286900549000014 �vo��qw[h2004332686< 904641000408ؚ n\igo��xhomoharringtonine ؚ n\igo��x�l\�mhomoharringtonine injection1ml:1mg �vo��qw[h3302000786904494000761�oxb�l�� etoposide�oxb�l���l\�metoposide injection �vo��qw[h3202558386901445000399 �vo��qw[h3702318386904021001070��w�� vindesine �l\(ukxx���w��vindesine sulfate for injection�~�kq �vo��qw[h2005702886904494002369 �vo��qw[h2005302086904141001530 �vo��qw[h2004642186901749000392 �vo��qw[h2004642086901749000408�%f�x vinblastinekxx��%f�x�l\�mvinblastine sulfate injectionz�ovu 10ml:10mghospira australia pty ltd. h2011022886979309000113�%f^t�n vinorelbine r��wx��%f^t�n�l\�mvinorelbine tartrate injectionl���[ �vo��qw[h2005160586904494002352 vinorelbine bitartrate injection���~,g@pierre fabre medicament production-aquitaine pharm international h2014008386978754000129�v��1ml:10mg��nc45h54n4o8�� �0 �vo��qw[h1999027886901444000246 �l\(ur��wx��%f^t�n"vinorelbine tartrate for injection10mg��nc45h54n408�� � �vo��qw[h200419278690331000050310mg(�nc45h54n4o8��) �vo��qw[h2005145986904141001677̖���s@l estramustine�xx�̖���s@l���vestramustine phosphate capsules~��s� 0.14g*40�|/�v h2012053786978720000740y��n[� docetaxely��n[��l\�mdocetaxel injection~� } 1.5ml:60mg �vo��qw[h2008036686901445002324y^� �vo��qw[h2004112986904021001773docetaxel injection�l"}^0.5ml�20mg (d�1/e�nbr1.5ml)3sanofi-aventis deutschland gmbh(rňon�[�����mg�] �6ro� gp�lq�s) �vo��qw[j2014003986978248000284docetaxel injection 0.5ml:20mg �vo��qw[h2002054386901445001419 2.0ml:80mg �vo��qw[h2003056186901445002164 �vo��qw[h20031244869040210017594ml�80mg �vo��qw[h2004112886904021001780 ^x[ 1.0ml�40mg �vo��qw[h2006012786900549000205docetaxel for injection!y��n[��l\�m:1ml:40mg;y��n[��l\�m�nbr:3.66ml �vo��qw[h2008044386901425000517!y��n[��l\�m:2ml:80mg;y��n[��l\�m�nbr:7.32ml �vo��qw[h2008044486901425000524 ؚ n\igo��x/ls��%homoharringtonine and sodium chloride n\igo��x harringtonine�f<\�l�� teniposide�f<\�l���l\�mteniposide injection���� �vo��qw[h1999004486900143000540teniposide injectionks �corden pharma latina s.p.a h2013031686978313000416&(453)�oxb�l��o����vetoposide soft capsuleszkq �vo��qw[h1094000386901445000740�oxb�l�����vetoposide capsules�b�s*yyr%takasaki plant,nippon kayaku co. �ltd. h2011025486979082000140 }ig�� paclitaxel }ig���l\�mpaclitaxel injection�[ }�l5ml:30mg h2009017586979309000021 16.7ml:100mg �vo��qw[h2008403386905826000268�l }bristol-myers squibb s.r.l. h2013035986978313000423 �vo��qw[h2005300686902918001578 �vo��qw[h2007341686905025000922 �vo��qw[h2006429986901736000404 �vo��qw[h2005300186901749000552 s�nns }6ro����n gp�lq�s �vo��qw[h1098006686900052000204 } }s�nos�to��s �vo��qw[h1098006986900190000234 �vo��qw[h2005740486904127000700 �l\(u }ig���(�so!paclitaxel liposome for injcetion�rqb } �vo��qw[h2003035786901586000043�s2u�ee� }demehylcantharidinp���lv�t�]$o�oi��s2u�ee� }grdemethylcantharidin tablets �vo��qw[h1302349586902699000920 �ee�x����~u }b6&disodium cantharidinate and vitamin b610.1.6 vq�n�~ހ�ko�ir蕬qp���v� asparaginase�l\(u蕬qp���v�'asparaginase �escherichia �for injection �vo��qw[h2005736986900148000217 �l\(u蕬qp���v�(�w ^)'asparaginase(escherichia) for injection1nusmo �vo��qw[h1999310786901379000410 �l\(u蕬qp���v�('k�e)"asparaginase�erwinia �for injection �vo��qw[h1999391486900375001230 10.2 �o }{|o�ir 10.2.1 �bė�o }o�irl�n�� flutamidel�n��grflutamide tablets �vo��qw[h1999014486901500001101  nwm y�e ynso�n gp�lq�s �vo��qw[h1095022086900662000694 10.2.2 �b̖�o }o�ir�n��f�� tamoxifen�g|jx��n��f��grtamoxifen citrate tablets 10mg( c�n��f����) �vo��qw[h3202147286901749001740 �vo��qw[h3302158386904561000205 �vo��qw[h3102154586900662000564 �vo��qw[h3702292586904105000289��mf�� raloxifene�vx���mf��gr raloxifene hydrochloride tablets��� �vo��qw[h2005089986901445002218f�~yr 60mg/gr�7grlilly, s.a.�es�ug��u2�z��|���l\�mmannatide injection2ml:5mg b��)r\o�n gp�lq�s �vo��qw[h2000363386902044000322�l\(uu2�z��|��mannatide for injection�r\�q �vo��qw[h1097042686903458000274 �vo��qw[h199900298690345800028110.4 vq�n�~ax� tretinoin�~ax�grtretinoin tablets  nwm��wo�n gp�lq�s �vo��qw[h2001048786900757000233 �n7xx�� n'ls�n7x � arsenious acid�arsenic trioxide ��n7xx�/ls��"arsenious acid and sodium chloride �n7xx�/ls���l\�m,arsenious acid and sodium chloride injection o�l��ў��_l�t\�n;s'yo�n gp�lq�s �vo��qw[h1999019186903732000440 11 �b�s`�s�^o�ir 11.1 h1�sso;��eo�ir 11.1.1 �p�w��{|o�ir/l�oechlorphenaminel�egx�/l�oegr chlorpheniramine maleate tablets �vo��qw[h4202060886901815000448chlorphenamine maleate tablets �vo��qw[h1202023686900886000159&(482) l�egx�/l�oe�l\�m chlorphenamine maleate injection �vo��qw[h120206118690087400097011.1.2 usyn����{|o�ir�wm�bfdiphenhydramine�vx��wm�bfgr%diphenhydramine hydrochloride tablets �vo��qw[h4102114586903139001309&(483) �vx��wm�bf�l\�m'diphenhydramine hydrochloride injection �vo��qw[h1202061786900874000857 �vo��qw[h4402238786900375001735�f!t��oetripelennamine 11.1.3 )t{v�u{|o�ir_n�u promethazine�vx�_n�ugr"promethazine hydrochloride tablets �vo��qw[h200733338690301000033912.5mg �vo��qw[h2102091886901157002223 �vo��qw[h1202023786900886000548&(484)�vx�_n�u�l\�m$promethazine hydrochloride injection �vo��qw[h31021490869006730008122ml:50mg �vo��qw[h1202096986900874001045 �vo��qw[h3102203386900673000140 11.1.4 �t�u{|o�ir��u hydroxyzine�s/l��u decloxizine��f)r�u cetirizine �s g8^ʑbr�w0�s g�msobr �%��s g�msobrp�?q�z�vx���f)r�ugr cetirizine hydrochloride tablets�r �vo��qw[h2000037986904012000914�� �vo��qw[h1999032186904021000202�n)ryr �vo��qw[h2000024586900453000605�nyrf3ucb farchim sa�rsňon�aesica pharmaceuticals s.r.l. � h2010074086978928000078f)r �vo��qw[h1998005986901749000880�vx���f)r�u���v!cetirizine hydrochloride capsules�� �vo��qw[h2001033186900073000092�vx���f)r�u�|fmcetirizine hydrochloride syrup�|fmbr 120ml:0.12g �vo��qw[h2005088986904010000206 �vx���f)r�u�s g�n�m&cetirizine hydrochloride oral solution 0.1%,100ml/�t s�n闎o��t gp�lq�s �vo��qw[h2009332086900041000130�]��f)r�ulevocetirizinep���f)r�u��s�487 ��l�u1y%��v�`� �vx��]��f)r�urcegr2levocetirizine dihydrochloride dispersible tablets��`�� �vo��qw[h2006114386904010000251�vx��]��f)r�ugr$levocetirizine hydrochloride tablets:_�n �vo��qw[h2004068886904636000024%levocetirizine hydrochloride tabletsꏿv5mg/gr �vo��qw[h20< 04024986901003000380&levocetirizine dihydrochloride tablets �vo��qw[h2006033386901650000580(levocetirizine dihydrochloride tabletso�lucb farchim sa h2010075886978928000092 11.1.5 �tvu{|o�ir[��^vucyproheptadine�vx�[��^vugr$cyproheptadine hydrochloride tablets2mg(      !"#$%&'()* ,-./0123456789:;<=>?@abcdefghijklmnopqrstuvwxyz[\]^_`abcdefghijklmnopqrstuvwxyz{|}~��������������������������������������������������������������������������������������������������������������������������������      !"#$%&'()* ,-./0123456789:;<=>?@abcdefghijklmnopqrstuvwxyz[\]^_`abcdefghijklmnopqrstuvwxyz{|}~��������������������������������������������������������������������������������������������������������������������������������      !"#$%&'()* ,-./0123456789:;<=>?@abcdefghijklmnopqrstuvwxyz[\]^_`abcdefghijklmnopqrstuvwxyz{|}~����������������������������������������������������������������������������������������������������������������������������������������� cc21h21n�hcl��) �vo��qw[h3702230986904127001547$cyproheptadine hydyochloride tablets �vo��qw[h3102137286900662000182 8^�]�vo�6ro� gp�lq�s �vo��qw[h3202497786901389000646?�o�e@l acrivastine/l���n�[ loratadine/l���n�[grloratadine tablets)ytfck� �vo��qw[h2003111286901523000174oe�z�s �vo��qw[h2005095386901450000131/l���n�[���vloratadine capsuleswm�s�b^t �vo��qw[h2002055986900503000616fcqso s�nf f;so����n gp�lq�s �vo��qw[h2005004086900198000274�vx�/l���n�[���v!loratadine hydrochloride capsuless�oegy10mg(�nc22h23cln2o2��) �vo��qw[h2004056586904203000235 �vo��qw[h2007003086902529000274_^tfw  nwmhqupf�ŗ6ro� gp�lq�s �vo��qw[h1097041086900784000015lbp[_lo�nɩ�v nwmwm<\o�n gp�lq�s �vo��qw[h2008013486900841000170)y�v �vo��qw[h2006706686903098003451/l���n�[rcegrloratadine dispersible tablets���[ �vo��qw[h2003020886900148000576�tu�e@l mizolastine�tu�e@lʑgr%mizolastine sustained-release tabletsey<\wc ns�m n]n;so����n gp�lq�s �vo��qw[h2006129486900474000356%mizolastine sustained release tablets�v�l�g sanofi winthrop industrie�rsňon���[hg�h6ro� gp�lq�s � �vo��qw[j2013011186979350000070�o�]�e@lebastine�o�]�e@lgrebastine tabletsς� �vo��qw[h2004011986901467000339_`�n&industrias farmaceuticas almirall,s.a. h2014085586978207000102`ё mg�]�o;s�oupo�n gp�lq�s �vo��qw[h2004050386904471000029yr^����[ terfenadine?��s�tu astemizole 11.1.6 vq�n6��wmfdimenhydrinate6��wmfgrdimenhydrinate tablets �p�s����o�n gp�lq�s �vo��qw[h3702023286904240001028 �vo��qw[h3202584586901450000629 �vo��qw[h1102103986900202000900 �vo��qw[h1102103886900202000917�fnf)rvu triprolidine�vx��fnf)rvu���v#triprolidine hydrochloride capsules;rmq2.5�kkq hc201200308697905300019311.2 vq�nn��f�� ketotifen�[l�x�n��f��grketotifen fumarate tablets1mg( cc19h19nos��) �vo��qw[h3302091786904681000369 �vo��qw[h3202464386901397000355 �vo��qw[h3202363686901470000364 12 ^y�~�|�~(uo�ir 12.1 �b^ё�h�uo�ir12.1.1 �by�]��{|o�ir12.1.1.1 �]�ey�]{|o�ir�]�ey�]levodopa�]�ey�]grlevodopa tablets �vo��qw[h3102088886900661000640~��^ebrёr�p�� amantadine�vx�ёr�p��gr amantadine hydrochloride tablets �vo��qw[h2102071486901162001532 amantadine hydrochloride tablets �vo��qw[h3102028086900804000490�ёr memantine p� n�~;sb�͑�u�`� �vx��ёrgrmemantine hydrochloride tabletsf p3urottendorf pharma gmbh h201202688697899600049912.1.1.3 y�]���sso�o�rbrnf�bkq"} pramipexole�vx�nf�bkq"}gr#pramipexole dihydrochloride tablets�h�yw0.25mg)boehringer ingelheim pharma gmbh & co. kg h2014091786980023000051 h2014091886980023000068!t�0w\ piribedil!t�0w\ʑgr#piribedil sustained-release tablets�l���7les laboratoires servier industrie�rsňon��e�~ŗ�)y%m �6ro� gp�lq�s) �vo��qw[j201400648697902000142012.1.1.4 us��'lsv�b�w�mao-b ��b6rbr�seg tpq selegiline�vx��seg tpqgr selegiline hydrochloride tablets�ty!t h2011039786978700000197ё`s^ �vo��qw[h201330558690413900055212.1.1.5 ?q6�z�-'lmo-2u�wl��yv��comt ��b6rbri`�nas g entacaponei`�nas ggrentacapone tablets�s9n��pqey�z�['yo��s(orion0corporation) h2014022186978672000201 12.1.2 �bƀ�x{|o�ir�wm"}trihexyphenidyl�vx��wm"}grbenzhexol hydrochloride tablets }gr �vo��qw[h3202312986901500000401 �vo��qw[h3702272686904105000722 12.2 �b͑�u���e�ro�ir�e�e�vf neostigmine 2ukxx��e�e�vf�l\�m#neostigmine methylsulfate injection �vo��qw[h3102277086900801000424 1ml:0.5mg �vo��qw[h4102226986903257000215�n!t�e�vfpyridostigmine bromide�n!t�e�vfgrpyridostigmine bromide tablets �vo��qw[h3102086786900748000457�n�e�e�vfneostigmine bromide�rpq�noe galanthamine&(511) "l�nx��rpq�noe�l\�m �vo��qw[h3102067186900808000731&(509)�oz�/l��edrophonium chloride 12.3 �bkv�uo�ir12.3.1 hqb�'`�s\o�l�uo�iry񂠔phenytoin sodiumky񂠔grphenytoin sodium tablets �vo��qw[h4102409586903139000265 �vo��qw[h2102181086901162000078 �vo��qw[h1202012086900886000128 �vo��qw[h1302097786902770000429&(513)n bx���sodium valproatehkn bx���grsodium valproate tablets �vo��qw[h4302087486904971000710< �vo��qw[h3702262786904083001179n bx����s g�n�msodium valproate oral solution�_�]ё 300ml�12g [�����mg�] �6ro� gp�lq�s �vo��qw[h2004143586904502000363n bx����|fmsodium valproate syrup100ml:5g(�nn bx�����) �vo��qw[h4302187386904971000635asl��s^ carbamazepineghkasl��s^grcarbamazepine tablets �vo��qw[h4202211786902000001547 �vo��qw[h3102136686900662000670 �vo��qw[h3202021286901436000285 �vo��qw[h3702132886904146000088�_ty200mg �vo��qw[h1102227986900100000170eyas�s^ oxcarbazepineeyas�s^groxcarbazepine tablets�n�o s�n�v�s6ro� gp�lq�s �vo��qw[h2005151886900153000028n�n �vo��qw[h2004019286901958000015�f�� h2013001586978679001638n bx�a�magnesium valproaten bx�a�ʑgr-magnesium valproate sustained release tablets �vo��qw[h2003053786904971000680&(514)n bp���grvalpromide tablets �vo��qw[h4302187586904971000703n bx���ʑgr6compound sodium valproate and valproic acid sr tablets 0.5g(�nn bx�����)[���� (mg�])6ro� gp�lq�s �vo��qw[h2001059586904502000356)sodiumvalproate sustained release tabletsxq�l �vo��qw[h1999139586901445001594&(515)�b�� n�u lamotrigine�b�� n�ugrlamotrigine tablets�[� nёɩ�vvnws nё6ro� gp�#��nlq�s �vo��qw[h2005059686905020000330)r�_�50mg/gr$glaxosmithkline pharmaceuticals s.a. h2014047886978916000264qbs|n� primidoneqbs|n�gr �vo��qw[h3102014586900787000180xb!to� topiramatexb!to����vtopiramate capsules�y�l-janssen-ortho llc�rsňon�janssen-cilag s.p.a. � h2014002386978536000224xb!to�grtopiramate tablets �vo��qw[h2002055786902529000106 �vo��qw[h2002055586902529000120yn%t�� ethosuximide&(521)�]yn�b�fw levetiracetam�]yn�b�fwgrlevetiracetam tablets_fmpqucb pharma s.a. h2011040986978930000110 h2011041086978930000097n bp��� valpromide(lj�x�aminobutyric acid(lj�x�graminobutyric acid tablets �vo��qw[h120210898690088600007412.3.2 �r'`�s\o�l�uo�ir�r�]�un gabapentin�r�]�un���v폛r �vo��qw[h2004052786901436000438�r�]�ungrgabapentin tablets wmws[��zkqo�n gp�lq�s �vo��qw[h2008022386905805000449gabapentin capsules>m@l �vo��qw[h200306628690144500203412.3.3 kv�uc�~�r`�l�uo�ir�l\(un bx���sodium valproate for injection �v�]�y^t�_6ro� gp�lq�s �vo��qw[h2008454086902049000211sodium valproate for injection)sanofi-aventis s.p.a. �rsň�[�����mg�] �6ro� gp�lq�s � �vo��qw[j2013003386978820000534 ws_aqlqo�n gp�lq�s �vo��qw[h2006813386901257000075 12.4 �@��{�u(uo�ir��҉���tau�vergotamine caffeine��҉���tau�vgrergotamine and caffeine tablets$,g�t:n y�e6rbr �vq�~�n:n��kgr tr��wx���҉��1mg ��e4l�tau�v100mg �lws-npgo�n gp�lq�s �vo��qw[h1999400286903227000337<\��0ws^ nimodipine<\��0ws^grnimodipine tablets �vo��qw[h1402282186902959000523 �vo��qw[h2004391586900928000710nimodipini tablets�kgr20mg �vo��qw[h3302228586904762000660 �vo��qw[h3102271986900800000135<\��\ �vo��qw[h1091004086900928000130 �vo��qw[h1098318886902292000730<\�� t �vo��qw[h2000301086900002000087 �vo��qw[h1091008186904187001945<\��0ws^o����vnimodipine soft capsules ^yzo�nɩ�v gp�lq�s �vo��qw[h1097015186902729001743�]�fv�(m��~v� �batroxobin (defibrase)�]�fv��l\�mbatroxobin injectionn�ꏙ� 0.5ml:5bu s�nxb�k�o�n gp�lq�s �vo��qw[h2003029586900175000020m��~v��l\�mdefibrase injection[� �1ml�5usmo �vo��qw[h2004092786900112000120�l\(um��~v�defibrase for injection �vo��qw[h11022188869001120002745usmo �vo��qw[h1102218786900112000298 p�n�s@l betahistine�vx� p�n�s@lgr!betahistine hydrochloride tablets nwm�o �o��s gp�lq�s��yxbu�n� nwm�o �]n�yo�n gp�lq�s � �vo��qw[h31022080869008180012232u�xx� p�n�s@lgrbetahistine mesilate tabletsoeog6�kkq kspg�-n�v �o�n gp�lq�s �vo��qw[h2004013086901693000059&(528) �vx� p�n�s@l/ls���l\�m7betahistine hydrochloride and sodium chloride injection500ml:�vx� p�n�s@l0.02gn/ls��4.5g  t�g�^cn\o�n gp�lq�s �vo��qw[h2202459686903387000345500ml:�vx� p�n�s@l0.02g,/ls��4.5g �vo��qw[h1302375486902763001112 �l\(u�vx� p�n�s@l(betahistine dihycrochloide for injection �vo��qw[h2003047386904383000667�%f�@l vinpocetine�l\(u�%f�@lvinpocetine for injection/o�lwsw�qghqz6ro����n gp�lq�s �vo��qw[h2004119786903160000999vinpoceting for injection �nws�vuo�n gp�lq�s �vo��qw[h2005175186905670000131 �vo��qw[h2005109086902959000226fp�hq �vo��qw[h2003123486903687000168�%f�@l�l\�mvinpocetine injection�mfw �vo��qw[h20010467869032570003212ml:10mg �10/e/�v, h2012008386979164000129 �%f�@l/ls���l\�m%vinpocetine sodium chloride injectionpg�r�~100ml:�%f�@l10mgn/ls��0.9g �l3��_p�o�n gp�lq�s �vo��qw[h2003007586901340000074 �%f�@la���|�l\�m!vinpocetine and glucose injectionr��y100ml:�%f�@l10mgna���|5g ns�no�n(�egq) gp�lq�s �vo��qw[h2006016386904075000685&(529)�%f�@lgrvinpocetine tablets ym_l�l)r�ho�n gp�lq�s �vo��qw[h3302234286904715000112y�r�^ �vo��qw[h1095021686901162000658< vinpocetine tablets 10mg/gr �30gr/�v h20130774869791640001439n�sn�iia tanshinon iia 9n�sn�a!a�xx����l\�m �vo��qw[h3102255886900651001749n�^�butylphthaliden�^�o����vbutylphthalide soft capsulesi`�_nf �vo��qw[h2005029986902774000067&(531)p�%`'`:@�'`�rs-n�`��ego(un�t0w\ buflomedil&(532)�n"l��҉�xdihydroergotoxine 2u�xx��s"l��҉�k�xgrco-dergocrine mesylate tablets�u�_g� �vo��qw[h1091005486900867000512co-dergocrine mesyiate tablets �vo��qw[h3102118286900818002268�l�0w\fasudil �vx��l�0w\�l\�mfasudil hydrochloride injection�o�zbs h2015025286979166000400�]z 2ml:30mg ��k�v3/e )y%m�~�eo�n���n gp�lq�s�vo��qw[ h2004035686900864000225lbh)r�u flunarizine�vx�lbh)r�u���v"flunarizine hydrochloride capsules �vo��qw[h2000325886900503000470"flunayizine hydrochloride capsules��kup5mg(�nc26h26f2n2��) �vo��qw[h1093000386902529000205 �vo��qw[h3702301286903944000030 �vo��qw[h1202009686900854000013 �vo��qw[h3102062286900808000809$flunarizine hydrochloride capsules �vo��qw[h2000325586900480000746 q\n�o �6ro� gp�lq�s �vo��qw[h3702144186904165000380_^t�g �vo��qw[h1202070386900952000380�vx�lbh)r�ugr!flunarizine hydrochloride tablets �vo��qw[h2000361086904105000777 �vo��qw[h2002386086904232000107ey�r�okq10mg( cc26h26f2n2��) �vo��qw[h2302246786903719000050[�9h }puerarin [�9h }a���|�l\�mpuerarin and glucose injection250ml:[�9h }0.3gna���|12.5g �vo��qw[h2002043386901493000273puerarin and glucose ijectionnf�m100ml�[�9h }0.2gna���|5.0g �vo��qw[h2004563286901606000138250ml:[�9h }0.5gna���|12.5g; �vo��qw[h20000634869016060001521u� �vo��qw[h2001013486900933000453���uc,g�t�k�t100ml t[�9h }0.2g �a���|5.0g ��r�vx��ϑ���phu�mx��v�]�|^y�~����� monosialotetrahexosylgangliosideus>u�mx��v�]�|^y�~��������l\�m1monosialotetrahexosylganglioside so< dium injection �vo��qw[h2008378486903730000046 �vo��qw[h2006460186903732000266 �vo��qw[h2005678286904021001896�l\(uus>u�mx��v�]�|^y�~�������5monosialotetrahexosylganglioside sodium for injection3uwc �vo��qw[h2005148586904021001254 �vo��qw[h200462138690402100185812.5 �b?�\(�wm؞�uo�iryhy�tp� donepezil�vx�yhy�tp����v donepezil hydrochloride capsules�v� �vo��qw[h2003077986904203000112�vx�yhy�tp�grdonepezil hydrochloride tablets �vo��qw[h2003047286901444000345vb�ekq �vo��qw[h2004074586900886001071�[t3u kspg(-n�v)o�n gp�lq�s �vo��qw[h2005097886901693000011 �vx�yhy�tp�rcegr donepezil hydrochloride dispersible tablets �vo��qw[h2008038186904141002124as�]�b@l rivastigmine p� n�~;sb��l�u-n�^�n n�uft ͑r��wx�as�]�b@l���v'rivastigmine hydrogen tartrate capsules~��e��3.0mgnovartis farmaceutica s.a. h2013008186978672000171�wig�x2u huperzine a�wig�x2u���v50�g �vo��qw[h2003062186900662000434�wig�x2ugr�s�vs^ �vo��qw[h1096013386900662000052huperzine a tablets �vo��qw[h2003371886904756000478 12.6 -n�gtqkyo�ir ހ�xƀ�x�ހ�n�xƀ�x � citicolineހ�xƀ�x���l\�mciticoline sodium injection �vo��qw[h1999327686904021000165 �vo��qw[h1999392886903705000132 �vo��qw[h1999344486900918000027 �vo��qw[h1999306286904187000344 ހ�xƀ�x��/ls���l\�m/citicoline sodium and sodium chloride injection50ml�ހ�xƀ�x��0.5gn/ls��0.45g �vo��qw[h2006368986904188000022�l\(uހ�xƀ�x��citicoline sodium for injection �vo��qw[h2005370286904152002663�y�^w��n�rwcŏo�n gp�lq�s �vo��qw[h20033948869047990001520.25g( cc14h25n4nao11p2) �vo��qw[h2004436486904744000589 �vo��qw[h2008373686903021000465 �vo��qw[h2004395286900151000341m��globelinee�vx�m��g�l\�m lobeline hydrochloride injection1ml:3mg �vo��qw[h3102134286900673000218 �vo��qw[h2004356586900135001173 �vo��qw[h11020542�[�pu�n86900144003762<\�s9rs| nikethamide<\�s9rs|�l\�mnikethamide injection 1.5ml�0.375g �vo��qw[h2005600486903205000212 1.5ml:0.375g �vo��qw[h3102152786900673000317 �vo��qw[h1202096286900874001120&(547)ހ�xƀ�xހ�xƀ�x�����vciticoline sodium capsules`��g �vo��qw[h2002022086904021000134ހ�xƀ�x��grciticoline sodium tablets0.1g��nc14h26n4o11p2���{ � �vo��qw[h2008074586903973001152#k�seg �v�]�hfj�[o�n gp�lq�s �vo��qw[h2006038986902300000066 !t�b�fw�ynp���!t�t�pn� � piracetam!t�b�fwgrpiracetam tablets �vo��qw[h2102177586901162000085 �vo��qw[h1302178786902777000262 �vo��qw[h3102071486900818000349 �vo��qw[h1202066786900873000063 �vo��qw[h4202038986901815000042piracetam tablets �vo��qw[h1302251986902763000139&(550)!t�b�fw�l\�mpiracetam injection20ml:4g �vo��qw[h200412948690408300018920ml�8g �vo��qw[h200579978690302000005320ml�4g �vo��qw[h2004657886903973000094 !t�b�fw/ls���l\�m'piracetam and sodium chloride injection250ml:!t�b�fw8gn/ls��2.25g �vo��qw[h2004501986904127000250 �vo��qw[h2005450386904145000119 �vo��qw[h2005962686900808000137 �vo��qw[h370232178690418700036850ml�!t�b�fw10gn/ls��0.45g �vo��qw[h2007341986904177000040�^�[ �vo��qw[h2003024486901427000140�l\(u!t�b�fwpiracetam for injection �vo��qw[h2005063886905781000266 �vo��qw[h2302297086903705000163!tkx�� pyritinol�vx�!tkx���l\�m!pyritinol hydrochloride injection�v�� �vo��qw[h2005143686904083000400�wi` u��_cq6ro� gp�lq�s �vo��qw[h2004121286902394000140y�lnf�ndoxapram �vx�y�lnf�n�l\�m doxapram hydrochloride injectionsoς�n �vo��qw[h3202298986901436000704 �l\(u�vx�y�lnf�n$doxapram hydrochloride for injection �vo��qw[h2005265786903356000154�n2u_�g dimefline4��b�fw aniracetam4��b�fwgraniracetam tablets�_�z�y �vo��qw[h2003022986902959000035 �vo��qw[h20000548869029590000594��b�fw���vaniracetan capsules vnwsns�~'yo��s gp�lq�s �vo��qw[h2006668586904929000250aniracetam capsules �vo��qw[h2005946086904141001172 *y3��w(uq\)o�n gp�lq�s �vo��qw[h2003300886902778000056 �vo��qw[h20059459869041410011892u/l��o� meclofenoxate �vx�2u/l��o�rcegr0meclofenoxate hydrochloride dispersible tablets �vo��qw[h2008076886904929000564�vx�2u/l��o����v$meclofenoxate hydrochloride capsules �vo��qw[h4402339186900353000057 �vo��qw[h3102214686900808000373&(555)p�y$o'`f�� �l\(u�vx�2u/l��o�)meclofenoxate hydrochloride for injection �vo��qw[h2005645586900353000385 �vo��qw[h1402371886902918000519 �vo��qw[h1402371786902918000458 �vo��qw[h2006345686902918000533 �vo��qw[h2005859486902946001526 �vo��qw[h3102006086900796000782 �vo��qw[h2004483786900796000799�t2uo�methylphenidate&(556)�vx��t2uo�ʑgr7methylphenidate hydrochloride prolonged-release tabletsn�l��18mg1janssen cilag manufacturing llc�rsňon���[hg�h6ro� gp�lq�s � �vo��qw[j201200288697853800012336mg �vo��qw[j2012002986978538000116xb���@l tomoxet< ine�vx�xb���@l���v"atomoxetine hydrochloride capsules�b`��'lilly del caribe inc.�rsňon�lilly s.a. � h2011014586978608000152&lilly del caribe inc�rsňon�lilly s.a. � h2011014786978608000091%lilly del caribe inc.�rsňon�lly s.a. � h2011015086978608000060�[���tcaffeine and sodium benzoateey�b�fw oxiracetamey�b�fw���voxiracetam capsulesepgf vnwsepgo�n gp�#��nlq�s �vo��qw[h2003003786904935000046'keg�[ �vo��qw[h2003103386902770000368&(557.2)ey�b�fw�l\�moxiracetam injection pnf5ml:1.0g ^nn�oo�n gp�lq�s �vo��qw[h2005086086900339000040'kpq t �vo��qw[h2006007086903662000053 12.7 g�y��p wo�ir��]�k�y phenobarbital��]�k�ygrphenobarbital tablets �vo��qw[h3102203886900818000240&(558)��]�k�y���l\�msodium phenobarbital injection �vo��qw[h1202038186900874000062�l\(u��]�k�y��"phenobarbital sodium for injection �vo��qw[h3102050186900796000898 �vo��qw[h2005738486904799000787phenobarbital sodium injection �vo��qw[h4402188886900267000198�s�s�]�k�y secobarbitalh_ b�]�k�y amobarbital�spo9skq�� eszopiclonenbegnf��zaleplonnbegnf��rcegrzaleplon dispersible tablets�[�n14  n��\[����~6ro� gp�lq�s �vo��qw[h2004003586903190000082nbegnf�����vzaleplon capsules�f�[ �vo��qw[h2003105486900148000606i`��#k �vo��qw[h2004027486901436001046nbegnf��grzaleplon tablets�`�[ �vo��qw[h2005223486900931000134po9skq�� zopiclonepo9skq�����vzopiclone capsulesr�\p� �vo��qw[h2001068086900867001137po9skq��grzopiclone tablets �vo��qw[h1098024786900340000992 n�� �vo��qw[h109801638690402100113128 �vo��qw[h1098016286904021000721u!tfwzolpidemr��wx�u!tfwgrzolpidem tartrate tablets`��`-sanofi winthrop industrie(rňon�[�����mg�] �6ro� gp�lq�s) �vo��qw[j2014002186978821001226-sanofi winthrop industrie�rňon�[�����mg�] �6ro� gp�lq�s �fm#k �vo��qw[h2002006586900785000120pnfw �vo��qw[h2000027686904960000165���[ �vo��qw[h2000011486901444000253 12.8 �bop4y�uo�ir)rnb�fnffw rizatriptanp�op4y�u%`'`�s\o�n�~(uo� �3�e�qo(u �2ux�)rnb�fnffwgrrizatriptan benzoate tablets'k�z\p 5mg(�n)rnb�fnffw��) vns'k�z6ro� gp�lq�s �vo��qw[h2008074086901814000722 �2ux�)rnb�fnffw���v!rizatriptan monobenzoate capsules#k n �vo��qw[h2006035286902300000073s|kspg�-n�v �o�n gp�lq�srň �vo��qw[j2013007686979086000689�l\(u2u����mecobalamin for injection!`^y�o �vo��qw[h2004181186902699000548 �vo��qw[h2005047586902777002235�fnb<\�[ tizanidine�vx��fnb<\�[gr tizanidine hydrochloride tablets�q��� �vo��qw[h2005078886902181000292z������� cobamamidez�������grcobamamide tablets 0.25mg��|c�gr � �vo��qw[h2007358786903205001790&(574)�l\(uz�������cobamamide for injection �vo��qw[h20058603869025570002601.5mg �vo��qw[h20058604869025570005430.5mg,1�t/\�v �10�t/-n�v u��'y�_)r6ro� gp�lq�s �vo��qw[h2005828686905891000460 �vo��qw[h3102296286900< 651001381 �vo��qw[h2005935686900651000124yn�t�z~g eperisone�vx�yn�t�z~ggreperisone hydrochloride tablets�[�[ �vo��qw[h2001065786904028000199�y�~ �vo��qw[h2004106186901693000035�ˆ}v4l�ircerebroprotein hydrolysate �ˆ}v4l�ir�l\�m$cerebroprotein hydrolysate injection�enf�u10ml//eever neuro pharma gmbh h20100440869791740003172ml//e h20100442869791740003315ml//e h2010044386979174000348 �l\(u�ˆ}v4l�ir(cerebroprotein hydrolysate for injection��ss^175mg((l�wx�):30mg(;`.l) �vo��qw[h2005144386900151000624�^t�l�k/e t8n�y(l�wx�175.55mgn;`.l30.50mg ^n��k�o�n gp�lq�s �vo��qw[h2005123086900336000425�[�l#k 30mg(�n;`.l��) �vo��qw[h2005101086900356001198 60mg��n;`n�� � �vo��qw[h2005218286902918001684 �vo��qw[h2004158086905670000186 �vo��qw[h2004158186905670000162&(1049) \[r@��sˆ}v�c�sir$deproteinised calf blood extractives \[r@�n�sˆ}v�l\�m(deproteinised calf blood serum injectioney�_ё &��]ey?�o�n gp�#��nlq�s �vo��qw[h2001076286901190000385 �vo��qw[h2000020286901190000095&(1048)\[r@�n�sˆ}vdeproteinised calf serum \[r@��sˆ}v�c�sir�l\�m4deproteinized hemoderivative of calf blood injection1r�~�l 10ml:400mgtakeda austria gmbh h2008035286979574000030.deproteinized calf blood extractives injection10ml:0.4g�;`�vso � �vo��qw[h200312018690372600053120ml�0.8g�;`�vso � �vo��qw[h2006449986903726000937 5ml:0.2g(;`�vso) �vo��qw[h200034348690372600074610ml:400mg�;`�vso � �vo��qw[h2005674686901940000559 2ml:80mg(;`�vso) �vo��qw[h2000376086901940000313 �l\(u\[r@��sˆ}v�c�sir0deproteinized calfblood extratives for injection?��n 400mg(;`�vso) �vo��qw[h20051009869036650006542deproteinized calf blood extractives for injection�e'k^t 200mg�;`�vso � �vo��qw[h20050974869037400000292deproteinized calf blood extractives for injection 0.4g(;`�vso) �vo��qw[h20061150869037400006091deproteinized calfblood extractives for injection#k�~�l �vo��qw[h20060121869033860009710.8g �vo��qw[h2006012086903386000070 n�xx�ހ���n��cytidine disodium triphosphate p��y$okb/gt�r�����x  n�xx�ހ���n���l\�m(cytidine disodium triphosphate injection �vo��qw[h2004636886900148000859 �vo��qw[h4402460286900377001245 �vo��qw[h2004534286903984000083 �vo��qw[h2005898386902770002584 �l\(u n�xx�ހ���n��,cytidine disodium triphosphate for injection �vo��qw[h2004310386900148000231 �vo��qw[h3702375886903984000328 �vo��qw[h2005745286904069000523 �vo��qw[h2006464186904127002445 �vo��qw[h2005930786904141001639 13 �l�u�|^y���xo�ir 13.1 �b�|^y�uo�ir13.1.1 xq�w�b�|^y�uo�ir�,{n�n�b�|^y�uo�ir �13.1.1.1 )t{v�u{|o�irkycny� perphenazinekycny�grperphenazine tablets �vo��qw[h3102108386900665000660 �vo��qw[h3102108486900665000639 �vo��qw[h3202312286901500001163&(576)/ln�uchlorpromazine�vx�/ln�ugr$chlorpromazine hydrochloride tablets ym_ln��o�n���n gp�lq�s �vo��qw[h3302132886904723000135 �vo��qw[h4102250686903139002665 �vo��qw[h3102153786900818001421 �vo��qw[h1102085186900202000290 �vo��qw[h3202313086901500000333 �vo��qw[h1102085286900202000467&(577)�vx�/ln�u�l\�m&chlorpromazine hydrochloride injection �vo��qw[h3102106086900673000584 �vo��qw[h31021061869006730003552ml�50mg �vo��qw[h4102137086903205001561/l.ls^ clozapine/l.ls^grclozapine tablets �vo��qw[h1102084686900202000658 �vo��qw[h3202373386901397000430clozapine tablets vnwsm�^o�n���n gp�lq�s �vo��qw[h4302057186904917000309 �vo��qw[h3202296386901436001053 �vo��qw[h3102180286900680000096 �vo��qw[h3102115286900818002008 nl�b�utrifluoperazinelkycny� fluphenazine�vx�lkycny�gr"fluphenazine hydrochloride tablets �vo��qw[h3102120286900818001742&(580) y�e�vx�/ln�u'compound chlorpromazine hydrochlorideinxvlkycny�fluphenazine decanoatexvlkycny��l\�m fluphenazine decanoate injection�n�r%atlantic laboratories corporatio,ltd. h2008025586978992000288 �vo��qw[h3102133586900673001321kx)r���u thioridazine�t�l^x�u pipotiazine �h�i�t�l^x�u�l\�mpipotiazine palmitate injection<\��� �vo��qw[h109300808690095100047313.1.1.2 np��{|o�irl�tvu�� haloperidol&(585)l�tvu���l\�mhaloperidol injection �vo��qw[h4302055586904917000880 xvx�l�tvu���l\�mhaloperidol decanoate injection�t�ry h2009041086978992000363ey.ls^ olanzapineey.ls^grolanzapine tablets�`oe 8^�]nsu6ro� gp�lq�s �vo��qw[h2003051286901371000012'kpq�[10mg0 �vo��qw[h2001079986901444000031 �vo��qw[h2005268886901444000024�qnfpn(lilly del caribe, inc.�rsňon�lilly s.a. � h2009097686978403000715 h2014060986978403001354l�t)ry droperidoll�t)ry�l\�m �vo��qw[h3102089586900808001332�ukxs^ quetiapine�[l�x��ukxs^grquetiapine fumarate tablets/t�~0.1g( cc21h25n3o2s��) �vo��qw[h200101178690491700095< 8�` ς�],{�x6ro� gp�lq�s �vo��qw[h2003074286901649000324`^t�^(astrazeneca uk limited(rsňon�?��e)r�^6ro� gp�lq�s � �vo��qw[j2013008086978241001127astrazeneca uk limited h2013004186978241001028 �vo��qw[j2013005786978241001097)r�wn� risperidone)r�wn��s g�n�mrisperidone oral solutionuskq 30ml�30mg �vo��qw[h2006500586901389001032)r�wn��s g�m�~`� 1mg/ml �30ml/�t,janssen pharmaceutica n.v.�rsňon���[hg�h6ro� gp�lq�s � �vo��qw[j2012001886978539000870)r�wn�grrisperidone tablets �vo��qw[h2005173186901389001063`)r� 1mg ,g�t:n}vr�����c�gr �vo��qw[h2005016086901436000308ss y �vo��qw[h2004180886904021001537ss� �vo��qw[h2005077686900951000107 �vo��qw[h2001030986902529000038 �vo��qw[h2001031086902529000021&(589)�st�)]�grp� nm�t go��`�)r�wn��st�)]�gr)risperidone orally disintegrating tablets �vo��qw[h2007031986904021002763�nl)ry penfluridol�nl)rygrpenfluridol tablets �vo��qw[h4302055886904917000576 20mg ,g�t:n�|c�gr �vo��qw[h3202297686901436000759�l\(u)r�wn��_t risperidone for depot suspension13.1.1.3 kxbg��{|o�irl�t{v(t flupentixol&(592)l�t{v(t�)r�f��flupentixol and melitracen l�t{v(t�)r�f��gr"flupentixol and melitracen tablets۞�r�el�t{v(t0.5mg�t�)r�f��10mg/grh.lundbeck a/s h2013012686978996000574/l�t{v(t clopenthixol/lnf{v(tchlorprothixene/lnf{v(tgrchlorprothixene tablets �vo��qw[h3202448086901518001223&(595)13.1.1.4 �2up���{|o�ir��_)r sulpiride��_)rgrsulpiride tablets �vo��qw[h3202297186901436000544sulpiride tablets �vo��qw[h3202312686901500000388 �vo��qw[h3102119786900818001698&(596)(l�x�_)r amisulpride(l�x�_)rgramisulpride tablets"}̑f-sanofi winthrop industrie�rňon�[�����mg�] �6ro� gp�lq�s � �vo��qw[j2014008086978821001271 �vo��qw[h2011323186904021003012kx�_)rtiapride�vx�kx�_)r�l\�m tiapride hydrochloride injection�~gy 2ml:100mg//e _lς�m4l6ro� gp�lq�s �vo��qw[h2004009486901466000149�xb�_)r sultopride13.1.2 ^�xq�w�b�|^y�uo�ir�,{�n�n�b�|^y�uo�ir �^)r�tn� paliperidone^)r�tn�ʑgr%paliperidone extended-release tablets����3mg/gr4janssen cilag manufacturing l.l.c.�rsňon���[hg�h6ro� gp�lq�s � �vo��qw[j20140068869785370004146mg/gr �vo��qw[j2014006686978537000391p��b�n� ziprasidone�vx�p��b�n����v"ziprasidone hydrochloride capsules`�m �vo��qw[h2004150686900834000019�[�_�q ym_l'y�q6ro� gp�lq�s �vo��qw[h2006130486904619000010&(602) 13.2 �b&qq�o�ir13.2.1 g�y��b&qq�o�ir�bdz{| �?�nfu�n alprazolam?�nfu�ngralprazolam tablets �vo��qw[h4102027286903098000016 �vo��qw[h1102089086900202000016 �vo��qw[h3702127786904146000019 �vo��qw[h3202021586901436000018 �vo��qw[h4302057886904917000019 �vo��qw[h1202018686900966000017 �vo��qw[h3702144486904165000021~��su�n estazolam~��su�ngrestazolam tablets �vo��qw[h1202029186900931000059 1mg 24gr*2g �vo��qw[h4302069686904917000057 �vo��qw[h1102089186900202000030 �vo��qw[h1302097486902770000207 �ls�)yo�n gp�lq�s �vo��qw[h1302056286902596000078 �vo��qw[h3202069986901389000011estazolam tablets �vo��qw[h37023047869041650000450w��ldiazepam0w��lgrdiazepam tablets �vo��qw[h1202011986900886000975 �vo��qw[h4202152886901884001087 �vo��qw[h1102089886900202000818diazepam tablets �vo��qw[h3702303986904165000595&(605)0w��l�l\�mdiazepam injection �vo��qw[h1202095786900874000147 nm�]o�nɩ�v gp�lq�s �vo��qw[h3202165286901453001326ey�l��loxazepamey�l��lgroxazepam tablets �vo��qw[h1102089486900202000092�r�b��l lorazepam�r�b��lgrlorazepam tabletsw�b h2013090986978992000431pn�b�[ �vo��qw[h2005231186901884001438 �vo��qw[h2003106586904917000194sonfpn �vo��qw[h2006010586904165000700 h2013091186978992000424 h2013091086978992000417/l]x��l clonazepam/l]x��lgrclonazepam tablets �vo��qw[h4302058786904917000842 �vo��qw[h1093000486901436000933 �vo��qw[h1093014486901436000667&(608)&(233)l�egx��t��u�ngrmidazolam maleate �vo��qw[h20041869869014360011387]x��l nitrazepam]x��lgrnitrazepam tablets �vo��qw[h320229668690143600071113.2.2 ^�g�y��b&qq�o�ir(^�bdz{|)n���sn� buspirone�vx�n���sn�grbuspirone hydrochloride tabletsς�e5mg(�nc21h31n5o2�hcl��) �vo��qw[h2000019986900052000235buspirone hydrochloride tabletsn� �vo��qw[h1999102486901436000896gy�kyr �vo��qw[h1999030286900976000410&(485)fw�^��n� tandospirone�g|jx�fw�^��n�grtandospirone citrate tablets ^�_csumitomo dainippon pharma co., ltd. ibaraki plant�rsň< �oo�s6ro��ς�] � gp�lq�s � �vo��qw[j2014002086978991000685 �g|jx�fw�^��n����vtandospirone citrate capsules�_�^ �vo��qw[h2005232886902181000124 13.3 �b�b��o�ir13.3.1 n�s{|�b�b��o�ir?�s|�f�g amitriptyline�vx�?�s|�f�ggr#amitriptyline hydrochloride tablets �vo��qw[h4302056186904917000477 �vo��qw[h3202376486901389000561ns|�u imipraminey^xs^doxepin�vx�y^xs^grdoxepin hydrochloride tablets 25mg(�ny^xs^��) �vo��qw[h3102044786900748000266 �vo��qw[h1102085086900202000191 �vo��qw[h3102142586900818001520 25mg� cy^xs^�� �  nwmr�s^o�n gp�lq�s �vo��qw[h3102066486900736000421 25mg(�ny^xs^�� � �vo��qw[h3202448986901518001018/ls|^f clomipramine&(615)�vx�/ls|^fgr"clomipramine hydrochloride tablets �vo��qw[h1090002786904917000484"clomipramine hydrochloride tablets 25mg ,g�t:n�|c�gr �vo��qw[h3202297486901436000599 �vo��qw[h120202788690095100039813.3.2 �v�s{|�b�b��o�irl�nf�f�g maprotiline�vx�l�nf�f�ggr!maprotiline hydrochloride tablets �vo��qw[h1102085486900202000313yyo�n gp�lq�s �vo��qw[h2302072786903729000583 �vo��qw[h4302056286904917000385&(616)s|�[r��g mianserin�vx�s|�[r��ggrmianserin hydrochloride tablets q\n�n�txo�n gp�lq�s �vo��qw[h200104418690416100059913.3.3 ��b'`5-ht�qdd�s�b6rbr~��s�^�nfpq escitalopram i�x�~��s�^�nfpqgrescitalopram oxalate tablets 5mg��n~��s�^�nfpq�� � q\n�nks6ro� gp�lq�s �vo��qw[h2008059986904111000129eg�xnf!h.lundbecka/s<br>rsňon���[hg�h6ro� gp�lq�s �vo��qw[j201001658697899600047510mg( cc20h21fn2o�� � �vo��qw[h2008078886902292001263lo�lf fluvoxaminel�egx�lo�lfgrfluvoxamine maleate tabletspqʑabbott healthcare sas h2014051986978890000380 �vo��qw[h2005892186900541000180l�@l fluoxetine�vx�l�@lrcegr,fluoxetine hydrochloride dispersible tablets~vo� patheon france�rsňon�m�u nsո��e!� �6ro� gp�lq�s �vo��qw[h2004165686901416000618^t��� h2014003186979034000679q\��^�[uir6r�t���n gp�lq�s �vo��qw[h2008010186902902000419s|\�[ �vo��qw[h200607028690366200170813.3.6 us��'lsv��b6rbrt/l��� moclobemide13.3.7 5-ht�sso�b�bbr/�qdd�s�b6rbr�fun� trazodone�vx��fun�grtrazodone hydrochloride tablets�k }�s �vo��qw[h2002035586901371000142��~ �l3��y�[o�n gp�lq�s �vo��qw[h2005022386901287000083��e�s50�kkqx20gr ��esf[6ro����n gp�lq�s hc200900058697911600004713.3.8 ��b'`�s2u�� nz� }�qdd�s�b6rbr�^m�@l duloxetine �vx��^m�@l���n���v)duloxetine hydrochloride enteric capsules#k~v��eli lilly and company h2011031786978396000143 h2011032086978396000112^t�l�@l reboxetine2u�xx�^t�l�@lgrreboxetine mesylate tablets �vo��qw[h2008015586900044000083 2u�xx�^t�l�@l���vreboxetine mesylate capsules�sm�b �vo��qw[h2004101086901066000839 13.3.9 vq�n/l�nbn� chlormezanone/l�nbn�grchlormezanone tablets �vo��qw[h2102260986901157001981{v< hynf@l tianeptine 13.4 �b���ro�ir�xx��lithium carbonate�xx��grlithium carbonate tablets �vo��qw[h4302075986904971000222 �vo��qw[h3102175686900787000098 �vo��qw[h4302037286904960000301&(632)�xx��ʑgr lithium carbonate sustained-release tablets �vo��qw[h1090001386901436000803 14 |t8t�|�~o�ir 14.1 [y�uo�ir�n�]�e bromhexine�vx��n�]�egr bromhexine hydrochloride tablets �vo��qw[h3302131586904723000289 �vo��qw[h1202030786900931000509(l�n"}ambroxol�s g8^ʑbr�w0�cʑbr�w �s g�msobr�vx�(l�n"}grambroxol hydrochloride tablets�m%m �vo��qw[h2001042586904141000533�[nf"} �vo��qw[h1999022886900863000127pqς �vo��qw[h2000066086901389000318��� �vo��qw[h1998001686901445001068�l�fw �vo��qw[h2003036086900638000062 �vo��qw[h2008354786900480001521�vx�(l�n"}���vambroxol hydrochloride capsulesfwy� �vo��qw[h2005059886902132000401�vx�(l�n"}rcegr)ambroxol hydrochloride dispersive tablets�bfwn �vo��qw[h2006025486902920000200*ambroxol hydrochloride dispersible tablets�_n �vo��qw[h2006036986901257000044)ambroxol hudrochloride dispersible tableti`ens^ �vo��qw[h2005231386900594000106 �vx�(l�n"}�s g�n�m$ambroxol hydrochloride oral solution^t0u5ml:15mg ў��_l-nbh6ro� gp�lq�s �vo��qw[h2001053486903804000101 100ml:0.3g �vo��qw[h1998017886901445000559 100ml:0.6g �vo��qw[h2006409086901445002256 0.3g/100ml �vo��qw[h2007374486900555000862 100ml�0.6g �vo��qw[h2003131486900638000031 10ml�30mg86903804000095 �vo��qw[h2006629686902777002365 10ml:30mg �vo��qw[h2015306686902132000722 �vo��qw[h2006720086903712002174 0.6%�100�kgs/�t � �vo��qw[h2000066186901389000707 �vx�(l�n"}ʑ���v1ambroxol hydrochloride sustained release capsules~v�l� �vo��qw[h2003064086900225002905&(634) �vx�(l�n"}/ls���l\�m4ambroxol hydrochloride and sodium chloride injection�~�s��100ml��vx�(l�n"}30mgn/ls��0.9g0 �vo��qw[h2003112086901444000505 �vx�(l�n"}a���|�l\�m(ambroxol hydrochloride glucose injectionfw;r�b50ml��vx�(l�n"}30mgna���|2.5g �vo��qw[h2005158086903804000170,ambroxol hydrochloride and glucose injection�_#k �vo��qw[h2004018186902763000504�vx�(l�n"}�l\�m ambroxol hydrochloride injection o���2ml:15mg �vo��qw[h20041473869009510002514ml�30mg �vo��qw[h2005160486900951000541 boehringer ingelheim espana,s.a. h2013077986978297000211�l\(u�vx�(l�n"}$ambroxol hydrochloride for injection �vo��qw[h2003134486901389000967$ambroxol hydrochloride for injectioney�s=n �vo��qw[h2006021386901425000197 �vo��qw[h2005140286904141001257h�qchёz�lmyrtol standardizedh�qchёz�l���n���v�b�nň �8myrtol standardized enteric coated soft capsules�adults)�k�| t300mgh�qchёz�l �_�v ^\6ro� gp�lq�s z2010000886978441000067h�qchёz�l���n���v(?q�zň);myrtol standardized enteric coated soft capsules (children)�k�| t120mgh�qchёz�l z20100007�%p�?q�z86978441000050�|ˆ}vv� chymotrypsin�l\(u�|ˆ}vv�4000usmo �vo��qw[h3102211286900651000698chymotrypsin for injection �vo��qw[h1102235186900144001836�2u�sfw carbocisteine�2u�sfwgrcarbocisteine tablets �vo��qw[h4402321186900381001811carbocysteine tablets �vo��qw[h1202030986900931000523�2u�sfw�s g�n�mcarbocisteine oral solution �vo��qw[h4402410486900381001699 s�nڋnm6ro� gp�lq�s �vo��qw[h2004496786909198000154&(633)�vx��n�]�e�l\�m �vo��qw[h3102270386900808000229ynp�js�(lx�acetylcysteineynp�js�(lx�gracetylcysteine tablets0.6g wmws^���6ro� gp�lq�s �vo��qw[h2008032686905838000126&(638) �����v� serrapeptase �����v����ngr#serrapeptase enteric-coated tablets�ffw �vo��qw[h2005044886901679000752ʑ^t�� hc2009002386979129000119ih�g��&eucalyptol �limonene and pinene entericih�g�����no����v4eucalyptol,limonene and pinene enteric soft capsulesr�� cih�g���l��:n0.12g/�| s�n]n�to�n gp�lq�s �vo��qw[h20070006869000660000234eucalyptol �limonene and pinene enteric soft capsules  cih�g���l��0.3g/�| �vo��qw[h2005240186900066000016 14.2 g��to�ir y�eui�6rbr compound liquorice�glycyrrhiza �preparations y�eui�grcompound liquorice tablets �vo��qw[h1202080286900886000821>,g�t:n y�e6rbr �g�~�n:n��kgr tui�xm���|112.5�kkq0b�|�g�c�sir�n4�kkq0j�2�kkq0kq҉4����l2�kkq0�2ux���2�kkq �vo��qw[h1202114286900867000161 �vo��qw[h3702244286904187002744compound liquorice tablets4���qx�t �vo��qw[h1102067186900228000144compound liquorice tabletsompound liquorice tablets.�kgr tui�xm���|0.1125g0?�gr�|4mg0j�2mg0kq҉4����l2mg0�2ux���2mg0 �vo��qw[h2102457786901161002288 y�eui��s g�n�m"compound glycyrrhiza oral solution�s g�m100�kgs �vo��qw[h42022905869019540006511�k�t100ml��k10ml tui�amxm��1.2ml � y�ej�j�1.8ml �ar(gz�u�l��0.05g � �vo��qw[h3702098986904043000730#compound glycyrrhiza oral solution  y�e �100ml/�t s�nwm�_�m6ro� gp�lq�s �vo��qw[h1102117686900038000334<  y�e �180ml/�t �vo��qw[h3102082886900727000416  y�e �2000ml/�t �vo��qw[h2102229486901161002295 y�e �120�kgs  y�e �90ml/�t  y�e �10ml*10s/�v ym_l�l�^o�nɩ�v gp�lq�s �vo��qw[h2005424186904714000595�uxb�~�g pentoxyverine�g|jx��uxb�~�ggrpentoxyverine citrate tablets �vo��qw[h4102427786903098001860 �vo��qw[h4102244386903139002139 �vo��qw[h6102216586902503001112pentoxyverine citrate tablets �vo��qw[h3102097486900818002237 �vo��qw[h1302315586902770002614 �vo��qw[h1202023486900886000685�n'ln�udioxopromethazine y�e�xx��s�_�vcompound codeine phosphate  y�e�s�_�v�s g�n�m(compound codeine phosphate oral solution�e�lmvq �vo��qw[h1097017186900600000496  y�e�xx��s�_�v�s g�n�mt���bk�t2� 60ml/�t � y�e �vo��qw[h1093019386900555000848ey�n hc2010001686979136000874  y�e�xx��s�_�v�n�m#compound codeine phosphate solution9120ml ��k1ml tl�egx��n�oe0.4mg,�xx��s�_�v0.9mg,�vx���ğ�x1.0mg,ar(gz�u�l��20mg �vo��qw[h2005400386905405000221860ml ��k1ml tl�egx��n�oe0.4mg,�xx��s�_�v0.9mg,�vx���ğ�x1.0mg,ar(gz�u�l��20mg�s�_�vcodeine&(643)�sa�|fmcodeine and guaifenesin syrup�%�p��n�~(uo�10ml��xx��s�_�v20mg,ar(gz�u�l��0.2g �s�nns�mؚ�y)y6qo�ir gp�lq�s �vo��qw[h1093020786900142000350�s��l��dextromethorphan"l�nx��s��l��gr&dextromethorphani hydrobromidi tablets �vo��qw[h2006634886902767000661az��n�e(guaifenesin and bromhexine hydrochloride!�ƀ�s g�n�mfowl bile oral solution10ml( te��s'lƀx�22mg) t�gwns�no�n���n gp�lq�s �vo��qw[h2005821486903405000357 14.3 s^�uo�ir 14.3.1 6��x{|o�ir(l6��x aminophylline(l6��xgraminophylline tablets �vo��qw[h3702189686904127000120 �vo��qw[h1302103386902770000320 �vo��qw[h1202011886900886000050(l6��xʑgr'aminophylline sustained-release tablets �vo��qw[h3702006586904240000045&(646)(l6��x�l\�maminophylline injection �vo��qw[h1202088486900874000031 �vo��qw[h1202098786900874000024 �vo��qw[h2006745986902087000068 �vo��qw[h4402173786900375000035 �vo��qw[h4402200786900375000073 �vo��qw[h41022266869032570000316��x theophylline6��xʑgr&theophylline sustained-release tablets ^�]ȏyrtqns6ro��s gp�lq�s �vo��qw[h4402379186900405001360 �vo��qw[h3702070086904187000726 6��xʑ���v(a!)*theophylline sustained release capsules(a!)�e\s^ �vo��qw[h10940037869044940010896��xʑ���v'theophylline sustained release capsules�^s|  nwm1r�v�s6ro� gp�lq�s �vo��qw[h2001041286900620000216'theophylline sustained-release capsules�w�e�s�� �vo��qw[h1096028386905801000573y"}6��x doxofylliney"}6��x���vdoxofylline capsules�q�[�]�  nwm�q�[o�n���n gp�lq�s �vo��qw[h2001004186900705000063y"}6��xgrdoxofylline tablets ym_lf)r�^6ro� gp�lq�s �vo��qw[h2000001186904706000084doxofylline tables�e�s^  nwm�[�lwm�o�n gp�lq�s �vo��qw[h2003063386901476000016&(648) y"}6��xa���|�l\�m!doxofylline and glucose injection�yr~��e100ml�y"}6��x0.3gna���|5g �q���s�^�no�n gp�lq�s �vo��qw[h2003082986903904000278�l\(uy"}6��xdoxofylline for injection�v"} �vo��qw[h2005223986904152003066100ml:y"}6��x0.3gna���|5g �vo��qw[h2003061986904145000256y"}6��x�l\�mdoxofylline lnjection�[[��sў��_l�y�tnsf6ro�ɩ�v���n gp�lq�s �vo��qw[h2000030486903731000984doxofylline injection�[^x�s �vo��qw[h2008388386903731001738doxolylline injection 20ml:0.3g �vo��qw[h2008375886903731001721�~�_eg �vo��qw[h2003076386904098000495"}� 10ml�0.1gym_lsuo�nilu6ro� gp�lq�s �vo��qw[h2004061786904610000095g� �vo��qw[h2005127586903134000581ep�e�� �vo��qw[h2005230986900978004423 ў��_l)y��o�n gp�lq�s �vo��qw[h2008056286903790000727doxofylline for lnjection vnshs�eo�n���n gp�lq�s �vo��qw[h2006077086901874000731"})r�[ �vo��qw[h2005240686902357000200 �vo��qw[h2005230886900978004416�n�n6��x diprophylline�n�n6��xgrdiprophylline tablets �vo��qw[h1202029486900931000301 �vo��qw[h3102077286900818003029&(649)�n�n6��x�l\�mdiprophylline injection �vo��qw[h1302276586902770002331 �vo��qw[h4402478486900375000301 �vo��qw[h1202095886900874000185 y�e6��x#compound theophylline preparations  y�e6��x��ğ�xgr �vo��qw[h1202122986900886000838 14.3.2 �bƀ�x{|o�ir{vxb�n��tiotropium bromide{vxb�n���|��br(tiotropium bromide powder for inhalation)ytf�pn�|��br 18�g�&^ňn � �vo��qw[h2006045486901523000747{vxb�n���|8teqbr`�rns8teq'`�|br18�g( c{vxb���� ��vs_�n{vxb�n��n4ltir22.5�g) h2014095486980023000037 h2014093386980023000044_nxb�n��ipratropium bromide 8teq(u_nxb�n���n�m ipratropium bromide solution for inhalation1rhqpn2ml:_nxb�n��250�glaboratoire unither h20100681869783020007312ml:_nxb�n��500�g h2010068286978302000724_nxb�n��l��bripratropium bromide aerosoll��br�k�t14g,�q t_nxb�n��8.4mg �vo��qw[h1102242186900038000129 20ug/�c,10ml//e �vo��qw[j201301358697830200082314.3.3 ��sso�o�ro�ir�ln���� salbutamol kxx��ln������s8teq�n�m.salbutamol sulfate nebules inhalation solutio< n�����y���s8teq�m20ml:0.1g( c�ln������) �m3w'y[oo�n gp�lq�s �vo��qw[h2000034886900500000046 kxx��ln����l��brsalbutamol sulfate aerosolnxb�g100ug/�c �200�c/�t.glaxo wellcome s.a.<br>rsňon t�y [�pq }�skq6ro��ς�] � gp�lq�s �vo��qw[j2014010486978470000670�ln����l��brsalbutamol aerosol2�k�t14g, t�ln����20mg,o��msm�^:n0.14%(g/g),200�c ��k�c t�ln����0.10mg �vo��qw[h31020560869008180005478teq'`�m�`�m14g:20mg �vo��qw[h5002045386901016000476 8teq(ukxx��ln�����n�m*salbutamol sulfate solution for inhalation��s�n�mbr 5mg/ml �20ml/�tglaxo wellcome operations h2009008786978462000442�s^yrw bambuterol�vx��s^yrwgr bambuterol hydrochloride tablets.^y10mg( cc18h29n3o5hcl��) ?��e)r�^6ro� gp�lq�s �vo��qw[h1999007286901359000232glpg �vo��qw[h2001010086904021000417nasyrw procaterol�vx�nasyrwgr procaterol hydrochloride tablets25ug r��\�v'yo�n gp�lq�s �vo��qw[h1999410186904030000040�nfn25�g �vo��qw[h1093001786904619000072 �vx�nasyrw�s g�n�m&procaterol hydrochloride oral solution 30ml�0.15mg �vo��qw[h2005390386900273000366�y��yrw formoterol �[l�x��y��yrw�|8teqbr)formoterol fumarate powder for inhalationeykq�e���or^�|8teqbr�k8t4.5ug(1g:10mg) �608t//e h2013037886979096001515&(656)�[l�x��y��yrwgrformoterol fumarate tablets�v�_#k40�g �vo��qw[h2004094386900886000791kq�nyrw clenbuterol/ln���g clorprenaline&(653)kxx��ln����grsalbutamol sulfate tablets2.4mg(�vs_�n�ln����2mg) �vo��qw[h3202412986901518000554�l�yrw salmeterolyr^�n�g terbutalinekxx�yr^�n�ggrterbutaline sulphate tabletszs)r�^<\ �vo��qw[h3202269486901359000157&(660) kxx�yr^�n�g��s�m.terbutaline sulphate solution for nebulization h2014010886979096001638 kxx�yr^�n�g�l\�mterbutaline sulfate injectionςz� 1ml:0.25mg b��ns�[6ro� gp�lq�s �vo��qw[h2001070386902035000058 14.3.4 �o }{|o�ir p/ls|~gbeclometasone dipropionate nx� p/ls|~gl��br"beclometasone dipropionate aerosol�k�t200�c,�k�c tnx� p/ls|~g250�g �vo��qw[h2005986786904111000051�k�t200�c,�k�c tnx� p/ls|~g50ug �vo��qw[h3102077086900818003128�k�t200�c,�k�c tnx� p/ls|~g50�g �vo��qw[h3702292886904111000037 50�g/�c*200�c �vo��qw[h3702215286904232000138^0why�_ budesonide 8teq(u^0why�_�m�`�m$budesonide suspension for inhalationnfs|kq�n�2ml:1mg �8teq'`�m�`�m �astrazeneca pty ltd h2014047586978239000101^0why�_�|8teqbr budesonide powder for inhalationnfs|kq���o0.1mg/8t �2008t//e/�v ��|8teqbr � h2013032286979096001485^0why�_l��brbudesonide aerosol t��k�t t^0why�_20mg,�k�t200�c,�k�c t^0why�_0.1mg �vo��qw[h2003098786904012001324^0why�_;��u��brbudesonide nasal spray6ml�7.68mg ��k�u t^0why�_64�geptn�ocq;so�u�b���n gp�lq�septn�s hc2013002086979414000022�����yr 64ug/�u �120�u//ebastrazeneca ab�rsňon�?��e)r�^6ro� gp�lq�sastrazeneca pharmaceutical co,.ltd � �vo��qw[j2014004886979096001720l�fas~g fluticasone nx�l�fas~g8teql��br&fluticasone propionate inhaled aerosol���n� 125�g/�c,60�c/�t9glaxo wellcome sa(rsň:glaxosmithkline australia pty ltd.) h201301908697847000057150�g/�c,120�c/�t��k�c tnx�l�fas~g50�g;glaxo wellcome sa�rsňon�glaxosmithkline australia pty ltd. � h201301898697847000056414.3.5 }v n�p�b�bo�ir_[���syr montelukast_[���syr��grmontelukast sodium tablets �vo��qw[h2008337286904010000558 10mg� c_[���syr�� � �vo��qw[h2006437086902132000456z�\�[(merck sharp & dohme ltd.�mg�]؞�ln6ro� gp�lq�srsň � �vo��qw[j2013004786978639001272r�ux���sodium cromoglicatenb���syr zafirlukast y�e�f<\�syrcompound tranilast 14.3.6 vq�n^0why�_�y��yrwbudesonide and formoterol ^0why�_�y��yrw�|8teqbr8budesonide and formoterol fumarate powder for inhalation�o�_�s���o��s8teqbr160�_kq/4.5�_kq/8t �608t//e�8teq�|��br � h201404588697909600174480ug:4.5ug/8t �608t//e�8teq�|��br � h2014045986979096001751�l�yrw�fas~g�l�fas~g�l�yrw � asalmeterol xinafoate and fluticasone �fluticasone and salmeterol � �l�yrw�fas~g�|8teqbresalmeterol xinafoate and fluticasone propionate powder for inhalation�)r�50ug/100ug/�l,60�l�k�vglaxo operations uk limited h201401668697846200062650ug/250ug/�l,60�l�k�v h201401648697846200060250ug/500ug/�l,60�l/�v h2014016586978462000619 y�e_nxb�n�� �_nxb�n���ln���� �"ipratropine bromide and salbutamol 8teq(u y�e_nxb�n���n�m4compound ipratropium bromide solution for inhalation�s�_yr2.5ml//e h2012054486978301000138�~̃�n㉧nirbacterial lysates�l�y�3.5g om pharma sa s201200518697869300010514.4 vq�n �rir�n��h�b�;m'`ir(��%�p��eu?q y�e2u'l��fcompound methoxyphenamine  y�e2u'l��f���v0compound methoxyphenamine hydrochloride capsuleskqkn)�k�| t(l6��x25mg,�vx�2u'l��f12.5mg,���sn7mg,l�egx�/l�oe2mg�tq6ro� gp�lq�s �vo��qw[h2002039386904465000028"compound methoxyphenamine capsules?��e�&�vx�2u'l��f12.5mg,���sn7mg,(l6��x25mg,l�egx�/l�oe2mg,{n nqq6ro�� nwm � gp�lq�s �vo��qw[h2003366986900745000078 15 < �ms�|�~o�ir15.1 �bx�o�ir�s�b�n�u�uo�ir15.1.1 �bx�o�ir�sà�|���o�bo�ir'yğ�xx�"l��rnei and sodium bicabronate y�e"l'lsݔcompound aluminium hydroxide y�e"l'lsݔgr$compound aluminium hydroxide tablets#"l'lsݔ0.245g, nexx�a�0.105g,���amxm��0.0026ml �vo��qw[h2102200586901157000496'compound aluminium hydroxide tablets �vo��qw[h1302167986902662001831�g|jx�˔��bismuth potassium citrate�g|jx�˔��gr!bismuth potassium citrate tablets=n�y�_��0.3g(�vs_�n˔0.11g) �vo��qw[h1090009386901828000480=n�s�_pn0.3g(�vs_�n˔110mg) �vo��qw[h1090008486900453001633 �vo��qw[h1302241386902699002306�_��gr 0.3g� t˔110mg �56 �vo��qw[h1092005186904759000123�g|jx�˔�����v"bismuth potassium citrate capsules 0.3g( t˔110mg) �vo��qw[h1098318586901650001167 �vo��qw[h2004305986901453001661 �vo��qw[h1092009886900453001619�g|jx�˔�����|"bismuth potassium citrate granules �k��1.2g�110mg˔ �[y }f���6ro� gp�lq�s �vo��qw[h2004400386905921000064�k�� t˔110�kkq��k��1g � �`�^o�nɩ�v gp�lq�s �vo��qw[h2004546686900239000249�xx�"l��sodium bicarbonate�xx�"l��grsoctium bicarbonate tablets �vo��qw[h1302272286902662001299sodium bicarbonate tablets �vo��qw[h1202022086900886000494 y�eݔx�˔compound bismuth aluminate y�eݔx�˔���|#compound bismuth aluminate granules�_�_�l1.3g/�� ���[ey��6ro� gp�lq�s �vo��qw[h1095031986901351000278 t�lo� gefarnate t�lo�grgefarnate tablets�`�r:_-gseikoeiyoyakuhinco.,ltd h2009015086979108000055��so�g��˔colloidal bismuth pectin��so�g��˔���v!colloidal bismuth pectin capsules�n˔���{50mg �vo��qw[h2004351686904606000153 50mg(�n˔���{) 5��] tnmx6ro� gp�lq�s �vo��qw[h2000319586905535000528 �k�|100mg��n˔�� � �vo��qw[h2003380686903740000012 100mg(�nbi��) �vo��qw[h2005847686902868000683 0.1g��nbi���{ � �vo��qw[h2005651786904606000207&(674)kx�|ݔ sucralfatekx�|ݔ�t�vgrsucralfate chewable tablets�t�vgr �vo��qw[h3202364486901470000999 �vo��qw[h3402119986904373000448ݔ�xx�a� hydrotalciteݔ�xx�a�grhydrotalcite tablets���u500mg/gr�b3�;so��oep gp�lq�s/tnrlq�s��yxb�e��b3�;so��oep gp�lq�s � �vo��qw[h2001341086900002000063^t�]>myr rebamipide^t�]>myrgrrebamipide tablets ym_l܏�repo�n gp�#��nlq�s �vo��qw[h2001001586904631000104���v`�� �vo��qw[h2002054186904619000089�fnf^tn� teprenone�fnf^tn����vteprenone capsules �vo��qw[h2009365686901693000097�xx�ݔaluminium phosphate�xx�ݔ�q��!colloidal aluminium phosphate gelm�~pn20g�11g boryung pharmaceutical co., ltd. h2013042286978305000066aluminium phosphate gelո\20g:2.5g �vo��qw[h1999110086901416000168aluminum phosphate gei11%(g/g) �20g*4��/�v �vo��qw[h2007404086901307001113�oas pyrecabet�oas pyr�����|ecabet sodium granules1.0g��nc20h27nao5s�5h2o�� � )y%m0u��6ro� gp�lq�s �vo��qw[h2010312486900945000113 y�e��ƀ�xx�"l��$compound gentianandsodiumbicarbonate 15.1.2 �bx�o�ir15.1.2.1 h2�sso;��eo�ir�l���fn famotidine�l���fngrfamotidine tablets vnws���6ro� gp�lq�s �vo��qw[h4302066786904914000159famotidine tablets �vo��qw[h4402095586900376001482ؚ����[�e�leg6ro��-n�v � gp�lq�s �vo��qw[h2102363186901076000041�l���fn���vfamotidine capsules �vo��qw[h2005326686901997000212&(683)�l���fn�l\�mfamotidine injection2ml�20mg �vo��qw[h2004374786903973000711�l\(u�l���fnfamotidine for injection �vo��qw[h2004393686905822000675��<\�fn ranitidine�vx���<\�fn���v!ranitidine hydrochloride capsules0.15kq( cc13h22n4o3s��) �vo��qw[h13022482869027630010200.15g� cc13h22n403s�� � �vo��qw[h12020306869009310004860.15g( cc13h22n4o3s��) �vo��qw[h5002024886901016001886pq~vx^ �vo��qw[h3302174186904502000271 �vo��qw[h3302038286904670000301 �vo��qw[h1302131786902777000996&(684) �vx���<\�fn�l\�m"ranitidine hydrochloride injection �vo��qw[h10890003869044940016452ml:50mg( cc13h22n4o3s��) �vo��qw[h2004426486900808001752 �l\(u�vx���<\�fn&ranitidine hydrochloride for injectiongy� �vo��qw[h2004083386902066000812��t�fn cimetidine��t�fngrcimetidine tablets �vo��qw[h3702263286904083000813�là� �vo��qw[h1202049986900969000199 �vo��qw[h1202021986900886000302 �vo��qw[h1202030486900931000776 �vo��qw[h4102158886903098003031 �vo��qw[h1202049886900969000175��t�fn���vcimetidine capsules �vo��qw[h4402075386900290000264 �vo��qw[h5002024786901016001589&(685)��t�fn�l\�m nwm,{nuso�n gp�lq�s��yxb nwm�o �ё1go�n gp�lq�su�n � �vo��qw[h3102247186900651000520cimetidine injection�l:n�-haupt pharma w�lfing gmbh�rsňon�-n�)y%m�skq6ro� gp�lq�s � �vo��qw[j2010015786978472000159�bkt�fn lafutidine�bkt�fn���vlafutidine capsules �vo��qw[h2008025086901493001416�bkt�fngrlafutidine tabletsz�q _lς�m��o�n gp�lq�s �vo��qw[h200611388690147500044415.1.2.2 (�p[�l�b6ro�irey��bu omeprazoleey��bu�����ngr(omeprazole sodium enteric-coated tablets)r��^ 10mg� cey��b< u�� � �vo��qw[h2005186486901679000011ey��bu���ngr!omeprazole enteric-coated tablets �vo��qw[h2008381586904127003756ey��bua����ngr omeprazole magnesium enteric-coated tabletsm[�kqmupsastrazeneca abrsňon�?��e)r�^6ro� gp�lq�s � �vo��qw[j2013009286979096001539 �vo��qw[h2004487186904188000015 astrazeneca ab�rsňon�?��e)r�^6ro� gp�lq�s � �vo��qw[j2013009386979096001546�~=n� �vo��qw[h1999011486900154000171 �vo��qw[h200838318690412700374921 s�n�n�[uiro�n gp�lq�s �vo��qw[h2012309686909542000021ey��bu���n���v"omeprazole enteric-coated capsules �vo��qw[h2008376386900239000812 �vo��qw[h2003344486904141000069 �vo��qw[h1094018886902503000214 wmwswm�r6ro� gp�lq�s �vo��qw[h2007406686905774000402 �vo��qw[h2008450786904141002230 �vo��qw[h2008438886901749002006 �vo��qw[h2004643086902770000375omeprazole enteric capsules �vo��qw[h2007406386903139002764 �w"}��bu�~��sey��bu � esomeprazole �w"}��bua����ngr-esomeprazole magnesium enteric-coated tablets��o �vo��qw[h2004637986901359000027 �vo��qw[h2004638086901359000010&(687) �l\(u�w"}��bu��!esomeprazole sodium for injection40mg/�t �vo��qw[h2009331486901359000287&(686)�l\(uey��bu��(y� ��n�l)5omeprazole sodium for injection(intravenous infusion)m[�kq �vo��qw[h2003339486901359000270�l\(uey��bu��omeprazole sodium for injectioneykq 40mg(�ney��bu�� � �vo��qw[h2001049686901389000677ey��^ 40mg��ney��bu�� � �vo��qw[h200590538690142500045640mg�d�n(u�n�z10ml � �vo��qw[h200446548690065100151040mg(�nc17h19n3o3s��) �vo��qw[h200542068690250300360460mg(�nc17h19n3o3s��) �vo��qw[h2006770786905793000278 20mg��ney��bu�� � �vo��qw[h2005905286901425000449 20mg(�ney��bu��) �vo��qw[h2005849286904141000137 �vo��qw[h2007328486901956000444 ^n~v�y6ro� gp�lq�s �vo��qw[h200731078690035600114340mg(�ney��buc17h19n3o3s��) �vo��qw[h2006301686902777001962pq"}�bu lansoprazolepq"}�bugrlansoprazole tablets �vo��qw[h2006531786904141001929pq"}�bu���ngr#lansoprazole enteric-coated tabletspq�`y �vo��qw[h1098013686900484000292 �vo��qw[h2006760586900818002534�sa�glbp[_lo�nɩ�v�v�]wmʉo�n gp�lq�s �vo��qw[h2006518686902313000084pq"}�bu���vlansoprazole capsules �vo��qw[h2006619786901841000368pq"}�bu���n���v$lansoprazole enteric-coated capsules��kqnf�� �vo��qw[h1098003586900948000042pq"}�bu�s)]gr*lansoprazole orally disintegrating tabletsnfxbs^ 30mg� cpq"}�bu�� �ctakeda pharmaceutical company limited,osaka plant�rsň� )y%mfk0uo��t gp�lq�s ) �vo��qw[j2012004286979133001089 �vo��qw[h2006674686901841000351 �vo��qw[h2008397486901841000450&(688)�l\(upq"}�bulansoprazole for injection �vo��qw[h2008033686901425000579����bu rabeprazole ����bu�����n���v*rabeprazole sodium enteric-coated capsulesnm�� �vo��qw[h2004091686901453001524 �vo��qw[h2006122086901453001548�0ur� �vo��qw[h2005022886900601000358����bu�����ngr)sodium rabeprazole enteric-coated tablets^t�lyr10 mg0 �vo��qw[h2002033086901444000215)rabeprazole sodium enteric-coated tablets�l)ryr 10mg��n����bu���� � �vo��qw[h2009009186901693000080�[�e� b��ꏷ^o�n gp�lq�s �vo��qw[h2004071586902135000354 �vo��qw[h2011016086905843001613 �vo��qw[h2004105786900453001695�oks�[ �vo��qw[h2003129286900818002596 �vo��qw[h2008012586902856001272�lxb�bu pantoprazole�lxb�bu�����ngr*pantoprazole sodium enteric-coated tabletsxo��lkq &��]]n�lo�n gp�#��nlq�s �vo��qw[h2001003586901192000338�l�<\kq 20mg(�n�lxb�bu��) ���[���~��6ro����n gp�lq�s �vo��qw[h2005906786901284000086 40mg(�n�lxb�bu��) �vo��qw[h1098019486901284000123�lxb�bu���ngr#pantoprazole enteric-coated tabletsxo�ymkq 40mg(�n�lxb�bu�� �'takeda gmbh production site oranienburg h2014065986978687000173 h2013016286978687000104 �lxb�bu�����n���v pantoprazole sodium enteric-coated capsules �y�]��wmo�n gp�lq�s �vo��qw[h2005241786904833000148 pantoprazole sodium enteric-coated capsules�l�zς �vo��qw[h2001003286904520000253 20mg��n�lxb�bu�� � ���[�^zs�x6ro� gp�lq�s �vo��qw[h2008029286901219000396*pantoprazole sodium enteric-coated tablets40mg� cc16h15f2n3o4s���{ � �vo��qw[h2005901986904929000267&(690)�l\(u�lxb�bu��!pantoprazole sodium for injectionks�s�[ �vo��qw[h1999016786901122000520!pantoprazole sodium for injection%takeda gmbh manufacturing site singen h2013013986978687000081 �vo��qw[h2006582386904152001918���h �vo��qw[h200306518690413900039240�kkq( cc16h15f2n3o4s���{) �vo��qw[h1999016986901284000109"pantolprazole sodium for injection80mg( cc16h15f2n3o4s���{) �vo��qw[h2005202286901284000079�� 40mg( c�lxb�bu��) �vo��qw[h1999017086901749001191 �vo��qw[h2006625686905843000234 �vo��qw[h1999016686904520000260 �vo��qw[h2005066886904520000062 q\�zgy��iqf6ro� gp�lq�s �vo��qw[h2006702986902954000597 �vo��qw[< h2006670486900792001783 15.2 �r�mso�irsnv�ulactasinsnv�ugrlactasin tablets �ls�swmo�n gp�lq�s �vo��qw[h1302029986902624000247 bh�gwso����n gp�lq�s �vo��qw[h4502033786905206001069s|�f̃��v�'oryz-aspergillus enzyme and pancreatin s|�f̃��v�gr-oryz-aspergillus enzyme and pancreatin tabletwa|_3u�kgr ts|�f̃ ��c�sir24mg,��v�220mg#nordmark arzneimittel gmbh & co. kg h2012006986979540000019��v� pancreatin��v����n���v"pancreatin enteric-coated capsules ͑�^so��uir�] z gp�lq�s �vo��qw[h5002087886901010000168��v����ngr!pancreatin enteric-coated tablets ���[9nuuir6ro� gp�lq�s �vo��qw[h2102140586901148000252 vq�]u�[6ro� gp�lq�s �vo��qw[h3702280786904256000152yv� multienzymeyv�grmultienzyme tablets��v�0.3g,àˆ}vv�13mg �vo��qw[h3102035386900757000486 y�eàˆ}vv�compound pepsin y�eàˆ}vv�cecompound pepsin powder�k��ň3g �n�[o�n'y t6ro� gp�lq�s �vo��qw[h1402276086902986001265 15.3 à����uo�ir?�xb�tatropinekxx�?�xb�tgratropine sulfate tabletes0.3mg �vo��qw[h3302008686904494000464��� belladonna���gr �kgr t���xm��10mg �vo��qw[z1202042586900886000951q\��ꃱx anisodamine�m�eq\��ꃱxgrreceanisodamine tablets �vo��qw[h3202101386901470001194raceanisodamine tablets �vo��qw[h3702111686904043000358&(696) �vx��m�eq\��ꃱx�l\�m'raceanisodamine hydrochloride injection �vo��qw[h3302170786904494001935 �vo��qw[h1202088986900874001021n�nn��ꃱxscopolamine butylbromide&(697) n�nn��ꃱx�l\�m"scopolamine butylbromide injection b��,{no�n gp�lq�s �vo��qw[h5102259486902065000073 �vo��qw[h2005848886904180000822 �l\(un�nn��ꃱx&scopolamine butylbromide for injection �vo��qw[h2008037586902066001758u�ypq �vo��qw[h2005257586905814000249n��ꃱx scopolamine&(698) "l�nx�n��ꃱx�l\�m"scopolamine hydrobromide injection 1ml:0.3mg �vo��qw[h44020567869003750018899s�~�n��pinaverium bromide9s�~�n��grpinaverium bromide tablets�_�yr h2012012786978888000088�f�^@l trimebutine l�egx��f�^@lrcegr'trimebutine maleate dispersible tablets<\:nz[ �vo��qw[h2004088286904606000054 l�egx��f�^@l���vtrimebutine maleate capsules^tep �vo��qw[h2004071386902868000430l�egx��f�^@lgrtrimebutine maleate tablets�=n/t�� �vo��qw[h2003029086900945000021�nn��*y�gpropantheline bromide 15.4 à�r�ro�iryxo�zn� domperidoneyxo�zn�grdomperidone tablets �vo��qw[h2009370086901397001055 �vo��qw[h2009377986904606000337 �vo��qw[h2009342686904960000530tniu �vo��qw[h1091000386902529000144 �vo��qw[h2001319686900453001510yxo�zn�rcegrdomperidone dispersible tablets���� _l�gl�no�n gp�lq�s �vo��qw[h2003126886905297000330yxo�zn��m�`�mdomperidone suspension1ml:1mg �100ml/�t �vo��qw[h1091008486902529000151&(702)���l�_)r mosapride �g|jx����l�_)rrcegr%mosapride citrate dispersible tablets�e�~�~ �vo��qw[h2003111086902016000152 �g|jx����l�_)r���vmosapride citrate capsules�/u�[5mg(�n�g|jx����l�_)r��) �vo��qw[h2005171986900818002220�g|jx����l�_)rgrmosapride citrate tablets^t*t5mg( cc21h25clfn3o3.c6h8o7���{) �vo��qw[h1999031586901444000192�_�r �vo��qw[h1999031786904012000501 oxb�_)ritopride�vx� oxb�_)r���v#itopride hydrchloride(inn) capsules�n�g�k�|���v t�vx� oxb�_)r50mg �vo��qw[h2003032786903712002617�vx� oxb�_)rgritopride hydrochloride tablets:n�rς8abbott japan co., ltd., katsuyama plant�rsň�s� nwmŗ�w6ro� gp�lq�s � �vo��qw[j2015006386900811000063�oxb�_)r 15.5 bkto�ir2u'l/lnf��metoclopramide2u'l/lnf��gr q\��no�6ro� gp�lq�s �vo��qw[h1402078286902968001658metoclopramide tablets �vo��qw[h4102114286903139000548&(706) �vx�2u'l/lnf���l\�m(metoclopramide dihydrochloride injection �vo��qw[h2002310386903205000441 �vo��qw[h3102152286900673000232 �vo��qw[h1202096786900874000796f9n�ses�uo(u �vx������sy�rsň�kspg�-n�v �o�n gp�lq�s � �vo��qw[j2013007786979084000216&(736)p��bqe0���r��p��z�t�]$o�oi�  y�eui�x����l\�mcompound glycyrrhizin injectiong20ml:ui�x���40mg(�nui�x�us���v�~�t��:n40.83mg)0l-�vx�js�(lx�20mg(�nc3h7no2s�hcl��),u(lx�400mg �vo��qw[h20058999869001060000374,g�t:n y�e6rbr �20ml//e �br tϑr r:n�ui�x���40mg0u(lx�400mg�t�vx�js�(lx�20mg0�e,gs|���s�n6ro�*h_o>y�rsň�kspg�-n�v �o�n gp�lq�s � �vo��qw[j2013007186979084000209 20ml:ui�x���40mg0�vx�js�(lx�20mg0u(lx�0.4g �vo��qw[h2006547586902770002577e20ml:ui�x���40mg(�nui�x�us���v�~�t��:n40.83mg)0�vx�js�(lx�20mg(�nc3h7no2s�hcl��)0u(lx�400mg �vo��qw[h200574788690250300053520< ml:ui�x���400�vx�js�(lx�20mg0u(lx�400mg lb�]-n�[6ro� gp�lq�s �vo��qw[h2006584586901744001240 �l\(u y�eui�x���#compound glycyrrhizin for injectionui�x���20mg,u(lx�200mg,l-�vx�js�(lx�10mg �vo��qw[h2008053886902049000235�k�t tui�x���80mg0u(lx�800mg0�vx�js�(lx�40mg �vo��qw[h2008042286904799000954ks otqui�x���120mg,�vx�js�(lx�60mg,u(lx�1.2g �vo��qw[h2006057286903662001760ui�x���40mg,�vx�js�(lx�20mg,u(lx�400mg �vo��qw[h2006057086903662001418ui�x���80mg,�vx�js�(lx�40mg,u(lx�800mg �vo��qw[h2006057186903662000756 �k/e t�ui�x���20mg0u(lx�200mg�t�vx�js�(lx�10mg �vo��qw[h2006053786904152001741ui�x���40mg �vx�js�(lx�20mg u(lx�400mg �vo��qw[h2008052986902777002860ui�x��n��diammonium glycyrrhizinate ui�x��n�����n���v2diammonium glycyrrhizinate enteric-coated capsules)ytfus^ �vo��qw[h2004062886901523001119ui�x��n�����v#diammonium glycyrrhizinate capsulesu)r#k �vo��qw[h1094019186901523001188&(737) ui�x��n��/ls���l\�m8diammonium glycyrrhizinate and sodium chloride injection250ml:ui�x��n��0.15g�t/ls��2.25g �vo��qw[h2001063086901523001218ui�x��n���l\�m$diammonium glycyrrhizinate injection 10ml�150mg �vo��qw[h2006672386901814000685�l\(uui�x��n��/compound diammonium glycyrrhetate for injection�wu�o �vo��qw[h2004194086902699001989(diammonium glycyrrhizinate for injection �vo��qw[h2005142186904141001646(diammonium glycyrrhizinate for injectionu傳~ �vo��qw[h2006049186901841000269؏�s�w7��u�� glutathione �l\(u؏�s�w7��u��!reduced glutathione for injection�~@l�� �vo��qw[h20030001869041390003231.2g �vo��qw[h20041619869041390004461.8g �vo��qw[h2004162086904139000453 �vo��qw[h2007001086900662000045 �vo��qw[h2003126586900662000403 �l\(u؏�s�w7��u����(reduced glutathione sodium for injection�s�b�[#pharminvest spa�rsňon�ff�y'y6ro����n gp�lq�s � �vo��qw[j2014001686978586000083!reduced glutathione for injection?��b��pq �vo��qw[h1999106886901066002062 �vo��qw[h1999106786901066001850 �vo��qw[h2004043586901066003175~g�l�e �vo��qw[h2008035386905589000871&(738)؏�s�w7��u��grreduced glutathione tablets �vo��qw[h2005066786901066000914 ��s }(��s;`�x)marine ��s }/ls���l\�m$marine and sodium chloride injectionr`ȏ100ml:��s }( c'ls��s�x��)0.6gn/ls��0.9g �vo��qw[h2002069586901445001839��s }�l\�mmarine injection2ml�0.2g �vo��qw[h20043831869040830010012ml:0.6g��n'ls��s�x�� � �vo��qw[h2005748086901523000969&(739)��s }���vmarine capsules)ytf y#k 0.1g( c'ls��s�x��) �vo��qw[h2001076386901523000983��s }grmarine tablets �p�s�szio�n gp�lq�s �vo��qw[h2008028486904251000850kxnfw�[ tioproninkxnfw�[grtiopronin tablets �vo��qw[h2006524886901997000144kxnfw�[���ngr tiopronin enteric-coated tablets�q��� �lwsw�e �o�n���n gp�lq�s �vo��qw[h4102079986903085000210kxnfw�[���n���v!tiopronin enteric-coated capsules _lς�[���6ro� gp�lq�s �vo��qw[h2008077286901495001384!tiopronin enteric-coated capsules �vo��qw[h2008067686900239000867#tiopronin enteric-coated capsules �vo��qw[h2009006886905755001787&(740)kxnfw�[�l\�mtiopronin injection�� tes�ug��}v�~ހ�q\�l\(u yt��v�coenzyme complex for injection��v�a100usmo,��v�`!0.1mg �vo��qw[h1102000186900148000743��v�a200usmo,��v�`!0.2mg �vo��qw[h1102000286900148000804 15.11 )rƀo�ir�q�s'lƀx�ursodeoxycholic acid�q�s'lƀx�grursodeoxycholic acid tablets �vo��qw[h4202209786902000000434 �vo��qw[h3102187586900818001384 �vo��qw[h3202373586901397000775�q�s'lƀx����vursodeoxycholic acid capuleso`_-losan pharma gmbh�rsňon�dr. falk pharma gmbh � h2010050286978373000166�q�s'lƀx�o����v"ursodeoxycholic acid soft capsules0.1g� c�q�s'lƀx�c24h40o4�� �@daewoong pharmaceutical co., ltd.�rsň�r.p.scherer korea limited � h2013043386978995000391�n��phenylpropanol y�e?��us|yrcompound azintamide  y�e?��us|yr���ngr*compound azintamide enteric-coated tablets�lyr lb�]n m6ro� gp�lq�s �vo��qw[h20000232869017420000544� nkxanethol trithione4� nkxgranethole trithione tablets b���v vt�t6ro� gp�lq�s �vo��qw[h5102346186902026000111 �vo��qw[h2006760886900356000849anethle trithione tablets �vo��qw[h2006645086901014000102anethol trithione tablets �v�]ey��o�n gp�lq�s �vo��qw[h5102356886902118000388�f9s^� trepibutone�f9s^�grtrepibutone tablets �vo��qw[h4302193286904960000318�s"lƀx�dehydrocholic acid 15.12 �����y(uo�iri�(g�ramxm�m melilotusi�(g�ramxm�mgrmelilotus extract tablet�m1�bk-m�kgr400mg ti�(g�ramxm�m25mgseiko eiyo yakuhin co.,ltd h20090793869791080000620wey�sfdiosmin0wey�sfgrdiosmin tablets1r �g6les laboratoires servier industrie�rňon:n�e�~ŗ�)y%m �6ro� gp�lq�s � �vo��qw[j2014012986979020001000 �kgr t0wey�sf0.45g �vo��qw[h2005847186901606000220 �vo��qw[h2006673786901954000576 y�e҉܃x�o�$compound carraghenates suppositories y�e҉܃x�o�h3.4kq �vo��qw[h200831508690252900030415.13 vq�n�ms�|�~o�ir�g.l�x!tvu sulfasalazine�g.l�x!tvu���ngr$sulfasalazine enteric-coated tablets �vo��qw[h1102081886900144006336�~�g�� �vo��qw[h3102045086900748001263 �vo��qw[h3102055786900800000432&(757)�g.l�x!tvuhsulfasalazine suppositories ^n�y&oo�n gp�lq�s �vo��qw[h2006524386900318000078 _lς܏r`o�n gp�lq�s �vo��qw[h2005666886901730000134�v��h �vo��qw[h1090009186902927000555 �n�[o�n�v�]6ro� gp�lq�s �vo��qw[h2005824486902281000338ey�f��[8��] octreotidep���z��p0ߘs�y� ��q@��s���z��'y�u��x�ey�f���l\�moctreotide acetate injection�onf�k�u 1ml:0.1mg �vo��qw[h2004040786900153000356 �vo��qw[h2004040686900153000349�v1��g �vo��qw[h2003120786902066001628�r\�[ 1ml:0.2mg �vo��qw[h2004155986903458000441�u�[ h2009094886978679001201uey�[1ml:0.1mg( cey�f����) �vo��qw[h2006017686900651001879�l\(u��x�ey�f�� octreotide acetate for injectionёꏗg0.1mg/�t �vo��qw[h2004153386903315000072�w�e0.1�kkq b���o�z��uir6ro� gp�lq�s �vo��qw[h2004063986902073000010�n2uex�l dimethicone㉈mss� n��u�r�v y�eotc6rbr y�eݔx�˔gr"compound bismuth aluminate tablets �t\�n�q z6ro� gp�lq�s �vo��qw[h2302213286903640000174 �vo��qw[h4402403086900310000083 y�e��<\�fn���vcompound ranitidine capsules�k�| t�vx���<\�fn150mg,�g|jx�˔��(�n˔��)110mg �vo��qw[h2003095386901650001051 y�e�ux�snfg̃gr)compound eosinophil-lactobacillus tablets�sёl�o�nɩ�v���n gp�lq�s �vo��qw[h1094011486903560000674 y�eàˆ}vv����|$compound saccharated pepsin granules y�e ��k��10gu��zs�huir6ro�6ro����nɩ�v gp�lq�s �vo��qw[h6102304386902463000590  y�e�msv����v�ii �%compound digestive enzyme capsules(a!)cs�~!`�8�k�| tàˆ}vv� n\�n144usmon��ˆ}vv� n\�n480usmon���m�|v� n\�n5700usmon�����v� n\�n3000usmo �vo��qw[h2005195186901379000076  y�e�msv����v(a!) y�e�msv����v"compound digestive enzyme capsules�� thanlim pharmaceutical co.,ltd. h2009050886979030000055 ^nf fo�n gp�lq�s �vo��qw[h2006464686905605000021�vàs^grgaviscontablets nexx�a�8.3mg,"l'lsݔ33.3mg,wm��x�0.167g �vo��qw[h1202123286900886000760ݔa��r�m�`�malmagate suspension�[�� 15ml:1.5g �vo��qw[h1098032286901742000047 �ng˔a�gr;cascara, bismuth subnitrate and magnesium carbonate tablets �vo��qw[h4402483286900310000168�~u���ݔ���v vitamin u,belladonna and aluminium capsules �vo��qw[h2202505286903454000230 vitamin u,belladonna and aluminiun capsules�~u }u50mg,"l'lsݔ0.14g �vo��qw[h3702319986904141000489�~u���ݔ���va!-vitamin u,belladonna and aluminium capsules a! �ocko�nɩ�v���n gp�lq�s �vo��qw[h2202623286903594001333  y�e�~u���˔ݔgrgcompound vitamin u,bismuth subcarbonate and aluminium hydroxide tablets �vo��qw[h4402476586900376001567�r�o�gabexate �l\(u2u�xx��r�o�gabexate mesilate f< or injection 8^�]ё܏o�n6r � gp�lq�s �vo��qw[h1095032686901373000089gabexate mesylate for injection �vo��qw[h2005976786901389000820gabexate mesilate for injection �vo��qw[h2005848986903662001449z�bh�� lauromacrogol p�%n͑�mss�'y�q@�z�bh���l\�mlauromacrogol injection u��)y�[6ro� gp�lq�s �vo��qw[h2008044586902433000056��l�b�u mesalazine��l�b�u���ngr!mesalazine enteric-coated tablets��\�ylosan pharma gmbh h2015012486978373000203�`�u���o�nɩ�vso(g�e�up6ro� gp�lq�s �vo��qw[h1998014886903810000546 mesalazin enteric-coated tablets�[m�� �[�_n�v6ro� gp�lq�s �vo��qw[h2002021186904285000017 ��l�b�yʑ���|brmesalazine sr granules~�ꏎ�500mg/�� ethypharm h2010006386978974000497&(763)��l�b�ylp���mmesalazine enemas60g:4gdr.falk pharma gmbh h2015012786978373000210��l�b�yhmesalazine suppositories h2014094886978373000173 ў��_l)y�[o�n���n gp�lq�s �vo��qw[h2006565086903789000318 u��b }[14��] somatostatin p���z��p0ߘs�y� ��q@��l\(uu��b }somatostatin for injection �vo��qw[h2005301186902066000966`�n�[3mgmerck serono sa aubonne branch h20140873869793230001683mg( cc76h104n18o19s2��) �vo��qw[h2005825086904188000121somatostatin for injection0.75mg( cu��b }��) �m3w��[o�n���n gp�lq�s �vo��qw[h2004546586900526000402 3mg( cu��b }��) �vo��qw[h2004527486900526000419 �vo��qw[h2005918886901940000450 �vo��qw[h2006670886901749000668ln�s�nn ulinastatin�l\(uln�s�nnulinastatin for injection)ynfm�[^n)ynfus;so����n gp�lq�s �vo��qw[h19990134869003440001895nusmo �vo��qw[h1999013386900344000141�2uex�l simethicone�2uex�lsnbrsimethicone emulsion�g�40mg/ml h2011024686978278000117ey�l�b�y olsalazineey�l�b�y�����volsalazine sodium capsuleseu� �vo��qw[h2000024786900886000098^�efw �vo��qw[h2001006186904759000048�bkq�f��lactitolp���'`��u�bkq�f��celactitol powder)ytf�^#k �vo��qw[h2002059686901523000990 16 �_�s�|�~o�ir 16.1 :_�_o�ir0wؚ��digoxinae0wؚ��grdigaoxin tablets �vo��qw[h3102067886900818002848digoxin tablets�s�r �vo��qw[h3302173886904502000127&(766)�k�k����kstrophanthin k�k����n lanatoside c�synp��k���� deslanoside �synp��k�����l\�m 2ml:0.4mg �vo��qw[h3102117886900808000595 �vo��qw[h3202153886901708000555s|�r�q milrinones|�r�q�l\�mmilrinone injection��ws�r�^5ml:5mg( cs|�r�q��) �vo��qw[h1097005186904012000600 16.2 �b�_�_1y8^o�ir���xn� amiodarone�vx����xn����v!amiodarone hydrochloride capsules �vo��qw[h1202026386900928000567 �vo��qw[h3202376586901389000639 �vo��qw[h3102012586900804000162�vx����xn�gr amiodarone hydrochloride tablets �vo��qw[h2000384386900056000033 �vo��qw[h3102187286900818001360�s���� �vo��qw[h1999325486904502000240&(771)�vx����xn��l\�m"amiodarone hydrochloride injection 3ml:0.15g �vo��qw[j2013003686978821001073ny<\n quinidine���_ mexiletine�vx����_gr mexiletine hydrochloride tablets �vo��qw[h1302131886902777001764 mexiletine hydrochloride tabltes �vo��qw[h3102187486900818001377 �vo��qw[h3702272886904105000951nf��as�v�� procainamidenfw^n� propafenone�vx�nfw^n�gr!propafenone hydrochloride tablets �vo��qw[h1302167086902777000576 �vo��qw[h3102049286900818000530�` y��150�kkqabbvie deutschland gmbh & co.kg h2014090486979541000063 �vo��qw[h3202390586901397000539 �vo��qw[h3702203086904127002247&(775) �vx�nfw^n��l\�m#propafenone hydrocnloride injection 10ml:35mg �vo��qw[h4402024986900375001858n!t�� disopyramide������u moracizine�vx�������ugrmoracizine hydrohloride tablets �l3�#wcqo�n gp�lq�s �vo��qw[h2005662786901316000534�l3�-n�v;s�y'yf[6ro� gp�lq�s �vo��qw[h2003017286901341000189xb��nă��bretylium tosilate 16.3 ]xx�o�{|o�ir]xx�u�l nitroglycerineg]xx�u�lgrnitroglycerin tablets �ls;s�y'yf[6ro��s �vo��qw[h1302250386902680000199&(779)]xx�u�l�l\�mnitroglycerin injection �vo��qw[h4402056986900375001810 �vo��qw[h1102028986900202000351 �vo��qw[h1402219786902902000181]xx�_q\�ho�isosorbide dinitrate]xx�_q\�ho�grisosorbide dinitrate tablets �vo��qw[h1202081686900931000868&(780) ]xx�_q\�ho��l\�misosorbide dinitrate injection1r p �vo��qw[h1096003686904021002336 �vo��qw[h1096003586904021000448_� tever pharm jena gmbh h2013037086978851000947 �l\(u]xx�_q\�ho�"isosorbide dinitrate for injection^t�z�u �vo��qw[h2005052186900151000648 �vo��qw[h2005086986902918000144 �vo��qw[h2005087086902918001073 �vo��qw[h2005052286900151000655 �vo��qw[h2005052386900151000631us]xx�_q\�ho�isosorbide mononitrate�s g8^ʑbr�w ʑ�cʑbr�w08nbraegus]xx�_q\�ho�grisosorbide mononitrate tablets �vo��qw[h2006601486904127003213 �vo��qw[h1093018986900453001527 �vo��qw[h1094028486900453001534#k�^ �vo��qw[h1094003986904012000341 �vo��qw[h2006568586904021001872 us]x< x�_q\�ho����visosorbide mononitrate capsulesq\ς �vo��qw[h1097033186900841000101 o�yr �vo��qw[h1097010586902777001658 �vo��qw[h1097010486902777001641 �vo��qw[h1096002186902699001750 us]xx�_q\�ho���8n$isosorbide mononitrate soft capsules��_��yr zwmns�eo�nɩ�v gp�lq�s �vo��qw[h2000021786904217000542 us]xx�_q\�ho�rcegr isosorbide mononitrate dispersible tablets �vo��qw[h2005209586904010000145us]xx�_q\�ho�ʑ���v(iv)5isosorbide mononitrate sustained-release capsules(iv)_pn�[ o�e�k��swm �6ro� gp�lq�s �vo��qw[h2003122486900610000011us]xx�_q\�ho�ʑ���v(`!)4isosorbide mononitrate sustained release capsules(`!)~��s�� �vo��qw[h2000072486900111000541 us]xx�_q\�ho�ʑ���v1isosorbide mononitrate sustained release capsules oȏn �vo��qw[h1998015086903712003249 �vo��qw[h2007391486907320000010us]xx�_q\�ho�ʑ���v(b!)~��r��<\ �vo��qw[h1999101986900620000292 us]xx�_q\�ho�ʑgr0isosorbide mononitrate sustained-release tabletskf�e�l �vo��qw[h10980298869001440058100isosorbide mononitrate sustained-release tablets�^���o �vo��qw[h20010643869008040014970isosorbide mononitrate sustained ralease tablets�o�yy �vo��qw[h20030417869013590001950isosorbide mononitrate sustained release tablets �vo��qw[h1999103986904012000310 �vo��qw[h2006671786904021001827 �vo��qw[h2003041886901359000201�qso �vo��qw[h2001024786901556000042"}<\yr �vo��qw[h1098001586900863000066 us]xx�_q\�ho��n8nisosorbide mononitrate pills )y%m�&o;so�ɩ�v gp�lq�s �vo��qw[h2006018486900888000225&(781) us]xx�_q\�ho��l\�m isosorbide mononitrate injection2ml:25mg �vo��qw[h20093252869008740012745ml:20mg �vo��qw[h20093327869047620010942ml�25mg �vo��qw[h2005388186904127001028 �vo��qw[h2005387986904127001035 us]xx�_q\�ho�/ls���l\�m5isosorbide mononitrate and sodium chloride injection9npo250ml:us]xx�_q\�ho�20mgn/ls��2.25g �vo��qw[h2001014186904127003206 �vo��qw[h2005725586903973000636 �vo��qw[h1098004586904012000372��n �vo��qw[h2000063786904021002060 �vo��qw[h2005686186904010000152 �l\(uus]xx�_q\�ho�$isosorbide mononitrate for injectiont�ed_ �vo��qw[h2002012386904685000105ey^�n �vo��qw[h2006116086901425000104s^�y �vo��qw[h2002031586904152002052 �vo��qw[h2006065386904152002908 us]xx�_q\�ho�a���|�l\�m,isosorbide mononitrate and glucose injection�rς<\100ml:us]xx�_q\�ho�20mgna���|5g �vo��qw[h2003075286904145000249 � ngrbr ]xx�_q\�ho�ʑgr.isosorbide dinitrate sustained-release tablets �vo��qw[h4202235986901815000523 �vo��qw[h3702344186904043000389 ^�n�[xo�n gp�lq�s �vo��qw[h4502113786905149000228 16.4 ���b�bo�ir<\�0ws^ nitrendipineabegi<\�0ws^grnitrendipine tablets �vo��qw[h1202029886900931000851 �vo��qw[h1302262986902777002020 �vo��qw[h3702190486904127002162 �vo��qw[h1202020886900858000439<\�0ws^o����vnitrendipine soft capsules �o��(r��\)6ro� gp�lq�s �vo��qw[h2007385986906454000019���yrs�n��w6ro��s �vo��qw[h1097033286900026000186�~�b^s| verapamil�vx��~�b^s|grverapamil hydrochloride tablets �vo��qw[h1202005186900928000215 �vo��qw[h4402071986900290000653 �vo��qw[h3102153886900818001940&(783) �vx��~�b^s|�l\�m!verapamil hydrochloride injection �vo��qw[h3102134386900673000331]x�0ws^ nifedipine]x�0ws^grnifedipine tablets �vo��qw[h3702263486904083000875 �vo��qw[h1202072786900858000552 �vo��qw[h1302131586902777002334 �vo��qw[h5002036586901016001237 �vo��qw[h1202030586900931000547 l �蕬q(lx�(l/l0ws^l-aspartic acid amlodipine(l/l0ws^ amlodipine �s g8^ʑbr�w08nbr��xx�(l/l0ws^gramlodipine besylate tablets�[�qw5mg(�nc20h25cln2o5��) �vo��qw[h2002039086901650000078pq� 5mg ( c(l/l0ws^��) �vo��qw[h2002046886900841000033 5mg( c(l/l0ws^��) �vo��qw[h2006684386901997000076�~;m�u �vo��qw[h1095022486901187000084l�egx�(l/l0ws^gramlodipine maleate tabletso�~n 5mg(�n(l/l0ws^��) �vo��qw[h2003039486901162000788 ��xx�(l/l0ws^���vamlodipine besylate capsuless^�� �vo��qw[h2003057686901620000039 �vo��qw[h2003028986900453000162�<\0ws^ benidipine�vx��<\0ws^gr benidipine hydrochloride tabletscq�l �vo��qw[h2005116286903957000126 �vo��qw[h2003007986903957000201�s�rm;kyowa hakko kirin co.,ltd. fuji plant�rsň�os�t�su������-n�v �6ro� gp�lq�s � �vo��qw[j2010014286979089002048 �vo��qw[j20100141869790890020550w\kxss diltiazem�vx�0w\kxssgrdiltiazem hydrochloride tabletst�_=r30�kkq �vo��qw[h1202012686900945000069l`\�_ �vo��qw[h1088001586900804000667 �vo��qw[h3302011286904744000466 �vx�0w\kxssʑ���v2diltiazem hydrochloride sustained release capsules~�kqg90mg �vo��qw[h2002071186900620000117 �vx�0w\kxssʑ���v(a!)5diltiazem hydrochloride sustained-release capsules(a!)t�=r90�kkq �vo��qw[h1999038886900945000052 �vx�0w\kxssʑgr1diltiazem hydrochloride sustained release tablets< l`\�e �vo��qw[h1097037586900804000629&(788) �l\(u�vx�0w\kxss%diltiazem hydrochloride for injection ؚ0u6ro�*h_o>y s�w�s�]�s rsňon�)y%m0u��6ro� gp�lq�s �vo��qw[j2011005086979327000355 �vo��qw[h2006373886904744000770 �vo��qw[h2005429786902777000361 �vo��qw[h2005478286900933000651^�m0ws^ felodipine^�m0ws^grfelodipine tabletst��s\�[ �vo��qw[h1097011186901467000520 vnws�_�^6ro����n gp�lq�s �vo��qw[h2005685886904912000144 �vo��qw[h1998003486900190000081 �vo��qw[h2008372986903973001084 �vo��qw[h2010329886904145001659^�m0ws^ʑ���v%felodipine sustained-release capsulest��s{�[ �vo��qw[h2005012086901467000551^�m0ws^ʑgr$felodipine sustained release tablets�l�o�[ �vo��qw[h2003041486901359000188 �vo��qw[h2003041586901359000164�^�[�_�~ �vo��qw[h1096017986902902000365$felodipine sustained-release tablets �vo��qw[h2010313886901389001421 ^�m0ws^ʑgr(a!)(felodipine sustained-release tablets (a!) t���z�e6ro����n gp�lq�s �vo��qw[h2004077386904394000205�b�0ws^ lacidipine�b�0ws^grlacidipine tabletspno`s^glaxowellcome,s.a. h2014029486978477000123�spns^�to�ɩ�v n�|f4lo�n gp�lq�s �vo��qw[h1098018086903705000903pnas0ws^ lercanidipine�vx�pnas0ws^gr#lercanidipine hydrochloride tablets�q�[s^recordati s.p.a. h2010024686979340000066<\as0ws^ nicardipineabgi&(792) �vx�<\as0ws^�l\�m#nicardipine hydrochloride injectionio\10ml:10mg//e �10/e/�v6astellas tokai co.,ltd.yaizu plant�rsň��[�e�leg6ro��-n�v � gp�lq�s � �vo��qw[j2010007486979363000319$nicarddipine hydrochloride injection2ml:2mg//e �10/e/�v �vo��qw[j2010007586979363000302 �vx��~�b^s|ʑgr1verapamil hydrochloride sustained-release tablets�va� �vo��qw[h1092001786901445000320"verapamil hydrochloride sr tabletsʑ_d�[240�kkq abbvie deutschland gmbh & co. kg h2014018286979541000056�<\0ws^ cilnidipine�<\0ws^grcilnidipine tablets�#k �vo��qw[h2002057786904288000557�<\0ws^���vcilnidipine capsulesen�` �vo��qw[h2008006686904942000619�pn �vo��qw[h2002058586902946000260&(784) ]x�0ws^ʑgr(`!)$nifedipine sustained-release tablets �vo��qw[h1102229686900228000076 ]x�0ws^ʑgr�`! � ]x�0ws^ʑgr(a!)'nifedipine sustained-release tablets(a!)2o�y�� �vo��qw[h1091005286904043000327(nifedipine sustained-release tablets (a!) �vo��qw[h2008379286903943000086]x�0ws^ʑgr$nifedipine sustained release tablets �vo��qw[h2008455886904929000502#extended release nifedipine tablets�~#k t �vo��qw[h1999108886904715000068 �vo��qw[h3202619886901747000219]x�0ws^�cʑgr%nifedipine controlled release tablets#k6q �vo��qw[h2000007986900785000373%nifedipine controlled-release tablets�b�e t"bayer pharma ag(rsňon:�b3�;so��oep gp�lq�s ) �vo��qw[j2013011586978269000362�]�e(l/l0ws^ levamlodipine ��xx��]�e(l/l0ws^grlevamlodipine besylate tablets2.5mg(�n�]�e(l/l0ws^��) _l��e�6ro� gp�lq�s �vo��qw[h2008336286905356000158 l�egx��]�e(l/l0ws^grlevoamlodipine maleate tablets�s�[2.5mg( c�]�e(l/l0ws^��) �vo��qw[h2003069086902770002300 5mg��n�]�e(l/l0ws^�� � �vo��qw[h2008345986904606000306�ega���ega��o�nɩ�v( t�g) gp�lq�s �vo��qw[h1999108386903447000025<\�s0w\ nicorandil 16.5 ��sso;��no�ir?��fm\atenolol?��fm\gratenolol tablets �vo��qw[h1202025986900928000048 �vo��qw[h3202419286901450000032 �vo��qw[h1102111186900202000078 �vo��qw[h1102111486900202000023�xbm\ metoprololr��wx��xbm\grmetoprolol tartrate tablets  nwm�o �~v�o�n gp�lq�s �vo��qw[h3102141786900799000123 �vo��qw[h3202516886901389000998 �vo��qw[h2007397286901984002243 �vo��qw[h2005728886900594000410 p�npnkq �vo��qw[h3202539186901359000102 �vo��qw[h3202511686901468000185 �vo��qw[h3202539086901359000089 ς�]1r�%m6ro� gp�lq�s �vo��qw[h2003409186901667000122 r��wx��xbm\���vmetoprolol tartrate capsules �vo��qw[h3702084886904098000280&(796) r��wx��xbm\�l\�mmetoprolol tartrate injection5ml:r��wx��xbm\5mgn/ls��45mg �vo��qw[h20073270869030100010532ml�r��wx��xbm\2mgn/ls��18mg �vo��qw[h2004360686904083000493 �vo��qw[h2001331286904127002889nf�m\ propranolol?�wm\ arotinolol�vx�?�wm\gr arotinolol hydrochloride tablets?�\l�\ �vo��qw[j2014016186978991000906�k"}m\ bisoprolol �[l�x��k"}m\���vbisoprolol fumarate capsulesmŗ �vo��qw[h2000004386900085000158�[l�x��k"}m\grbisoprolol fumarate tabletszsς �vo��qw[h1097008286900052000273 �vo��qw[h2002313286900052000266 �vo��qw[h2008300886902181000339�^�_ h2010067786979462000067 �vo��qw[h2008300786902181000322 h2010067886979462000074as�~0wm carvedilolas�~0wm���vcarvedilol capsules�q�~ �vo��qw[h2000056886909586000018as�~0wmgrcarvedilol tablets�ga� �[�l)ya�o�n���n gp�lq�s �vo��qw[h2005242786904561000977carvedilol tabletsё�~6.25mg �vo��qw[h2002053586904021002534�~�_ s�n�]��6ro� gp�#��nlq�s �v< o��qw[h2000000586900068000038 �vo��qw[h2000010086904021002268�b�m\ labetalol r��wx��xbm\�cʑgr.metoprolol tartrate controlled-release tablets �vo��qw[h2003001886900377000835 �vo��qw[h2003001786900377000828 %t�sx��xbm\ʑgr.metoprolol succinate sustained-release tablets47.5mg �vo��qw[j201500448690135900035595mg �vo��qw[j2015004586901359000362&(797)"}�nm\sotalol�vx�"}�nm\grsotalol hydrochloride tablets�u�[�g �vo��qw[h2001044886901397000782oyr �vo��qw[h2000023886904012000969&(802) �l\(u�vx�"}�nm\"sotalol hydrchloride for injection �vo��qw[h200418918690418800005316.6 \o(u�n��sso�vo�irz��y�bf phentolamine 2u�xx�z��y�bf�l\�m �vo��qw[h3102058986900808000946 �l\(u2u�xx�z��y�bf �vo��qw[h1089004686900662000120�tu�uprazosin�vx��tu�ugrprazosin hydrochloride tablets �vo��qw[h3102153986900818001582 �vo��qw[h3202390686901397000584yr�bu�u terazosin�vx�yr�bu�u���v terazosin hydrochloride capsules>m� �vo��qw[h2001002886904021001025?�ktu�u alfuzosiny�lu�u doxazosinz�ăfphenoxybenzamine&(808)�vx�z�ăfgr&phenoxybenzamine hydrochloride tablets �vo��qw[h4102037286903098000436 �vo��qw[h3702304286904165000120 �vo��qw[h32020030869015180013772u�wy�] methyldopa �spn�[��(l�tuiu � clonidine�vx��spn�[grclonidine hydrochloride tablets75ug �vo��qw[h3202168186901397000508ln�b0w\urapidilln�b0w\ʑ���v#urapidil sustained release capsules �vo��qw[h2007016186902469000136ln�b0w\ʑgr"urapidil sustained-release tablets)r�u�[ �vo��qw[h2000046386902503003512&(811)ln�b0w\�l\�murapidil injection)r�y#k �vo��qw[h2004050186903731001622 �vx�ln�b0w\�l\�m urapidil hydrochloride injection�n�[�[ bipso gmbh h20140423869786870001425ml:25mg(�nln�b0w\��) �vo��qw[h2000025486902503003246 �l\(u�vx�ln�b0w\$urapidil hydrochloride for injectionwim 25mg��nln�b0w\�� � �vo��qw[h200518898690414100014416.7 @��{'} _ }l�bcv��b6ro�irasxbnf)r captoprilasxbnf)rgrcaptopril tablets �vo��qw[h1302130986902777002006 �vo��qw[h4102249886903139001958 �vo��qw[h2011321486909542000014 �vo��qw[h3102044886900748000761 �vo��qw[h3102298686900842000476 �vo��qw[h3102123586900802000133 �vo��qw[h3202373186901397000256 25mg/gr,100gr/�t �vo��qw[h3102056486900808001202 �vo��qw[h1202072386900858000125 �vo��qw[h1202082586900873000445 �vo��qw[h4102157186903098002058�o��nf)r enalapril l�egx��o��nf)r���venalapril maleate capsules�y)ypn �vo��qw[h1093008986900567000768l�egx��o��nf)rgrenalapril maleate tablets �vo��qw[h3202237886901445000887 �vo��qw[h2006638386904960000127 �vo��qw[h3102193786900785000526!`���g �vo��qw[h1093006186901397000683�r�so` �vo��qw[h2005581286902770002799�oς �vo��qw[h3202656786901747000240 �vo��qw[h3202656886901747000233 �vo��qw[h1093006286901397000652enalapril maleate tablets�`�[�[,merck sharp & dohme limited�rsň�mg�]؞�ln6ro� gp�lq�s � �vo��qw[j2012006486978633001148 �vo��qw[j2012006586978633001155 �vo��qw[h2000022186904641000910 l�egx��o��nf)rrcegr$enalapril maleate disperible tablets�w)rŗ �vo��qw[h2005100286904140000213���nf)r benazepril�vx����nf)rgr benazepril hydrochloride tabletsm@l�e �vo��qw[h2003051486900100000149 benazepri1 hydroch1oride tab1ets �vo��qw[h2004484086900795000158 �vo��qw[h2004364886900553000482 b��0wey6ro�ɩ�v gp�lq�s �vo��qw[h2005339086902019000012 �vo��qw[h2000029286900100000057 �vo��qw[h2005477186900553000130�y��nf)r fosinopril�y��nf)r�����vfosinopril sodium capsules �vo��qw[h2008031186900785000601�y��nf)r��grfosinopril sodium tablets �vo��qw[h2006414886904647000167����ĉ(��^t6ro� gp�lq�sۏ�srň � �vo��qw[j2013012886978718001315?�pn20mg[�n?�xbo�n@l(c33h35fn2o5)��] �vo��qw[h200938198690005600028610mg(�nc33h35fn2o5��) �vo��qw[h1999025886900056000026(pfizer pharmaceuticals llc(��^t6ro� gp�lq�sۏ�srň � �vo��qw[j2013012986978718001322?�xbo�n@l�����vatorvastatin calcium capsules$\so �vo��qw[h2005198486903098000092 �vo��qw[h2007005486903098000108lo�n@l fluvastatin �s g8^ʑbr�w00�cʑbr�wlo�n@l�����vf1uvastatin sodium capsules �vo��qw[h2007016786904641001511 �vo��qw[h2007016886904641001054fluvastatin sodium capsuleseg��s �vo��qw[h2001051886900100000194mo�n@l lovastatinmo�n@l���vlovastatin capsulesς#k �vo��qw[h1999003386901493000983mo�n@lgrlovastatin tablets �vo��qw[h2006573286904141001127 �vo��qw[h2006573186904141000809#k2� �vo��qw[h3702008986904129001026wns�[ �vo��qw[h1096017586902697000106mo�n@lrcegrlovastatin dispersible tablets~�pn@l �vo��qw[h2000023086904021000462nfo�n@l pravastatinnfo�n@l�����vpravastatin sodium capsule �vo��qw[h2008067486900455000290nfo�n@l��gr�~vpng� �vo��qw[h2004010186900745000030pravastatin sodium tablets�y�n�[ �vo��qw[h2005073686902697000083 �vo��qw[h2006027186900745000085fm�`�e �vo��qw[h2005045686900785000557�[)r�nkn �vo��qw[h2005014986904641002259 �vo��qw[h2005015086904641002280nf�b�v �vo��qw[h1095031586900842000230 �vo��qw[h2003321586900842000049^t�o�n@l rosuvastatin^t�o�n@l��grrosuvastatin calcium tablets 5mg��n^t�o�n@l�� � �vo��qw[h2008024086904010000510 �vo��qw[h2008048286904658000750 �vo��qw[h2008048386904658000767 �vo��qw[h2008066986901606000398 �vo��qw[h2008067086901606000404�s�[ ipr pharmaceuticals, inc.�rsňon�?��e)r�^6ro� gp�lq�s � �vo��qw[j2012000686978241000953 �vo��qw[j2012000586978241000960&(843)�n8nbr��o�n@l�n8nsimvastatin pillsqrkn�ntq�[o�n gp�lq�s �vo��qw[h20030711869048760000519so�n@l pitavastatin9so�n@l��grpitavastatin calcium tablets�rnknkowacompany,ltd.,nagoyafactory h2014041786978555000212 16.11.2 vq�n?�f���sacipimox?�f���srcegracipimox dispersible tablets�vs^ �vo��qw[h2006031886904010000039?�f���s���vacipimox capsulespn�w��pfizer italia s.r.l. h2011005186978720000580 �vo��qw[h2001076986904012000051 �v�]kq�e��6ro� gp�lq�s �vo��qw[h2001080186902182000017�nb�yr bezafibrate�nb�yrgrbezafibrate tablets?���n �vo��qw[h2001001386901499000017 �vo��qw[h2009350386904744000947�vknyr �vo��qw[h2001046186901533000027�nb�yrrcegrbezafibra< te dispersible tablets �vo��qw[h2007026586901503000071^����yr fenofibrate^����yrgrfeinuobeite pian �vo��qw[h3202296486901436000155fenofibrate tablets �vo��qw[h3702289886903944000184 ^����yr���v(a!)fenofibrate capsules (a!)0.2g/�| �vo��qw[h2005732386902448000157^����yr���vfenofibrate capsules�rs^knrecipharm fontaine h2014036986978574000217^����yrʑ���v&fenofibrate sustained release capsules)r�_^� �vo��qw[h1999030386900620000230 t^�wp� gemfibrozil t^�wp����vgemfibrozil capsules8^a��g �vo��qw[h3202329886901397000157capsulae gemfibrozili �vo��qw[h2302099486903712002501 �vo��qw[h1402043886902959000295 �vo��qw[h1202082486900873000513nfw^�probucolnfw^�grprobucol tabletsknpn �vo��qw[h1098005486904021000837eu�l �� y�^o�nɩ�v gp�lq�s �vo��qw[h1096016186902569001651�px�����o�inositol nicotinate�����px�o�grinositol nicotinate tablets �vo��qw[h3202355586901470000807 16.12 vq�no�ir?�o�x���sodium ferulate?�o�x���grsodium ferulate tablets �vo��qw[h5102360886902020000018 b���n��o�n gp�lq�s �vo��qw[h2007311586902030000053?�o�x��t�upiperazine ferulate?�o�x��t�ugrpiperazineferulatetablets �vo��qw[h5102336886902030000039piperazine ferulate tablets wmws�gr`6ro� gp�lq�s �vo��qw[h4602060386905792000026�o#w�^ �^nfo�n���n gp�lq�s �vo��qw[h4302176086904945000036 �vo��qw[h4302182586904960000035�]���u ligustrazine �vx��]���u/ls���l\�m8ligustrazine hydrochloride and sodium chloride injection)y�l�]�100ml:�vx��]���u0.12gn/ls��0.9g �y�^)y�lo�n���n gp�lq�s �vo��qw[h2006128386904817000072 �xx��]���u/ls���l\�m4ligustrazine phosphate and sodium chloride injection100ml:�xx��]���u0.1gn/ls��0.9g r��]'\�s6ro� gp�lq�s �vo��qw[h2004036186904058000961p��u100ml:�vx��]���u120mgn/ls��0.9g0 �vo��qw[h2006088786904145000638100ml:�vx��]���u40mgn/ls��0.9g �vo��qw[h2001012886904145000706200ml:�vx��]���u80mgn/ls��1.8g0 �vo��qw[h2002044586904145000942100ml��vx��]���u0.08gn/ls��0.9g �vo��qw[h2002063086901493000655�vx��]���u�l\�m$ligustrazine hydrochloride injection �vo��qw[h1202088886900874000734�l\(u�vx��]���u(ligustrazine hydrochloride for injection�]r� �vo��qw[h2003055386903662000497 �vo��qw[h2004117186903662000954 �vo��qw[h2004117586903662000961�l\(u�xx��]���u$ligustrazine phosphate for injectionzs�v�^ �vo��qw[h2004091486903310000534�r�~�e �vo��qw[h2004174486904799000817�`�^ }#k�nc8h12n2.h3po4.h2o��50mg �vo��qw[h2004161086900239000324��v�q10 coenzyme q10 ��v�q10/ls���l\�m*coenzyme q10 and sodium chloride injectiont y250ml:��v�q10 5mgn/ls��2.25g �vo��qw[h2006113586900978001576�s�xz���cyclic adenosine monophosphate �s�xz���/ls���l\�m7adenosine cyclophosphate and calcium chloride injection�gup250ml��s�xz���40mgn/ls��2.25g r�wmy��;so� gp�lq�s �vo��qw[h2006028686905952000255�s�xz����l\�m"adenosine cyclophosphate injection�^�e�o �vo��qw[h2005168586900153000318)y�[#k �vo��qw[h2005153386903662000275up���r5ml�40mg �vo��qw[h2005047086905793000087�l\(u�s�xz���&adenosine cyclophosphate for injection �vo��qw[h2004361786902918001479%adenosine cyclphosphate for injection �l3�iq'y6ro� gp�lq�s �vo��qw[h2005814386901291000345�sn��[cycleanine dimethobromide p� n�~;sb�hq������o(umrr0w\ alprostadilp����l'`�_�@��{:@�'`�u�u0ba'`�r ��^x�umrr0w\�l\�malprostadil injection�q�e1ml:5�g �vo��qw[h10980023869001560000252ml:10�g �vo��qw[h1098002486900156000018�f��n�u trimetazidine�vx��f��n�ugr#trimetazidine hydrochloride tablets �vo��qw[h2006653486904152003028%trimetazidine dihydrochloride tabletsn=r�r �vo��qw[h2005546586900847000082%trimetazidine dihydrochloride tablets �vo��qw[h2007370986901645001592 n�xx�z���adenosine triphosphatep�%`qe  n�xx�z����n���l\�m)adenosine disodium triphosphate injection �vo��qw[h2001320786903205001691 �l\(u n�xx�z����n�� �vo��qw[h3102155486900651001169-adenosine disodium triphosphate for injection �vo��qw[h3402336286904287000381�o��nf)r�sx�enalapril and folic acid l�egx��o��nf)r�sx�gr(enalapril maleate and folic acid tabletsl�egx��o��nf)r10mg/�sx�0.8mg �m3wey(�6ro� gp�lq�s �vo��qw[h2010372386979306000055��v�i coenzyme `!9n�s�]���u=salviae miltiorrhizae liguspyragine hydrochloride and glucose9n�s�]���u�l\�m:salviae miltiorrhizae ligustrazine hydrochloride injection5ml 5��]�byr6ro� gp�lq�s �vo��qw[h5202095986905441000070�s��a���|�l\�mgsalivae miltiorrhizae,liguspyragine hydrochloride and glucose injection100ml:9n�s�vs_�n9n�s }20mg,�vx��]���u100mg 5��]of�\�l\br gp�lq�s �vo��qw[h5202070386905550000138 17 �l?\�|�~o�ir 17.1 )r?\o�ir17.1.1 ؚhe��)r?\o�irkt^xs| furosemideeikt^xs|grfurosemide tablets �vo��qw[h3102107486900665000752 �vo��qw[h1202016386900886000845&(865)kt^xs|�l\�mfurosemide injection �vo��qw[h1202052786900874000< 314 �vo��qw[h3102106386900673000935�l\(ukt^xs|furosemide for injection �vo��qw[h2006065986905781000389 �vo��qw[h2007027686905006001504 �vo��qw[h2005111686905781000075^��n<\ bumetanide^��n<\grbumetanide tablets �vo��qw[h4502093886905206000383&(866)^��n<\�l\�mbumetanide injection �vo��qw[h4502096086905206000369 �vo��qw[h2005722586905206001625xb�b^xs| torasemidexb�b^xs|���vtorasemide capsules=n�� �vo��qw[h2005052686904615000076xb�b^xs|grtorasemide tables oȏ�st��s�� �vo��qw[h2007310486900944000053y�����g�m(snx��v-g1.5%),peritoneal dialysis solution (lactate-g1.5%) t1.5%a���|(2l/��) �vo��qw[h2013327686900384000460 t1.5%a���|(5l/��) �vo��qw[h2013327886900384000453y�����g�m(snx��v-g2.5%),peritoneal dialysis solution (lactate-g2.5%)  t2.5%a���|(2l) �vo��qw[h2013328186900384000590  t2.5%a���|(5l) �vo��qw[h2013328386900384000484y�����g�m(snx��v-g4.25%)-peritoneal dialysis solution (lactate-g4.25%)  t4.25%a���|(2l) �vo��qw[h2013328686900384000583xbyrw�[ tolterodiner��wx�xbyrw�[grtolterodine tartrate tablets�[� �vo��qw[h2000061486904012000082 �<\�n �vo��qw[h2000060286901575000054^���!tvuphenazopyridinep����\��h�go(ub�|�x papaverine �vx�b�|�x/ls���l\�m6papacerine hydrochloride and sodium chloride injection50ml��vx�b�|�x30mgn/ls��0.45g �vo��qw[h2004171886904098001478�vx�b�|�x�l\�m"papaverine hydrochloride injection1ml:30mg �vo��qw[h3202096786901445000863�]as<\@l levocarnitine�l\(u�]as<\@llevocarnitine for injection<\\ �vo��qw[h2004112086903671000235�_�[�e �vo��qw[h2004137286904152002526 �vo��qw[h2007028686905754002549���� �%fwm�`o�n gp�lq�s �vo��qw[h2005044286903307000196ey�)r �vo��qw[h2006430286901425000418 �vo��qw[h2004130286905754001689�]as<\@l�l\�mlevocarnitine injection��as5ml�1g 8^�]pqu�6ro� gp�lq�s �vo��qw[h2000054386901376000550�s�v��5ml:2g0sigma-tau industrie farmaceutiche riunite s.p.a. h2013076786978871000088&(885)�]as<\@l�s g�n�mlevocarnitine oral solutionn�~�r �vo��qw[h1999037286901162001327 18 @��m�|�~o�ir18.1 bk@�o�ir�s�b�~�~ˆ}v�n�o�ir(l2u�x�aminomethylbenzoic acid(l2u�x�graminomethylbenzoic acid tablets �vo��qw[h4302191686904917000071(l2u�sx�tranexamic acid (l2u�sx�/ls���l\�m-tranexamic acid and sodium chloride injectionwc�[100ml�(l���sx�1gn/ls��0.7g �vo��qw[h2003062586902013000025�^t�[100ml:(l2u�sx�0.5gn/ls��0.84g �vo��qw[h2003110086901017000055100ml:(l2u�sx�1gn/ls��0.68g �vo��qw[h2003110186901017000086(l2u�sx��l\�mtranexamic acid injection �vo��qw[h2005698586900377000088 �vo��qw[h1402088686902918000045 �vo��qw[h1402088786902918000052 �vo��qw[h2012300486901748000225�l\(u(l2u�sx�tranexamic acid for injection^��h�]6ro�(ɩ�v)���n gp�lq�s �vo��qw[h2003058786905156002420�r��^� �vo��qw[h2004069686904152002496 �vo��qw[h2004069586904152002502w���^x �vo��qw[h2003117086904656000134 �vo��qw[h2003117186904656000264 �vo��qw[h2003117286904656000301�qr^�n�q@��vp[g!'human coagulation factor g!,freeze dried�n�q@��vp[g!human coagulation factor g!�^�es^%200iu/10ml/�t�k�t t�n�q@��vp[g!200iu � y�ntso�y10ml0 nspquir�] z���n gp�lq�s �vo��qw[s2000300486903115000050&300iu/10ml/�t �k�t t�n�q@��vp[g!300iu � y�ntso�y10ml0 �vo��qw[s2000300386903115000265 �n�q@��vp[viii(human coagulation factor g!, freeze dried200iu�~asw[(-n�v)uir6r�t gp�lq�s �vo��qw[s2000300886904426000128200�ve�usmo nwm���x@��m6r�t���n gp�lq�s �vo��qw[s1095002886900714000139300�ve�usmo �vo��qw[s10950030869007140001152u�"l��menadiol�q@�v�thrombiny(u�qr^6rbr�q@�v��qr^�| �vo��qw[h3102201486900651000889 �vo��qw[h2003334586903310000428 �vo��qw[h2202155186903310000541�~u }k1 vitamin k1�~u }k1�l\�mvitamin k1 injectionq\�kf�e�sd�o�n gp�#��nlq�s �vo��qw[h1102116786902899000232�nkxx�"l��2u���menadione sodium bisulfite|��|ˆ}v protamine kxx�|��|ˆ}v�l\�m �vo��qw[h3102051586900651001435(l�w�]x�aminocaproic acid&(894)(l�w�]x��l\�maminocaproic acid injection10ml:2g �vo��qw[h3102165686900801000042&(886)(l2u�x��l\�m!aminomethylbenzoic acid injection �vo��qw[h3202494786901376000024 �vo��qw[h3102049786900801000097&(887)(l2u�sx�grtranexamic acid tablets�y^xoe!cmic cmo co., ltd. shizuoka plant h2010067486979008000377tranexamic acid tablets �vo��qw[h4302056486904917000118}v wdž�k@��qv� hemocoagulase �l\(u}v wdž�k@��qv�hemocoagulase for injection���n1usmo(ku) �vo��qw[h2004173086901190000750 0.5usmo�ku � �vo��qw[h< 2008042886901190000781 �qr^�n�q@�v��s ytir3prothrombin complex concentrate(human) �freeze dried'p�kb/g'y�q@� ���lx�s0��ow{k�[�v�q@� �@��s�uyn0@��s�u4o�b6rir�s���_'`@��s�u�n�q@�v��s ytirhuman prothrombin complex�^��[<200iu/20ml/�t �k�t th!�vp[200iu0a!�vp[200iu0f!�vp[50iu0i!�vp[200iu, y�ntso�y20ml �vo��qw[s2008305786903115000357<300iu/20ml/�t �k�t th!�vp[300iu0a!�vp[300iu0f!�vp[75iu0i!�vp[300iu, y�ntso�y20ml �vo��qw[s2008305886903115000364$200iu/�t(�k�t tii0ix0x�vp[200iu,vii�vp[80iu)  nwm�etq;so����n gp�lq�s �vo��qw[s1097005086900794000142%300iu/�t(�k�t tii0ix0x�vp[300iu0vii�vp[120iu) �vo��qw[s1097004986900794000135%400iu/�t(�k�t tii0ix0x�vp[400iu0vii�vp[160iu) �vo��qw[s1097005186900794000111z��xyn�� etamsylatez��xyn���l\�m �vo��qw[h3102189586900651001572etamsylate injection �vo��qw[h37022828869040830003322ml�0.5g�10/e/�v � �vo��qw[h1202060986900874000307 �vo��qw[h1202060886900874000284\;tn�dž@��qv�haemocoagulase agkistrodon as�]kq�~�as�~�x�� �carbazochrome sodium�� nz�r�y�grcarbazochrome tablets �vo��qw[h3102204286900818001230&(899)�l\(uas�~�x��,carbazochrome sodium sulfonate for injectionm�s �vo��qw[h1097033086901504000629 �vo��qw[h2004432686901504000254 �vo��qw[h2005661686904141001943�n�~�~ˆ}v�shuman fibrinogen p�no�~�~ˆ}v�s@��u�v�bqehuman fibrinogen_l�zsŗuir6ro����n gp�lq�s �vo��qw[s2001300686905265000164�qr^�n�~�~ˆ}v�shumanfibrinogen,freezedried �vo��qw[s2000301186904426000104dž�k@��qv�dž�k@��qv��l\�mhemocoagulase injection�pn�m1ml:1usmo fq�yo�n�t�� � gp�lq�s �vo��qw[h2006089586904461000053&(891)�~u }k1grvitamim k1 tablets �vo��qw[h1092001286901708000715 �vo��qw[h3302086486904615000205 �vo��qw[h3702198886904127001882 �vo��qw[h3102196786900651001107 �w4yn�dž@��qv���]�fv� �hemocoagulase atrox �l\(u�w4yn�dž@��qv�!hemocoagulase atrox for injection�]�f�n0.5usmo 성����^o�n gp�lq�s �vo��qw[h20051839869040170003081usmo �vo��qw[h2004141986904069000578&(892)menadionesodiumbisulfite͑�~�n�q@��vp[g! recombinant coagulation factor g!p��e�n@��ng!�vp[�`�q n@��s�u�n%n͑�q@��eo(u�l\(u͑�~�n�q@��vp[viii0recobinant coagulation factor viii for injection�b�ygy250 iu/�tbayer healthcare llc s2007002886978266000027r�džv�acutobin18.2 �b�q@�o�ir�s�nho�ir 18.2.1 �b�q@�o�ir18.2.1.1 �� }�snorp[ϑ�� }{|o�ir�� }heparinaegi�� }���l\�mheparin calcium injection1ml:1nusmo �vo��qw[h1202050486900918000188 1ml:7500usmo �vo��qw[h1202050386900918000171 1ml:5000usmo �vo��qw[h1202051186900918000157�� }���l\�mheparin sodium injection 2ml:1.25nusmo �vo��qw[h1202050586900918000195�l\(u�� }��heparin calcium for injection10000usmo �vo��qw[h2008059786905793001275 2ml:12500usmo �vo��qw[h3202208886901379000083 �vo��qw[h2008059886905793001282 �vo��qw[h3202061286901729000183norp[�� })low molecular weight heparin(enoxaparin � ���� }���l\�mdalteparin sodium injection�l�[f0.2ml:5000iu*10/e/�v%vetter pharma-fertigung gmbh & co. kg �vo��qw[j20140024869787290003760.3ml:7500iu*10/e/�v �vo��qw[j2014002586978729000369��h\�� }���l\�m.low molecular weight heparin calcium injection��x�g0.3ml:3075axaiu*glaxo wellcome production([�pq }�skq�)y%m � gp�lq�srň) �vo��qw[j20130167869785640004180.4ml:4100axaiu �vo��qw[j2013016886978564000425/low-molecular-weight heparins calcium injection0.6ml:6150axaiu,glaxo wellcome production�rsň�[�pq }�skq�)y%m � gp�lq�s � �vo��qw[j2013016986978564000432 norp[ϑ�� }���l\�m$\<\� 1ml:5000iu �vo��qw[h2001030086905822000804 norp[�� }���l\�m[�zs)r0.5ml�5000axausmo �m3w[��o\uiro�n gp�lq�s �vo��qw[h20060191869005170000221.0ml:5000axausmo �vo��qw[h2006019086900517000015 norp[ϑ�� }���l\�m-low molecular weight heparin sodium injection[��~�us^ 0.5ml:5000iu �vo��qw[h2001023386903373000380�o���� }���l\�menoxaparin sodium injectionkq[�0.4ml:4000axaiu-aventis intercontinental�rsňon�[�����s�n �6ro� gp�lq�s � �vo��qw[j20150059869002310000630.6ml:6000axaiu �vo��qw[j2015006086900231000070 norp[�� }���l\�m ^_hq0.3ml:3200iuaxaalfa wassermann s.p.a. h20140280869781990002960.4ml:4250iuaxa h20140281869781990003020.6ml:6400iuaxa h2014028286978199000319.low-molecular-weight heparin calcium injection�ls8^q\uso�n���n gp�lq�s �vo��qw[h2006391086902597000244zs�tr� 0.4ml:4000iu �vo��qw[h2000070686900864000171 0.6ml:6000iu �vo��qw[h2002047086900864000140p��_ 0.4ml:5000iu �vo��qw[h2003042986904021001926 0.2ml:2500iu �vo��qw[h2003042886904021001919 �l\(unorp[ϑ�� }��1low molecular weight heparin sodium for injectionς�s��2500iu �vo��qw[h20020179869017290002681low-molecular-weight heparin sodium for injection5000iu �vo��qw[h2002024786901729000220�x����xv�� fondaparinux�x����xv���l\�mfondaparinux sodium injection�[ss 0.5ml:2.5mgglaxo wellcome produ< ction h2013003086978453000192 18.2.1.2 vq�nns�l�gwarfarinegins�l�g��grwarfarin sodium tablets �vo��qw[h3102212386900818002152marevanorion corporation orion pharma h2011010886978700000180 �vo��qw[h3702131486904021002640)ro�l�s rivaroxaban 18.2.2 �nho�ir ���ov�[ t͑�~���ov�](streptokinase�recombinant streptokinase �?\�ov� urokinase�l\(u?\�ov�urokinase for injection �vo��qw[h4402064586900453000827 �vo��qw[h4402064686900453000698 �vo��qw[h1202049286900918000416 �vo��qw[h1202048586900918000461urokinase for injection,g�t;n��b�n:n?\�ov�025nusmo �vo��qw[h1202049186900918000331 �vo��qw[h1202048486900918000348?��fnfv� alteplasep�%`'`�_���h{k�s�u12\�e�q�s��h{k�s�u3\�e�q�nh�l�u�l\(u?��fnfv�alteplase for injection1r��z50mg//e s201100528697830200074820mg//e s2011005186978302000755���ov� lumbrokinase���ov����n���v$lumbrokinase enteric-coated capsules~vey30nusmo s�n~veyo�n gp�#��nlq�s �vo��qw[h110211298690000600002160nusmo �vo��qw[h2005634586900006000076$lumbrokinase enteric �coated capsuleszsmkq _l-no�n���n gp�lq�s �vo��qw[h1095011786905394000608$lumbrokinase enteric-coated capsulesnfi` y �vo��qw[h2006808186904030000019���ov����ngr$lumberokinase enteric-coated tablets30.0nusmo �vo��qw[h2004142386903310000435�~�nv� fibrinogenase�l\(u�~�nv�fibrinogenase for injection100usmo �vo��qw[h1102211086900112000441 18.3 �b �@�o�ir 18.3.1 ��brkxx��n��ferrous sulfatekxx��n��grferrous sulfate tablets  nwmğwm6ro� gp�#��nlq�s �vo��qw[h3102175286900690000611kxx��n��ʑgr)ferrous sulfate sustained-release tablets  t�g�|o�}vq\o�n gp�lq�s �vo��qw[h22021532869033820001350.45kq ^��h�] n�{6ro� gp�lq�s �vo��qw[h1089003286905153000528�s�e�|p��� iron dextran�s�e�|p����l\�miron dextran injection�y��^�2ml:100mg(�n����)pharmacosmos a/s h2013037386979334000034�[l�x��n��ferrous fumarate�s g8^ʑbr�w �t�vgr0���|br�%����|brp�?q�z�[l�x��n�����|ferrous fumarate granules2g:0.2g^�r`�bɩ�v�n�v6ro� gp�lq�s �vo��qw[h4502105686905095000372 �vo��qw[h2302266286903712003003�[l�x��n���t�vgr!ferrous fumarate chewable tablets  nwm~�^t6ro� gp�lq�s �vo��qw[h3102231686900677000146%t�sx��n��ferrous succinate%t�sx��n��grferrous succinate tablets �vo��qw[h2008300386902118000579a���|x��n��ferrous gluconatea���|x��n�����vferrous gluconate capsules^��h�]6ro��ɩ�v ����n gp�lq�s �vo��qw[h108700218690515600192836 �vo��qw[h1087001786905156001904q\�h���� iron sorbitex��|��ferrous saccharose��|���l\�miron sucro injection�~pn�y5ml:100mg�v���t1.6kq�v��| h2013063686978941000031iron sucrose injection �vo��qw[h2005575686902066000683iron sucrose injection 5ml�100mg��� � �vo��qw[h2004604386901565000330y�|�� ytiriron polysaccharide complexy�|�� ytir���v$iron polysaccharide complex capsules�r���"kremers urban pharmaceuticals inc. h2012030186978854000135�~�n�� nwm;so�ɩ�vr��\�vθo�n���n gp�lq�s �vo��qw[h2003003386904032000321 18.3.2 vq�n&(258)�~u }b12 vitamin b12 �vo��qw[h3102196386900651001480 1ml�0.25mg �vo��qw[h1202038886900874000987 �vo��qw[h1202038786900874001182 �vo��qw[h4402210086900377001900 �vo��qw[h4202150986901884000653 �vo��qw[h4102173386903139001293 1ml�0.1mg �wo���vn6ro� gp�lq�s �vo��qw[h1402257586902954001808�sx� folic acid�sx�grfolic acid tablets �vo��qw[h3202330286901397000843 �vo��qw[h2000314386901397000942 �vo��qw[h2006743786900858000279�)y�y �vo��qw[h199830438690084800014231 �vo��qw[h2005935586900886000593folicacid tablets �vo��qw[h1202059786900858000521 �vo��qw[h1202021586900886000371&(920)�l\(u�sx�folic acid for injection �vo��qw[h2005073986904141000458 �vo��qw[h2005074086904141001660 ͑�~�n�o�~ }�cho�~ހ �*recombinant human erythropoietin�cho cell �p���'` �@�͑�~�n�o�~ }�l\�m(cho�~ހ)4recombinant human erythropoietin injection�cho cell �ꖾ�gs6000iu//e���eq_�l\hv � �vo��qw[s20073009869037080003137recombinant human erythropoietin injection(cho cell)�s\zs6000iu/0.6ml//e(��eq_�l\hv) �vo��qw[s2008302486900152000197͑�~�n�o�~ }�l\�m�cho�~ހ �4recombinant human erythropoietin injection(cho cell))r@��[6000iu/0.5ml//e$os�t�su�����*h_o>yؚ]�]�s�rsň�os�t�su������-n�v �6ro� gp�lq�s � �vo��qw[j2013010486979076000330*recombinant human erythropoietin injectionnm �#k 1ml:2000iunss6ro�ёfwuir�b/g���n gp�lq�s �vo��qw[s20053076869027000000173000iu/0.6ml//e���eq_�l\hv � �vo��qw[s20020045869001520000814recombinant human erythropoietin injection(cho cell) 5000iu/1ml/�t �vo��qw[s20000023869001520001421500iu �vo��qw[s20000025869027000000553000iu �vo��qw[s2000002686902700000086 3000iu/2ml//e �vo��qw[j20130105869790760003235recombinant human erythropoietin injection (cho cell)so�gj� 3000iu/1ml//e q\n?�nsuiro�n gp�lq�s �vo��qw[s< 2003002286904064000030�onf�[6000iu/1ml//e��eq_ q\n�ytquir6r�t gp�lq�s �vo��qw[s2003008986904115000088[�zs\ �vo��qw[s20010018869005170000773000iu//e �m3w�eo�uir�] z gp�lq�s �vo��qw[s2005307986900552000063�v�key 10000iu//e �vo��qw[s20010001869013130000252000iu/0.4ml//e���eq_�l\hv � �vo��qw[s2002004486900152000111 12000iu/1ml//e �vo��qw[s2004307786904064000085 5000iu/1ml//e �vo��qw[s2003002486904064000047 9000iu/1ml//e �vo��qw[s20043076869040640000922000iu//e �vo��qw[s1998007386901313000131�l\(u͑�~�n�o�~ }(cho�~ހ)8recombinant human erythropoietin for injection(cho cell)�o p2000iu �vo��qw[s1998000786902018000082 �vo��qw[s1999100586902018000068�l\(u͑�~�n�o�~ }�cho�~ހ �!`�[  nwm�q�uir;so� gp�lq�s �vo��qw[s1999102486900713000178 18.4 gs}v�~ހo�ir����inosinebci�l\(u����inosine for injectionꏛr �vo��qw[h2003122186905754001573 �vo��qw[h2005026386905754000798 �vo��qw[h2003122286905754000835gy�e�� �vo��qw[h2005086286905814000102����/ls���l\�m%inosine and sodium chloride injection#k0n100ml:����0.5gn/ls��0.9g �vo��qw[h2003048486904127003565�]�y �vo��qw[h2003101286904075000302�����l\�minosine injection �vo��qw[h4102158486903098001990 �vo��qw[h3702061186904187002904 �vo��qw[h4202042886901842000206(l�� }amino polypeptide (l�� }gramino-polypeptide tablets �vo��qw[h2102280786901148000054��v�a coenzyme a�l\(u��v�acoenzyme a for injection �vo��qw[h4102241286903021000267coenzyme a for injection200usmo �vo��qw[h2006810986903010000551 �vo��qw[h1202048986900918000393&(922)bc����grinosine tablets �vo��qw[h2000368786902000001905 �vo��qw[h4402320386900376001260 �vo��qw[h3102064386900818002435)r�st()r@�u)leucogen)r�stgrleucogen tablets �vo��qw[h3202544486901452000252������batiol������grbatilol tablets �vo��qw[h3202358186901470001750tabellae batiloli �vo��qw[h3102212886900804000940 �~u }b4��xx�z� vdt � vitamin b4�~u }b4grvitaminb4 tablets �vo��qw[h1202012486900886000296 ͑�~�n�|�~ހɩ=�:r�o�vp[8recombinant human granulocyte colony-stimulating factor p�>es�ut�v��ӛ�b6r�s�]$o�oi� ͑�~�n�|�~ހ:r�o�vp[�l\�marecombinant human granulocyte colony-stimulating factor injection t[�#k 0.3ml:75�g �vo��qw[s1999101886902700000031 0.6ml:150�g �vo��qw[s1999101786902700000116 1.2ml:300�g �vo��qw[s1999101686902700000147͑�~�n�|�~ހɩ=�:r�o�vp[�l\�m�zu }250�g/�t �vo��qw[s2006311686900148000064%md`�r250�g//e�wo�ɩ�v~vkq(q\n)uir6ro� gp�lq�s �vo��qw[s2005001586904089000039100�g/�t �vo��qw[s2003004886900148000248 150�g/�t ^���eq �vo��qw[s1998001086900148000828 300�g/�t ^���eq �vo��qw[s1998001186900148000729#k�|u150ug/0.6ml//e(��eq_�l\hv) �vo��qw[s200200518690015200002975ug/0.3ml//e(��eq_�l\hv) �vo��qw[s2002005086900152000036ё�x[�:_750niu/75�g/0.5ml/�t �vo��qw[s1098009886903315000164arecombinant human granulocyte colony stimulating factor injection t�|��0.2ml:4000000iu/50ug �vo��qw[s19990056869044880000810.3ml:6000000iu/75ug �vo��qw[s10980030869044880002410.6ml:12000000iu/150ug �vo��qw[s10980031869044880002341.2ml:24000000iu/300ug �vo��qw[s1098002986904488000227m#k 75�g/0.4ml//e_lς4t-n;so�ɩ�v gp�lq�sς�]-n�quir6ro��s �vo��qw[s1999100286901505000024 150�g/0.5ml//e �vo��qw[s1999100386901505000017 300�g/1.0ml//e �vo��qw[s1999100486901505000031^t}v6.0�10e6 iu(100�g):0.6ml//e �vo��qw[s1999004986904021000363�`\@�os�t�su�����(-n�v)6ro� gp�lq�s �vo��qw[s2001006286900617000014 �vo��qw[s2001006386900617000038 �vo��qw[s2001006486900617000021^t@��e 100�g/0.4ml//e �vo��qw[s2002007586900552000087arecombinant human granulocyte colony-stimulating factor injectionyr\%m100�g//e �vo��qw[s2003305086904870000064�l\(u͑�~�n�|�~ހ:r�o�vp[(cho�~ހ)orecombinant human granulocyte colony-stimulating factor for injection(cho cell)y0��\�]�s h2011056886979327000386ݔa�9s�galuminium,magnesium and aspinin 18.6 gs@�\go�ir ͑�~�n@�\gub } recombinant human thrombopoietin ͑�~�n@�\gub }�l\�m*recombinant human thrombopoietin injectionyr�k�o 7500u/1ml/�t �vo��qw[s200500498690131300016215000usmo(1ml)/�t �vo��qw[s200500488690131300015519 ���4l05u�(��sx��xs^a�o�ir19.1 �|{|a���|glucosea���|�l\�mglucose injection100ml:5g �vo��qw[h2001314986904127001578 �vo��qw[h5102063586902180000545 250ml:12.5g �vo��qw[h3702175686904127001776 �vo��qw[h5102063686902180000583 �vo��qw[h3702182586904127001493 �vo��qw[h5102063486902180000552 100ml:10g �vo��qw[h2001314886904127002056 �vo��qw[h5102033086902180000903 250ml:25g �vo��qw[h3702175786904127001967 �vo��qw[h5102063386902180000538 �vo��qw[h3702182486904127001585 �vo��qw[h5102063286902180000569 �vo��qw[h2002382686904098001232 �vo��qw[h3702275486904098000747 �vo��qw[h3702275386904098001041 �vo��qw[h2002381286904098001379 �vo��qw[h3702275686904098000990 �vo��qw[h370227558690409800111920ml:10g �vo��qw[h4102003986903205001707 1000ml:100g �vo��qw[h2003312186904042000502 �vo��qw[h1999406186900628000089 1000ml:50g �vo��qw[h2003315386904042000175 �vo��qw[h1998315186900628000256 �vo��qw[h2004331386904494001126glucose injection �vo��qw[h1202001986< 900967000214 �vo��qw[h2005484786900933000705 �vo��qw[h1302247886902763000597 �vo��qw[h3702077586904145000775 �vo��qw[h1102062086900144000709 �vo��qw[h4402019686900273000106 �vo��qw[h2002375486904042000021 )y%m~vyr;s�u(u�t gp�lq�s �vo��qw[h1098304786900850000093 �vo��qw[h1999373686900628000379 �vo��qw[h3302140686904494001430 �vo��qw[h2002382886904058000060 �vo��qw[h1202002386900967000108 �vo��qw[h2004457286900933000620 �vo��qw[h2003372486902763000726 �vo��qw[h3702077686904145000713 �vo��qw[h1102062786900144001263 �vo��qw[h4402020086900273000175 �vo��qw[h2002376486904042000014 �vo��qw[h3202429886901493001249 �vo��qw[h1098304886900850000185 �vo��qw[h1999407086900628000218 �vo��qw[h3302140386904494001515 �vo��qw[h2005542386900967000276 150ml:15g �vo��qw[h2002331086902763000610 150ml:7.5g �vo��qw[h2002331186902763001389 �vo��qw[h2008348986903662002095 �vo��qw[h2004366486903387000048 �vo��qw[h2005374086904058000305 200ml:10g �vo��qw[h2002344086904145000812 �vo��qw[h2004327286900967000320 �vo��qw[h1202051986900874000949 �vo��qw[h3702115986903973000353 �vo��qw[h2004636486900967000245 �vo��qw[h4102004086903205001646 �vo��qw[h3702121886903973000230 �vo��qw[h3702126186904075000111 �vo��qw[h1202002186900967000061 �vo��qw[h1202036086900933000972 �vo��qw[h1302247486902763000948 �vo��qw[h3402187886904289000129 �vo��qw[h3702077386904145000829 �vo��qw[h1102062186900144001270 �vo��qw[h4402020186900273000045 �vo��qw[h2002319686904042000458 �vo��qw[h1098304986900850000154 �vo��qw[h1999407186900628000140 �vo��qw[h3302140586904494001249 250ml:125g �vo��qw[h1102062486900144000716 �vo��qw[h1202001886900967000030 �vo��qw[h1202035286900933000736 �vo��qw[h1302247586902763000955 �vo��qw[h1102062286900144001379 �vo��qw[h4402019786900273000069 �vo��qw[h2002319786904042000069 �vo��qw[h1098304186900850000024 �vo��qw[h1999406386900628000348 �vo��qw[h1998312286904653000175 �vo��qw[h3302140486904494001775 �vo��qw[h3402316686904289000013 �vo��qw[h2001321986900628000102 300ml:30g �vo��qw[h2002325386902763001372 500ml:100g �vo��qw[h2001321886900628000126 �vo��qw[h1202002086900967000177 �vo��qw[h1202035986900933000811 �vo��qw[h1302247686902763001051 �vo��qw[h1102062586900144000952 �vo��qw[h4402019586900273000014 �vo��qw[h2002319886904042000434 �vo��qw[h1098305086900850000048 �vo��qw[h1998315086900628000133 �vo��qw[h1998312386904653000205 �vo��qw[h3302163086904494001669 �vo��qw[h3402187786904289000143 �vo��qw[h1202002286900967000139 �vo��qw[h1202035586900933000729 �vo��qw[h3202429986901493001317 �vo��qw[h1302247786902763000962 �vo��qw[h3702077286904145000911 �vo��qw[h1102062686900144001386 �vo��qw[h4402019886900273000076 �vo��qw[h2002319986904042000397 �vo��qw[h1098303986900850000215 �vo��qw[h1999406286900628000331 �vo��qw[h3302163186904494001553 �vo��qw[h3402316786904289000020 50ml:2.5g �vo��qw[h2002333186904288000106 �vo��qw[h2005484986900933000682 50m1:2.5g �vo��qw[h2004456486902763001334 �vo��qw[h4402019986900273000052 �vo��qw[h2006419386904145001154 �vo��qw[h2003320686904042000519 �vo��qw[h1999374786900628000225 �vo��qw[h2004432186904494002420 �vo��qw[h2005674486904127000434 �vo��qw[h200233308690096700018450ml�5g �vo��qw[h2005484886900933000675 �vo��qw[h2005516386902763000863 �vo��qw[h2005631886904286000115 �vo��qw[h2003392386900273000380 �vo��qw[h2006419286904145001253 �vo��qw[h2003320786904042000205 �vo��qw[h1999374886900628000164 �vo��qw[h2001316986904653000090 �vo��qw[h2005674386904127000427�g�|fructosep��|?\�u�u�n�s/gt n)y�qo(u�g�|/ls���l\�m&fructose and sodium chloride injection0nwms^500ml��g�|25gn/ls��4.5g �vo��qw[h2005193086901521000947upn�r250ml��g�|12.5gn/ls��2.25g �vo��qw[h2005217886902180001313�g�|�l\�mfructose injectionnf)r�^ �vo��qw[h20051908869042860004290nwm�� �vo��qw[h2003117786901521000992 �vo��qw[h2003117886901521000961 �vo��qw[h2003118086901521001005���n 250ml�25g �vo��qw[h2005217786902180001320fructose injection�b�] �[�_�sd�o�n gp�#��nlq�s �vo��qw[h2006013086904346000260 �vo��qw[h2007028386904346000994�l\(u�g�|fructose for injectionfŗ12.5g �vo��qw[h200509138690579300031525g �vo��qw[h2005091286905793000308 �vo��qw[h2006038886905843000692 �vo��qw[h2005206386905781000242&,g�t:n y�e6rbr �vq�~�n:n��k�t250ml t�g�|12.5g �/ls��2.25g0 �vo��qw[h2008045186901749001986�g�|�n�xx���fructose diphosphate sodium �g�|�n�xx����l\�m%fructose sodium diphosphate injection�nc6h11na3o12p2�� 100ml:10g �vo��qw[h2005690986904127003602�nc6h11na3o12p2�� 50ml:5g �vo��qw[h200569< 0886904127000892zs�~k�50ml:5g( c�e4lir��) �vo��qw[h1095028786904187002843 �l\(u�g�|�n�xx���)sodium fructose diphosphate for injection[o� �vo��qw[h1095020886905765000121)fructose sodium diphosphate for injection7.5g �vo��qw[h200339418690576500040410g( cc6h11na3o12p2���{) �vo��qw[h53021655869058210005225g( cc6h11na3o12p2���{) �vo��qw[h5302165486905821000515)fructose diphosphate sodium for injection �vo��qw[h109200568690079600056010g*60�t/�{ m�n(u�n�z�mp̃�l\(u4l � �vo��qw[h2004512586900594000588l�s�| invert sugarp��v���\ }�b�b�e�lo(ua���|�v�bqe�`��l\(ul�s�|invert sugar for injection^t�y�n�g�|12.5gna���|12.5g �vo��qw[h2006041586905793000988�g�|6.25gna���|6.25g �vo��qw[h2006041486905793000896inverl sugar for injection25.0g��g�|12.5g�ta���|12.5g � �vo��qw[h2008004186902946002356 l�s�|5u�(��l\�m'invent sugar and electrolytes injection0u�r �vo��qw[h20051608869008410001560multiple electrolytes and invert sugar injectionwm�e�~\250ml:�g�|6.25gna���|6.25gnsnx���0.7004gn/ls��0.3652gn/ls��0.4660gn/lsa�0.0714gn�xx��n"l��0.1875gn�nkxx�"l��0.1301g �vo��qw[h2005049486902189000485l�s�|�l\�m��q�250ml�a���|12.5g�t�g�|12.5g nwm��_�[lёq\6ro� gp�lq�s �vo��qw[h2006117886900687000662invert sugar injection���250ml:�g�|12.5gna���|12.5g �vo��qw[h2004001486902189000034250ml:�g�|6.25gna���|6.25g �vo��qw[h2004001386902189000164250ml:mg�'y�n ��g�|6.25gna���|6.25g�mt�|5u�(�carbohydrate and electrolytep�/gt n)yo(u �mt�|5u�(��l\�m&carbohydrate and electrolyte injection�ewm�� �vo��qw[h2006107386901521000893# y�e5u�(�a���|�ma mg m3a m3b r2a r4a mg3)p�kb/gmr5u�(� }qnbkb/gt n)y�qo(u y�e5u�(�a���|mg3�l\�m2electrolytes and glucose composition mg3 injection �vo��qw[h1202063586900967000504 y�e5u�(�a���|r2a�l\�m/compound electrolytes and glucose r2a injection �vo��qw[h1202102486900967000511 y�e5u�(�a���|�l\�m-m3a4electrolytes and glucose composition injection - m3a �vo��qw[h1090004686900967000474 y�e5u�(�a���|�l\�m-m3b3electrolytes and glucose composition injection- m3b �vo��qw[h1090004786900967000481 y�e5u�(�a���|�l\�m-r4a2electrolytes and glucose composition lnjection-r4a �vo��qw[h109000488690096700049819.2 �v{| y�e/ls��compound sodium chloride y�e/ls���l\�m"compound sodium chloride injection �vo��qw[h2004381886902180001108!500ml:/ls��4.25g,/ls��0.15g,/ls��0.165g �vo��qw[h3702202386904127003459 �vo��qw[h1302303686902763000474 �vo��qw[h3702084486904098000587 �vo��qw[h1202036186900933000309 �vo��qw[h1998303886900850000314 �vo��qw[h3302003586904494000907 �vo��qw[h2003307486904042000267 �vo��qw[h1998311786904653000380 �vo��qw[h3402187386904289000402 �vo��qw[h1302175386902662001824�s ge��m�voral rehydration salts�s ge��m�vb!oral rehydration salts b!05.125g�/ls��0.65g ��g|jx���0.725g �/ls��0.375g�t�e4la���|3.375g �vo��qw[h2009020586902456000569/ls��potassium chloride�s g8^ʑbr�w ʑ�cʑbr�w ���|br/ls��grpotassium chloride tablets �vo��qw[h1202016786900886001033/ls��ʑgr,potassium chloride sustained-release tablets �vo��qw[h2003337186900543000324e����y �vo��qw[h1091006986900405001063&(946)/ls���l\�mpotassium chloride injection �vo��qw[h1202051886900874000093 10ml:1.5g �vo��qw[h1102032186900202000641 10ml�1.5g �vo��qw[h2005371186900967000368 10ml�1.0g �vo��qw[h2005371086900967000375 �vo��qw[h2001300586903205000892 �vo��qw[h1302212886902662000155 �vo��qw[h3702121986903973000483/ls��sodium chloride/ls���l\�msodium chloride injection 50ml:0.45g �vo��qw[h2005675886904127000557 100ml:0.9g �vo��qw[h2001331086904127001981 �vo��qw[h5102115686902180000613 250ml:2.25g �vo��qw[h3702233686904127002223 �vo��qw[h5102115786902180000620 500ml:4.5g �vo��qw[h3702233786904127001486 �vo��qw[h5102115886902180000606 150ml�1.35g �vo��qw[h2005358886904058000220 �vo��qw[h2002342886904098000754 �vo��qw[h3702275086904098000983 �vo��qw[h3702274986904098000976 10ml:90mg �vo��qw[h20044024869032050009392ml:18mg �vo��qw[h3102169186900801000950sm/ls���l\�m'concentrated sodium chloride injection �vo��qw[h2001300686903205000694 1000ml:9g �vo��qw[h2002375086904042000083 �vo��qw[h1202001186900967000085 �vo��qw[h1998314986900628000171 �vo��qw[h2004330486904494002444 �vo��qw[h1202002486900967000092 �vo��qw[h2004365286900933000637 �vo��qw[h1302320286902763001266 �vo��qw[h3402187486904289000082 �vo��qw[h1102119086900144002789 �vo��qw[h4402018486900273000199 �vo��qw[h2002368286904042000052 �vo��qw[h1098305286900850000079 �vo��qw[h1999406786900628000263 �vo��qw[h3302177286904494000549 10ml:0.09g �vo��qw[h2004327186900967000399 �vo��qw[h1202099586900874000697 �vo�< �qw[h3702299086903973000728 150ml:1.35g �vo��qw[h2002325286902763001402 �vo��qw[h2004309386903387000086 200ml:1.8g �vo��qw[h2002324986904145000850 �vo��qw[h1202034686900933000743 �vo��qw[h1202002586900967000160 �vo��qw[h1302320186902763001303 �vo��qw[h1102119186900144000655 �vo��qw[h4402018586900273000182 �vo��qw[h2002314686904042000380 �vo��qw[h1098305586900850000123 �vo��qw[h1999406686900628000232 �vo��qw[h3302157686904494000556 �vo��qw[h3402187586904289000099 �vo��qw[h1202001086900967000016 �vo��qw[h1202034886900933001078 �vo��qw[h1302320086902763001327 �vo��qw[h1102119286900144002741 �vo��qw[h4402018686900273000205 �vo��qw[h3702076486904145000836 �vo��qw[h2002314586904042000199 �vo��qw[h1098305486900850000208 �vo��qw[h1998314886900628000270 �vo��qw[h3302157586904494001911 �vo��qw[h3402187686904289000075 �vo��qw[h2002333286900967000078 �vo��qw[h2004365386900933000644 50m1:0.45g �vo��qw[h2004456586902763001341 �vo��qw[h2005634286904289000273 �vo��qw[h4402018386900273000113 50ml�0.45g �vo��qw[h2006362286904145000669 �vo��qw[h2003320886904042000151 �vo��qw[h1999374586900628000324 �vo��qw[h2004387686904494001119ut/ls���n�m&sodium chloride physiological solutionmbr �vo��qw[h2002315786904653000489�qmbr �vo��qw[h2006653386902763000795 �vo��qw[h1202002686900967000221�g|jx���potassium citrate�g|jx������|potassium citrate granules2g:1.46g �%fsnso�n gp�lq�s �vo��qw[h22024249869032930002312g:1.46g(�ks͑2g, t�g|jx���1.46g) �vo��qw[h2006559386903302000375�s�~�r1.45g �vo��qw[h1097022086904139000354蕬q(lx���a�potassium magnesium aspartate p�no��noa�@��u蕬q(lx���a�gr%potassium magnesium aspartate tablets�e4l蕬q(lx���79mg;�e4l蕬q(lx�a�70mg �vo��qw[h31022534869007850005193potassium aspartate and magnesium aspartate tabletsxowsё�kgr t�e4l蕬q(lx�a�0.140g�t�e4l蕬q(lx���0.158g h2013059586979164000136%potassium magnesium aspareate tablets�e4l蕬q(lx���79mg,�e4l蕬q(lx�a�70mg �vo��qw[h3302188186904759000253%potassium magnesiun aspartate tablets�e4l蕬q(lx���79mg,�e4l蕬q/lx�a�70mg �vo��qw[h1402289386902959000622&(949) 蕬q(lx���a��l\�m6potassium aspartate and magnesium aspartatse injection%10ml:1.006g�,�-蕬q(lx�850mg0��114mg,a�42mg � �vo��qw[h20023067869032050004345potassium aspartate and magnesium aspartate injection �vo��qw[h2005330986903257000918 10ml:1.006g �vo��qw[h3302003886904494002093 �vo��qw[h3702228186904021000776 �vo��qw[h2002383686927001417041;10ml��e4l蕬q(lx���452mg��vs_�n103.3mg���yp[ ��t�e4l蕬q(lx�a�400mg��vs_�n33.7mga��yp[ � �vo��qw[h2006511186904152001949;20ml��e4l蕬q(lx���904mg��vs_�n206.6mg���yp[ ��t�e4l蕬q(lx�a�800mg��vs_�n67.4mga��yp[ � �vo��qw[h2006511286904152001956 �vo��qw[h310218678690080800030410ml�400mg�e4l蕬q(lx�a��t452mg�e4l蕬q(lx��� h2013059086979164000150 �l\(u蕬q(lx���a�9potassium aspartate and magnesium aspartate for injection#k�so1.0g(蕬q(lx���0.5gn蕬q(lx�a�0.5g) �vo��qw[h20041731869029180016082.0g:蕬q(lx���1.0gn蕬q(lx�a�1.0g �vo��qw[h2003109786902918000953�b)y�o#1.006g��k�t tl-蕬q(lx�850mg0��114mgna�42mg � �vo��qw[h2003093886905754000415����a���a���|.sodium potassium magnesium calcium and glucosep�5u�(� }qno(u ����a���a�a��|�l\�m8sodium potassium magnesium calcium and glucose injectionpn�ri500ml�/ls��3.186gn/ls��0.15gn/lsa�0.102gn��x���1.026gn�g|jx���0.294gna���|x���0.336gna���|5g �vo��qw[h2005199586901445001167蕬q(lx���potassium aspartatep�no@����u5u�(�e��~!pediatric electrolyte supplements \?q5u�(�e��~�l\�m pediatric electrolyte supplements injection250ml�a���|9.375gn/ls��0.5625g �vo��qw[h2006119586902180000309100ml�a���|3.75gn/ls��0.225g �vo��qw[h2006114986902180000132 19.3 x��xs^a����o�irsnx���sodium lactatesnx����l\�msodium lactate injection 20ml:2.24g �vo��qw[h3102173386900801000899snx����gm^t~g15g:0.15g(]xx��v�^u1%) �vo��qw[h2000045486902529000212vb%n�[15g:��x��f�[hy�_16.5mg,]xx��v�^u150mg �vo��qw[h2002012686901749001450asn�px�undecylenic acid&(125)�vx�yr�k���sn��cterbinafine hydrochloride cream;unguentum terbinafini hydrochloridi �vo��qw[h1097013586904021000660terbinafine hydrochloride creamǒyr ĉy��{v�]�s�rsňon��s)y6ro�(-n�v) gp�lq�s � �vo��qw[j2010004686978986000669ls|���^'y � }fluorometholone and gentamicin kxx��^'y � }ls|���nm�zf 5ml:50mg(1%) h2014097686978195000207&(1030)20.2.2.5 mrrz� }{|o�ir��mrr } bimatoprost ��mrr }�ny�n:��]�s�rsň��s)y6ro��-n�v � gp�lq�s � �vo��qw[j2013006286978986000928fluorometholone eye drops �s)y6ro�*h_o>y�n:��]�s�rsňon��s)y6ro��-n�v � gp�lq�s � �vo��qw[j2013006186978986000911 ��x��l<\~g���ny��{v�]�s(rsň��s)y6ro��-n�v � gp�lq�s) �vo��qw[j2013015086978986001031sodiumhyaluronateeyedrops 5ml:5mg(0.1�) �vo��qw[h2006395086904655000180 �vo��qw[h2004035286900600000472&(1046)�s�tx����l\�msodium hyaluronate injection?�\�l 2.5ml�25mg$seikagaku corporation takahagi plant h2014053386979107000056�e�lyr �vo��qw[h1096013686904072000343 2.5ml:25mg  nwmof�\6ro����n gp�lq�s �vo��qw[h2000064386900629000026 nwm fwmuir�y�b���n gp�lq�s �vo��qw[h20051837869006880000743ml:30mg �vo��qw[h2005183886900688000081�y�buiu tolazoline \[r@��sˆ}v�c�sirrecombinant human epidermal growth factor derivative eye dropsё�v� 15000iu/3ml//e �vo��qw[s2004000686900528000011&(387) ͑�~�nr^pb }�2b�ny h20070382869791900000221054..4!t��kq�� pirenoxine!t��kq���ny��{v�]�s�rsňon��s)y6ro��-n�v � gp�lq�s � �vo��qw[j2010009186978986000720!t��kq�����nu��(yrht�[)rice bran sterol�|>u��grrice bran sterol tablets �vo��qw[h4102471686903134000727�!t/l��cetylpyridinium chloride�!t/l�� t1o�mcetylpyridnium chloride gargle�o�o 200ml:0.2g �vo��qw[h2001075386904494001348cetylpyridinium chloride gargle1r��)yep0.1%�240ml:0.24g � �vo��qw[h2001036586901565000224 20.5 �y�n�y(uo�ir 20.5.1 p[�[6e)o�ir&(297)posterior pituitary�wsot�s�l\�mposterior pituitary injection1ml:6usmo �vo��qw[h32026638869015980001232ml:6usmo �vo��qw[h3102225986900651001831 �vo��qw[h3402297786904373000349 �vo��qw[h1202078786900918000218��҉�e�x ergometrine)�[ }oxytocin)�[ }�l\�moxytocin injection �vo��qw[h1999352686903021000366 �vo��qw[h3102085086900673000539 �vo��qw[h31020862869006510002470w��mrrn� dinoprostone0w��mrrn�hdinoprostone suppositories#knf�u'ferring controlled therapeutics limited h2009048486979504000031as�)�[ } carbetocinp��bqeasmrr2uo�carboprost methylateasmrr2uo�h#carboprost methylate suppositoritesasu[ �vo��qw[h1080000786901162000337asmrr }(ln n��carboprost tromethamine asmrr }(ln n���l\�m!carboprost tromethamine injection#k�k�l 1ml�250�gpharmacia & upjohn company h2012038886978736000260s|"}mrr�� misoprostols|"}mrr��grmisoprostol tablets �vo��qw[h2000066886900225002707vns[��^�n�yo�n gp�#��nlq�s �vo��qw[h2007369686901802000222�ukq��200ugpiramal healthcare uk limited h2010018686978745000213 20.5.2 p[�[~g_o�ir)rxbt ritodrine�vx�)rxbtgrritodrine hydrochloride tablets�[�[ hc2013002886979160000154&(1080)�vx�)rxbt�l\�m!ritodrine hydrochloride injection �vo��qw[h2006744486900353000064 hc2013002986979160000147�l\(u�vx�)rxbt%ritodrine hydrochioride for injection �vo��qw[h200806068690584300132320.5.3 @\萗ba�go�ir4�s��l~�gr hbr2u]xu4�s��l~�gr(metronidazole vaginal effervescent table t�gven�^��o�n���n gp�lq�s �vo��qw[h20067557869033570003064�s��l~�gr ��[ؚ�yu��ё�eo�nlq�s �vo��qw[h6102079386902477000555*metronidazole vaginal effervescent tablets�l~�gr �vo��qw[h31021285869008180023432u]xuhmetronidazole suppositories< �vo��qw[h4202178486901792000387 vnws�e�v6ro����n gp�lq�s �vo��qw[h43021486869049200002594�s�gr hbrkq �u4�s��l~�gr!clotrimazole effervescent tablets �vo��qw[h2004467886904141000908kq �u4�s�grclotrimazole vaginal tablets�q�y@l4�s�gr0.5g/gr,1gr/�v� t�o�hv �(bayer vital gmbh�rsňon��b3�;so��oep gp�lq�s/tnrlq�s � �vo��qw[j2013017486978271002613 �vo��qw[h2006528386905848000093kq �uhclotrimazole suppositories �vo��qw[h2006385586901730000790]xx��t�^uh miconazole nitrate suppositories ^nwnmq\�vo����n gp�lq�s �vo��qw[h2006592686900312001682!mico nazole nitrate suppositories�s�[ �vo��qw[h1091006586904873000993 �vo��qw[h2005997686901556000141 �vo��qw[h1093021486902529000236&(120)6r � }4�s�hnysfungin vaginal suppositories20nusmo �vo��qw[h3202610186901730000370 y�e��/g�l compound zedoary turmeric oil suppositories y�e��/g�lh4�s�h�k�g t]xx��v�^u50mgn��/g�l0.21ml �vo��qw[h2003357286903790000024 �k�| t]xx��v�^u50mg �vo��qw[h2005542886902281000789�^�yyr *y3��w�uq\ �o�n gp�lq�s �vo��qw[h2003315786902778000544 �vo��qw[h2000334786902778000209 y�e2u]xucompound metrnidazole2u]x�~�s4�s�h$compound metronidazole suppositoriesz[��� �k�| t2u]xu0.5kq  t�gvf�so�n gp�lq�s �vo��qw[h1093016686903381000020 y�e2u]xu4�s�h,compound metronidagole vaginal suppositories3g*7�g/�v �lsn�ё[ro�n gp�lq�s �vo��qw[h1302455486902628000083#compound metrnidazole suppositories 0.5g( c2u]xu��) �t\�n'k�fo�n gp�lq�s �vo��qw[h1999921886903649000083z�2uz��x�� policresuleny(u�msobr hbrz�2uz��x���n�mpolicresulen solution�mbr10ml:3.6g(36%) �vo��qw[h20040228869001440060221r�[�u36%(w/w),25ml:9g takeda gmbh h201301838697868700011136%�g/g �,25ml/�t �vo��qw[h2005956186902699002559�k�t25ml �36%(g/g) �vo��qw[h2004435786901565000422(36%�15ml:5.4g (36%)(g/g,�k1g-n tz�2uz��x��360mg) �vo��qw[h2006548786904685000396z�2uz��x��hpolicresulen suppositories �vo��qw[h2004340986902699001880 �vo��qw[h2005573086904188000060z�2uz��x��4�s�h"policresulen vaginal suppositories h20130204869786870001284�s��l~�gr 4�s�gr 4�s�o����v ]xx��t�^u4�s��l~�gr/miconazole nitrate vaginal effervescent tablets �vo��qw[h2008018686904141002070 ]xx��t�^u4�s�o����v(miconazole nitrate vaginal soft capsules/catalent france beinheim s.a.�rsňon���[hg�h6ro� gp�lq�s) �vo��qw[j20090130869785390005800catalent france beinheim s.a..(rsňon���[hg�h6ro� gp�lq�s � �vo��qw[j2009012986978539000603�f]xuhtinidazole suppositories1kq �vo��qw[h2005524886901730000066 ,g�t�k�| t�f]xu1kq �vo��qw[h2013311586901863000131�f]xu4�s��l~�gr'tinidazole vaginal effervescent tablets �vo��qw[h2005854986902120000123 �vo��qw[h2000020886901679000271]xkt*y\ nifuratel]xkt*y\4�s�grnifuratel vaginal tablets���t��250mg/grdoppel farmaceutici s.r.l. h2010021086979336000100]xkt*y\6r �̃ }nifuratel and nysfunginhbr 4�s�o����v ]xkt*y\6r � }4�s�o����v-nifuratel and nysfungin vaginal soft capsules4lr��k�| t]xkt*y\0.5g �6r � }20nusmo �vo��qw[h2006017986902778000261)nifuratel nysfungin vaginal soft capsulesg�o]xkt*y\0.5g,6r � }200,000usmo �vo��qw[h20051563869000850001894�s�o����v]xkt*y\500mg �6r � }20nusmo �vo��qw[h2008031386902014000246&(980)]xx��v�^uheconazole nitrate suppositories �vo��qw[h2302243386903649000038 20.5.4 vq�nn(l^t�galarelinl����x�flufenamic acid&(833)nfw̖�p promestrienenfw̖�psn��promestriene cream�f�[��1g:0.01g �15g//elaboratoires chemineau h2011057886978566000126&(1088)4�s����v 4�s�gr 4�s�o����vnfw̖�p4�s����vpromestriene vaginal capsuleslaboratoire theramex h2010065686978566000102snfg̃;m̃#living preparation of lactobacillus4�s����v 4�s�(usnfg̃;m̃���v)live lactobacillus capule for vsginal use�[tu 0.25g/�|,�k�|�q tsnfg̃;m̃�^ nno�n2.5�10^5cfu �vo��qw[s2003000586903914000039&(1013)/l�u��ynfw̖�pchlorquinaldol-promestrienehbr�4�s�gr � /l�u��y �nfw̖�p4�s�gr chlorquinaldol-promestriene vaginal tablets�s�[�q�kgr t/l�u��y200mg �nfw̖�p10mg �|xx�100mg h2009079986978566000096 /l�u��y/nfw̖�p4�s�gr chlorquinaldol/promestriene vaginal tablets�kgr t/l�u��y200mg,nfw̖�p10mg �vo��qw[h200515048690228100041321 ��ko�ir21.1 ͑ё^\0{|ё^\-n�k��ko�ir�n�]n�� dimercaprol�n�]n�x��"sodium dimercaptopropane sulfonate�n�]n�x���l\�m,sodium dimercaptopropane sulfonate injection 2ml:0.125g �vo��qw[h3102151486900673000980 �vo��qw[h2005748186900808001578�n�]n�n��sodium dimercaptosuccinate�n�]n�nx�dimercaptosuccinic acid�u�fx�����calcium trisodium pentetater� ��� penicillamine�s���� deferoxamine �l\(u2u�xx��s����&desferrioxamine mesilate for injection�_�e�� h2014067886978679002116�o0wx�����calcium disodium edetate�o0wx������l\�m"calcium disodium edetate injection �vo��qw[h120208908690087400076521.2 0lsir-n�k��ko�irkx�nkxx���sodium thiosulfate< �l\(ukx�nkxx��� sodium thiosulfate for injection0.64g(�vs_�n1gna2s2o3.5h2o) �vo��qw[h3102053486900796001352�n]xx���sodium nitrite�n]xx�_ bo� amyl nitrite21.3 g:g�xx�o�{|��ko�irkxx�?�xb�t�l\�matropine sulfate injection �vo��qw[h4102029186903098002300)y%mo�nɩ�v�eѐ���n gp�lq�s �vo��qw[h4102125686903204000701 �vo��qw[h1202038386900874000567 �vo��qw[h3102117286900673001116 �vo��qw[h1202038286900874000529 �vo��qw[h1202038486900874000536 �vo��qw[h4102032386903257000154�x��x�[pralidoxime iodide�x��x�[�l\�m 20ml:0.5g �vo��qw[h3102080386900808001677/l��x�[pralidoxime chloride/l��x�[�l\�mpralidoxime chloride injection �vo��qw[h3102080686900808000632�s y�xobidoxime chloride 21.4 vq�n��ko�irjs�(lx� l-cysteine��f 100ml:30g(i) h2011037686978485000429 100ml:35g(i) h2011037886978485000443 50ml:15g(i) h2011037786978485000436 50ml:17.5g(i) h2011037586978485000412�x[o��ioversol�x[o���l\�mioversol injection�[\�rmallinckrodt canada ulc h2013026886978927000376100ml:35g(i)�ؚ�s��eq_ � h2013027086978927000390125ml:40g(i) (ؚ�s��eq � h2013026686978927000352ioversol injection20ml:13.56g(�k1ml t320mg�x) �vo��qw[h200678958690144500155650ml:33.9g(�k1ml t320mg�x) �vo��qw[h2006789686901445001563�xwm��iohexol�xwm���l\�miohexol injection�ss �vo��qw[h1998021886900014000075 100ml:35g(`!) �vo��qw[h2005380086900014000112 20ml:6g(`!) �vo��qw[h1998003786900014000068 20ml:7g(`!) �vo��qw[h2005379986900014000105 50ml:15g(`!) �vo��qw[h1998021986900014000082 75ml:22.5g(`!) �vo��qw[h2003116986900< 014000136 �vo��qw[h2006691686904925001701�g;rf 50ml:32.35g �vo��qw[h1098032186904561000564 100ml:30g�i � �vo��qw[h2006646886904075000579 �vo��qw[h2006312886904127003251 �vo��qw[h2006312986904127003268'kcn>mkq 100ml:30g(`!)�(u5ulo�n� nwm � gp�lq�s �vo��qw[h2000059586900839000090�(u5ulo�n( nwm) gp�lq�s �vo��qw[h2000059986900839000014 10ml:3g(`!) �vo��qw[h2000059186900839000083 200ml:70g(`!) �vo��qw[h2000060086900839000076 �vo��qw[h2000059286900839000021 �vo��qw[h2000059686900839000052 �vo��qw[h2000059386900839000045 50ml:17.5g(`!) �vo��qw[h2000059786900839000069 �vo��qw[h2000059486900839000038'kς �vo��qw[h1097035886901749001252 �vo��qw[h1097032686901749001269 �vo��qw[h1097032786901749001313 75ml:22.5g(i) �vo��qw[h2000055186901749001245�x^�� iopamidol�x^���l\�miopamidol injectionxq�kpn30g(`!)/100ml/�t nwmzs���y�o �o�n gp�#��nlq�s �vo��qw[h200533858690063900015337g(`!)/100ml/�t �vo��qw[h2005338886900639000122 15g(`!)/50ml/�t �vo��qw[h200533848690063900013918.5g(`!)/50ml/�t �vo��qw[h2005338786900639000177 �xnfw����xnf�� � iopromide�xnfw���l\�miopromide injectiono�~>f 100ml:62.34g'bayer pharma ag�rsňon:�b3�;so��oep gp�lq�s^�]rlq�s � �vo��qw[j2013015586978271002583 100ml:76.89g&bayer pharma ag�rsňon��b3�;so��oep gp�lq�s^�]rlq�s � �vo��qw[j2013015786978271002606 20ml:12.47g'bayer pharma ag(rsňon��b3�;so��oep gp�lq�s^�]rlq�s ) �vo��qw[j2013015286978271002552 50ml:31.17g �vo��qw[j2010002786978271001517 50ml:38.44g'bayer pharma ag(rsňon:�b3�;so��oep gp�lq�s^�]rlq�s ) �vo��qw[j2013015686978271002590�lq_a���maglumine diatrizoate�lq_a����l\�mmegluminediatrizoateinjection20ml:12g �vo��qw[h4302131586904925001862meglumine diatrizoate injection 100ml:60g �vo��qw[h4302210686904925000469�xkq�l�� iodixanol�xkq�l���l\�miodixanol injectionzɖ>mkq32g(i)/100ml/�t ge healthcare ireland0rsňon��(u5ulo�n� nwm � gp�lq�s0 �vo��qw[j201401598697844600091827g(i)/100ml/�t �vo��qw[j2014015886978446000901 50ml:16g(i) �vo��qw[j2014015786978446000895 50ml:13.5g(i) ge healthcare ireland�rsňon��(u5ulo�n� nwm � gp�lq�s � �vo��qw[j2014015686978446000888�x�nf\iomeprol�x�f�niotrolan�lq_x���sodium diatrizoate �vo��qw[h2005924686900808001561 y�e�lq_a���$compound meglumine and diatrizoate  y�e�lq_a����l\�m(compound meglumine diatrizoate injection 20ml:15.2g �vo��qw[h430211208690492500034620ml:12g(d�1ml:0.3gջ����) �vo��qw[h310216078690080800129520ml:15.2g(d�1ml:0.3gջ����) �vo��qw[h3102160686900816000358 22.1.3 �xqq/c �q_br���s�� gadodiamide���s���l\�mgadodiamide injection'kcnq_ 10ml:2.87g)ge healthcare ireland(rsň��(u5ulo�n� nwm � gp�lq�s) �vo��qw[j2014016286978446000925 15ml�4.305g �vo��qw[j2014016386978446000932 20ml:5.74g �vo��qw[j2014016486978446000949���a���gadobenate dimeglumine���a����l\�m gadobenate dimeglumine injection����s'10ml:5.290g���a���(�vs_�n���x�3.340g,a�2u��1.950g) �vo��qw[h2005470186900639000023���ux�a����l\�m#gadopentetate dimeglumine injection.10ml:4.69g[�n���ux��sa�2u��(c14h20gdn3o10�2c7h17no5)��] �vo��qw[h1086000286900014000143.12ml:5.63g[�n���ux��sa�2u��(c14h20gdn3o10�2c7h17no5)��] �vo��qw[h2001308886900014000181.15ml:7.04g[�n���ux��sa�2u��(c14h20gdn3o10�2c7h17no5)��] �vo��qw[h1086000186900014000167.20ml:9.38g[�n���ux��sa�2u��(c14h20gdn3o10�2c7h17no5)��] �vo��qw[h1096004586900014000174,gadopentetic acid dimeglumine salt injectionl�9h�~>f469.01mg/ml*15ml �vo��qw[j2013008786978271002293469.01mg/ml*20ml&bayer pharma ag�rsňon��b3�;so��oep gp�lq�s^�]rlq�s) �vo��qw[j201300868697827100228610ml:4.69g( cc28h37o15n4gd��) ^�]�^�o�n gp�lq�s �vo��qw[h109502318690040000003012ml:5.63g( cc28h37o15n4gd��) �vo��qw[h109502718690040000004715ml:7.04g( cc28h37o15n4gd��) �vo��qw[h109502728690040000005420ml:9.38g( cc28h37o15n4gd��) �vo��qw[h1095027086900400000023���ux�a���gadopentetate dimeglumine��yrx�a���gadoteric acid meglumine salt���a��� ferucarbotran 22.1.4 vq�n �q_brmqlskx�_�l!sulphur hexafluoride microbubbles �l\(umqlskx�_�l/sulphur hexafluoride microbubbles for injection�x���~59mgmqlskx(bra      !"#$%&'()* ,-./0123456789:;<=>?@abcdefghijklmnopqrstuvwxyz[\]^_`abcdefghijklmnopqrstuvwxyz{|}~��������������������������������������������������������������������������������������������������������������������������������     g��������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������hijklmnopqrstuvwxyz{|}~�ccoimagingb.v.�rsňon� nwmzs���y�o �o�n gp�#��nlq�s � �vo��qw[j2013004586978306000126�s͑ �q_�nl���|22.2 vq�[^l̃ } brucellin �~8h̃ }�~ˆ}vm�uir&purified protein derivative tuberculin�e�~8h̃ }old tuberculin23 uir6r�t}v�u�b�k }diphtheria antitoxin y�nl'`ow�u�b�k }gas-gangrene antitoxin(mixed)�b�r�r�u@�nantirabies serumrabies antiserum400iu/�t�%fuir6r�txvz@b gp�#��nlq�s �vo��qw[s1082024886903320001316 �bdž�k@�n�l\6rbr4preparation of anti-snake venom serum for injection��b�p�u@�nanthrax antiserum4x$oθ�b�k }tetanus antitoxin1500iu//e �0.75ml _l�uir6r�txvz@b �vo��qw[s1097002186905348000012���k�b�k }b< otulinum antitoxina�w���k�b�k }botulinum antitoxin a�|6r�b�r�r�u@�npurified antirabies serum�|6r�bdž�k@�nrefined anti-cobra venom serum�|6r�b�p�u@�npurified anthrax antiserum�|6r4x$oθ�b�k }purified tetanus antitoxin 4x$oθ��n �mq�utˆ}v�human tetanus �immunoglobulin 4x$oθ�nmq�utˆ}vhuman tetanus immunoglobulin250iu/�t  t�uir6ro����n gp�lq�s �vo��qw[s2006314286904445000055i250iu/�t�2.5ml ��k�t t4x$oθ�bso250iu �ňϑ2.5ml0b250iu//e�2.5ml ��k/e t4x$oθ�bso250iu �ňϑ2.5ml0 nspquir�] z gp�lq�s �vo��qw[s2002303686903115000197ʉu8�nf 2.5ml,250iu/�t b��ʉuo�n gp�#��nlq�s �vo��qw[s1088000186902055000120�v�]܏'y�3�o�n���n gp�lq�s �vo��qw[s2004309386902291000144 �n�r�r�umq�utˆ}vhuman rabies immunoglobulin�nmq�utˆ}vhuman lmmunoglobulin y��l�nmq�utˆ}v(ph4)3human immunoglobulin(ph4) for intravenous injection 1g�5� �20ml �/�t �vo��qw[s20083055869044450002394human immunoglobulin (ph4) for intravenous injection)1.25g(5%25ml)�k�t tigg1.25g �igg tϑ:n5% �ňϑ25ml0 �vo��qw[s1097003186903115000104'2.5g(5%50ml)�k�t tigg2.5g �igg tϑ:n5% �ňϑ50ml0 �vo��qw[s10970032869031150001352human immunoglobulin(ph4)for intravenous injectionzs#k 5% 5g/100ml/�t �vo��qw[s19993011869052650000723human immunoglobulin(ph4)for intravenous injection5% 1.25g/25ml/�t �vo��qw[s19993009869052650000105% �2.5g/50ml/�t �vo��qw[s19993012869052650000271.25g�5� �25ml �/�t �vo��qw[s2008305386904445000215ʉuy�n5% 50ml 2.5g/�t �vo��qw[s19993042869020550000143human immunoglobulin (ph4)for intravenous injection 5%,50ml/�t �vo��qw[s1999302686904426000067 y��l�nmq�utˆ}v�ph4 �5%,50ml(2.5g/�t) �vo��qw[s19994004869029020002805% 2.5g/50ml/�t �vo��qw[s20013041869007940001805g/�t(5%,100ml) �vo��qw[s20013037869022910004271.25g/�t(5%,25ml) �vo��qw[s10980025869022910003732.5g/�t(5%,50ml) �vo��qw[s1098002686902291000380 �vo��qw[s2006313986904445000123human immunoglobulin10% 3ml 300mg/�t �vo��qw[s1098002386902055000182�qr^y��l�nmq�utˆ}v(ph4)@human immunoglobulin(ph4) for intravenous injection,freeze-dried1.25g �vo��qw[s1998303986904445000093 �vo��qw[s1998303886904445000109�n@�}vˆ}vhuman serum albuminp��bqe0��lxs1y�npg�t�]$o�oi� human albumin%5g(10%50ml)�k�t tˆ}v(�5g �ˆ}v(�sm�^:n10% �ňϑ50ml0 �vo��qw[s1999302486903115000029'10g(20%50ml)�k�t tˆ}v(�10g �ˆ}v(�sm�^:n20% �ňϑ50ml0 �vo��qw[s109500098690311500017310kq/�t ��20%50ml �baxterag s2013011486978256000085 20% 25ml 5g/�t �vo��qw[s109400258690205500013720% 50ml 10g/�t �vo��qw[s1094002486902055000205 human albumin��g 10g/50ml/�tcsl behring gmbh s2014007886979250000187 20% 5g/25ml/�t �vo��qw[s109400128690526500010220% 10g/50ml/�t �vo��qw[s1094001186905265000218"albumin prepared from human plasma�l\(u�n�mbr 20%,25ml/�t �vo��qw[s1098001686904426000012 20%,50ml/�t �vo��qw[s1098001586904426000029 5%,250ml/�tbaxter healthcare corporation s2010008486978257000251 25ml:5.0g�5% � �vo��qw[s200830208690290200043320%50ml�10g/�t � �vo��qw[s200830198690290200042620%,25ml �vo��qw[s1093001386900794000029 50ml:10.0g �vo��qw[s20013040869007940000435g/�t(20%,25ml) �vo��qw[s10940027869022910000212g/�t(20%,10ml) �vo��qw[s109400288690229100010610g/�t(20%,50ml) �vo��qw[s1094002686902291000014 20%(10ml:2g) �vo��qw[s1096008586904445000031 20%(25ml:5g) �vo��qw[s1096008486904445000116 20%(50ml:10g) �vo��qw[s1096008386904445000024�n(u�r�r�u�uׂrabies vaccine for human use �^y�~u��vp[mouse nerve growth factor �l\(u �^y�~u��vp['mouse nerve growth factor for injectionς��u30�g(uirf[;m'`e"15000au)��t0��l^y(s�n)uir6ro����n gp�lq�s �vo��qw[s2006002386900233000030ё�wc20�g( nno�n9000au)/2ml/�tfkilwmyruir6ro����n gp�lq�s �vo��qw[s2006005186901938000196i`�~ y18�g( nno�n9000au)/�t *g tuir;so� gp�lq�s �vo��qw[s2006005286904857000018 �l�u(ua�w���k�k }%botulinum toxin a for therapeutic use&(1053)y(u͑�~[r�x'`b�~�~�~ހu��vp[brecombinant bovine basic fibroblast growth factor for external use� ynm35000iu/�t, y�ntso�y:n8ml �vo��qw[s1098007586900612000064͑�~�n�x'`b�~�~�~ހu��vp[0recombinant human basic fibroblast growth factor24 yto� (l/l0ws^?�xbo�n@l�� (l/l0ws^?�xbo�n@l��gr4amlodipine besylate and atorvastatin calcium tablets5mg/10mg (�n(l/l0ws^/?�xbo�n@l��)npfizer manufacturing deutschland gmbh (betriebsstatte freiburg) (rsň���^t6ro� gp�lq�s � �vo��qw[j2013003086978718001056�s��lfw"l/l{v�u �s��lfw"l/l{v�ugr*irbesartan and hydrochlorothiazide tablets�[zs�� 150mg/12.5mg �vo��qw[j20130041ؚ@��s ��_�rp��z �%`'`�_���h{k086978814000922*irbesartan and hydrochlorothiazide tablets�kgr t�s��lfw150mg �"l/l{v�u12.5mg0 �vo��qw[h2005722786901606000213�kgr t�s��lfw75mg �"l/l{v�u6.25mg �vo��qw[h2005870986904647000273/l�lfw��"l/l{v�u /l< �lfw��"l/l{v�ugr2losartan0potassium0and0hydrochlorothiazide0tablets�kgr t/l�lfw��50mg�t"l/l{v�u12.5mg �vo��qw[h20083009869016500012282losartan potassium and hydrochlorothiazide tablets �vo��qw[h2007402186900177000240wmwc�n�kgr t/l�lfw��50mg �"l/l{v�u12.5mg.merck sharp & dohme limited�rsňon�mg�]؞�ln6ro� gp�lq�s � �vo��qw[j2013003586978633001292o��t{| r1 �q�y(uo�1.1 �h�br 1.1.1 ��)n�h�bra�qn�p���|  y�e ��k��ň6g��e��| � �vo��qw[z20003334  y�e ��k��ň12g �vo��qw[z2005510786904971000857 �vo��qw[z2006321486903944000191 y�e ��k��ň3g �vo��qw[z5302137586905719000153 ]nst�;m8n����| �]nst�;m8n4l8n y�e ��k��ň6g �v�]�y�m6ro� gp�lq�s �vo��qw[z5102043086902153000640]nst�;m���|  y�e ��k��ň15g �vo��qw[z2003000286902033000159ck�g�n����|�k��ň10kq �vo��qw[z3202036186901622002345 �k��ň3g��e��| � �vo��qw[z3202036286901622002116 �k��ň5kq�\�|�w � �vo��qw[z2000301386901622002086&�1 �a�qn�p���v�k�|ň0.45g s�n�nnuir6ro� gp�lq�s �vo��qw[z2004341186900200000414 t�gvenɩ�v�r�n6ro����n gp�lq�s �vo��qw[z2004304986903355000452 a�q�uθ���|����v0gr �[�9hdl���|�gr �[�9hdl���| �vo��qw[z2003007786904152002168bh�g���|�k��ň5g q\�*yl�o�n���n gp�lq�s �vo��qw[z2001001186902943000652f�2�tbr����| �&�2 �]nst�;mgr ��ğbk�u8n����v �\?qn�pa�qgr\?q�[8n'y�8n�k8n͑1.5g)y%m-n�eo�nɩ�v���n gp�lq�s���nx6ro��s �vo��qw[z1202011786900960001089��ogu�wo����va�qo����v�k�|ň0.425kq(�vs_�n;`o�pg1.8kq �  t�gi�؏9no�n gp�lq�s �vo��qw[z2202280486903362000230�k�|ň0.5g(�vs_�n;`o�pg1.8g) �vo��qw[z1202070186900960000570ayrup���v�k�|ň0.2g( t�[ynp�(l�wz�50mg) �vo��qw[z2202148586903373000298 �vo��qw[z2202069286903405000449�k�|ň0.2kq( t�[ynp����wz�50�kkq)  t�g }k�o�n���n gp�lq�s �vo��qw[z2202016686903503001652 1.1.2 ���q�h�br�g��l\�m�k/eň2ml �vo��qw[z4102074386903020000336 �vo��qw[z3502011886904785000135a�qn���v�gr ��sğޏtbr����|0���v0gr ��sğޏ���|�k��ň5g( t�|�w,�vs_�n�so�pg15g) �t\�n?q�z6ro��s gp�lq�s �vo��qw[z2302079086903628000110 )y%m t�nxɩ�v���n gp�lq�s �vo��qw[z1095001486900946000372�to�ɩ�v-no��n�s �vo��qw[z2002012586903714001144�sğޏgr�kgr͑0.53g o���6ro�ɩ�v���n gp�lq�s �vo��qw[z1097005286902816002141 u��}v�6ro����n gp�lq�s �vo��qw[z1096003686902353000433 �vo��qw[z1096005786903665000159�����k8n����|0���v0gr ������k8n�k8n͑9g �vo��qw[z1202012086900960001096�����kgr�kgr͑0.5g �vo��qw[z2009355586902067000552�����k���v�k�|ň0.4g n��^�s6ro� gp�lq�s �vo��qw[z2006322386900248000056 )y%m�[�nxo�n gp�lq�s �vo��qw[z1093001986900865000354&�11 � �g��n8n��s g�m ��g��n8n �k��ň0.551g )y�x�r6ro�ɩ�v���n gp�lq�s �vo��qw[z2002005386900941000063�gğ���v�gr ��g���s g�m�k�tň20ml ��ws�snf6ro� gp�lq�s �vo��qw[z2001012486904012001072  y�ea�qup���|����v0gr �a�t�sn���v[rğna���v qhʃa�q8n����|0gr �qhʃa�qgr�kgr͑0.55kq �vo��qw[z2006399686900888000331�kgr͑0.6g)y%m-n�eo�nɩ�v���n gp�lq�s��z��i6ro��s �vo��qw[z1202024186900963000034qhʃa�q���|�k��ň11g)y%m-n�eo�nɩ�v���n gp�lq�spn�nx6ro��s �vo��qw[z1202046286900962000820�uθ��k���v&�13 ��sğޏ�s g�mtbr20ml//e �vo��qw[z109200538690370500231086903705000200�k/eň20ml �vo��qw[z4102232586903020000589�sğޏ�l\�m[ t�l\(u�qr^�|��]�sğޏ�l\�m �vo��qw[z4102075086903020000596 �vo��qw[z2302078586903783000185 �l\(u�sğޏ(�qr^ ��k/eň600mg �vo��qw[z1096005886903714000260�k/eň1.2g �vo��qw[z2004342586903714001083 �~c������|����v0gr ��n�|�v�n\?q�[�l�^���| \?q�p�n���|��s g�m �\?q�p�n���|�k��ň2g �vo��qw[z1098010186903665000197�k��ň6g _l� p��o�n gp�lq�s �vo��qw[z2002303486905261000137\?q�p�n�s g�m  t�gncko�nɩ�v gp�lq�s �vo��qw[z1090002086903494000443 ��ʃ nn8n����|0gr ���ʃ nn8n �vo��qw[z1202046086900962001131&�14 � �����ktbr�o����v0�m ������ko����v �vo��qw[z2001001986901463000500͑aup���v�gr ��a�[���v�k�|ň0.3g(�k�| t�[ynp�(l�wz�100mg) �vo��qw[z1202048686900888000096��wa�qgr �kgr͑0.265g �vo��qw[z1202052086900962000561�|6r�����kgr�kgr͑0.25kq��kgr t�[ynp�(l�wz�44�kkq � �vo��qw[z1202023886900963000645�kgr͑0.26g( �kgr t�[ynp�(l�wz�44�kkq � �vo��qw[z2005401186900946000617 �kgr tqb�po`�u44mg �vo��qw[z2010303086900958000308�u�uup���v�k�|ň0.25g �vo��qw[z1202065786900888000218q\!��h�s���|�k��ň10g _l�qo�6ro� gp�lq�s �vo��qw[z2002711386905366000100�p�p�[tbrğ����s��k���v�k�|ň0.36g �vo��qw[z2008001086903405000470 1.1.3 h�̑�s�br 2�θ�#w8n����| �2�θ�#w8n �k208n͑1g ��k��ň6g10��/�v ��[ck'y6ro� gp�lq�s �vo��qw[z6102140786902533000260 �k208n͑1kq ��k��ň6g �vo��qw[z12020523869009620004482�θ�#w���| �p�s)ycko�n gp�lq�s �vo��qw[z1999100886904245000057 \�g�8n����|0���v0gr �\�gဗ��| �vo��qw[z199831288690020000008786900200000124 �vo��qw[z4402021186900372001585 �vo��qw[z3202017286901463000647 �k��ň2.5g��e��| �86901463001644 �k��ň5g(�e�|�w) _l�nml�s�oo�n gp�lq�s �vo��qw[z2003318286905300000975\�g�gr�kgr͑0.4g �vo��qw[z4402269686900294000093\�g�dl8nsm)8n�k88n�vs_�n�so�pg3g�88n/�� � g�ɩ�vnc�o�n gp�lq�s �vo��qw[z1402007886902982001047]nst�s��s g�m�k�tň100ml t�gё�l�[q\o�nɩ�v���n gp�lq�s �vo��qw[z2001000186901115000209 \?q�gbh��p���|��s g�m �\?q�gbh��p���|�k��ň4g5��]~vuponɩ�v6ro����n gp�lq�s �vo��qw[z2005042986905437000862vnsd�3���-no�nɩ�v gp�lq�s �vo��qw[z2005071686901994000727\?qi��n�p���| �vo��qw[z2005015486901453000237\?q�sn���|�k��ň2kq �υ��ꏷ^o�n���n gp�lq�s �vo��qw[z< 1999101886905746000041&�33 ��sntbr�k�t100ml �vo��qw[z2001005386900928000611�s�gce4s�g[rğce�k�tň0.36g ^�]}v�nq\gyfo�n gp�lq�s �vo��qw[z4402279186900412000165%t�s�b��8n�fna�q�qbr 1.1.4 vbck�h�br�so\θ���|15��/�v �vo��qw[z1093003686900294000116h�z�a�q���| �sς8n����v0gr ��sς���v 5��]�o��6ro����n gp�lq�s �vo��qw[z1098006886905547000097&�35 ��so\θ���v�sς�[��8n�k100�|͑6g ��k��ň6g �vo��qw[z12020599869009620005541.2 [y�fbr 1.2.1 �h�[y�fbr�onm8n�k��ň3.7g30��/�v �vo��qw[z4402293186900256001731�k�tň3.7kq ^�]�s� to�n���n gp�lq�s �vo��qw[z4402061086900424000054����ckl8n�4l �����ckl4l10/e/�v�v�]�y��3�iq6ro����n gp�lq�s �vo��qw[z5102135286902154000403�k/eň10�kgs �vo��qw[z1202024986900963000751 �nws}vo�ɩ�v���n gp�lq�s �vo��qw[z2004410386905629000175&�38 ��onm�s g�m&�39 �����ckl���|����v0o����v0gr0�s g�m0�n8n �����cklo����v �vo��qw[z1089001986900960000693 �vo��qw[z1302079786902729000531����ckl�n8n�k��ň2.6g �vo��qw[z2000004886900941000100����ckl8n�k88n�vs_�n�suo�3g �248n/��  t�gwck��lqo�n gp�lq�s �vo��qw[z2202367686903463000436����cklgr�kgr͑0.3g �vo��qw[z1202027886900963000782 1.2.2 n�p[y�fbru2��m�k8nmqnce�k�tň50g �vo��qw[z1202022886900865000095 1.2.3 epà[y�fbras�n4l�k/eň5ml ^�ga�[�n6ro� gp�lq�s �vo��qw[z4502153586905101000198�vcemqt�[-n8n�k8n͑9kq �vo��qw[z1502146286903860001333 }ё-��ce �1.3 �l nbr ���n�m��8n�o����v ����n�m��8n�k8n͑6g108n/�v q\�ns�^o�n���n gp�lq�s �vo��qw[z1402011786902891001435�k8n͑6kq _l�r�%f�^�n6ro� gp�lq�s �vo��qw[z2009359386905336000130 nğ���v�gr � nğgr�kgr͑0.2g )y%m��z��i�su\6ro� gp�lq�s �vo��qw[z2006369486900887000165 �vo��qw[z1402151986902959001162 �lwsw�[�6ro����n gp�lq�s �vo��qw[z4102207086903082001142�o����v�gr ��o����v�k�|ň0.35gfkileplo�nɩ�v���n gp�lq�s �vo��qw[z1999007186901946000140����h��ʉ��o�s g�m�k�tň10mlu��)y4l�\ğo�n gp�#��nlq�s �vo��qw[z1091003286905880001195 'yğ��o���|����v0gr ��s4g�cltbrm����o���v ���n8n����v0o����v ����no����v�k�|ň0.6g �vo��qw[z1094003186900928000369���n�n>�8n8nbr)y%m���nx�nn�~o�n gp�lq�s �vo��qw[z2001307186900855000234 �vo��qw[z1202001186900960001645��ʉ�m���s g�m s�nskso�n gp�#��nlq�s �vo��qw[z2000003486900016000028&�46 � nğ8n��oup���v �[�v�nno�n gp�lq�s �vo��qw[z2005463786900200000575 �vo��qw[z4402269586900294000055 �vo��qw[z2004336486902767000067 �vo��qw[z1999404086900858000323 �vo��qw[z1202023786900865000279��o�[gr y�e��_����v�k�|ň0.43g �lsn�� y4no�n gp�lq�s �vo��qw[z1302030686902651000203�vl�m����nq��br�k�tň60g �vo��qw[z1202067586900888000072�k�tň180g )y%m^zs1r6ro� gp�lq�s �vo��qw[z1202016886900896000385�vc[ nğo����v1.4 n�pbr 1.4.1 n�p�lkpbrğޏ nn8n����|0���v0gr �ğޏ nn8n q\�/cn_cq6ro� gp�lq�s �vo��qw[z1402161786902901000250 �vo��qw[z6102105286902533000697 �vo��qw[z1202062586900962000219 �vo��qw[z1202008086900960000662ğޏ nn���|12��/�v ͑�^n�eo�n���n gp�lq�s �vo��qw[z2002684986900994000577ğޏ nngr�kgr͑0.33kq48gr/�v �vo��qw[z2006368986900887000073�wgr͑0.33g �vo��qw[z1202013786900958000049�kgr͑0.31g �vo��qw[z2008335186905590000471  y�e �gr��͑0.3g24gr/�� �vo��qw[z5202012386905437000800[rğ��k8n����v0o����v0gr �[rğ��k8n�k8n͑3g �vo��qw[z1402162186902901000625 �vo��qw[z1202010486900960000983[rğ��ko����v�k�|ň0.4kq48�|/�v s�n�^ ��yo�n gp�#��nlq�s �vo��qw[z1097006686900074000077[rğ��kgr�kgr0.3g24gr/�v �vo��qw[z5002002886900994000188�kgr͑0.25g100gr/�v �vo��qw[z120200218690094600009986900946000426 �vo��qw[z2006369386900887000141�wgr͑0.25g �vo��qw[z1202013986900958000162 )y%m�l��o�n gp�lq�s �vo��qw[z1202003086900932000065 [rğ nn8n����v0gr �[rğ nn8n �vo��qw[z14020376869028910016264l�8n6��/�v �vo��qw[z2005487286903319001952fkil-nt�o�nɩ�v���n gp�lq�s �vo��qw[z4202083186901986000551 �vo��qw[z1202028586900960001553[rğ nn���v�k�|ň0.3g36�|/�v _l�)y�e�^ _3�6ro� gp�lq�s �vo��qw[z1096001386905363000806[rğ nngr40gr/�v �vo��qw[z1202053086900962001032 �wgr͑0.265g �vo��qw[z1202014086900958000148 s_r_��_�8n����v0gr �[rğnkp8n[rğnà8n[rğ�[8nn�[8n�k�tň6g �vo��qw[z1202060786900962000684  nn8n����v0gr � nngr�wgr͑0.3g*y�gɩ�v�v�]�~3�6ro� gp�lq�s �vo��qw[z2002537086902303000315 nn8n �vo��qw[z1202010986900960001539\?q�[d�gr �vo��qw[z1202024486900963000041�kgr͑0.17g �vo��qw[z2009305286903319002089 nn���|����v0gr �nn���v�k�|ň0.5g b���^_6ro� gp�lq�s �vo��qw[z1999104786902041000080nn���|�k��ň7.5kq9 �vo��qw[z2002341986902763001426 �vo��qw[z2005479286900200000568�k��ň7.5g �vo��qw[z5102021086902033000098 �vo��qw[z2002318286902082000124���[n�[8n �vo��qw[z1202039486900952000236nàğޏ8n�gr �nàğޏ8n�k��ň9g �vo��qw[z1202068686900962000790nàğޏgr�wgr͑0.32g �vo��qw[z1202014286900958000254 �vo��qw[z1202025886900963000065[rğs�kgr �vo��qw[z1202002486900946000204nm�gr�8n �nm�gr �kgr͑0.125kq �vo��qw[z1202028786900946000389&�68.4 �\?qnm�gr 1.4.2 n�p��kbrg݄9h���|20��/s �vo��qw[z2202357086903357000146 �k��ň3g��e�|�w �20��/-n�� �vo��qw[z3302095786904684000052 �vo��qw[z1202001986900946000730�k��ň10g��vs_�nn�gr14g �^�]^���w6ro��s �vo��qw[z4402033486900415000087�k��ň5kq �vo��qw[z2006369< 886900887000011 �vo��qw[z1202048186900888000010z�_�����v�gr �z�_��gr�kgr tz�_��r^xm��0.105g^�]}v�nq\�t��ğ�w-no� gp�lq�s �vo��qw[z4402176486900374001309z�_�����v�k�| tz�_��r^xm��0.105g �vo��qw[z1202021086900865000149 �vo��qw[z1202048386900888000232 n_up���|����v0gr �n_up���|�k��ň10g( tğ����20mg)20��/�v �vo��qw[z1095008886900375001087�k��ň3g( tğ����20mg)�yj���w � �vo��qw[z1093001086903845000337�k��ň1.5g( tğ����20mg,�e�|�w)18��/�v86903845000313�k��ň3g( tğ����20mg)24��/�v86900375001056n_up���v�k�|ň0.25g( tğ����10mg) �vo��qw[z1095008786900375000790n_upgr36gr/�v �vo��qw[z1098009886903665000142 �vo��qw[z1097004386904631000036n_uprcegr�kgr͑0.4g( tğ����10mg)�to�ɩ�v n�|csd�6ro� gp�lq�s �vo��qw[z2005056486903704000218 n�p��k���|����v0gr �n�p��k���v u��ek�6ro� gp�lq�s �vo��qw[z1098004686902537000136n�p��kgr�kgr͑0.52g �vo��qw[z2001002586903719000333n�p��k���|�k��ň18g �lsn�\o�n gp�lq�s �vo��qw[z2005518786902667000525&�69 � g݄9hgr��s g�m �z�_���qo��n8n0.6g y�e( tz�_���qo�0.15g) �vo��qw[z2004007886900941000056&�70 �z�_��8n�q�qi����v�gr �  y�e�s�����|�gr0�s g�m � y�e�s�����| �k��ň6g(�e�|�w)�vo�ɩ�v�|�e��[�_ �o�n���n gp�lq�s �vo��qw[z1998000286904312000768 y�e�s��gr�kgr͑0.62g u���^�`6ro����n gp�lq�s �vo��qw[z1999006286902395000330 y�e�s���|fm �[�_�|�eo�n���n gp�lq�s �vo��qw[z2001004986904312000744;m@���k8nep?qn㉲m �vo��c���m3w-no� gp�lq�s �vo��qw[z4402340486900430000369 �vo��qw[z200233098690043000035286900430000444 _l���q\o�n gp�#��nlq�s �vo��qw[z3602040986905390000268 �vo��qw[z3302032386904557000165 ё�������|����v0gr �ё�������v �ls~v�uo�n gp�lq�s �vo��qw[z2006370386902685000453 �vo��qw[z2000012886905551000014ё����gr�kgr t;`ğn� n�_\�n0.042kq b�_)y�so�n gp�lq�s �vo��qw[z1302045686902571000130ё����rcegr�kgr͑0.7kq �p�s-n2m6ro� gp�lq�s �vo��qw[z2006411686904253000070ё��n�p���|����v0�l~�gr �ё��n�p���| �k��ň5g��e��| � �vo��qw[z1094006886905914002549ё��n�p���v �vo��qw[z2008008186905914003508ё��n�p�l~�gr�kgr͑4g )y%m-n�vwm)y6ro� gp�lq�s �vo��qw[z2010307686979304000040�b�u�k8n����|0���v0gr0�s g�m0o����v ��b�u�k���v t�gw��ws)y�[o�n���n gp�lq�s �vo��qw[z1092003586903424000291�b�u�k�s g�m �vo��qw[z3202123286901463001156�k/e10�kgs �[�_n�v�s��6ro� gp�lq�s �vo��qw[z3402082386904284000179�b�u�kgr �vo��qw[z1999107986900873000667�b�u�ko����v �vo��qw[z2003016886900381000777�b��ӛ�pgr݄���s g�m�k/e10ml �vo��qw[z1999100586901749001542���_�l�l\�mp��n�~�n n;sb�&�72 � n�p��k�s g�m�o����v �n�p��ko����v�k�|ň1.2g �vo��qw[z2000009386902770001587n�p��k�s g�m �lws)y�eo�n-no� gp�lq�s �vo��qw[z2002010886903099000145 �k/eň10ml��e�|�w � �vo��qw[z1999309686905300001682 �vo��qw[z2302094286903714000659n�p��k�l\�m n�pce�~���v�gr �nv��k8n�gr �nv��kgr �vo��qw[z2006301686900888000294 �vo��qw[z1202024086900963000416nv��k8n �vo��qw[z1202010786900960001157�p�k�[�l\�m �vo��qw[z2005021786901463001262n�^���v �v�]� fhg)y6ro� gp�lq�s �vo��qw[z1097004586902267000505�u�ps^�l\�m 2ml:50mg//e �vo��qw[z2002624986905337000696 5ml:125mg//e86905337000702y�gi�������|0���v0gr0�s g�m �y�gi����k�tň130g �v�]-n�e6ro� gp�lq�s �vo��qw[z5102074186902298000222y�gi����v z�os f�s�n �o�n gp�lq�s �vo��qw[z1999103386900188000093y�gi��s g�m �k/eň10ml��e��| � 5�3��e)yo�n���n gp�lq�s �vo��qw[z1999005286905421000175 \?qs�kce����v �\?qs�kce �vo��qw[z4202167086901946000720\?q�tab���|�k��ň8g 5��]^ygyo�n gp�lq�s �vo��qw[z2005515986905509000141 pq�]�t�vx6ro� gp�lq�s �vo��qw[z6202001486905894000191�e@vgr �s�-no��s gp�lq�s �vo��qw[z3502006386904875000250�en�[���v�gr � �e�8n����|0���v0gr ��e�gr�kgr͑0.56g �vo��qw[z4402279586900412000684 �s?��[o�n gp�lq�s �vo��qw[z2006389486903553000377������kgr�s�s��k���|�|���n�uce�k�tň8g �vo��qw[z1202022486900865000316 ����θ���|����v0gr �����θgrgr��͑0.25g _l�)y�e�^-no����n gp�lq�s �vo��qw[z3602167786905363001827&�98 �����θ�l\�m ��0w݄�m�pgr��s g�m ���0w݄�m�pgr �vo��qw[z2005510186900896000354�kgr͑0.73g �vo��qw[z1202014186900958000230�kgr͑0.31kq �vo��qw[z1202026886900963000058�kgr͑0.9g q\nt[�^6ro� gp�lq�s �vo��qw[z3702022486904117000277��0w݄�m�p�s g�m �vo��qw[z2003009586901453000244gr�n@v���v~vj����v����| �n�p�m�p�[o����v�k�|ň0.66g( t]n��6�r^xm��0.33g) 5��]0ws�o�n gp�lq�s �vo��qw[z2009075586905451000022�un���|9��/�v �vo��qw[z1098013286903373001011 1.4.3 n�q��pbr 1.4.3.1 n�pt��br ��ğ���|����v0gr ���ğ���|�k��ň4kq �vo��qw[z4102207486903082001487 �vo��qw[z1202045086900962001414 �k��ň2g(�e�|�w) �vo��qw[z2002300586905300000500 �k��ň2g��e�|�w � ws fnmz�6ro� gp�lq�s �vo��qw[z3602138186905403000049 �vo��qw[z1202042486900931000745 �vo��qw[z3202049986901493000815��ğ���v �vo��qw[z2003317386902763000696۞�ce ޏ��nv���|����v0gr �ޏ��nv���v �vo��qw[z2004006386902767000395 n���bkp8n����v0gr �n���bkpgr�kgr͑0.78g �vo��qw[z1202027986900958000247�kgr͑0.6kq �vo��qw[z1202025786900963000454 �vo��qw[z2006400986900888000355n���bkp8n �vo��qw[z1202000286900960001652�u�pn�l\�m �vo��qw[z2003005486900705000087 \?qn�p)r���s g�m^�]}v�nq\xoؚ�[o�n���n gp�lq�s �vo��qw[z1999101086900411000395&�99 ���ğ8n��s g�m0 tsgr0�n8n ���ğ�n8n�k��ň2.5kq �vo��qw[z2006014486900958000117�k��ň0.7g ym_l�~�^o�n gp�lq�s �vo��qw[z2005070286< 904728000253�k��ň208n��k8n͑60�kkq � �p�s'y m6ro� gp�lq�s �vo��qw[z2008065586904235000142��ğ tsgr �vo��qw[z3702037086904012000853��ğ�s g�m �vo��qw[z3202017586901463000579��ğ�l\�m|�e�i��l\�mğh���s g�m�k/eň10ml �10ml:1.35g  t�gğh��o�n gp�lq�s �vo��qw[z2202570486900220000555 1.4.3.2 n����kbr �b�����|����v0gr ��b�����| q\n�mnso�n gp�lq�s �vo��qw[z2011302286904154000100�b�����v48�|/ �vo��qw[z2002771086901493000228 �vo��qw[z1096003886903373000144�b��gr �k }gr͑0.35g �vo��qw[z2006305486902067000088�wgr͑0.35g ў��_lu���o�n���n gp�lq�s �vo��qw[z2000333686903747000435�kgr0.35kq �[�_]n�e6ro� gp�lq�s �vo��qw[z2005328486904296000112�kgr͑0.36g �t\�n-no�mq�s gp�lq�s �vo��qw[z230203258690384600029986903747000411�kgr͑0.72g �vo��qw[z2006390086900958000056�v��up���v�gr ��v��upgr 77mg(�n4lޘ߄�[��) �v�]�_܏^�t6ro� gp�lq�s �vo��qw[z1999401986902294000141�kgr͑0.18g( t4lޘ߄�[38.5mg) _lς-ntqo�n gp�lq�s �vo��qw[z3202009086901527000309 �o�lpn���|����v0gr ��o�lpn���|�k��ň15g �vo��qw[z220212218690335500003286903355000049  y�e�v��up���v�gr � y�e�v��up���v0.37g/�|&�yxbon�vnwscsёxn_lo�n���n gp�lq�s<br>�sxbon�vnws�[��6ro� gp�lq�s �vo��qw[z2005008386904960000479300mg vnws)y0wr`n6ro� gp�lq�s �vo��qw[z2011302586904912000595 y�e�v��upgr21mg( t4lޘ߄ }�n4lޘ߄�[��) �vo��qw[z1102033086900143000182 �vo��qw[z2202513386903503001812�kgr͑0.32g( t4lޘ߄ }�n4lޘ߄�[��:n21mg) �vo��qw[z3202066486901527000071 ��ς8n����|0���v0gr � �b���[8n����v0gr ��b���[gr�kgr͑0.35g �vo��qw[z2003311886905547000387 �vo��qw[z2202478286903503001867 �vo��qw[z2000320686903784000160�kgr0.27g �vo��qw[z2001302886900858000101&�106 ��b��8n )r�������|����v0gr �)r�������| �vo��qw[z2000311786900026000391�sn�n�����|�k��ň12g s�nns^y6ro� gp�lq�s �vo��qw[z1098011886900051000083 �no�8n����|0���v0gr ��no����v�k�| t�nstp[2u }11.25mg �v�]�yck6ro� gp�#��nlq�s �vo��qw[z1098301386902155000082�no�gr�wgr͑0.27g( t�nstp[o�2u7.5mg) ^��eeuo�nɩ�v gp�lq�s �vo��qw[z2002576686905078000047yn��ep���v�gr �yn��epgr�kgr͑0.26g nnfo�n gp�lq�s �vo��qw[z2002308086905957000335yn��n�p��k���|����v0gr �yn��n�p��k���v �vo��qw[z2005439486905381000079yn��n�p��k���| �k��ň6g��e�|�w � ���[ns�m,g�n no� gp�lq�s �vo��qw[z20013203869012140003155���n�����|��>��^���v1.4.3.3 n��ƀn�pbr��ƀ�l��8n����|0���v0gr ���ƀ�l�����v�k�|ň0.25kq �v�]w�e�o�n gp�lq�s �vo��qw[z200536908690223900006986906951000017��ƀ�l��8n �vo��qw[z1202052886900962000080��ƀ�l��gr �vo��qw[z1202023986900963000829 5�hğ���|��s g�m �5�hğ���| �vo��qw[z20030028869040120013795�hğ�s g�m�k/eň10ml( tğ����0.4g)6/�v �vo��qw[z110206078690014200009110/�v&�119 �5�hğ�l\�m �vo��qw[z1302077286902729001149 kq�[9n�kq�[9n���v �kq�[9n���v�k�|͑0.3g �vo��qw[z109400068690487500004512�| �s�����^���v�gr ��s�����^���v ��[fqtq6ro� gp�lq�s �vo��qw[z2002665486902532000087�w�vi����|�gr ��w�vi�gr�kgr t�w�vi�r^xm��0.32g u��[o�n6ro��y�b gp�lq�s �vo��qw[z6202069486905855000376 'yğ)rƀ���v�gr �'yğ)rƀ���v r�wmtto�n gp�lq�s �vo��qw[z2002560986905937000058 s_ޘ)r���[���v�gr �s_ޘ)r���[���v �v�]�'y�^o�n���n gp�lq�s �vo��qw[z5102008586902190000252���l����vr�wmvf�sυo�ؚ�e�b/g�nn���n gp�lq�s �vo��qw[z2002514386905935000166bh��g��ugrёğ)rƀ���v�ğ���|&�128 ��ğ�l\�m 8^�q��aq n6ro� gp�lq�s �vo��qw[z1096000486901363000167)rƀgr�ƀ���v�gr ��ƀgr �kgr�vs_�n�so�pg1.15g u��il�so�n gp�lq�s �vo��qw[z6102016886902374000962\?q��à�^���| _l��t�oo�n gp�lq�s �vo��qw[z2000310886905414000076\?q�l�\p���| �vo��qw[z19991035yn���[���|�gr �5�h��nӂ8n5����� y���|5�hğ���v�gr �����[�l\�m��qh�v��8n1.4.3.4 n)r��àn�pbr y�eğޏ }gr �kgr t�vx�\�j�x30mg100gr/ �vo��qw[z5102042786902153000411 �vo��qw[z5102021286902303001497 ��ޏ8n����v0gr �͂ӂbk�l�s g�m?q�l\p���| �g����à�^���|����v0gr ��g����à�^���v�k�|ň0.37g �vo��qw[z1098006086905755000254�g����à�^���| �vo��qw[z109100558690575800118086905758001159�g����à�^gr�kgr͑0.24g �vo��qw[z2000340486905758001166[�9h��ޏ8n����|0���v0gr0�s g�m �[�9h��ޏgr u��)rt�s�n-no� gp�lq�s �vo��qw[z6102134086902397000840mqst��ޏ���v�sӂbk�l�s g�m��ޏs�n8n�gr ���ޏs�n8n �vo��qw[z1202000186900960001492�k�tň5g �vo��qw[z1202046486900962001421�l\p���v1.5 )n̑br 1.5.1 )n-nce�[br 1.5.1.1 )n-nce�[brd�p[t-n8n�gr �d�p[t-ngr �vo��qw[z1202062386900962000639d�p[t-n8n\�8n �k1008n͑20kq450 �vo��qw[z2005543686902816000642 �vo��qw[z1202005286900855001330 �vo��qw[z1202070086900960000259t-n8n �vo��qw[z4402307886900256000239?q�l�^4��� y�eà�u���vbhd�t-n8nğ���^-n8n&�147 �t-ngro�d�8n )nà����|����v0gr �)nà�gr�kgr͑0.55g�����c�gr � _l��]gyo�n gp�lq�s �vo��qw[z2006033386905272000188 b��8l�^6ro� gp�lq�s �vo��qw[z2008067786902076000413)nà����v t��ns�m^y�o�n gp�lq�s �vo��qw[z3402028886904398000096)nà����| �vo��qw[z3402073386904398000119ln�h8n\?qy��l4� \�^-n���|����v0gr �\�^-n���v 5��]*y�t6ro� gp�lq�s �vo��qw[z1096004686905528000023 z��[à�u���|����v �z��[à�u���| �vo��qw[z2102151886901214000087 1.5.1.2 )n-nd�nbr��x{qà8n����|0���v0gr ���x{qà8n �vo��qw[z5102051886902153000893 �vo��qw[z1202045786900962001117 u����ʃo�nɩ�v gp�lq�s �vo��qw[z6102057686902440000315 ��x{qà8n(sm)8n)�k8n͑0.2g(�k88n�vs_�n�so�pg3g) �2008n/�t200 ]n��x���n gp�lq�s �vo��qw[z2003306186905015000338��x{qà���| �vo��qw[z2004311986900200000261��x{qàgr �vo��qw[z2002552186905590000174 �nws'yu< il�e6ro� gp�lq�s �vo��qw[z2002552286905642000206��xt-n8n ��xs^à8n�ce0���| ���xs^à���| ff-no��s gp�lq�s �vo��qw[z5302087586905615001049��xs^à8n ng�e�s;so�ɩ�v gp�lq�s �vo��qw[z4202138586901912001225 �vo��qw[z1202063586900962001728 1.5.2 �v3�qe�br�sd��l\�m p��n�~�n n;sb�%`qe�t�bqe ŗ�[ n]no�n gp�lq�s �vo��qw[z5102066486902312000276�v�dl 1.6 s�u0bk�t0s^�ubr 1.6.1 )ns�[�ubr��[t��8n����|0���v0gr ���[t��8n�k1008n͑10g ��k��ň7g �vo��qw[z5102039786902153001197 �vo��qw[z1202009186900960000839�k1008n͑10g ��k�tň708n10�t/�v �vo��qw[z1202063386900962001179 �vo��qw[z1202005386900855000555 �vo��qw[z2102175386901174000639��[t�����| �vo��qw[z4202012386901874000281��[t�����v24�|/�vq\nf�n�y^t��6ro����n gp�lq�s �vo��qw[z1096008786903965000606��[t��gr�kgr͑0.3kq _l�o���jh6ro� gp�lq�s �vo��qw[z2002704086905379001637�nws}vo�ɩ�v=n_lo�n gp�lq�s �vo��qw[z2002704486905630000539 �vo��qw[z2002704386900963000201�nh�8n�k�tň9g �vo��qw[z1202050286900962001704 xj�~�u�tnq������|0�m �xj�~�u�t���| ў��_lwnm�no�n gp�lq�s �vo��qw[z2005527286903767000057�v�]�_܏ v�[o�n gp�#��nlq�s �vo��qw[z2005400086902295000034xj�~�u�t�m ^ns�]-no��s6ro� gp�lq�s �vo��qw[z4402218086900293000155 (�e��|�w)�k�tň10ml86900293000124xj�~�u�tnq���k�tň200g �vo��qw[z4402217886900293000131&�163 ���[t���s g�m \r������|����v �\r������| �k��ň6g(�e��|) �vo��qw[z1202002886900932000140ogςbk�t�|fm����|0�s g�m �ogςbk�t�|fm�k�tň240ml fkilёt�o�n gp�lq�s �vo��qw[z4202052586901948000094ogςbk�t���| �l3�^y��o�n gp�lq�s �vo��qw[z2005339086901314000017�k��ň12kq �vo��qw[z4202060886901945000875g��t�[�|fm����|0���v0�s g�m �g��t�[���v �vo��qw[z1096002586902041000073 1.6.2 t��bk�tbr[y�ubk�t���| �k��ň3g(�e��|) �vo��qw[z4402014386900415000872  g�|�w��k��ň6g86900415000858 džƀh��vce����v0gr �džƀh��v���v�k�| tdžƀal49mg,h��v(��)295mg �vo��qw[z3602058986905363001209džƀ�]��m �vo��qw[z4502024286905156000495 �m�t�u���|����v0gr ��m�t�u���v �vo��qw[z2005336286902076000352 �vo��qw[z2003319186903355000124�m�t�ugr �vo��qw[z2302136286903696000388}v~v�b�u���|ё^������v�gr �ё^���gr �vo��qw[z3202085586901622000686�kgr͑0.33g ў��_l�^���eo�n gp�lq�s �vo��qw[z2302003886903744000353kq�t���v�gr �kq�t���v 5��]�vpo6ro����n gp�lq�s �vo��qw[z5202023986905549000132)r��gr �vo��qw[z2001318586905957000564 q\��_cqxo�n gp�lq�s �vo��qw[z1402016986902877000285[rğdžƀ�]�ce����v0gr0�n8n0�m �[rğdžƀ�]����v!niuhuang shedan chuanbei jiaonang �k�|ň0.25g(\�| � t���n��6ro� gp�lq�s �vo��qw[z2002713186904389000432 �k�|ň0.25g(\�|)ns�m n]n�ğ�w �o�n gp�lq�s �vo��qw[z2002713486901916000828[rğdžƀ�]��m _l�ws fqhwm6ro��s �vo��qw[z1088000686905328001022[rğdžƀ�]��n8n�k8n͑35mg �vo��qw[z1098004086900074000091n�[bk�t���| �vo��qw[z1999006686901493001133[y�uup�s g�m&�169 �[y�ubk�t���v&�170 �džƀh��v�s g�m _l�~v^y f��o�n gp�lq�s �vo��qw[z1090000386905267000025 �vo��qw[z3602196886905300000685džƀh��v�m͑�^[���uiro�n���n gp�lq�s �vo��qw[z199831408690102700012010�kgs fkilepl'yo�o�n gp�lq�s �vo��qw[z1090000486901944000258&�171 � džƀ�]�ce����v �džƀ�]����vvnsz�nuiro�n���n gp�lq�s �vo��qw[z4202010986901873000275džƀ�]��gwg���k�tň345g �vo��qw[z4402331686900411000272 vnws�egl6ro����n gp�lq�s �vo��qw[z4302007186904990000692ςğbk�t���v �vo��qw[z2010307586900237000128�u�t�qce�gr ��u�t�qce�k�vň6g(�k1g t�tau�v100mg) ^�]�|ns6ro� gp�lq�s �vo��qw[z4402265786900426000205&�172 ��m�t�u�|fm �vo��qw[z2302160786903714000338 �vo��qw[z1202045886900962000998�[��bk�utbrbk�t8n�gr � �l�t�]��gwg2���n8n ��l�t�]��gwg�n8n�k8n͑30mg)y%m-n�eo�nɩ�v���n gp�lq�s,{mq-no��s �vo��qw[z2001012886900961000043�l�t�]��gwg2��k�tň150ml �vo��qw[z4402239386900411000142�l}v�|fm�k�tň10�kgs �vo��qw[z1202024686900963000362�t�\p���vm�6��t8n �vo��qw[z1202077386900855000920\?qbk�t�|fm �vo��qw[z1202035886900900000165ğ���t�u���v 1.6.3 n�ps�ubr%`/e���| xj�~8n����|0���v0gr �xj�~8n�k1008n͑10g �7.2g/�� �vo��qw[z5302128986905615000547 �vo��qw[z1402162886902901000830�k45�|͑9g �vo��qw[z1302124086902816001243 �to�ɩ�vnnx6ro��s �vo��qw[z2302035186903709001685 �vo��qw[z1202040586900960000433 �k1008n͑10kq �vo��qw[z2202013486903503000143xj�~���v50�|/�v �vo��qw[z2001000586902190000382xj�~gr ͑�^��vlbr e�-n�vl8n����| �e�-n�vl8n �vo��qw[z1402159086902901000090 �k88n�vs_�n�suo�3kq �vo��qw[z3602176586905379001217�k1008n͑20g ��k�tň90g4508n �vo��qw[z2005546686902816000604 �k88n�vs_�n�suo�3g �vo��qw[z4302014386905015000284 �vo��qw[z1202059886900962000509 �vo��qw[z1202000686900960000310e�-n�vl���| s�nilxq6ro� gp�lq�s �vo��qw[z2004012086900042000023 �sӂ}v/g8n�ce0���| ��sӂ}v/gce �vo��qw[z2005389186900983000359�sӂ}v/g8n5��/�v �vo��qw[z120203528< 6900962000516�sӂ}v/g���| �nws~�o�6ro����n gp�lq�s �vo��qw[z5302028086905693000347&�244 � e�-n�vltbr�gr0�s g�m �&�245 � �sӂ}v/g���v�gr ��sӂ}v/g���v �vo��qw[z2008342186905843001255�s��asnst���|0asnst�s�����v�gr � p�v`'`��$v>es�ug��@�a�chno n ��hvp��zasnst�s�����v�k�|͑0.33g 'yޏil�eo�n gp�lq�s �vo��qw[z1098010786901108000025�s��asnst���| _l�q\ؚ6ro� gp�lq�s �vo��qw[z1098000286905344000061asnst�s��grgr�_͑0.3g �vo��qw[z1090002986903502000021 :r�n�r���|����v0gr �&�247 �:r�n�r�l\�m �vo��qw[z2302078086903784000207 ў��_llnς̑_l6ro� gp�lq�s �vo��qw[z2302321586903793000519 �vo��qw[z2302116286903793000106�k�tň250ml �vo��qw[z2302321686903793000526ğ�����|�gr �ğ�����| 5��]il�eo�n gp�lq�s �vo��qw[z1999325486905463000362 �k��ň4g��e�|�w � �vo��qw[z2000338086902120000277 �vo��qw[z1999338186902120000260�vtp[8n����| ��n�s��s�v��gr�n�s��s;`�v��gr�kgr͑0.11g  t�gw�b~g6ro����n gp�lq�s �vo��qw[z2002664186903409000124 1.9.1.2 ep>��tàbr��xmqt8n �vo��qw[z1202045686900962001018 vns)y#wn'y6ro� gp�lq�s �vo��qw[z4202069586901843000168�[à�u���v �k�|ň0.2gğn�{|stir �`�]^]n�`6ro����n gp�lq�s �vo��qw[z1097005986900435000012 �k�| tğn�{|stir0.2g �e�uhq�[o�n gp�lq�s �vo��qw[z1095006286905988000038e�>��v��8n?q>������|�k��ň2.5g 5��]�mu6ro� gp�lq�s �vo��qw[z2002562786905443000078ep?q�mߘ�s g�m �vo��qw[z1302095586902778000155�v��_ɩ�vym_l�nn6ro� gp�lq�s �vo��qw[z3402077286904531000174 ep>�u@����|�gr �ep>�8nep>�bk�l�[���|mqtp[8n�ks͑9kq �vo��qw[z2202478486903503001171/t>�8n��s g�m �/t>�8n �vo��qw[z1202040386900960001102�n�sep>�8n�gr ��n�sep>�8n300 �vo��qw[z2005546186902816002967�k108n͑2g �vo��qw[z1202061386900962001148 �vo��qw[z1202010886900960001461�n�sep>�gr �vo��qw[z2006372886902685000194à y%f���v�gr �à y%fgr80 �vo��qw[z2004000386904481001719150&�250 ���xmqtgr��>�{q?q���| �vo��qw[z2002541586905478000098{qà���|�gr �{qà���| �k��ň5g(*g�m�r��|) �vo��qw[z3302017486904762000127 {qà����|����v �{qà����v �vo��qw[z3402073486904398000126{qà����| �vo��qw[z3402028986904398000133 y�e4s4y���| �vo��qw[z3302072086904579000877&�k��ň5g(�e��|, tkx�|ݔ0.5g,!k]xx�˔0.2g, nexx�a�0.25g)  nwmn�^yr6ro� gp�lq�s �vo��qw[z2006326386900760000237���ltbr �vo��qw[z2002741986901027000014up�����v�k�|ň0.27g �vo��qw[z5202004486905521000150 �vo��qw[z5002055986901055000178�n�uup���v �vo��qw[z2006377686900958000087�z�^gr�k }gr͑0.2g ^�]�^�to�n gp�lq�s �vo��qw[z4402133086900401000107\?qà�[8n�l�hr^snbr u��wm)y6ro� gp�lq�s �vo��qw[b2002106486902371000064 1.9.2 {q@�brr_>�8n�tbr �r_>�8n �vo��qw[z4102223086903082000480 �vo��qw[z3602173186905379001002 �vo��qw[z2004411986902374001174 �vo��qw[z4102189786903082000862�k�t120g �vo��qw[z4302083386904971000840 kq�s8n����|0���v0gr �kq�s���|�k��ň3.5g �vo��qw[z5102227086902154000014 �vo��qw[z2008330786902154000656s_r_e�@�8n����|0���v0�s g�m �s_r_e�@��s g�mѐ�]^os�t6ro��s �vo��qw[z1097000186903266000084s_r_e�@�8n6g �vo��qw[z22025016869035030015220w�igs}vgr y�e?���fmp�-n͑�^ �@� q\nn?�?������n gp�lq�s �vo��qw[z3702137186904080000434 �k�tň250�kgs086904080000281.&�265 � r_>����|����v0gr �gs@�\g���v u��ݐvq�q6ro����n gp�lq�s �vo��qw[z2002502986902375000084u@��[gr fkilt�to�n gp�#��nlq�s �vo��qw[z2003008886901953000164 �vir������|0���v0gr ��virtbr  t�l�[(�v�])o�n gp�lq�s �vo��qw[z5102202586902096000103 �vo��qw[z5102226786902273000063�vir���| �vo��qw[z2002001686902096000042� �{q�_8n�k108n͑1g ��k�tň3208n �vo��qw[z1202058986900962000844�~@��[���| �k��ň8g��e�|�w � _lς�o��6ro� gp�lq�s �vo��qw[z3202040786901455000129\?qu@��|fm{q@�n��s g�m �vo��qw[z2202122686903355000889{q4�u@�tbr�k�tň50ml �vo��qw[z1999108186900051000090 �vl�~@����|����v0gr ��vl�~@����| ^n�~�szto�n gp�lq�s �vo��qw[z1095003486900287000024 �q �u@����v�gr ��q �u@�gr�kgr͑0.38g���n�����nno�n gp�#��nlq�s �vo��qw[z2202585686903510000372u@�8nbcim�k�n͑5g �vo��qw[z1088000586900960001324%f@��[���v �vo��qw[z1202021186900865000132 1.9.3 �n4�br 1.9.3.1 �ne���4�brmqst0wğ8n �vo��qw[z1202045186900962000066�k88n͑1.44kq��k88n�vs_�nn�gr3kq �  t�gё�[o�n���n gp�lq�s �vo��qw[z2202180686903379000346480 �vo��qw[z1202005086900855000937�k30�|͑6g �vo��qw[z1202059286900960000167270 �vo��qw[z1302105686902816000925�k88n͑1.4g(�k88n�vs_�n�so�pg3g) �2008n/�t �vo��qw[z2005505386900374000814 �k88n�vs_�n�so�pg3kq �vo��qw[z4102212886903082000756�k�t60g �vo��qw[z4402320586900374001071 �vo��qw[z1302045886902571000093 �vo��qw[z1202008586900960000181 �vo��qw[z2005442986900896000330�k88n͑1.6g(�vs_�n�so�pg3g � �vo��qw[z2005554886900888000324�w�g0wğ8n �vo��qw[z1202061786900962001063 �vo��qw[z4102190486903082001227 �vo��qw[z3602177986905379002634 �vo��qw[z1202058286900960001508e����v�8n��ʉ�v�����| �q���spq*yo�n gp�#��nlq�s �vo��qw[z2003009986903907000107'ye�4�8n �vo��qw[z3302013786904481001313&�280 � mqst0wğ���|����v0gr �mqst0wğ���v �vo��qw[z2004311486900200000285 �vo��qw[z1999329586900200000506 �vo��qw[z2005504786905521000167 �vo��qw[z5202006286905551000021 _lςޘl�o�n gp�lq�s �vo��qw[z2005465886901614000069mqst0wğgr �vo��qw[z1202031286900963000850�kgr͑0.64g �vo��qw[z2004441386900958000124 ��st< 0wğ8n����v0gr ���st0wğ8n �vo��qw[z1202070286900960001355 vnsl�^6ro� gp�lq�s �vo��qw[z4202143786901833000659&�281 � �w�g0wğ���|����v0gr ��]r_8nr_��0wğ8n �vo��qw[z1202004486900855001064 1.9.3.2 �ne��_��br ~vt�vё8n����|0gr �e���;m@����v ^n��aq no�n gp�lq�s �vo��qw[z2003006386900365000373�~8h8nu��vbcko�n�y�b���n gp�lq�s �vo��qw[z6202063786905856000375 �k208n͑3.5kq �vo��qw[z2002518786905880001386 �n�_4����|����v0�s g�m ��n�_4����v �vo��qw[z1998001086905363000813�n�_4����| �vo��qw[z1998010286905363000752�n�_4��s g�m vns�y�nё��o�n gp�lq�s �vo��qw[z1091005986901796000079 1.9.3.3 �ne�����br ^gʃ0wğ8n����v0gr �^gʃ0wğ8n �vo��qw[z3602178186905379002085 �vo��qw[z1302231886902816002707120g/�t �vo��qw[z4302084486904971000468 �vo��qw[z2102207786901174000967 �vo��qw[z1202012386900960001300 �vo��qw[z4302014986905015001472 �vo��qw[z1202004886900855000579^gʃ0wğ���v�k�|ň0.3kq80�|/�v �vo��qw[z2202446386903380000113 �vo��qw[z2006407586900888000348�n�8n �k10�|͑1.7g �vo��qw[z1202053686900962000431 ba��{q4����v�gr �ba��{q4����v �vo��qw[z2202114486903373000922)wuf�[���|�gr �)wuf�[gr�kgr͑0.38g(�vs_�n�so�pg6g) �vo��qw[z4502060586905244000802yn��{q4�;m@����|zf^g���|1.9.3.4{q4�n�p0�tàbr�m4n�^���|dh u��1rlo�n���n gp�lq�s �vo��qw[z2002004586902427000062 4�z�à�u���|����v0gr � 1.9.4 )n3�brnmu��l8n�gr �ё.s��l8n�gr �ё.s��l8n �vo��qw[z5302129386905615000479 �k1008n͑20g �vo��qw[z2006302186902816001014 �vo��qw[z1202060586900962000301 �vo��qw[z2102148686901174000417 �vo��qw[z1202004686900855001132 �vo��qw[z1202010286900960000440�v^y8n�gr ��v^y8n �vo��qw[z1302115986902816002325�v^ygr �vo��qw[z1202026986900963000492 �vo��qw[z2006342186901323000800 �vo��qw[z1202045586900962000745bhd�0wğ8n����|0���v0gr �bhd�0wğ���v�k�|ň0.34g 5��]r`8�o�n gp�#��nlq�s �vo��qw[z2003318686905466000154bhd�0wğ8n �vo��qw[z4302014486905015000772 �k88n�vs_�nn�gr3kq �vo��qw[z2202180586903379000162�sr_8n����v ��sr_���v �vo��qw[z2003013486905381000291�sd�:_�_8n �vo��qw[z1089001886900960000297�v���mr�br �vo��qw[z1202032386900855000418:_��grp� n�~;sb�o(ugr��͑0.30g���[}y�b�xo�n(ɩ�v) gp�#��nlq�s �vo��qw[z2102174986901210000135�kgr͑0.63g �vo��qw[z2102175086901210000210�xcq:_�����| 1.9.5 4�3��se�br y�e��ʉ�vzf���v �_�#k8n����v0gr ��_�#k���v �vo��qw[z2002586686905957000311 1.9.6 l@��se�br e����v�8n����v0gr �e����v����v �vo��qw[z2001017086905535000696 �vo��qw[z1998312086900436000080 �vo��qw[z2202306786903391000461 �vo��qw[z2001017186902532000094e����v�8n �vo��qw[z2002576486903820000482)r��^���v����gs}v���v :_��8n����|0���v0gr �:_�����|�q���s�^i`�o�n gp�lq�s#w��rlq�s �vo��qw[z2005005086903919000027:_�����v �w�[�^n�eo�n gp�lq�s �vo��qw[z1098001286902732000023�n�sr_>�8n �vo��qw[z2202344386903391001437180 �vo��qw[z1202061286900962001049 �vo��qw[z1202005186900855000609�n�s{qc�8n �vo��qw[z2302170486903830000922 {q�_�[�`���|����v ��~��sgrp�mq�u�r��no n 1.9.7 �vl{q4�br�m4n8n�k108n͑2.5g( tuso;`�v��100mg(�vs_�n>uso;`�v��cq35mg)20�|/�v �vo��qw[z1091005186902019000067 y�e9n�s���|����v0gr0�n8n �de y�e9n�sgr �k�wgr͑0.25g60gr/q\nns�o6ro�ɩ�v���n gp�lq�s �vo��qw[z2009303286904100001199���[}y�b�xo�n(ɩ�v � gp�#��nlq�s �vo��qw[z2005419286901181000103 �vo��qw[z4402337286900374001569 �vo��qw[z3302015086904481001160�kgr͑0.28kq �vo��qw[z3402007886904296000143 y�e9n�s�n8n�k8n27mg1808n �vo��qw[z1095011186900941000087 y�e9n�s���| �vo��qw[z1094000186901463000791�heqe�_8n�k�|͑40mg150�|/�v �vo��qw[z1202002586900961000067��9n�l\�m �vo��qw[z2003328286903793000144 �vo��qw[z2004374186902210002112 �vo��qw[z5102130986902210001115 �vo��qw[z4202039286901842000466 �vo��qw[z4202039186901842000459 �vo��qw[z3302005486904762000257 @��^�v8n����v0gr �@��^�v8n �vo��qw[z1302106086902816001366�k678n�~͑1g(�k��ň4g) �vo��qw[z2005535286903709001920 �k8n͑0.2g ��k��ň6g �vo��qw[z2005485586902816003094@��^�v���v �vo��qw[z12020223869008650003859nno����v�v�s�q�_�[gr&�386 � y�e9n�s8n�q ��[���v�gr ��q ��[gr s�n�_,gxo�n gp�lq�s �vo��qw[z2005306686900167000243 �vo��qw[z2202234986903373001103 �s t�o�n gp�lq�s �vo��qw[z2005512186903563000060 �vo��qw[z2004316786902397000833�k�wgr͑0.4g �vo��qw[z2005511186901314000161�q�_9n�s���|����v0gr0�n8n ��q�_9n�s�n8n�k�|͑0.04g-n�s�[nɩ�vn�o�n gp�lq�s �vo��qw[z2001003786903847000052�q�_9n�s���v �vo��qw[z1999001786903310000640 �vo��qw[z1097006086900430000338 u��id��_6ro� gp�lq�s �vo��qw[z1098016186902402000155�q�_�����v �vo��qw[z2002005586902537000211ğhg�[gr�kgr t�s�~ğhgfd0.5mg �lws����o�n gp�lq�s �vo��qw[z4102185186903051000169 _\}v�n6ro� gp�lq�s �vo��qw[z4102013086903131000119 ws�n\%�o�nɩ�v gp�lq�s �vo��qw[z3202080386901596000033 pn �8n����|0���v0gr �pn ����| �vo��qw[z5102229286902129000056)r��_���v�gr �)r��_���v �vo��qw[z2202245686903357000429 ��_u8n����|0���v0gr ���_ugr�kgr͑0.28g ^�]���l6ro� gp�lq�s �vo��qw[z4402267586900402000441 �vo��qw[z2006355086902767000104 ��_u8n(sm)8n � �vo��qw[z2006002386904912000403&�385 ���㄂v���s g6rbr0wey�_@��^o����v�k�|ň0.35g( t>uso;`�v��100mg) �vo��qw[z2005061686902019000043��㄂v��grdioscornin tabletsn�v�y�b���n gp�lq�s��[6ro��s �vo��qw[h2000374386902341000186 �_�s�8n����|0���v0gr ��_�s����vq\n�lns;so��y�b���n gp�lq�s �vo��qw[z3702006086904181000982 ͑�^ ^\�[o�n gp�lq�s �vo��qw[z1999300286901061001220�_�s�gr �vo��qw[z3702004286904181000913�_�s����| �k��ň3g(*g�m�r��|)�v�]�y^t�_6ro� gp�lq�s(�yxbu�nlq�s��v�]�^�yego�n gp�lq�s) �vo��qw[z2008061186902181000384�_��[���v&�389 �@��^�v���|��s g�m0o����v �@��^�v���| �vo��qw[z2005001986903919000041@��^�v�s g�m �vo��qw[z1095006386903357000856��9n�_��o����v �vo��qw[z2002714486905437000923�_�y�grgr��͑0.4g �vo��qw[z1202053286900962001339 �l3�n�eo�n gp�lq�s �vo��qw[z2102135986901283001206qe�_8n �kas�|͑0.25g �[�_nswo�vo����n gp�lq�s �vo��qw[z3402106986904301000762�����_�pn���v'y*h�~of)y�l\�m�k/e5ml �s�s#wo�n gp�lq�s �vo��qw[z2006036186903585000062�_�t�����v;m�_8n�k }8n͑20mg �vo��qw[z4402341886900381000838��_� ����v 1.12.3 {q@�;m@�br9n�s�l\�mp��_�@��{�u�s\og ��n�~�n n;sb� �vo��qw[z51021303 p��_�@��{�u�s\og86902210000224 �vo��qw[z3202016286901478000106 �vo��qw[z3302017786904762000172 �l\(u9n�s(�qr^ ��k/eň400mg �vo��qw[z1097009386903714001175&�402 �9n�stbr����|0���v0gr0�n8n0�s g�m �9n�s���v0.28g/�|��shr�~薗g6ro� gp�#��nlq�s �vo��qw[z20050720869056230000109n�s��_���v �lws���nx6ro� gp�lq�s �vo��qw[z1098312286903022000273 vnwsw�v%fxo�n gp�lq�s �vo��qw[z43020399869049680003419n�~�l\�m q\n9n�~6ro� gp�lq�s �vo��qw[z200268668690396200016686903962000173&�390 �9nn���v�gr �9nngr�kgr͑0.34g �vo��qw[z4402240586900381000425 �vo��qw[z1202018186900946000662 vbcksv���v�gr �vbcksv���v �vo��qw[z2002007386900690000475 �vo��qw[z2002007486900690000468  y�e�]�����v�gr � y�e�]�����v q\n�q�q6ro����n gp�lq�s �vo��qw[z2000003586904085000460 �s9n���|����v0gr ��s9n���v �vo��qw[z1098011386900402000380��9n�_�l�n8n �k108n͑0.35g 5��]tknx6ro� gp�lq�s �vo��qw[z2002568786905481000054n�|�s�k50�|͑3g ��k��ň1.5g �vo��qw[z1202056986900962001483 1.12.4 )n3�;m@�br�sbh���v��ȃ:_�_���v �vo��qw[z2004014186902767000074 1.12.5 �n4�;m@�br ��~�[�l\�m �vo��qw[z3202110286901529000574&�411 �  ��~�[���|��s g�m � ��~�[�s g�m �vo��qw[z2002335586901529001533 �^x ����|����v0gr ��^x �gr�k }gr͑0.35g� tr^xm��0.35g � _lς�^3�iqo�n gp�lq�s �vo��qw[z3202053586901469000078 1.12.6 e���;m@�br9n��cwgrğ9hgrp��w���wcq�����v�k�|ň0.6kq �vo��qw[z2000002286903050000474�_�[8n�_�s�[���v �vo��qw[z5102005286902082000100ў��_llnς̑_l6ro� gp�lq�s�t\�nrlq�s �vo��qw[z2302115186903795000678 �vo��qw[z22020876869034< 22000156 �vo��qw[z1998302486900858000446 )y%mu�v��15mg0 �vo��qw[z2202196586903356000246�_���gr�wgr͑0.26g��kgr tkt>u�v��15mg^� �vo��qw[z2002631986903356000222�kgr͑0.26g(�kgr tkt>u�vu15mg) �vo��qw[z2001000886900662000342���v�_ ��n8n�v� ����v �vo��qw[z2000013886903704000256@��_�q�l\�m �vo��qw[z2004003386900864000218�t���v�l\�m�����bh���v�@�hgr �vo��qw[z120201738690094600024286900946000143�nh���v q\�-n܏zo�n gp�lq�s �vo��qw[z1096006386902972000029[�n���~���v �vo��qw[z2006043986904296000129op�v�� }�n8n�k8n͑22mg ws f_�vo�n gp�lq�s �vo��qw[z2008007686905400000219����l\�m 1.12.9 ;m@��mevbr֜2unq8n50g/�t �vo��qw[z4202077286901986000186 'yğňk�8n����v0gr �'yğňk����v  t�gwep�no�n gp�#��nlq�s �vo��qw[z1999006486903426000596'yğ��k����v _lς��wmo�n gp�#��nlq�s �vo��qw[z2005402686901516000273'yğňk�8n3g/�� �vo��qw[z4302039786904968000068 �vo��qw[z1202028486900960000341 y�e֜2uo���gr�q���s�y^t;s�u�y�b���n gp�lq�s �vo��qw[z1999101186903894000043 ;m@�� ����v�gr �;m@�� ����v q\��n-n6ro� gp�#��nlq�s �vo��qw[z1088000486902969000179;m@�� �gr �nws�~�to�n���n gp�lq�s �vo��qw[z5302113486905698000632 �kgr͑0.5g(����c�) �vo��qw[z2202015686903503000358 m3�z��ro�n gp�lq�s �vo��qw[z4102110986903154000530�h����v�@��^8n����|0���v0gr0�n8n0�s g�m ��@��^�n8n �vo��qw[z1098003986900074000084�@��^���v �k�|�q�[ir͑0.15g q\n f�y6ro� gp�lq�s �vo��qw[z1096000986904178000049�mv�^���v�gr � 1.12.10 [yvs�ubr9n��gr�k�wgr͑0.3g �vo��qw[z2005024486903386000902�n}v�s�|fm �vo��qw[z2004008886905535000757 ����q �8n����v �����q ����v 5��]܏ z6ro� gp�#��nlq�s �vo��qw[z5202040686905555000072 �vo��qw[z2202012186903503000884 �vo��qw[z1202006486900858000477 ��['yu6ro�ɩ�v gp�lq�s �vo��qw[z6102000786902467000183����q �8n t�gw�szseyo�n���n gp�lq�s �vo��qw[z2004394086903450000463 �vo��qw[z22021104869033190016241.13 tlbr 1.13.1 �u�����br9nh �e�8n �e�8n����| � �e�8n �vo��qw[z5102043786902153001166 �vo��qw[z1302116486902816001472 �k88n�vs_�n�so�pg3g q\n�n�lo�n gp�lq�s �vo��qw[z3702106586904183000690 �vo��qw[z3202001686901591000380 �vo��qw[z6102057886902440000162 �e����|�k��ň15kq �vo��qw[z2000339386905379001804 �vo��qw[z2000332086900067000039 �vo��qw[z2005422386902295000058�g����8n�k8n͑10g �vo��qw[z2302163486903830001509&�15 ��gğ���|g3�8n����v �g3����v�k�|ň0.42g s�n�r6q6ro� gp�lq�s �vo��qw[z2000009086900036000039&�465 � 9nh �e����v�gr � �~�� �e����|����v0gr ��rst �e�8n����|0���v0gr ��rst �e�8n �vo��qw[z1202052686900962000196 �vo��qw[z1302013086902667000044 *h2mcsёo�n���n gp�lq�s �vo��qw[z4302094086905046000383]nst���l���v vnws�^\so6ro� gp�lq�s �vo��qw[z2002517386904889000413s^����~8n���������v ���8n�ce0���|0gr ����gr b��ʃpn6ro� gp�lq�s �vo��qw[z1999321186902040000210 �vo��qw[z1202076986900963000300< ���8n �vo��qw[z2202343186903391000966 �vo��qw[z1202011286900960001393&�162 ��v�ce&�466 � �e����v�gr �yn���vl������|����8n�l�����8n�gr ��l�����gr �vo��qw[z2006368786900887000035�l�����8n �vo��qw[z1202009886900960000358����l8nas��bk�u8n �vo��qw[z1202011086900960001584#w�~�i��c�sirgr #w�%�~�i��c�sirgr!extract of st.john's wort tablets�o�l300mg/gr-�_�vz�s��wzs�xo��s�dr. willmar schwabe gmbh & co. kg � z2009000586979356000029k��� }gr�kgr0.1mg( tk��� }b0.06mg) �vo��qw[z3702157686903944000177 �vo��qw[z1202012886900951000190 1.13.2 �u���tàbr l�nà�u���|����v0gr �l�nà�u���| �k��ň2.5g��e�|�w � �vo��qw[z2102152286901214000254 n]nà�l���|�k��ň20g �vo��qw[z4402070586900474000011 �k��ň2.5g��e�| �86900474000066àς���|3��/�v �vo��qw[z1093000286901747000226 àς���|(�e�|�w) �vo��qw[z1095000786901747000158 àς���|��e�|�w �cq�bk�u���|����v0gr0�n8n �cq�bk�ugr �vo��qw[z120200208690094600033450gr/ �vo��qw[z4102197786903082001234cq�bk�u�n8n50mg/8n1808n/�vu��g�^yb�so�n���n gp�lq�s �vo��qw[z20010024869058650000521208n/�v3608n/�v\�ôà�u���|1000gr/ �vo��qw[z6102163886902503000795 y�eh���àgr �vo��qw[z2004900186900374001545 _l�,gwo�n gp�#��nlq�s �vo��qw[z3602036086905270000456 �vo��qw[z3602068886905363002305  y�e0unà�u���v�gr � y�e0unà�u���v�k�|ň0.5g(�vs_�n�so�pg0.73g) �vo��qw[z4502061186905244000994 �����^���|����v0gr ��rst�]ё8n�k1008n͑6kq ��k��ň6kq �vo��qw[z2009330786905379002825epà�m�p���| �k��͑5g(�e�|�w) �vo��qw[z3202049686901493000303 epàa�u���|����v0gr �epàa�u���| vnwsxnŗ6ro� gp�lq�s �vo��qw[z1096001886904987000131epàa�ugr �vo��qw[z1999407686901583000497f���à�^��8n�k�|ň80�kkq �vo��qw[z1097006786900941000124�_àgr�kgr͑0.7g �vo��qw[z3702109986904034000138idw9n�k55�|͑�~9g �550�|/�t ����idw9no�n���n gp�lq�s �vo��qw[z1302132486902591001117 (g��z�l8n����| �(g��z�l8n �k50�|͑3g ��k��ň6g �vo��qw[z6102057486902440000285�k50�|͑3g q\nt[#wx6ro� gp�lq�s �vo��qw[z1999336386904118000184&�478 � n]nà�l���v���epà8n �vo��qw[z1302133386902591000721���bk�u8nà���[8n �k48n͑0.08g �vo��qw[z1088001086900962000806à�^���v �vo��qw[z2102121486901314000093�k�|ň0.3g(�vs_�n�suo�0.5g) �l3�n)yuir6ro� gp�lq�s �vo��qw[z2102190786901337000049 �nws�ocqxo�n gp�#��nlq�s �vo��qw[z5302162486905633000048 à�^up8n����|0���v0gr �à�^up���v �vo��qw[z2302165786903747000787 �vo��qw[z2202010786903503000631 �vo��qw[z2000331286904579000396 �vo��qw[z2006354086900858000255à�r�^���| �vo��qw[z1999000786902122000244à�u�[gr�kgr͑0.25kq �vo��qw[z4102012986903050000375à�u�[gr b�_�e1rl6ro� gp�lq�s �vo��qw[z1302160186902572000405 }gr͑0.25gvnws�_�^6ro����n gp�lq�s��sxb�e�vnws)ynmi�x6ro� gp�lq�s � �vo��qw[z2005435786904912000441��x�g/g8n�k�tň10g �vo��qw[z120206368690096200090586900962001735\?q��xj8n&�480 �cq�bk�u�s g�m�g/g8n����| ��g/g�[-n���v �vo��qw[z2002000386902907000391-n�nr�m8n �]ё8n����v0gr �}������v �k�| t��ƀ���80mg �vo��qw[z2003010186902533001267�à9n1.14 �m�[br �o�t8n����|0gr ��o�t8n~v�uuz(�l�])o�n gp�lq�s �vo��qw[z1302175886902661000057 �vo��qw[z1402158986902901000052 �vo��qw[z2005520786902816000260�o�t8n�sm)8n � �vo��qw[z4202011186901874000069�o�tgr �vo��qw[z4402118486900347000063�o�t���|�k��ň4.5g �vo��qw[z3402007186904296000037�i�i�v�m8n�gr ��i�i�v�m8n �vo��qw[z1202012486900960000150 �vo��qw[z1202046186900962000042�i�i�v�mgr �vo��qw[z12020250�%�p�?q�z86900963000027�l��s�n8ns�y�s g�m _��z�l8n����v �_��z�l8n �vo��qw[z6102057286902440000063 �vo��qw[z1202069186900962000288(g���i�i8n �vo��qw[z2302164086903830000830�v�xdl�s g�m �vo��qw[z2002504486904925001039�sl�od�8n�k1208n͑0.3g ��k/e608n �vo��qw[z3202064586901622001751�m�ym}v8n \?qsߘ8n��s g�m �\?qnf6��s g�m \?q�mߘ���|�gr � n{cё[c:cebr]����v �n{cё fkil���[6ro� gp�lq�s �vo��qw[z4202198286901928000342�k��ň1.2g�����o�t8n �vo��qw[z1202045986900962001285�g�[�[�n8n �vo��qw[z2202016986903389000565epà�[��8n �vo��qw[z1202052786900962000295ep���m�[���| �vo��qw[z1202035686900900000080tz?qep>��s g�m �vo��qw[z2006439986901945000165�mߘ��p�|fm �vo��qw[z1090001686900855000180\?q�v�u8n���z����|1.15 �lθbr 1.15.1 �uceyθbr �]��6��8n�ce0���|0gr ��]��6�����| �k��ň4g(�e��|�w) �vo��qw[z2005485386902295000171�k��ň7.8kq �vo��qw[z2202473386903503000433�]��6��ce �vo��qw[z1302158686902572000351&�522 ��]��6���s g�m ���ho����v��n8n ����h�n8n�k8n͑30�kkq �vo��qw[z2000000786900067000121���ho����v�k�|ň0.54kq �vo��qw[z2005518586901007000461;m�~8n�yr_;m�~�s g�m [yθbk�u8n����v0gr �[yθbk�u���v �vo��qw[z1097003886902537000150[yθbk�ugr �[�_wꖫgo�n gp�lq�s �vo��qw[z3402042186904341000593�uθ;m�~8n�gr ��uθ;m�~gr�kgr0.3g,�vs_�n�suo�0.76g �vo��qw[z4302006286904937000082�)y�s g�m �vo��qw[z10980058869009730005814yθ�u8n����v �4yθ�u���v �vo��qw[z2003013186902281001052g���[���v �vo��qw[z1092003786903546000155��#k�n8n�k8n͑42mg �vo��qw[z2005004186900961000104mq�~4y�ugr �vo��qw[z1202025586900963000836 1.15.2 s^���qθbr [rğm��s8n����v0gr �[rğm��s8n�k8n͑1.6g �vo��qw[z1202010386900960001065 �k208n͑1.3g �vo��qw[z1202058186900960001683[rğm��s���v �vo��qw[z1302233286902661000361 �vo��qw[z12< 02040186900960000938[rğm��sgr �vo��qw[z2002000486903709000367~g��@� ��^���v �vo��qw[z10960023869020410000359n�s4y�u���v �t�[gr �vo��qw[z4202153886901986000254[rğ�b��8n :_�r�[)w���v�gr �:_�r�[)wgr �vo��qw[z6102013986902374000887n��m��s���v s�n*m)y�ro�n gp�lq�s �vo��qw[z2009371286907600000013 n�m��s���|����v0gr �n�m��s���| �vo��qw[z1097000486901427000751n�m��sgr �vo��qw[z4302040686904968000228hq)y�����v�gr �hq)y�����v5��]�vn���e6ro����n gp�lq�s �vo��qw[z5202042586905523000295 �vo��qw[z5202006386905551000069)yʃ��[���v)y����䅗��|�m)wbkufgr�kgr͑0.35g(�vs_�n�suo�1g) ͑�^ilns6ro� gp�lq�s �vo��qw[z2002002786900984000419�sʃm��sgr  y�e ��kgr͑0.26g �vo��qw[z1402077286902959001155%�kgr͑0.25g( t�vx��spn�[0.03mg,"l/l{v�u5mg,��n20mg) ��aq no�n gp�lq�s �vo��qw[z2005333386901539000878�x��sq�����v���m��s8n �k10�|͑2.2g �vo��qw[z1202053386900962000813m��s�θgr �vo��qw[z1202075986900963000676��҉�l\�m�k/e2ml �vo��qw[z1502080186903881000018&�544.3 ���҉���|\?q�b�u���v �vo��qw[z1098004886900865000415 1.15.3 s^��\o3�br�[�[m��s8n  y�ew^�����|�gr � y�ew^�����| �vo��qw[z2004429986900294000543 �vo��qw[z2004452986903503001775 y�ew^��gr`! compound kendir leaves tablets `!kw^���s218.5g,αʃ��171.0g,2��]184.2g, nexx�a�15.0g,kxx��s��h\�u1.6g,"l/l{v�u1.6g,�vx�_n�u1.05g,/l.lss1.0g,�~u }b10.5g,�~u }b60.5g,�lx���0.25g �vo��qw[h1402293786902959000264 ��zn8n����v0gr ���zn8n �k108n͑1.1g �vo��qw[z2202077786903319001761 �vo��qw[z1202062986900962000769��zn���v �vo��qw[z1999329686900200000049 �vo��qw[z2202557386903594001326s^)w���v q\�~6�m��s���v�gr �q\�~6�m��s���v �vo��qw[z2008019786901307001175�w��n@����| �vo��qw[z1999007286903339000065)yzf���| 1.15.4 s�u�qθbrjsy)y��8nkv�u�^���vkv�us^grsθ9n)yğ4s�gcep�\?q�s�p�`θ 1.15.5 sv[yθbrck)y8n����v �ck)y���v �vo��qw[z2001014286900474000103ck)y8n �vo��qw[z44020711869004740000429n�����| y�ey)y�egr0.32g/gr �vo��qw[z2000310586905363001988 :_�r)y��\g�n8n����v �:_�r)y��\g�n���v u��}v�n6ro� gp�lq�s �vo��qw[z6102153986902354000494 5��] n�r6ro� gp�#��nlq�s �vo��qw[z5202000786905506000052 �vo��qw[z2102121186901314000116)y�� }�l\�mgastrodin injection �vo��qw[h2006307086904373000790 �vo��qw[h2005830986905783000165)y)wn �vo��qw[h2001304686905614000548 �vo��qw[h2005931186902463000323 �vo��qw[h2005931286902463000767 5ml�500mg �vo��qw[h2006439286900978004638 �vo��qw[h2005813886900239000553�l\(u)y�� }gastrodin for injection oneg �vo��qw[h2005016286905822000224)y����v�gr �)y����v �vo��qw[z10950004869014630004704y�u�[���v �vo��qw[z2002685186902537000303���u�[���v �lseyfɩ�vo�n gp�lq�s �vo��qw[z1302149686902743000418 1.15.6 {q@�[yθbr {q@�n�8n����| �{q@�n����| �vo��qw[z1096008286900941000032{q@�n�8n �vo��qw[z2006380886900941000025{q@�c�k{8n 1.15.7 [yθ��~brnswo�q �8n8g y�e �vo��qw[z4402074886900412000172�n�s�q �8n �vo��qw[z2202541186903463000658 �vo��qw[z2004393186903450000371'y;m�~8n����v �'y;m�~8n�k8n͑3.5g �vo��qw[z1202062086900960000402 �vo��qw[z5002002786900994000942 �vo��qw[z4202082186901986001534'y;m�~���v �vo��qw[z1999004486905379001378�nasst�l��8n�������vceθ;m�~8n�k1008n͑15g ��k��ň158n �[3�_o�n gp�#��nlq�s �vo��qw[z4102231986902995000723����wml���θ��)y�t��θ�� )y��8n����v0gr �)y��8n �vo��qw[z1202004786900855000494��~_�ugr }gr͑0.3g12gr/�v �ls��~o�n gp�lq�s �vo��qw[z1999006186902666000151\;m�~8n�gr �\;m�~8n �vo��qw[z1202011886900960001348�q �8n-nθ�v�n����|0���v0gr �vy^����o�&�580 �vy^��gr�y�v�\^q\wmsqo�n gp�#��nlq�s �vo��qw[z2002301886902718000085vy^���l\�m �vo��qw[z14020999869029820011151.16 [ynbr 1.16.1 ce�[d�nbr ��θ���8n����v0gr ���θ���8n�k108n͑1kq ��k��ň6g0 �l3��~o�6ro����n gp�lq�s �vo��qw[z2102137586901343000781 �k108n͑1g ��k��ň6g �vo��qw[z4402271186900398000623 θn���u���|����v0gr �θn���u���v �vo��qw[z3402002586904312000621θn[y�u���v �vo��qw[z2002012986903560000483 d�bh���u���|����v0gr �d�bh���u���v0.33g/�| �vo��qw[z1999107886902395000293d�bh���u���| �k��ň5g�*g�m�r��| �5��]sq�_tq�[���go�n gp�lq�s �vo��qw[z2000002086905454000043nns�_�n��[x^�y6ro� gp�lq�s �vo��qw[z1999105086902349000287 y�eꖲ����vsq��bk�u��aj����br7�10�ss|n?�?���?�ns;s�uhv�h gp�lq�so�nrlq�s �vo��qw[z37021436869039450000227cm�10cm �vo��qw[z4102030286903050000689�[n�u���|�gr �ёln������v �vo��qw[z2004362186905523000103wnmq\θn��o�(g�t8n�gr �(g�t8n�k108n͑1.8g �308n/�� �vo��qw[z2202109886903319001617  t�g�vo�6ro� gp�#��nlq�s �vo��qw[z2202229386903371001303n�k{��gr�wgr͑0.28g �sn�o�n���n gp�lq�s �vo��qw[z2002518386903576000101fk�r�b�[ce 1.16.2 n�pd�nbr�n�y8n �vo��qw[z1202062286900962001711 vnws)ynmi�x6ro� gp�lq�s �vo��qw[z2005351286904934000054 n�p�u���|����v0gr �n�p�ugr �vo��qw[z2004406386901089000106�v�y8n �k15�|͑1g �6kq/�� �vo��qw[z2202496086903503000259�uθ�[���v�gr ��uθ�[���v �vo��qw[z1097002586902082000148 1.16.3 [yθd�nbr��lq��s g6rbr��lq�gr �kgr t��lq�2u }12ugns�m n]n(ğ�w)o�n gp�lq�s �vo��qw[z4202153486901916001030 5��]il�eo�np�lq�s �vo��qw[z5202036986905463000324 �vo��qw[z3102041586900662000656 �[�_�eg�wmo�n gp�lq�s �vo��qw[z3402104886904359000479θnl���gr  y�eθn�[���|����v0gr �sq��kq�u8n ў�����θ;m�~���v n��rce����v0gr �< n��rce���v�k�|0.3g �nws�n�lo�n���n gp�lq�s �vo��qw[z5302080886905726000603�rst)y�����vё�������v�gr �������θ���uθ�[�u8n of�_q\�vo��uq\ � gp�lq�s �vo��qw[z1302135186902786000888 �vo��qw[z1302205486902561000096��~��(��[��cknθ�u�[���v�gr0ʑgr �cknθ�u�[ʑgr �kgr t�vx�r�䅱x60mg �vo��qw[z2001017486905000000756cknθ�u�[gr �kgr t�vx�r�䅱x20mg �vo��qw[z4302027886905000000985�kgr͑0.16g� t�vx�r�䅱x20mg � �vo��qw[z2006400186904929000359&�608 �cknθ�u�[�l\�m �vo��qw[z4302027986905000000749θn�[�ugr �vo��qw[z1202002286900946000648h�ph8n �k10�|͑1.6g240 �vo��qw[z1202057286900962001520h�~{8n�gr0�m �h���gr �vo��qw[z1202027786900963000447h����m �vo��qw[z1202030386900963000423p��ugr �vo��qw[z1202019286900946000112 y�e^x�����v 1.16.4 sv[ynbr ���p�vst���v�gr �ȏknupgr�l�h�yp[�c�sirgr �l�h�yp[�c�sirgr z2013000286979356000043ȏknupgr260mg��kgr tl�h�c�sir150mg ��_�ves�u@�a�chno n�smq�u�r��no n�k/eň10ml��vs_�n�so�pg20g � �vo��qw[z1302099986902729000517�k/eň10ml(�vs_�n�so�pg20g) �vo��qw[z2302078286903783000123 �vo��qw[z3302017986904762000295ep>��v�����| ep>��v�����|(�e��|�w) �vo��qw[z2002330686900026000339ё y�^�s g�mp���lv  t�gё y�^o�n gp�lq�s �vo��qw[z1999104386905380000759�^~��l\�m �}vq\6ro����n gp�lq�s �vo��qw[z2002686886903291000301�^�r#k���v���e�����v�gr �p�v`'`��$v>es�u@�a�chno n���e�����v�k�|0.35g �vo��qw[z4602007686905792000156 �vo��qw[z6102128986902510000214 �vo��qw[z5302022786905701000024���e��gr �kgr t���e���|0.2g �vo��qw[z5302022686905701000031 u@��[tbr����| �{qck�m�y���v �vo��qw[z2004009586902767000685�v@�u���v�%�p�v`'`��$v>es�u@�a�chno n �vo��qw[z19983056p�@�a�chno n86900437000010 ���vbck���|����v0gr ����vbck���v�k6�|�vs_�n�suo�12.5g �vo��qw[z6202041486905856000948 u���epqo�o�n gp�lq�s �vo��qw[z6202098786905863000610�k�|ň0.35g(�vs_�n�so�pg3.125g) �vo��qw[z2001324486905547000240���vbck���| �vo��qw[z6202041586905856001020 t�gveno�nɩ�v�^ t���n gp�lq�s �vo��qw[z2202396686903358000329 �vo��qw[z1402088386902877000384 �vo��qw[z1402099886902982001221 �vo��qw[z2005339886903594000404*sӂy�|�l\�m p�v`'`��$vmq�u�r��no nu}v�s g�mu}vtbr vns�h3�o�n���n gp�lq�s �vo��qw[z2011300586909538000035 �vo��qw[z201130068690953800002886909538000011�n��̃���vp�mq�u�r�����x�sv`'`��$v>es�u@�a�ch�^ n�k�|ň0.32g _lς^ynso�n gp�lq�s �vo��qw[z32021221p�mq�u�r�����x�sv`'`��$v>es�u@�a�chno n86901477000145 �vo��qw[z2102048486901323000428zs\�[���v p�v`'`��$v�`�s�ug��o(u�k�|ň0.15g �vo��qw[z2005445986902732000054�sn���vp���lv0��lv�`�s�ug��o(u�k�| t�n�s�v��rg3 10mg  t�g�n�l6ro����n gp�lq�s �vo��qw[z2003004486903490000249�v��ns���k�tň120g �vo��qw[z1095007386< 900960001836#k�r�^���|4 �y�y(uo�4.1 t@�br 4.1.1 tl{q@�br�y�yasstgr �vo��qw[z4202004186901874001011 e�@��v�k8n����| � �y�y��~���|����v0gr ��y�y��~���|�k��ň14kq �vo��qw[z2002667786901912002055 �ysy�u�~8n����| ��~����|����v ��~����| �vo��qw[z2002010286900026000360n6r��d�8n �vo��qw[z120206308690096200163686900962000776�n�rus���v �vo��qw[z1095004386903729000163 4.1.2 ;m@�svbr�v�ki�� t���v�ki� �������|0���v0gr ��v�ki����|20��/'y�� �vo��qw[z5102197086902154000083 �k��ň5g(�e�|�w � �vo��qw[z200031788690530000043216��/�v�v�ki����v �l3�8l'y6ro� gp�lq�s �vo��qw[z1095006786901338000048�v�ki�gr �kgr t�vx�4lς�x15mg �vo��qw[z2005458886905719000337���v�ki����v ym_l'y�_o�nɩ�v gp�lq�s �vo��qw[z2008005286904616000341�v�ki����k�tň125g �vo��qw[z5202045386905437000176�k�t͑250g �vo��qw[z42020130869018740002679n���y�^nq���k�tň150g �vo��qw[z2002525386905583000198 9nğ[yv���v�gr �9nğ[yv���v �vo��qw[z2002601086903389000237�_u8n�_ugr �vo��qw[z1202030786900963000614 ��~;m@����v�gr ���~;m@�grgr��͑0.34g �vo��qw[z4302087486904937000068  y�e�v�k���|����v0gr � y�e�v�k���v q\n��[ep�^6ro� gp�lq�s �vo��qw[z2003000686904186000062 bh�g/�ӂ8n����v0gr �bh�g/�ӂ���v �vo��qw[z1095000586901463000975bh�g/�ӂ8n�k108n͑2.2g,68n/�� �vo��qw[z2002756386902982000569�k108n͑2.2g �68n/�� �vo��qw[z1402148486902941000746126 �vo��qw[z2002756286902039001396dw y�^���v�gr �dw y�^���v �vo��qw[z2002583486902425000187dw�[�s g�m c� f6ro�(�mzs � gp�lq�s �vo��qw[z2014300486904134000991ce�~g��u���v �vo��qw[z2003012786901463001347 \y��v8n����|0���v �\y��v���|�k��ň1.6g �vo��qw[z2004431486900016000288 �vo��qw[z2000004186903357000771\y��v���v0.45g/�| n?��ono�n gp�lq�s �vo��qw[z2000008586903946000014us8n �\�~���|����v0gr ��\�~���vwmwszs'y6ro��s �vo��qw[z20025985869057640000920un�u�~���v �vo��qw[z2004357486903310000206 �vo��qw[z4402381386900435000203�ny�o�nɩ�v�s�nuir6ro� gp�lq�s �vo��qw[z2004416186905699000112�u�~�[���|�eus���|�gr ��eus���|�k��ň6g(�vs_�n�so�pg9g) �vo��qw[z4402095686900381001538�k��ň6g,�vs_�n�so�pg9g �vo��qw[z5202037286905463000126�k��ň9g(�vs_�n�so�pg18g) �vo��qw[z199831698690253200006386902532000056 �vo��qw[z1402044486902986000244 y�e�v�ki����k�tň100g �vo��qw[z1202005686900896000255 �vo��qw[z1202066886900888000263 4.1.3 bk@�br�[�[bk@����| �vo��qw[z2001011286904080000083f��[bk@����| �vo��qw[z2010305986979304000033������v�gr � y�e'y�~��bk@�gr4.2 n�pbr 4.2.1 �q go� �y�ycsё���v�gr ��y�ycsё���v �vo��qw[z2002002486905046000086�y�ycsёgr144 �vo��qw[z4302002786905046000192�[@��[���v�k�|ň0.13g �vo��qw[z2002008786905629000410}v&^8n �ypn���|����v0gr ��ypn���| �vo��qw[z3202022386901463000777�y�ps^���v �vo��qw[z4402119086900347000308�y�p����v�gr ��y�p����v hg�qn�y����h6ro� gp�lq�s �vo��qw[z2002572786902545000326�y�p�m���v �vo��qw[z2002533386905438000243�[�ps^���v�gr ��[�ps^gr �vo��qw[z2001322186900312000920�v�~8n ���~���|����v0gr �ёr�8n��|fm0���|0���v0gr �ёr����v �vo��qw[z1999103186901797000085ёr�gr �vo��qw[z2003003286902168000017ёr��|fm �vo��qw[z4202039686901797000092 �vo��qw[z4202004086901874001264 ё!����|����v0gr ��^�y�p���v0.4g/�| q\nek�^y�]6ro� gp�lq�s �vo��qw[z2005563486904158000014 �b�[�p���|����v0gr ��b�[�pgr0.25g/gr �vo��qw[z3602109886905300001002 �vo��qw[z3602056686905363002718 �v�p�q���|����v0gr ��v�p�q���v�k�|ň0.55g �v�]ёo�^6ro� gp�lq�s �vo��qw[z2013304686904626000331 �vo��qw[z2006024086902354000104�v�p�q���| �vo��qw[z2001312486905589000413 4.2.2 y(uo��o�y�^h�k�|͑1.74g wmws�x�qo�n gp�lq�s �vo��qw[z4602005886905763000086 y�e�l�h}|�lh2.7g/�| �vo��qw[z1999107686902371000057�[���p�^h�k�|͑1.2g ^��^nso�n gp�#��nlq�s �vo��qw[z2001006586905115000108�^�y�m�ph�k�|͑2.8gu���o�nɩ�v� o%f � gp�lq�s �vo��qw[z2302214386903814000085��so���3g//e  nwm�[��o�n gp�lq�s �vo��qw[z2003011586900632000341�l�|�^h�k�|͑3g �vo��qw[z2202559986903560000698�y�_�^�l�lbr��^�q��br5g/�t q\n�g3�6ro� gp�lq�s �vo��qw[z1999003086904068000029u�mbr mg�]f�yro�n gp�lq�s �vo��qw[z1999000186904518000098150ml/�t�k�tň80ml869045180001044.3 vbckbr~�d��f�[8n �vo��qw[z1202009786900960000013 kq�s�v�k8n����v0gr �kq�s�v�k8n �vo��qw[z1302072786902816000185kq�s�v�k���v36�|/ �vo��qw[z1998000986905328000025 �vo��qw[z1202039786900960000037�ft^�[gr �vo��qw[z2007329386905328000667 �vo��qw[z2001313086900962000189  y�e ��kgr͑0.3g �n�[o�n*y�s6ro� gp�lq�s �vo��qw[z1402192686902987000229 �k }gr͑0.28g �vo��qw[z3602130886905300001156 ln!�}v�q8n����v0gr �ln!�}v�q8n �vo��qw[z3602177486905379000395 �vo��qw[z4302104986905015001182 �vo��qw[z1202049786900960000822 �vo��qw[z3302004086904481000934 �vo��qw[z1202001086900960001560 �vo��qw[z1202004386900855000357ln!�}v�qgr �vo��qw[z1998005786900962000974�[dw���| ��[ꁛr-no�ɩ�v gp�lq�s �vo��qw[z6102119486902536000021�[dw^���8n�n y�^���|�[dw9n&�835 ��ft^�[8n����v �dw�l���v �vo��qw[z2000008386905421000250 syё8n����v0gr �syёgr �vo��qw[z1202076086900963000126sy�s���|csёbk&^8n&�836 � ln!�}v�q���|��s g�m �u[�^���|�n����΀8n�o΀8n �vo��qw[z1202000886900960000136)n�~8n 4.4 �m��ce�~br snvv�m���|����v0gr �snvv�m���v60�|/�v �vo��qw[z1097011< 586900365001790snvv�mgr�kgr͑0.67g �vo��qw[z2000325886901343001023 �vo��qw[z2102074786901343000842 �[$v�[���|����v0gr ��[$v�[���v �vo��qw[z2005022486903405000173 �vo��qw[z2008029886902354000623�k�|ň0.30g54�|/ �vo��qw[z2006041386905853000422 �[$vn���|����v0gr ��[$vn���v �vo��qw[z1098003286902082000056�[$v�m���v �vo��qw[z2005563586904158000052 sn8hce�~���v�gr � sn�^8n����|0���v0gr �sn�^gr �vo��qw[z2000322786902329000764 snww�m8n����|0���v0gr �snww�m���v �vo��qw[z1097006286902329000757snww�m���| �vo��qw[z1097011386900200000063snww�mgr �vo��qw[z6102118486902329000771�n�[s-n'y�s�n �6ro� gp�lq�s �vo��qw[z1102027186900223000101�n�[s-n'y(s�n)6ro� gp�lq�ssn�[8n����| � snvvce�~���|����v0gr �snvvce�~���v�k�|ň0.53g �vo��qw[z2001001086902353000341sn�x�[���v�gr �sn�x�[���v �vo��qw[z1095001186904288001547�msnce�~���v �vo��qw[z2005563686904158000021 �\�sn�^���v�gr ��\�sn�^���v 10�|/g,3g/�v�nws��wm)y6q iiro�n gp�lq�s �vo��qw[z2002537986905704000144 bk�usev���|����v0gr �bk�usev���v �vo��qw[z2202084586903379000537ce�~snvv4���ce�~snvv���k4�͑7g ў��_ld��6ro� gp�#��nlq�s �vo��qw[z20040073869037340000115 t\o�n gp�#��nlq�s �vo��qw[z6502016686906004000032�[�uvy^���| �vo��qw[z2005393286905996000198�~��n��as nst8n tey�[dw8n �vo��qw[z1502177886903931000425m}v8n����v �m}v���v �vo��qw[z1095004086905894000313 �[yy�~o�n gp�lq�s �vo��qw[z1097001586905908000100m}v8n�k48n͑0.8g �vo��qw[z2000325286905851000158�k8n͑0.8g �vo��qw[z6302007786905934000211ama8n mqst�[�mce����v0gr �mqst�[�m���v �vo��qw[z1095004786905547000073 �vo��qw[z1095002786905381000208mqst�[�mce �vo��qw[z1502179686903931000401 �vo��qw[z6302005286905934000235 mqst���m8n����v �mqst���m���v �υυo�ɩ�v���n gp�lq�s �vo��qw[z1098009086905735000076�f�[nst8n�ce ��f�[nstce �vo��qw[z1502023386903891001913 ��ꏷ^���|����v0gr ���ꏷ^���v �vo��qw[z1098002086905746000027 nst�~���k܀8n�ce � r�o�o����r�o���br �r�o�o����k��ň100gr�wmw�)y�lυo�6ro� gp�#��nlq�s �vo��qw[z6302028686905948000078�k��ň50g86905948000030�k��ň30g86905948000092 �vo��qw[z5402014086905742000069�k/eň35g86905742000168na]nst8n n�pkqst8n�ce0���v � n�_�l��kqst8n�ce �n�_�l��kqst8n7.5g/�t ��e��o� gp�#��nlq�s �vo��qw[z2102027586901173000401�nr���ɉ����v ��nr���ɉ �vo��qw[z6302006386905934000570 �k8n͑1g-1.5g �vo��qw[z5402005586905752000530�nr���ɉ���v �vo��qw[z2005017786905851000196��;��nst8n�ya�s�[8n�k8n͑0.5g �vo��qw[z6302006486905934000723asst�������v �vo��qw[z2002004786905746000010 asst��ƀ�����|����v �asst��ƀ�����v �vo��qw[z2001004686905735000069asst��ƀ�����| �vo��qw[z1098009186905735000090 �w�iepà8n�ce0���v0gr � ��nς�m_l���v�gr ���nς�m_l���v �vo��qw[z2005317486901946000805 �vo��qw[z6502017386906004000162y(u�n�uce�k�tň0.5g �vo��qw[z1502045886903909001799�nst����8n0.3g/108n �vo��qw[z2000305586905908000209�^�o�v���m �vo��qw[z6502001286905996000112�m�u4����k4�ň1.2g �90mm*120mm/4� �vo��qw[z5402011386905742000038�k4�ň1g �70mm*95mm/4�86905742000045 �q\ёwilbk�u�m��br�k�tň20�kgs �υ�^��o�n gp�lq�s �vo��qw[z2001009586905741000022�k�tň45�kgs86905741000015�p�m�z?q�|fm {q�_���t�os|�kq��� �v�_�]�6q t^�n���| �vo��qw[z6502017686906004000186nb�qas nst8n �vo��qw[z1502119186903891001883�s�[8n �vo��qw[z1502161586903931001194 �vo��qw[z1502041086903909000877zfxbm}v8n�k108n͑14g �vo��qw[z5402005386905752000516vyas(g���| �k��ň6g��e��| � �vo��qw[z2005421386905996000136 �vo��qw[z6502017986906004000094pw�s��� �vo��qw[z6302006886905934000648 �vo��qw[z6302029286905934000662 �vo��qw[z5402005886905752000189�~���ya8n�qƀ���)rƀ���v� �8 qro-q<��"����v���" j�)�g� �d@ ��'��=��;�����*d0-bl'�f, ��(k��9��%�\g�{��j4r�wn�p��� u�� ���� ��(b �bz�e ~���13�\������k �)@ d�%`y�{��������� ��[��b 8��th&o`�� 0�#�����d��wx6��r��p�����n��^ ��y r�9 ��<#w;�p���} ��g��$q� c��� �6 .s  q �ջ � � ��� f� �� ��" > !'x �u ��� d ԭ \ v� � � q� v$ umc l^d �| f�� "c� �� `>� ��� �� � #o1 1 �h ��_ ��w �z� ���  �� ��� � ' ` k� ��4 ��k v` ��v ?ٍ 6v� ��� ��� � � !�� � � ��� ��%_a!�y)i-��at��% ~��=/�����9;�i��d���p�����t����ak��ol��1q_��$�|��i,ك��-ɂ��3�����0�w�-';��y {� ?� .!��!��!3"ۇ"q�"�1#�#��#�0$��$��$2%!�%��%33&щ&��&�5'}�'��'a5(�(��(�2)��)��)y8*ñ*��*�b � �� wc, �,m�,i-��-��-�m.�.}�.im/3�/��/�o0��0/�0gr1��1�1�q2ר2��21n3ۢ3��3�m4�4��4�s53�5�6�x6i�6[7[\7o�7; 8^8ѳ8�9�^9u�99 :s^:m�:q ;gc;�;i<�h<i�<=i=ͼ=>�o>��>-? r?��?�"@�v@�@_"a�za��a{'b#|b�be)c]}c��c�-d�d��de4e#�es�eq6f�f�f�@g��g�g�dh՝hi�h�li}�i��iwnjg�ja�jurk��k��ktlөl��l�xm-�m= ncne�n�o�ho��o�ptp�p%q�|q�q'.rc�r �r�5s��s �sc=t�t��tq;u9�u��u�8v9�vm�v�5wu�wi�w2x��x��x�.y�yw�y7)z�|z7�z([�x[;�[�!\qv\��\�]�p]��]�^  d����mbp?_* ��%����&ffffff�?'ffffff�?(�?)�?�" dxx333333�?333333�?�&� u} ��} 7�} ��} 7�} ��} ��} ��} ��} � �} ��} ��} � �} q�} ��} ��} � �} � �} � �} ��} [ �} \� �} �� ����v���j���j���j���j���j���j���j������ ���� ���� ���� ���� ���������������������������������������������������������������������������������������������������������������������������������������������������      !"#$%&'()* ,-./0123456789:;<=>?@abcdefghijklmnopqrstuvwxyz[\]^_`abcdefghijklmnopqrstuvwxyz{|}~��������������������������������������������������������������������������������������������������������������������������������                           ! " # $ % & ' ( ) * , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ a b c d e f g h i j k l m n o p q r s t u v w x y z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~  � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � �                           ! " # $ % & ' ( ) * , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ a b c d e f g h i j k l m n o p q r s t u v w x y z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~  � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � �                           ! " # $ % & ' ( ) * , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ a b c d e f g h i j k l m n o p q r s t u v w x y z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~  � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � �                           ! " # $ % & ' ( ) * , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ a b c d e f g h i j k l m n o p q r s t u v w x y z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~  � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � �                           ! " # $ % & ' ( ) * , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ a b c d e f g h i j k l m n o p q r s t u v w x y z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~  � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � �       !"#$%&'()* ,-./0123456789:;<=>?@abcdefghijklmnopqrstuvwxyz[\]^_`abcdefghijklmnopqrstuvwxyz{|}~��������������������������������������������������������������������������������������������������������������������������������      !"#$%&'()* ,-./0123456789:;<=>?@abcdefghijklmnopqrstuvwxyz[\]^_`abcdefghijklmnopqrstuvwxyz{|}~��������������������������������������������������������������������������������������������������������������������������������      !"#$%&'()* ,-./0123456789:;<=>?@abcdefghijklmnopqrstuvwxyz[\]^_`abcdefghijklmnopqrstuvwxyz{|}~��������������������������������������������������������������������������������������������������������������������������������      !"#$%&'()* ,-./0123456789:;<=>?@abcdefghijklmnopqrstuvwxyz[\]^_`abcdefghijklmnopqrstuvwxyz{|}~��������������������������������������������������������������������������������������������������������������������������������      !"#$%&'()* ,-./0123456789:;<=>?@abcdefghijklmnopqrstuvwxyz[\]^_`abcdefghijklmnopqrstuvwxyz{|}~��������������������������������������������������������������������������������������������������������������������������������      !"#$%&'()* ,-./0123456789:;<=>?@abcdefghijklmnopqrstuvwxyz[\]^_`abcdefghijklmnopqrstuvwxyz{|}~��������������������������������������������������������������������������������������������������������������������������������      !"#$%&'()* ,-./0123456789:;<=>?@abcdefghijklmnopqrstuvwxyz[\]^_`abcdefghijklmnopqrstuvwxyz{|}~��������������������������������������������������������������������������������������������������������������������������������      !"#$%&'()* ,-./0123456789:;<=>?@abcdefghijklmnopqrstuvwxyz[\]^_`abcdefghijklmnopqrstuvwxyz{|}~��������������������������������������������������������������������������������������������������������������������������������      !"#$%&'()* ,-./0123456789:;<=>?@abcdefghijklmnopqrstuvwxyz[\]^_`abcdefghijklmnopqrstuvwxyz{|}~��������������������������������������������������������������������������������������������������������������������������������      !"#$%&'()* ,-./0123456789:;<=>?@abcdefghijklmnopqrstuvwxyz[\]^_`abcdefghijklmnopqrstuvwxyz{|}~��������������������������������������������������������������������������������������������������������������������������������      !"#$%&'()* ,-./0123456789:;<=>?@abcdefghijklmnopqrstuvwxyz[\]^_`abcdefghijklmnopqrstuvwxyz{|}~��������������������������������������������������������������������������������������������������������������������������������      !"#$%&'()* ,-./0123456789:;<=>?@abcdefghijklmnopqrstuvwxyz[\]^_`abcdefghijklmnopqrstuvwxyz{|}~��������������������������������������������������������������������������������������������������������������������������������      !"#$%&'()* ,-./0123456789:;<=>?@abcdefghijklmnopqrstuvwxyz[\]^_`abcdefghijklmnopqrstuvwxyz{|}~��������������������������������������������������������������������������������������������������������������������������������      !"#$%&'()* ,-./0123456789:;<=>?@abcdefghijklmnopqrstuvwxyz[\]^_`abcdefghijklmnopqrstuvwxyz{|}~��������������������������������������������������������������������������������������������������������������������������������      !"#$%&'()* ,-./0123456789:;<=>?@abcdefghijklmnopqrstuvwxyz[\]^_`abcdefghijklmnopqrstuvwxyz{|}~��������������������������������������������������������������������������������������������������������������������������������      !"#$%&'()* ,-./0123456789:;<=>?@abcdefghijklmnopqrstuvwxyz[\]^_`abcdefghijklmnopqrstuvwxyz{|}~��������������������������������������������������������������������������������������������������������������������������������      !"#$%&'()* ,-./0123456789:;<=>?@abcdefghijklmnopqrstuvwxyz[\]^_`abcdefghijklmnopqrstuvwxyz{|}~��������������������������������������������������������������������������������������������������������������������������������      !"#$%&'()* ,-./0123456789:;<=>?@abcdefghijklmnopqrstuvwxyz[\]^_`abcdefghijklmnopqrstuvwxyz{|}~��������������������������������������������������������������������������������������������������������������������������������                           ! " # $ % & ' ( ) * , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ a b c d e f g h i j k l m n o p q r s t u v w x y z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~  � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � !!!!!!!!! ! ! ! ! !!!!!!!!!!!!!!!!!!! !!!"!#!$!%!&!'!(!)!*! !,!-!.!/!0!1!2!3!4!5!6!7!8!9!:!;!!?!@!a!b!c!d!e!f!g!h!i!j!k!l!m!n!o!p!q!r!s!t!u!v!w!x!y!z![!\!]!^!_!`!a!b!c!d!e!f!g!h!i!j!k!l!m!n!o!p!q!r!s!t!u!v!w!x!y!z!{!|!}!~!!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!�!""""""""" " " " " """"""""""""""""""" "!"""#"$"%"&"'"(")"*" ","-"."/"0"1"2"3"4"5"6"7"8"9":";"<"=">"?"@"a"b"c"d"e"f"g"h"i"j"k"l"m"n"o"p"q"r"s"t"u"v"w"x"y"z"["\"]"^"_"`"a"b"c"d"e"f"g"h"i"j"k"l"m"n"o"p"q"r"s"t"u"v"w"x"y"z"{"|"}"~""�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"�"######### # # # # ################### #!#"###$#%#&#'#(#)#*# #,#-#.#/#0#1#2#3#4#5#6#7#8#9#:#;#<#=#>#?#@#a#b#c#d#e#f#g#h#i#j#k#l#m#n#o#p#q#r#s#t#u#v#w#x#y#z#[#\#]#^#_#`#a#b#c#d#e#f#g#h#i#j#k#l#m#n#o#p#q#r#s#t#u#v#w#x#y#z#{#|#}#~##�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#�#$$$$$$$$$ $ $ $ $ $$$$$$$$$$$$$$$$$$$ $!$"$#$$$%$&$'$($)$*$ $,$-$.$/$0$1$2$3$4$5$6$7$8$9$:$;$<$=$>$?$@$a$b$c$d$e$f$g$h$i$j$k$l$m$n$o$p$q$r$s$t$u$v$w$x$y$z$[$\$]$^$_$`$a$b$c$d$e$f$g$h$i$j$k$l$m$n$o$p$q$r$s$t$u$v$w$x$y$z${$|$}$~$$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$�$%%%%%%%%% % % % % %%%%%%%%%%%%%%%%%%% %!%"%#%$%%%&%'%(%)%*% %,%-%.%/%0%1%2%3%4%5%6%7%8%9%:%;%<%=%>%?%@%a%b%c%d%e%f%g%h%i%j%k%l%m%n%o%p%q%r%s%t%u%v%w%x%y%z%[%\%]%^%_%`%a%b%c%d%e%f%g%h%i%j%k%l%m%n%o%p%q%r%s%t%u%v%w%x%y%z%{%|%}%~%%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%�%&&&&&&&&& & & & & &&&&&&&&&&&&&&&&&&& &!&"&#&$&%&&&'&(&)&*& &,&-&.&/&0&1&2&3&4&5&6&7&8&9&:&;&<&=&>&?&@&a&b&c&d&e&f&g&h&i&j&k&l&m&n&o&p&q&r&s&t&u&v&w&x&y&z&[&\&]&^&_&`&a&b&c&d&e&f&g&h&i&j&k&l&m&n&o&p&q&r&s&t&u&v&w&x&y&z&{&|&}&~&&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&�&''''''''' ' ' ' ' ''''''''''''''''''' '!'"'#'$'%'&'''(')'*' ','-'.'/'0'1'2'3'4'5'6'7'8'9':';'<'='>'?'@'a'b'c'd'e'f'g'h'i'j'k'l'm'n'o'p'q'r's't'u'v'w'x'y'z'['\']'^'_'`'a'b'c'd'e'f'g'h'i'j'k'l'm'n'o'p'q'r's't'u'v'w'x'y'z'{'|'}'~''�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'�'((((((((( ( ( ( ( ((((((((((((((((((( (!("(#($(%(&('((()(*( (,(-(.(/(0(1(2(3(4(5(6(7(8(9(:(;(<(=(>(?(@(a(b(c(d(e(f(g(h(i(j(k(l(m(n(o(p(q(r(s(t(u(v(w(x(y(z([(\(](^(_(`(a(b(c(d(e(f(g(h(i(j(k(l(m(n(o(p(q(r(s(t(u(v(w(x(y(z({(|(}(~((�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�(�())))))))) ) ) ) ) ))))))))))))))))))) )!)")#)$)%)&)')()))*) ),)-).)/)0)1)2)3)4)5)6)7)8)9):);)<)=)>)?)@)a)b)c)d)e)f)g)h)i)j)k)l)m)n)o)p)q)r)s)t)u)v)w)x)y)z)[)\)])^)_)`)a)b)c)d)e)f)g)h)i)j)k)l)m)n)o)p)q)r)s)t)u)v)w)x)y)z){)|)})~))�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)�)********* * * * * ******************* *!*"*#*$*%*&*'*(*)*** *,*-*.*/*0*1*2*3*4*5*6*7*8*9*:*;*<*=*>*?*@*a*b*c*d*e*f*g*h*i*j*k*l*m*n*o*p*q*r*s*t*u*v*w*x*y*z*[*\*]*^*_*`*a*b*c*d*e*f*g*h*i*j*k*l*m*n*o*p*q*r*s*t*u*v*w*x*y*z*{*|*}*~**�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*�*                           ! " # $ % & ' ( ) * , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ a b c d e f g h i j k l m n o p q r s t u v w x y z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~  � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � � ,,,,,,,,, , , , , ,,,,,,,,,,,,,,,,,,, ,!,",#,$,%,&,',(,),*, ,,,-,.,/,0,1,2,3,4,5,6,7,8,9,:,;,<,=,>,?,@,a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,[,\,],^,_,`,a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,{,|,},~,,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,�,--------- - - - - ------------------- -!-"-#-$-%-&-'-(-)-*- -,---.-/-0-1-2-3-4-5-6-7-8-9-:-;-<-=->-?-@-a-b-c-d-e-f-g-h-i-j-k-l-m-n-o-p-q-r-s-t-u-v-w-x-y-z-[-\-]-^-_-`-a-b-c-d-e-f-g-h-i-j-k-l-m-n-o-p-q-r-s-t-u-v-w-x-y-z-{-|-}-~--�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-�-......... . . . . ................... .!.".#.$.%.&.'.(.).*. .,.-.../.0.1.2.3.4.5.6.7.8.9.:.;.<.=.>.?.@.a.b.c.d.e.f.g.h.i.j.k.l.m.n.o.p.q.r.s.t.u.v.w.x.y.z.[.\.].^._.`.a.b.c.d.e.f.g.h.i.j.k.l.m.n.o.p.q.r.s.t.u.v.w.x.y.z.{.|.}.~..�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.�.///////// / / / / /////////////////// /!/"/#/$/%/&/'/(/)/*/ /,/-/.///0/1/2/3/4/5/6/7/8/9/:/;//?/@/a/b/c/d/e/f/g/h/i/j/k/l/m/n/o/p/q/r/s/t/u/v/w/x/y/z/[/\/]/^/_/`/a/b/c/d/e/�/����������������������������������������������������������������������������������������������������������������������������������������������������������������� ������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������������ �� ����������  ��  ��  ��  ��  �� �� u � � � � � � � � � �� u� �� u� ����������������������������������������������������������������������������������������������������������������������������������������������������������������������������